Query 041558
Match_columns 495
No_of_seqs 541 out of 4655
Neff 10.4
Searched_HMMs 46136
Date Fri Mar 29 08:23:38 2013
Command hhsearch -i /work/01045/syshi/csienesis_hhblits_a3m/041558.a3m -d /work/01045/syshi/HHdatabase/Cdd.hhm -o /work/01045/syshi/hhsearch_cdd/041558hhsearch_cdd -cpu 12 -v 0
No Hit Prob E-value P-value Score SS Cols Query HMM Template HMM
1 PLN00113 leucine-rich repeat r 100.0 2.9E-59 6.3E-64 510.4 35.2 489 1-495 190-767 (968)
2 PLN00113 leucine-rich repeat r 100.0 2.9E-48 6.2E-53 424.0 30.9 385 1-386 166-585 (968)
3 KOG4194 Membrane glycoprotein 100.0 4.1E-40 8.9E-45 309.1 3.1 343 3-362 82-428 (873)
4 KOG4194 Membrane glycoprotein 100.0 2.9E-38 6.3E-43 296.7 2.2 352 1-370 104-459 (873)
5 KOG0472 Leucine-rich repeat pr 100.0 1.8E-36 3.8E-41 272.9 -7.2 373 1-384 70-540 (565)
6 KOG0444 Cytoskeletal regulator 100.0 2.1E-34 4.6E-39 273.0 -4.5 352 2-362 10-374 (1255)
7 KOG0444 Cytoskeletal regulator 100.0 6.8E-34 1.5E-38 269.5 -5.3 363 20-390 4-380 (1255)
8 KOG0472 Leucine-rich repeat pr 100.0 2.5E-34 5.3E-39 259.1 -9.5 383 1-397 47-529 (565)
9 KOG0618 Serine/threonine phosp 100.0 6.8E-31 1.5E-35 259.8 -3.4 371 1-383 47-487 (1081)
10 KOG0618 Serine/threonine phosp 99.9 3.8E-28 8.2E-33 240.5 -4.8 346 1-361 70-487 (1081)
11 PLN03210 Resistant to P. syrin 99.9 2.9E-24 6.4E-29 235.6 24.0 334 15-362 550-905 (1153)
12 KOG4237 Extracellular matrix p 99.9 2.1E-27 4.6E-32 214.2 -3.5 264 2-266 70-358 (498)
13 PLN03210 Resistant to P. syrin 99.9 6.1E-24 1.3E-28 233.2 22.6 323 1-337 560-904 (1153)
14 PRK15387 E3 ubiquitin-protein 99.9 2.4E-22 5.2E-27 205.4 17.0 166 158-348 302-467 (788)
15 PRK15387 E3 ubiquitin-protein 99.9 5.8E-22 1.3E-26 202.6 17.4 264 3-325 205-468 (788)
16 KOG4237 Extracellular matrix p 99.9 9.2E-24 2E-28 190.8 -2.3 218 1-218 93-358 (498)
17 PRK15370 E3 ubiquitin-protein 99.8 7E-21 1.5E-25 195.9 10.4 220 3-267 182-401 (754)
18 PRK15370 E3 ubiquitin-protein 99.8 2.2E-20 4.8E-25 192.3 9.6 223 24-291 179-401 (754)
19 cd00116 LRR_RI Leucine-rich re 99.8 6.3E-21 1.4E-25 182.6 -2.8 281 51-362 2-319 (319)
20 cd00116 LRR_RI Leucine-rich re 99.8 7.4E-21 1.6E-25 182.1 -3.0 280 27-338 2-319 (319)
21 KOG0617 Ras suppressor protein 99.7 3.9E-19 8.5E-24 143.0 -2.5 166 178-349 29-195 (264)
22 KOG0617 Ras suppressor protein 99.7 4.4E-19 9.5E-24 142.7 -4.1 169 151-325 26-195 (264)
23 PLN03150 hypothetical protein; 99.5 2.8E-14 6E-19 146.8 12.4 117 279-396 419-538 (623)
24 PLN03150 hypothetical protein; 99.4 1.1E-12 2.4E-17 135.1 11.7 112 255-366 419-532 (623)
25 KOG0532 Leucine-rich repeat (L 99.3 2.5E-13 5.4E-18 129.4 -3.0 170 161-339 78-247 (722)
26 COG4886 Leucine-rich repeat (L 99.3 1.3E-11 2.9E-16 121.6 8.6 198 27-249 97-296 (394)
27 KOG0532 Leucine-rich repeat (L 99.3 1.5E-13 3.3E-18 130.8 -5.2 179 180-367 73-251 (722)
28 KOG1259 Nischarin, modulator o 99.2 8.6E-13 1.9E-17 116.1 -1.0 130 232-367 286-416 (490)
29 COG4886 Leucine-rich repeat (L 99.2 1E-11 2.2E-16 122.4 6.0 153 183-342 141-293 (394)
30 KOG1909 Ran GTPase-activating 99.2 7.1E-13 1.5E-17 119.2 -4.3 251 67-338 26-310 (382)
31 KOG4658 Apoptotic ATPase [Sign 99.2 1.8E-11 3.9E-16 128.9 5.3 122 2-126 526-649 (889)
32 KOG3207 Beta-tubulin folding c 99.2 4.6E-12 1E-16 117.2 0.1 205 158-362 121-338 (505)
33 PF14580 LRR_9: Leucine-rich r 99.1 3.6E-11 7.8E-16 101.6 4.3 81 22-107 18-100 (175)
34 KOG1909 Ran GTPase-activating 99.1 2.1E-12 4.4E-17 116.3 -4.0 248 89-364 24-312 (382)
35 PF14580 LRR_9: Leucine-rich r 99.1 7.1E-11 1.5E-15 99.8 4.6 121 231-356 20-146 (175)
36 KOG3207 Beta-tubulin folding c 99.1 1.1E-11 2.3E-16 114.9 -1.4 65 179-244 219-285 (505)
37 KOG1259 Nischarin, modulator o 99.0 3.9E-11 8.4E-16 105.9 0.8 134 178-317 280-414 (490)
38 PF13855 LRR_8: Leucine rich r 99.0 2E-10 4.4E-15 79.8 3.2 59 24-82 2-60 (61)
39 PF13855 LRR_8: Leucine rich r 98.9 6.1E-10 1.3E-14 77.3 3.5 61 47-107 1-61 (61)
40 KOG4658 Apoptotic ATPase [Sign 98.9 9E-10 2E-14 116.2 6.1 241 1-244 547-808 (889)
41 KOG0531 Protein phosphatase 1, 98.9 1.1E-10 2.4E-15 115.2 -0.9 241 69-362 70-317 (414)
42 KOG0531 Protein phosphatase 1, 98.9 3.4E-10 7.4E-15 111.7 -0.2 265 24-319 50-322 (414)
43 KOG1187 Serine/threonine prote 98.7 6.2E-09 1.3E-13 99.9 3.0 32 464-495 124-156 (361)
44 KOG1859 Leucine-rich repeat pr 98.6 2.6E-09 5.6E-14 105.3 -4.3 163 199-367 102-296 (1096)
45 KOG1859 Leucine-rich repeat pr 98.5 3.2E-09 7E-14 104.6 -5.0 157 175-338 102-291 (1096)
46 KOG2982 Uncharacterized conser 98.5 1.6E-08 3.5E-13 89.5 -0.9 39 70-108 70-110 (418)
47 KOG2120 SCF ubiquitin ligase, 98.4 6.4E-09 1.4E-13 92.1 -6.5 145 72-216 186-348 (419)
48 KOG2120 SCF ubiquitin ligase, 98.3 5.5E-09 1.2E-13 92.4 -7.8 177 24-216 186-373 (419)
49 COG5238 RNA1 Ran GTPase-activa 98.2 1.9E-08 4.2E-13 87.9 -6.2 86 21-107 28-132 (388)
50 KOG4579 Leucine-rich repeat (L 98.2 2.4E-08 5.2E-13 78.2 -6.0 82 254-338 53-135 (177)
51 KOG4579 Leucine-rich repeat (L 98.2 1.3E-07 2.9E-12 74.1 -2.0 125 255-383 28-156 (177)
52 COG5238 RNA1 Ran GTPase-activa 98.1 8.2E-08 1.8E-12 84.1 -5.4 252 68-340 27-317 (388)
53 KOG2982 Uncharacterized conser 98.0 1.2E-06 2.5E-11 78.0 0.6 18 474-491 399-416 (418)
54 KOG1094 Discoidin domain recep 98.0 4.7E-06 1E-10 80.9 4.5 32 464-495 588-619 (807)
55 PF12799 LRR_4: Leucine Rich r 97.9 4.2E-06 9.1E-11 53.0 1.7 35 24-59 2-36 (44)
56 PF12799 LRR_4: Leucine Rich r 97.9 1.2E-05 2.6E-10 50.9 2.8 36 303-339 2-37 (44)
57 KOG1644 U2-associated snRNP A' 97.8 2.9E-05 6.4E-10 65.4 4.5 104 255-360 43-150 (233)
58 KOG1644 U2-associated snRNP A' 97.8 2.8E-05 6E-10 65.6 4.3 84 23-108 42-126 (233)
59 PF13306 LRR_5: Leucine rich r 97.8 0.00012 2.6E-09 59.4 7.8 38 177-215 7-44 (129)
60 PF13306 LRR_5: Leucine rich r 97.7 0.00016 3.4E-09 58.7 8.1 126 198-329 4-129 (129)
61 KOG3665 ZYG-1-like serine/thre 97.7 4.2E-06 9.1E-11 86.6 -1.8 152 1-164 124-281 (699)
62 KOG1026 Nerve growth factor re 97.7 0.00012 2.6E-09 74.7 7.8 31 464-494 542-572 (774)
63 PRK15386 type III secretion pr 97.5 0.0002 4.3E-09 68.6 6.1 54 181-240 51-104 (426)
64 PRK15386 type III secretion pr 97.4 0.00055 1.2E-08 65.7 8.3 135 202-360 48-187 (426)
65 KOG0192 Tyrosine kinase specif 97.4 0.00011 2.4E-09 70.4 2.8 32 464-495 92-124 (362)
66 KOG2739 Leucine-rich acidic nu 97.2 0.00019 4.1E-09 63.3 2.0 93 15-109 35-130 (260)
67 KOG2739 Leucine-rich acidic nu 97.2 0.00021 4.5E-09 63.1 2.2 65 276-340 63-130 (260)
68 KOG3665 ZYG-1-like serine/thre 97.1 0.00019 4.1E-09 74.6 1.5 113 229-343 147-267 (699)
69 KOG0196 Tyrosine kinase, EPH ( 97.1 0.0011 2.3E-08 67.3 6.1 32 464-495 683-714 (996)
70 KOG0197 Tyrosine kinases [Sign 97.0 0.00048 1E-08 66.6 3.0 32 464-495 254-285 (468)
71 KOG2123 Uncharacterized conser 96.9 6.3E-05 1.4E-09 66.6 -3.4 87 22-112 18-105 (388)
72 KOG2123 Uncharacterized conser 96.7 7.4E-05 1.6E-09 66.2 -4.4 95 2-100 22-122 (388)
73 KOG1025 Epidermal growth facto 96.6 0.0004 8.8E-09 70.6 -0.5 30 464-494 751-780 (1177)
74 KOG4278 Protein tyrosine kinas 96.6 0.00046 9.9E-09 68.0 -0.2 32 464-495 316-347 (1157)
75 KOG4341 F-box protein containi 96.6 0.00012 2.6E-09 68.6 -4.3 14 228-241 318-331 (483)
76 cd05076 PTK_Tyk2_rpt1 Pseudoki 96.4 0.0024 5.1E-08 59.5 3.4 32 464-495 69-100 (274)
77 PF07714 Pkinase_Tyr: Protein 96.2 0.003 6.6E-08 58.2 2.6 32 464-495 54-85 (259)
78 KOG0600 Cdc2-related protein k 96.0 0.0045 9.8E-08 59.8 2.7 32 464-495 169-202 (560)
79 KOG0615 Serine/threonine prote 96.0 0.0049 1.1E-07 58.0 2.8 32 464-495 229-260 (475)
80 KOG1095 Protein tyrosine kinas 95.9 0.0044 9.6E-08 66.0 2.4 32 464-495 748-779 (1025)
81 PF00560 LRR_1: Leucine Rich R 95.8 0.0037 8E-08 32.8 0.7 12 73-84 2-13 (22)
82 PF00560 LRR_1: Leucine Rich R 95.7 0.0032 7E-08 33.0 0.3 12 25-36 2-13 (22)
83 KOG0595 Serine/threonine-prote 95.6 0.011 2.3E-07 55.7 3.2 31 464-494 62-92 (429)
84 cd05064 PTKc_EphR_A10 Catalyti 95.4 0.011 2.4E-07 54.7 3.0 32 464-495 59-90 (266)
85 cd05105 PTKc_PDGFR_alpha Catal 95.4 0.01 2.2E-07 58.5 2.8 32 464-495 93-125 (400)
86 KOG0194 Protein tyrosine kinas 95.4 0.011 2.3E-07 58.3 2.7 32 464-495 214-245 (474)
87 PTZ00267 NIMA-related protein 95.4 0.014 3E-07 59.2 3.6 32 464-495 118-149 (478)
88 PHA02988 hypothetical protein; 95.4 0.013 2.8E-07 54.8 3.2 32 464-495 71-106 (283)
89 cd05087 PTKc_Aatyk1_Aatyk3 Cat 95.3 0.011 2.4E-07 54.7 2.6 32 464-495 48-79 (269)
90 KOG4308 LRR-containing protein 95.3 0.00013 2.9E-09 72.4 -10.9 83 160-242 89-184 (478)
91 KOG4341 F-box protein containi 95.3 0.00064 1.4E-08 63.9 -5.7 263 1-266 140-438 (483)
92 cd05077 PTK_Jak1_rpt1 Pseudoki 95.2 0.014 3E-07 53.9 2.7 32 464-495 57-88 (262)
93 cd05096 PTKc_DDR1 Catalytic do 94.8 0.023 5E-07 53.7 3.3 32 464-495 72-103 (304)
94 cd06650 PKc_MEK1 Catalytic dom 94.8 0.022 4.8E-07 54.7 3.1 32 464-495 56-87 (333)
95 KOG1947 Leucine rich repeat pr 94.8 0.0023 5E-08 64.9 -4.0 64 179-242 240-307 (482)
96 cd05104 PTKc_Kit Catalytic dom 94.7 0.015 3.3E-07 56.9 1.8 32 464-495 91-123 (375)
97 cd05086 PTKc_Aatyk2 Catalytic 94.7 0.02 4.3E-07 53.1 2.4 32 464-495 48-79 (268)
98 PTZ00426 cAMP-dependent protei 94.6 0.027 5.8E-07 54.3 3.2 32 464-495 84-115 (340)
99 KOG1947 Leucine rich repeat pr 94.6 0.0047 1E-07 62.7 -2.3 85 22-106 187-280 (482)
100 cd06620 PKc_MAPKK_Byr1_like Ca 94.6 0.027 5.8E-07 52.7 3.0 32 464-495 56-87 (284)
101 cd06624 STKc_ASK Catalytic dom 94.6 0.026 5.7E-07 52.2 2.9 32 464-495 58-89 (268)
102 cd08227 PK_STRAD_alpha Pseudok 94.6 0.032 6.9E-07 53.4 3.5 32 464-495 52-83 (327)
103 KOG4308 LRR-containing protein 94.5 9.6E-05 2.1E-09 73.4 -14.1 38 278-315 262-303 (478)
104 cd06615 PKc_MEK Catalytic doma 94.5 0.03 6.6E-07 53.1 3.2 32 464-495 52-83 (308)
105 cd05097 PTKc_DDR_like Catalyti 94.4 0.026 5.7E-07 53.1 2.5 32 464-495 70-101 (295)
106 cd05066 PTKc_EphR_A Catalytic 94.3 0.031 6.7E-07 51.7 2.8 32 464-495 58-89 (267)
107 cd06649 PKc_MEK2 Catalytic dom 94.2 0.037 8.1E-07 53.1 3.2 32 464-495 56-87 (331)
108 cd05114 PTKc_Tec_Rlk Catalytic 94.1 0.035 7.6E-07 50.9 2.8 32 464-495 52-83 (256)
109 cd05582 STKc_RSK_N N-terminal 94.1 0.04 8.7E-07 52.5 3.2 32 464-495 51-82 (318)
110 cd05094 PTKc_TrkC Catalytic do 94.1 0.038 8.3E-07 51.8 3.0 32 464-495 60-91 (291)
111 cd05044 PTKc_c-ros Catalytic d 94.0 0.035 7.6E-07 51.3 2.6 32 464-495 52-83 (269)
112 cd08221 STKc_Nek9 Catalytic do 94.0 0.047 1E-06 50.0 3.3 32 464-495 52-83 (256)
113 cd06607 STKc_TAO Catalytic dom 93.9 0.042 9E-07 52.0 2.7 32 464-495 68-99 (307)
114 cd05042 PTKc_Aatyk Catalytic d 93.8 0.042 9.1E-07 50.8 2.6 32 464-495 48-79 (269)
115 cd05107 PTKc_PDGFR_beta Cataly 93.8 0.042 9.2E-07 54.2 2.7 32 464-495 93-125 (401)
116 cd08529 STKc_FA2-like Catalyti 93.8 0.04 8.7E-07 50.4 2.5 32 464-495 52-83 (256)
117 cd05113 PTKc_Btk_Bmx Catalytic 93.7 0.05 1.1E-06 49.9 2.9 31 464-494 52-82 (256)
118 cd06641 STKc_MST3 Catalytic do 93.7 0.062 1.4E-06 49.9 3.5 32 464-495 55-86 (277)
119 cd07836 STKc_Pho85 Catalytic d 93.7 0.048 1E-06 50.8 2.8 32 464-495 51-82 (284)
120 cd05093 PTKc_TrkB Catalytic do 93.7 0.049 1.1E-06 51.0 2.8 32 464-495 60-91 (288)
121 KOG0473 Leucine-rich repeat pr 93.6 0.0028 6E-08 55.0 -5.0 90 17-109 36-125 (326)
122 cd05037 PTK_Jak_rpt1 Pseudokin 93.6 0.043 9.3E-07 50.3 2.3 31 464-495 54-84 (259)
123 cd06642 STKc_STK25-YSK1 Cataly 93.6 0.029 6.2E-07 52.2 1.1 32 464-495 55-86 (277)
124 cd05090 PTKc_Ror1 Catalytic do 93.6 0.058 1.2E-06 50.3 3.2 31 464-494 60-90 (283)
125 cd05589 STKc_PKN Catalytic dom 93.6 0.063 1.4E-06 51.3 3.4 32 464-495 55-86 (324)
126 cd06621 PKc_MAPKK_Pek1_like Ca 93.5 0.06 1.3E-06 50.4 3.2 32 464-495 52-85 (287)
127 cd06631 STKc_YSK4 Catalytic do 93.5 0.06 1.3E-06 49.6 3.1 32 464-495 55-86 (265)
128 cd06640 STKc_MST4 Catalytic do 93.5 0.07 1.5E-06 49.6 3.5 32 464-495 55-86 (277)
129 cd06619 PKc_MKK5 Catalytic dom 93.5 0.069 1.5E-06 49.7 3.5 32 464-495 52-83 (279)
130 cd05050 PTKc_Musk Catalytic do 93.5 0.047 1E-06 51.1 2.4 32 464-495 61-92 (288)
131 cd05062 PTKc_IGF-1R Catalytic 93.5 0.058 1.3E-06 50.1 2.9 32 464-495 62-93 (277)
132 cd05603 STKc_SGK2 Catalytic do 93.4 0.062 1.3E-06 51.3 3.1 32 464-495 49-80 (321)
133 cd06632 STKc_MEKK1_plant Catal 93.4 0.054 1.2E-06 49.6 2.6 32 464-495 55-86 (258)
134 cd07847 STKc_CDKL1_4 Catalytic 93.4 0.065 1.4E-06 50.0 3.2 32 464-495 53-84 (286)
135 cd06654 STKc_PAK1 Catalytic do 93.4 0.072 1.6E-06 50.1 3.5 32 464-495 70-101 (296)
136 cd07872 STKc_PCTAIRE2 Catalyti 93.4 0.064 1.4E-06 50.8 3.1 32 464-495 57-88 (309)
137 cd05595 STKc_PKB_beta Catalyti 93.4 0.062 1.3E-06 51.3 3.0 32 464-495 48-79 (323)
138 cd05626 STKc_LATS2 Catalytic d 93.4 0.067 1.5E-06 52.5 3.3 32 464-495 54-85 (381)
139 cd05063 PTKc_EphR_A2 Catalytic 93.3 0.066 1.4E-06 49.4 3.1 32 464-495 59-90 (268)
140 cd05078 PTK_Jak2_Jak3_rpt1 Pse 93.3 0.054 1.2E-06 49.7 2.5 32 464-495 52-83 (258)
141 cd06656 STKc_PAK3 Catalytic do 93.3 0.071 1.5E-06 50.2 3.3 32 464-495 69-100 (297)
142 cd05629 STKc_NDR_like_fungal C 93.3 0.068 1.5E-06 52.3 3.2 32 464-495 54-85 (377)
143 cd05085 PTKc_Fer Catalytic dom 93.3 0.064 1.4E-06 48.9 2.8 32 464-495 45-76 (250)
144 cd06635 STKc_TAO1 Catalytic do 93.2 0.077 1.7E-06 50.5 3.4 31 464-494 78-108 (317)
145 cd05045 PTKc_RET Catalytic dom 93.2 0.066 1.4E-06 50.2 2.9 32 464-495 56-87 (290)
146 cd08528 STKc_Nek10 Catalytic d 93.2 0.087 1.9E-06 48.6 3.7 30 466-495 64-93 (269)
147 KOG0658 Glycogen synthase kina 93.2 0.023 5E-07 52.8 -0.2 32 464-495 70-106 (364)
148 cd05584 STKc_p70S6K Catalytic 93.2 0.064 1.4E-06 51.2 2.8 32 464-495 53-84 (323)
149 PLN00034 mitogen-activated pro 93.2 0.063 1.4E-06 52.0 2.7 32 464-495 125-156 (353)
150 cd05585 STKc_YPK1_like Catalyt 93.2 0.073 1.6E-06 50.6 3.1 32 464-495 46-77 (312)
151 cd06625 STKc_MEKK3_like Cataly 93.1 0.077 1.7E-06 48.7 3.2 32 464-495 57-88 (263)
152 cd05106 PTKc_CSF-1R Catalytic 93.1 0.05 1.1E-06 53.2 2.0 32 464-495 94-126 (374)
153 cd07844 STKc_PCTAIRE_like Cata 93.1 0.082 1.8E-06 49.5 3.3 32 464-495 56-87 (291)
154 cd06629 STKc_MAPKKK_Bck1_like 93.1 0.07 1.5E-06 49.4 2.8 32 464-495 61-92 (272)
155 cd05084 PTKc_Fes Catalytic dom 93.1 0.066 1.4E-06 48.9 2.6 32 464-495 46-77 (252)
156 cd05600 STKc_Sid2p_Dbf2p Catal 93.0 0.079 1.7E-06 50.8 3.2 32 464-495 54-85 (333)
157 cd06655 STKc_PAK2 Catalytic do 93.0 0.078 1.7E-06 49.9 3.1 32 464-495 69-100 (296)
158 PTZ00263 protein kinase A cata 93.0 0.077 1.7E-06 50.8 3.1 32 464-495 71-102 (329)
159 cd05061 PTKc_InsR Catalytic do 93.0 0.071 1.5E-06 49.9 2.8 32 464-495 62-93 (288)
160 cd05052 PTKc_Abl Catalytic dom 93.0 0.058 1.3E-06 49.7 2.1 32 464-495 55-86 (263)
161 cd06628 STKc_MAPKKK_Byr2_like 93.0 0.078 1.7E-06 48.9 3.0 32 464-495 59-90 (267)
162 cd07842 STKc_CDK8_like Catalyt 92.9 0.076 1.6E-06 50.4 2.9 32 464-495 55-88 (316)
163 cd05605 STKc_GRK4_like Catalyt 92.9 0.073 1.6E-06 49.8 2.7 32 464-495 53-84 (285)
164 cd05072 PTKc_Lyn Catalytic dom 92.9 0.073 1.6E-06 48.9 2.7 32 464-495 54-85 (261)
165 cd06611 STKc_SLK_like Catalyti 92.9 0.088 1.9E-06 49.0 3.2 32 464-495 55-86 (280)
166 cd05625 STKc_LATS1 Catalytic d 92.9 0.085 1.9E-06 51.7 3.3 32 464-495 54-85 (382)
167 KOG4721 Serine/threonine prote 92.9 0.076 1.6E-06 52.5 2.7 31 464-494 165-195 (904)
168 cd07869 STKc_PFTAIRE1 Catalyti 92.9 0.086 1.9E-06 49.8 3.1 31 464-494 56-86 (303)
169 cd05055 PTKc_PDGFR Catalytic d 92.8 0.079 1.7E-06 50.0 2.8 31 464-494 91-122 (302)
170 cd08218 STKc_Nek1 Catalytic do 92.8 0.086 1.9E-06 48.2 3.0 32 464-495 52-83 (256)
171 cd05571 STKc_PKB Catalytic dom 92.8 0.087 1.9E-06 50.3 3.2 32 464-495 48-79 (323)
172 cd06630 STKc_MEKK1 Catalytic d 92.8 0.056 1.2E-06 49.8 1.7 31 464-494 56-86 (268)
173 cd05036 PTKc_ALK_LTK Catalytic 92.8 0.083 1.8E-06 49.1 2.9 32 464-495 62-93 (277)
174 cd07873 STKc_PCTAIRE1 Catalyti 92.7 0.086 1.9E-06 49.7 3.0 31 464-494 57-87 (301)
175 cd05608 STKc_GRK1 Catalytic do 92.7 0.092 2E-06 48.9 3.1 32 464-495 46-77 (280)
176 cd05593 STKc_PKB_gamma Catalyt 92.7 0.096 2.1E-06 50.2 3.2 32 464-495 48-79 (328)
177 cd05047 PTKc_Tie Catalytic dom 92.7 0.083 1.8E-06 48.9 2.7 32 464-495 48-80 (270)
178 cd07848 STKc_CDKL5 Catalytic d 92.6 0.056 1.2E-06 50.5 1.5 32 464-495 53-84 (287)
179 cd06643 STKc_SLK Catalytic dom 92.6 0.1 2.2E-06 48.6 3.2 32 464-495 55-86 (282)
180 cd07860 STKc_CDK2_3 Catalytic 92.6 0.046 9.9E-07 51.0 0.8 31 464-494 52-82 (284)
181 cd05148 PTKc_Srm_Brk Catalytic 92.5 0.082 1.8E-06 48.5 2.5 32 464-495 55-86 (261)
182 cd08225 STKc_Nek5 Catalytic do 92.5 0.057 1.2E-06 49.4 1.4 32 464-495 52-83 (257)
183 cd05604 STKc_SGK3 Catalytic do 92.5 0.1 2.3E-06 49.8 3.3 32 464-495 49-80 (325)
184 cd05596 STKc_ROCK Catalytic do 92.5 0.11 2.3E-06 50.8 3.3 32 464-495 96-127 (370)
185 cd07871 STKc_PCTAIRE3 Catalyti 92.5 0.1 2.3E-06 48.8 3.1 32 464-495 56-87 (288)
186 PLN00009 cyclin-dependent kina 92.5 0.1 2.2E-06 49.0 3.0 31 464-494 54-84 (294)
187 cd05092 PTKc_TrkA Catalytic do 92.4 0.11 2.4E-06 48.4 3.1 32 464-495 60-91 (280)
188 cd05033 PTKc_EphR Catalytic do 92.4 0.1 2.2E-06 48.2 2.9 32 464-495 58-89 (266)
189 KOG0473 Leucine-rich repeat pr 92.3 0.0046 1E-07 53.7 -5.5 87 226-315 38-124 (326)
190 cd05046 PTK_CCK4 Pseudokinase 92.3 0.088 1.9E-06 48.8 2.4 31 464-494 61-91 (275)
191 KOG0593 Predicted protein kina 92.3 0.026 5.6E-07 51.2 -1.1 44 451-494 27-84 (396)
192 cd05572 STKc_cGK_PKG Catalytic 92.3 0.095 2.1E-06 48.2 2.6 32 464-495 46-77 (262)
193 cd05607 STKc_GRK7 Catalytic do 92.2 0.13 2.8E-06 47.9 3.4 32 464-495 46-77 (277)
194 cd05048 PTKc_Ror Catalytic Dom 92.2 0.11 2.3E-06 48.5 2.8 32 464-495 61-92 (283)
195 cd06646 STKc_MAP4K5 Catalytic 92.2 0.13 2.8E-06 47.4 3.3 32 464-495 59-90 (267)
196 cd05039 PTKc_Csk_like Catalyti 92.2 0.1 2.2E-06 47.8 2.6 32 464-495 53-84 (256)
197 cd05115 PTKc_Zap-70 Catalytic 92.2 0.12 2.5E-06 47.5 3.0 31 464-495 48-78 (257)
198 cd05081 PTKc_Jak2_Jak3_rpt2 Ca 92.2 0.11 2.4E-06 48.4 2.9 32 464-495 58-91 (284)
199 cd06647 STKc_PAK_I Catalytic d 92.2 0.087 1.9E-06 49.5 2.2 32 464-495 69-100 (293)
200 cd08219 STKc_Nek3 Catalytic do 92.2 0.13 2.9E-06 47.0 3.4 32 464-495 51-82 (255)
201 cd05059 PTKc_Tec_like Catalyti 92.2 0.12 2.6E-06 47.4 3.0 32 464-495 52-83 (256)
202 cd05594 STKc_PKB_alpha Catalyt 92.1 0.12 2.7E-06 49.3 3.2 32 464-495 48-79 (325)
203 cd05609 STKc_MAST Catalytic do 92.1 0.13 2.9E-06 48.5 3.4 32 464-495 54-85 (305)
204 KOG3653 Transforming growth fa 92.1 0.45 9.8E-06 46.2 6.7 32 464-495 257-292 (534)
205 cd05065 PTKc_EphR_B Catalytic 92.0 0.11 2.4E-06 48.0 2.7 32 464-495 58-89 (269)
206 PF13504 LRR_7: Leucine rich r 91.9 0.087 1.9E-06 25.5 1.0 12 327-338 2-13 (17)
207 cd05095 PTKc_DDR2 Catalytic do 91.9 0.12 2.7E-06 48.5 2.9 32 464-495 72-103 (296)
208 cd05088 PTKc_Tie2 Catalytic do 91.9 0.1 2.2E-06 49.3 2.3 32 464-495 60-92 (303)
209 KOG0663 Protein kinase PITSLRE 91.9 0.083 1.8E-06 48.8 1.5 42 453-494 117-160 (419)
210 cd05599 STKc_NDR_like Catalyti 91.8 0.13 2.9E-06 49.9 3.1 32 464-495 54-85 (364)
211 cd07846 STKc_CDKL2_3 Catalytic 91.8 0.051 1.1E-06 50.7 0.2 32 464-495 53-84 (286)
212 cd05102 PTKc_VEGFR3 Catalytic 91.8 0.11 2.4E-06 49.9 2.5 32 464-495 63-96 (338)
213 cd05621 STKc_ROCK2 Catalytic d 91.8 0.15 3.3E-06 49.7 3.4 32 464-495 96-127 (370)
214 PHA03211 serine/threonine kina 91.7 0.14 3E-06 51.4 3.2 31 464-494 213-243 (461)
215 cd08222 STKc_Nek11 Catalytic d 91.7 0.035 7.7E-07 51.0 -1.0 32 464-495 55-86 (260)
216 cd06633 STKc_TAO3 Catalytic do 91.6 0.16 3.4E-06 48.3 3.3 31 464-494 74-104 (313)
217 cd05049 PTKc_Trk Catalytic dom 91.6 0.12 2.6E-06 48.0 2.4 32 464-495 61-92 (280)
218 cd07870 STKc_PFTAIRE2 Catalyti 91.6 0.16 3.5E-06 47.5 3.3 31 464-494 56-86 (291)
219 cd05068 PTKc_Frk_like Catalyti 91.6 0.12 2.6E-06 47.5 2.4 31 464-494 54-84 (261)
220 KOG0033 Ca2+/calmodulin-depend 91.6 0.08 1.7E-06 46.7 1.0 32 464-495 63-94 (355)
221 cd05612 STKc_PRKX_like Catalyt 91.5 0.062 1.3E-06 50.4 0.4 32 464-495 54-85 (291)
222 cd07843 STKc_CDC2L1 Catalytic 91.5 0.15 3.3E-06 47.8 3.0 31 464-494 57-89 (293)
223 cd06617 PKc_MKK3_6 Catalytic d 91.5 0.13 2.9E-06 47.8 2.6 32 464-495 53-84 (283)
224 cd05618 STKc_aPKC_iota Catalyt 91.4 0.19 4E-06 48.2 3.6 28 468-495 53-80 (329)
225 cd07861 STKc_CDK1_euk Catalyti 91.4 0.16 3.6E-06 47.2 3.1 31 464-494 52-82 (285)
226 cd05631 STKc_GRK4 Catalytic do 91.4 0.17 3.6E-06 47.3 3.1 32 464-495 53-84 (285)
227 cd05575 STKc_SGK Catalytic dom 91.4 0.17 3.7E-06 48.3 3.3 32 464-495 49-80 (323)
228 cd05051 PTKc_DDR Catalytic dom 91.3 0.15 3.3E-06 47.8 2.9 32 464-495 72-103 (296)
229 cd05100 PTKc_FGFR3 Catalytic d 91.3 0.14 2.9E-06 49.2 2.5 32 464-495 70-102 (334)
230 cd05098 PTKc_FGFR1 Catalytic d 91.3 0.16 3.5E-06 48.0 3.0 32 464-495 76-108 (307)
231 cd05057 PTKc_EGFR_like Catalyt 91.3 0.16 3.4E-06 47.3 2.9 30 464-494 62-91 (279)
232 cd05580 STKc_PKA Catalytic dom 91.3 0.16 3.5E-06 47.5 3.0 32 464-495 54-85 (290)
233 cd06609 STKc_MST3_like Catalyt 91.2 0.18 3.8E-06 46.7 3.1 32 464-495 52-83 (274)
234 cd05598 STKc_LATS Catalytic do 91.2 0.18 3.8E-06 49.4 3.3 32 464-495 54-85 (376)
235 cd05032 PTKc_InsR_like Catalyt 91.2 0.15 3.3E-06 47.2 2.6 31 464-494 62-92 (277)
236 cd06634 STKc_TAO2 Catalytic do 91.2 0.17 3.6E-06 47.9 3.0 31 464-494 68-98 (308)
237 cd06659 STKc_PAK6 Catalytic do 91.2 0.098 2.1E-06 49.3 1.4 32 464-495 71-102 (297)
238 cd06613 STKc_MAP4K3_like Catal 91.1 0.19 4.1E-06 46.1 3.2 31 464-494 53-83 (262)
239 cd07833 STKc_CDKL Catalytic do 91.1 0.14 3.1E-06 47.7 2.4 32 464-495 53-84 (288)
240 cd05577 STKc_GRK Catalytic dom 91.1 0.19 4.1E-06 46.6 3.2 32 464-495 46-77 (277)
241 cd06626 STKc_MEKK4 Catalytic d 91.0 0.16 3.4E-06 46.6 2.6 32 464-495 52-83 (264)
242 cd07841 STKc_CDK7 Catalytic do 91.0 0.12 2.7E-06 48.5 1.9 30 464-493 55-84 (298)
243 cd08228 STKc_Nek6 Catalytic do 91.0 0.19 4.1E-06 46.3 3.1 32 464-495 55-86 (267)
244 cd07864 STKc_CDK12 Catalytic d 91.0 0.14 2.9E-06 48.3 2.2 32 464-495 59-100 (302)
245 KOG0580 Serine/threonine prote 91.0 0.11 2.3E-06 45.7 1.3 32 464-495 75-106 (281)
246 cd07835 STKc_CDK1_like Catalyt 90.9 0.1 2.3E-06 48.5 1.3 31 464-494 51-81 (283)
247 cd06612 STKc_MST1_2 Catalytic 90.9 0.18 3.9E-06 46.0 2.9 32 464-495 51-82 (256)
248 PTZ00024 cyclin-dependent prot 90.9 0.18 3.9E-06 48.4 2.9 32 464-495 73-104 (335)
249 cd05116 PTKc_Syk Catalytic dom 90.9 0.17 3.6E-06 46.4 2.6 31 464-495 49-79 (257)
250 cd05602 STKc_SGK1 Catalytic do 90.9 0.2 4.3E-06 47.9 3.1 32 464-495 49-80 (325)
251 cd05578 STKc_Yank1 Catalytic d 90.8 0.07 1.5E-06 48.9 -0.0 32 464-495 53-84 (258)
252 cd05588 STKc_aPKC Catalytic do 90.8 0.19 4.1E-06 48.1 3.0 32 464-495 48-80 (329)
253 cd06623 PKc_MAPKK_plant_like C 90.8 0.2 4.3E-06 45.9 3.0 31 464-494 52-82 (264)
254 smart00370 LRR Leucine-rich re 90.8 0.26 5.6E-06 26.8 2.3 15 303-317 3-17 (26)
255 smart00369 LRR_TYP Leucine-ric 90.8 0.26 5.6E-06 26.8 2.3 15 303-317 3-17 (26)
256 cd05099 PTKc_FGFR4 Catalytic d 90.8 0.19 4.1E-06 47.7 2.9 32 464-495 70-102 (314)
257 cd05101 PTKc_FGFR2 Catalytic d 90.7 0.17 3.7E-06 47.7 2.5 32 464-495 73-105 (304)
258 cd08216 PK_STRAD Pseudokinase 90.7 0.12 2.7E-06 48.9 1.6 31 464-494 52-82 (314)
259 cd05108 PTKc_EGFR Catalytic do 90.6 0.16 3.4E-06 48.3 2.2 31 464-495 62-92 (316)
260 cd05041 PTKc_Fes_like Catalyti 90.6 0.23 4.9E-06 45.3 3.1 31 464-494 45-75 (251)
261 smart00369 LRR_TYP Leucine-ric 90.5 0.22 4.7E-06 27.1 1.8 16 71-86 2-17 (26)
262 smart00370 LRR Leucine-rich re 90.5 0.22 4.7E-06 27.1 1.8 16 71-86 2-17 (26)
263 cd06644 STKc_STK10_LOK Catalyt 90.5 0.24 5.1E-06 46.4 3.3 32 464-495 62-93 (292)
264 cd08226 PK_STRAD_beta Pseudoki 90.5 0.2 4.3E-06 48.0 2.8 31 464-494 52-82 (328)
265 cd08229 STKc_Nek7 Catalytic do 90.5 0.15 3.2E-06 47.0 1.8 32 464-495 55-86 (267)
266 cd05089 PTKc_Tie1 Catalytic do 90.5 0.15 3.4E-06 47.9 2.0 32 464-495 55-87 (297)
267 cd06658 STKc_PAK5 Catalytic do 90.5 0.095 2.1E-06 49.2 0.6 32 464-495 72-103 (292)
268 KOG0585 Ca2+/calmodulin-depend 90.5 0.19 4.1E-06 48.7 2.5 31 464-494 161-193 (576)
269 cd05091 PTKc_Ror2 Catalytic do 90.4 0.21 4.6E-06 46.4 2.9 31 464-494 61-91 (283)
270 cd05111 PTK_HER3 Pseudokinase 90.4 0.21 4.6E-06 46.4 2.9 31 464-495 62-92 (279)
271 cd07840 STKc_CDK9_like Catalyt 90.3 0.18 4E-06 46.9 2.4 32 464-495 51-84 (287)
272 cd06638 STKc_myosinIIIA Cataly 90.3 0.18 3.9E-06 47.0 2.3 32 464-495 67-104 (286)
273 cd06648 STKc_PAK_II Catalytic 90.2 0.23 5E-06 46.3 3.0 32 464-495 69-100 (285)
274 cd06645 STKc_MAP4K3 Catalytic 90.2 0.27 5.9E-06 45.2 3.4 32 464-495 59-90 (267)
275 cd05622 STKc_ROCK1 Catalytic d 90.2 0.25 5.4E-06 48.2 3.3 32 464-495 96-127 (371)
276 cd06614 STKc_PAK Catalytic dom 90.2 0.28 6E-06 45.8 3.5 31 464-494 68-98 (286)
277 KOG0659 Cdk activating kinase 90.2 0.088 1.9E-06 47.0 0.1 31 464-494 54-84 (318)
278 cd05043 PTK_Ryk Pseudokinase d 90.2 0.22 4.7E-06 46.3 2.7 31 464-494 61-92 (280)
279 cd05601 STKc_CRIK Catalytic do 90.2 0.23 4.9E-06 47.6 2.9 32 464-495 54-85 (330)
280 cd06622 PKc_MAPKK_PBS2_like Ca 90.2 0.11 2.3E-06 48.6 0.6 32 464-495 52-83 (286)
281 cd05040 PTKc_Ack_like Catalyti 90.2 0.22 4.8E-06 45.5 2.7 30 464-494 49-78 (257)
282 cd05058 PTKc_Met_Ron Catalytic 90.2 0.24 5.2E-06 45.4 3.0 32 464-495 49-81 (262)
283 PHA03212 serine/threonine kina 90.1 0.24 5.2E-06 48.7 3.1 31 464-494 136-166 (391)
284 cd05628 STKc_NDR1 Catalytic do 90.1 0.25 5.4E-06 48.1 3.2 32 464-495 54-85 (363)
285 cd05034 PTKc_Src_like Catalyti 90.1 0.24 5.2E-06 45.4 2.9 32 464-495 54-85 (261)
286 cd06657 STKc_PAK4 Catalytic do 90.1 0.21 4.5E-06 46.9 2.5 32 464-495 70-101 (292)
287 cd06917 STKc_NAK1_like Catalyt 90.0 0.25 5.4E-06 45.8 3.0 32 464-495 52-86 (277)
288 cd05611 STKc_Rim15_like Cataly 89.9 0.28 6.2E-06 44.9 3.3 31 465-495 51-81 (260)
289 cd05079 PTKc_Jak1_rpt2 Catalyt 89.9 0.24 5.2E-06 46.2 2.8 32 464-495 59-92 (284)
290 cd05035 PTKc_Axl_like Catalyti 89.9 0.22 4.7E-06 46.0 2.5 32 464-495 54-91 (273)
291 cd05630 STKc_GRK6 Catalytic do 89.8 0.29 6.2E-06 45.7 3.2 32 464-495 53-84 (285)
292 cd07859 STKc_TDY_MAPK_plant Ca 89.8 0.22 4.8E-06 47.8 2.5 32 464-495 52-88 (338)
293 cd05579 STKc_MAST_like Catalyt 89.7 0.12 2.5E-06 47.5 0.5 32 464-495 46-77 (265)
294 cd08224 STKc_Nek6_Nek7 Catalyt 89.7 0.26 5.7E-06 45.3 2.8 32 464-495 55-86 (267)
295 cd05080 PTKc_Tyk2_rpt2 Catalyt 89.7 0.31 6.7E-06 45.4 3.3 32 464-495 59-92 (283)
296 PHA03209 serine/threonine kina 89.7 0.2 4.3E-06 48.6 2.1 31 464-494 110-140 (357)
297 PRK13184 pknD serine/threonine 89.7 0.28 6E-06 52.9 3.3 32 464-495 55-86 (932)
298 cd05053 PTKc_FGFR Catalytic do 89.6 0.26 5.7E-06 46.1 2.8 32 464-495 68-100 (293)
299 cd05597 STKc_DMPK_like Catalyt 89.6 0.28 6.1E-06 47.0 3.1 32 464-495 54-85 (331)
300 cd05624 STKc_MRCK_beta Catalyt 89.3 0.35 7.5E-06 46.4 3.4 32 464-495 54-85 (331)
301 cd05075 PTKc_Axl Catalytic dom 89.3 0.26 5.7E-06 45.5 2.5 32 464-495 53-90 (272)
302 cd05623 STKc_MRCK_alpha Cataly 89.2 0.36 7.8E-06 46.2 3.5 32 464-495 54-85 (332)
303 cd07865 STKc_CDK9 Catalytic do 89.1 0.27 5.9E-06 46.4 2.6 31 464-494 64-102 (310)
304 cd05110 PTKc_HER4 Catalytic do 89.1 0.24 5.2E-06 46.7 2.1 31 464-495 62-92 (303)
305 cd05627 STKc_NDR2 Catalytic do 89.0 0.36 7.9E-06 46.8 3.4 32 464-495 54-85 (360)
306 cd05619 STKc_nPKC_theta Cataly 88.9 0.42 9.2E-06 45.4 3.7 28 468-495 53-80 (316)
307 cd05632 STKc_GRK5 Catalytic do 88.9 0.35 7.5E-06 45.1 3.1 32 464-495 53-84 (285)
308 cd08220 STKc_Nek8 Catalytic do 88.9 0.31 6.6E-06 44.5 2.7 32 464-495 52-83 (256)
309 cd07867 STKc_CDC2L6 Catalytic 88.8 0.33 7.1E-06 46.1 2.9 32 464-495 51-84 (317)
310 cd05112 PTKc_Itk Catalytic dom 88.8 0.35 7.5E-06 44.2 3.0 32 464-495 52-83 (256)
311 cd05082 PTKc_Csk Catalytic dom 88.3 0.42 9.1E-06 43.7 3.1 32 464-495 52-84 (256)
312 cd06627 STKc_Cdc7_like Catalyt 88.2 0.46 1E-05 43.1 3.4 32 464-495 52-83 (254)
313 cd06637 STKc_TNIK Catalytic do 88.1 0.43 9.4E-06 44.0 3.1 32 464-495 55-93 (272)
314 PF13516 LRR_6: Leucine Rich r 88.0 0.14 3.1E-06 27.3 -0.1 13 72-84 3-15 (24)
315 KOG0581 Mitogen-activated prot 88.0 0.43 9.4E-06 44.7 2.9 31 464-494 130-161 (364)
316 cd05069 PTKc_Yes Catalytic dom 87.9 0.4 8.8E-06 43.9 2.7 31 464-495 54-84 (260)
317 KOG0575 Polo-like serine/threo 87.8 0.63 1.4E-05 46.6 4.1 32 464-495 71-102 (592)
318 cd06610 STKc_OSR1_SPAK Catalyt 87.8 0.53 1.1E-05 43.2 3.5 32 464-495 52-83 (267)
319 cd07831 STKc_MOK Catalytic dom 87.8 0.41 9E-06 44.4 2.8 31 464-494 50-83 (282)
320 cd05573 STKc_ROCK_NDR_like Cat 87.6 0.27 5.9E-06 47.4 1.5 32 464-495 54-85 (350)
321 cd05038 PTKc_Jak_rpt2 Catalyti 87.6 0.4 8.6E-06 44.5 2.6 32 464-495 59-92 (284)
322 KOG0661 MAPK related serine/th 87.6 0.13 2.7E-06 49.9 -0.8 31 464-494 61-93 (538)
323 PHA03390 pk1 serine/threonine- 87.6 0.63 1.4E-05 42.9 3.8 27 469-495 67-93 (267)
324 cd06652 STKc_MEKK2 Catalytic d 87.5 0.47 1E-05 43.6 3.0 32 464-495 57-90 (265)
325 cd05570 STKc_PKC Catalytic dom 87.4 0.54 1.2E-05 44.7 3.4 27 469-495 54-80 (318)
326 cd07856 STKc_Sty1_Hog1 Catalyt 87.4 0.43 9.4E-06 45.6 2.7 31 464-494 62-93 (328)
327 cd07862 STKc_CDK6 Catalytic do 87.3 0.59 1.3E-05 43.6 3.5 31 464-494 57-92 (290)
328 cd07832 STKc_CCRK Catalytic do 87.2 0.45 9.7E-06 44.3 2.7 30 464-493 52-81 (286)
329 cd07852 STKc_MAPK15 Catalytic 87.1 0.38 8.3E-06 46.1 2.2 31 464-494 59-92 (337)
330 cd08530 STKc_CNK2-like Catalyt 87.1 0.23 5E-06 45.3 0.6 32 464-495 52-83 (256)
331 cd06606 STKc_MAPKKK Catalytic 87.0 0.56 1.2E-05 42.6 3.2 31 464-494 52-84 (260)
332 cd00192 PTKc Catalytic domain 86.9 0.44 9.6E-06 43.4 2.4 31 464-494 49-79 (262)
333 cd05591 STKc_nPKC_epsilon Cata 86.9 0.62 1.3E-05 44.4 3.5 28 468-495 53-80 (321)
334 cd06618 PKc_MKK7 Catalytic dom 86.8 0.32 7E-06 45.6 1.4 30 465-494 67-97 (296)
335 PHA03207 serine/threonine kina 86.7 0.5 1.1E-05 46.5 2.8 31 464-494 139-169 (392)
336 cd05073 PTKc_Hck Catalytic dom 86.7 0.47 1E-05 43.5 2.5 31 464-495 54-84 (260)
337 cd07853 STKc_NLK Catalytic dom 86.6 0.31 6.7E-06 47.6 1.3 32 464-495 52-88 (372)
338 cd05060 PTKc_Syk_like Catalyti 86.6 0.55 1.2E-05 42.9 2.9 30 464-494 49-78 (257)
339 cd06639 STKc_myosinIIIB Cataly 86.6 0.54 1.2E-05 43.9 2.9 32 464-495 71-108 (291)
340 cd06608 STKc_myosinIII_like Ca 86.5 0.51 1.1E-05 43.5 2.6 32 464-495 55-93 (275)
341 smart00219 TyrKc Tyrosine kina 86.5 0.51 1.1E-05 43.0 2.6 32 464-495 54-85 (258)
342 cd05592 STKc_nPKC_theta_delta 86.5 0.7 1.5E-05 43.9 3.6 29 467-495 52-80 (316)
343 cd05610 STKc_MASTL Catalytic d 86.4 0.61 1.3E-05 49.5 3.4 32 464-495 57-88 (669)
344 cd05070 PTKc_Fyn_Yrk Catalytic 86.3 0.54 1.2E-05 43.0 2.7 31 464-495 54-84 (260)
345 cd06605 PKc_MAPKK Catalytic do 86.3 0.38 8.3E-06 44.1 1.6 31 464-494 52-82 (265)
346 cd05590 STKc_nPKC_eta Catalyti 86.1 0.66 1.4E-05 44.2 3.2 27 469-495 54-80 (320)
347 cd05056 PTKc_FAK Catalytic dom 86.0 0.47 1E-05 43.8 2.1 30 464-494 60-89 (270)
348 cd05083 PTKc_Chk Catalytic dom 86.0 0.57 1.2E-05 42.7 2.7 31 464-495 52-82 (254)
349 cd05122 PKc_STE Catalytic doma 86.0 0.74 1.6E-05 41.6 3.4 31 464-494 50-80 (253)
350 KOG3864 Uncharacterized conser 85.8 0.12 2.6E-06 44.3 -1.8 83 23-105 101-186 (221)
351 KOG0586 Serine/threonine prote 85.7 0.62 1.3E-05 46.7 2.8 31 464-494 108-138 (596)
352 cd07837 STKc_CdkB_plant Cataly 85.7 0.54 1.2E-05 44.0 2.3 32 464-495 53-90 (295)
353 cd06651 STKc_MEKK3 Catalytic d 85.5 0.77 1.7E-05 42.2 3.3 32 464-495 57-90 (266)
354 cd05574 STKc_phototropin_like 85.5 0.59 1.3E-05 44.3 2.5 31 464-494 54-84 (316)
355 cd05071 PTKc_Src Catalytic dom 85.5 0.59 1.3E-05 42.9 2.5 31 464-495 54-84 (262)
356 cd07838 STKc_CDK4_6_like Catal 85.2 0.78 1.7E-05 42.6 3.2 31 464-494 54-89 (287)
357 cd05617 STKc_aPKC_zeta Catalyt 85.1 0.99 2.1E-05 43.1 3.9 32 464-495 48-80 (327)
358 cd06616 PKc_MKK4 Catalytic dom 85.0 0.65 1.4E-05 43.3 2.5 31 464-494 55-86 (288)
359 cd05613 STKc_MSK1_N N-terminal 85.0 0.66 1.4E-05 43.3 2.6 32 464-495 57-89 (290)
360 cd05118 STKc_CMGC Catalytic do 84.9 0.29 6.3E-06 45.4 0.1 32 464-495 51-82 (283)
361 cd07839 STKc_CDK5 Catalytic do 84.9 0.32 6.9E-06 45.3 0.4 31 464-494 52-82 (284)
362 cd05103 PTKc_VEGFR2 Catalytic 84.6 0.47 1E-05 45.7 1.4 32 464-495 63-96 (343)
363 KOG0616 cAMP-dependent protein 84.4 0.93 2E-05 41.4 3.0 32 464-495 97-128 (355)
364 KOG0662 Cyclin-dependent kinas 84.4 0.26 5.7E-06 41.2 -0.4 30 464-493 54-83 (292)
365 KOG1024 Receptor-like protein 84.3 2.9 6.3E-05 39.9 6.3 30 464-493 340-370 (563)
366 smart00220 S_TKc Serine/Threon 84.2 0.41 8.9E-06 42.9 0.8 32 464-495 40-71 (244)
367 cd07868 STKc_CDK8 Catalytic do 84.2 0.68 1.5E-05 43.9 2.3 32 464-495 51-84 (317)
368 cd08217 STKc_Nek2 Catalytic do 84.0 0.79 1.7E-05 41.9 2.6 32 464-495 52-85 (265)
369 cd07876 STKc_JNK2 Catalytic do 83.9 0.82 1.8E-05 44.3 2.8 32 464-495 73-110 (359)
370 KOG0583 Serine/threonine prote 83.9 0.91 2E-05 44.1 3.1 32 464-495 72-104 (370)
371 cd07845 STKc_CDK10 Catalytic d 83.3 0.98 2.1E-05 42.7 3.0 31 464-494 59-91 (309)
372 KOG3864 Uncharacterized conser 83.3 0.18 3.9E-06 43.2 -1.8 80 256-335 103-185 (221)
373 cd08223 STKc_Nek4 Catalytic do 83.1 0.91 2E-05 41.3 2.6 32 464-495 52-84 (257)
374 cd06636 STKc_MAP4K4_6 Catalyti 83.0 0.82 1.8E-05 42.4 2.3 32 464-495 65-103 (282)
375 cd07849 STKc_ERK1_2_like Catal 82.9 0.6 1.3E-05 44.8 1.4 32 464-495 56-92 (336)
376 cd05620 STKc_nPKC_delta Cataly 82.9 1.3 2.8E-05 42.0 3.7 29 467-495 52-80 (316)
377 cd05054 PTKc_VEGFR Catalytic d 82.8 0.8 1.7E-05 44.0 2.2 32 464-495 63-96 (337)
378 cd05067 PTKc_Lck_Blk Catalytic 82.7 0.96 2.1E-05 41.4 2.6 31 464-495 54-84 (260)
379 cd06653 STKc_MEKK3_like_1 Cata 82.6 1 2.3E-05 41.3 2.8 32 464-495 57-90 (264)
380 PF00069 Pkinase: Protein kina 82.6 0.88 1.9E-05 41.5 2.3 32 464-495 51-82 (260)
381 cd05576 STKc_RPK118_like Catal 82.5 0.77 1.7E-05 41.4 1.9 32 464-495 38-69 (237)
382 cd05109 PTKc_HER2 Catalytic do 82.5 0.96 2.1E-05 41.9 2.5 31 464-495 62-92 (279)
383 cd05616 STKc_cPKC_beta Catalyt 82.2 1.5 3.2E-05 41.8 3.8 27 469-495 59-85 (323)
384 KOG4279 Serine/threonine prote 82.0 0.38 8.2E-06 49.1 -0.4 32 464-495 625-656 (1226)
385 KOG0597 Serine-threonine prote 82.0 0.41 8.9E-06 47.6 -0.2 31 464-494 54-84 (808)
386 cd08215 STKc_Nek Catalytic dom 82.0 1.1 2.4E-05 40.7 2.7 32 464-495 52-83 (258)
387 cd05074 PTKc_Tyro3 Catalytic d 81.8 1.1 2.5E-05 41.2 2.8 31 464-494 54-90 (273)
388 cd07830 STKc_MAK_like Catalyti 81.8 0.4 8.6E-06 44.5 -0.3 31 464-494 50-81 (283)
389 cd05633 STKc_GRK3 Catalytic do 81.7 1.5 3.2E-05 40.7 3.6 32 464-495 50-81 (279)
390 KOG0594 Protein kinase PCTAIRE 81.6 1.2 2.5E-05 41.6 2.7 31 464-494 63-100 (323)
391 cd07829 STKc_CDK_like Catalyti 81.6 0.41 8.9E-06 44.4 -0.3 31 464-494 51-81 (282)
392 smart00221 STYKc Protein kinas 81.2 0.99 2.2E-05 39.9 2.1 32 464-495 50-81 (225)
393 cd07863 STKc_CDK4 Catalytic do 81.2 1.3 2.8E-05 41.3 2.9 31 464-494 55-90 (288)
394 PLN03224 probable serine/threo 81.2 0.54 1.2E-05 47.6 0.4 32 464-495 225-269 (507)
395 KOG0198 MEKK and related serin 81.1 0.86 1.9E-05 42.8 1.6 32 464-495 67-100 (313)
396 cd05614 STKc_MSK2_N N-terminal 81.0 1.4 2.9E-05 42.2 3.1 32 464-495 57-89 (332)
397 cd05123 STKc_AGC Catalytic dom 80.5 0.55 1.2E-05 42.6 0.2 31 464-494 46-76 (250)
398 PTZ00036 glycogen synthase kin 80.4 1.3 2.8E-05 44.4 2.8 31 464-494 112-150 (440)
399 PHA03210 serine/threonine kina 80.4 1.3 2.9E-05 45.2 2.8 30 464-493 216-245 (501)
400 smart00364 LRR_BAC Leucine-ric 80.0 1.3 2.8E-05 24.1 1.4 19 350-368 2-20 (26)
401 cd05606 STKc_beta_ARK Catalyti 79.7 1.8 3.9E-05 40.1 3.3 31 465-495 51-81 (278)
402 cd05583 STKc_MSK_N N-terminal 79.4 1 2.3E-05 41.9 1.6 32 464-495 57-89 (288)
403 cd07858 STKc_TEY_MAPK_plant Ca 78.9 0.8 1.7E-05 44.0 0.7 31 464-494 57-92 (337)
404 KOG0666 Cyclin C-dependent kin 78.8 0.23 4.9E-06 45.5 -2.8 31 464-494 80-111 (438)
405 KOG0578 p21-activated serine/t 78.8 0.75 1.6E-05 45.6 0.5 32 464-495 323-354 (550)
406 PTZ00266 NIMA-related protein 78.7 1.6 3.4E-05 47.8 2.8 32 464-495 65-98 (1021)
407 cd05581 STKc_PDK1 Catalytic do 78.5 0.58 1.3E-05 43.3 -0.4 31 464-494 54-85 (280)
408 cd07875 STKc_JNK1 Catalytic do 78.2 1.4 3E-05 42.9 2.1 32 464-495 76-113 (364)
409 KOG0598 Ribosomal protein S6 k 77.7 2 4.3E-05 40.4 2.8 32 464-495 78-109 (357)
410 TIGR00864 PCC polycystin catio 77.4 1.3 2.9E-05 52.6 2.0 37 333-369 2-38 (2740)
411 KOG4257 Focal adhesion tyrosin 77.2 1.5 3.3E-05 44.4 2.0 30 464-494 444-473 (974)
412 cd07874 STKc_JNK3 Catalytic do 77.1 1.3 2.8E-05 42.8 1.6 31 464-494 69-105 (355)
413 cd05586 STKc_Sck1_like Catalyt 76.7 2.5 5.5E-05 40.3 3.5 27 469-495 54-80 (330)
414 cd07866 STKc_BUR1 Catalytic do 76.3 1.1 2.5E-05 42.1 0.9 31 464-494 60-98 (311)
415 KOG0200 Fibroblast/platelet-de 76.1 1.7 3.6E-05 45.6 2.1 31 465-495 356-386 (609)
416 KOG0588 Serine/threonine prote 76.1 2 4.4E-05 43.8 2.6 32 464-495 65-96 (786)
417 cd07879 STKc_p38delta_MAPK13 C 75.2 1.4 3E-05 42.4 1.3 31 464-494 67-103 (342)
418 smart00365 LRR_SD22 Leucine-ri 75.1 2.4 5.2E-05 23.1 1.6 12 72-83 3-14 (26)
419 cd07834 STKc_MAPK Catalytic do 74.7 0.88 1.9E-05 43.4 -0.3 31 464-494 52-87 (330)
420 cd07850 STKc_JNK Catalytic dom 74.5 2.2 4.8E-05 41.2 2.4 31 464-494 68-104 (353)
421 cd05615 STKc_cPKC_alpha Cataly 74.1 3 6.4E-05 39.7 3.2 32 464-495 53-85 (323)
422 cd07855 STKc_ERK5 Catalytic do 73.9 1.1 2.3E-05 43.0 0.1 31 464-494 57-91 (334)
423 cd07880 STKc_p38gamma_MAPK12 C 73.4 2.1 4.6E-05 41.1 2.0 31 464-494 67-103 (343)
424 KOG0589 Serine/threonine prote 71.6 2.3 5E-05 41.6 1.7 32 464-495 56-88 (426)
425 KOG0582 Ste20-like serine/thre 70.6 3.9 8.4E-05 39.7 2.9 31 464-494 77-107 (516)
426 cd05587 STKc_cPKC Catalytic do 70.5 4.9 0.00011 38.2 3.8 32 464-495 53-85 (324)
427 KOG0032 Ca2+/calmodulin-depend 70.2 4.2 9.2E-05 39.6 3.2 31 464-494 88-119 (382)
428 cd00180 PKc Catalytic domain o 70.0 4.3 9.3E-05 35.0 3.1 31 464-494 44-74 (215)
429 smart00368 LRR_RI Leucine rich 68.0 3.7 8.1E-05 22.8 1.4 14 23-36 2-15 (28)
430 KOG0195 Integrin-linked kinase 67.8 2 4.2E-05 38.8 0.3 31 464-494 240-270 (448)
431 PF02009 Rifin_STEVOR: Rifin/s 66.5 4.1 8.9E-05 37.9 2.2 25 415-439 261-285 (299)
432 KOG4242 Predicted myosin-I-bin 64.5 12 0.00025 36.9 4.8 59 1-59 216-280 (553)
433 PF12191 stn_TNFRSF12A: Tumour 64.3 4 8.7E-05 31.9 1.4 9 430-438 98-106 (129)
434 cd07854 STKc_MAPK4_6 Catalytic 62.7 3.2 7E-05 39.9 0.8 32 464-495 55-100 (342)
435 KOG0599 Phosphorylase kinase g 62.7 3.5 7.6E-05 37.3 1.0 28 468-495 80-107 (411)
436 KOG0611 Predicted serine/threo 62.6 3.6 7.9E-05 39.4 1.1 31 464-494 106-136 (668)
437 PRK09188 serine/threonine prot 61.5 5.1 0.00011 38.8 1.9 29 464-495 74-102 (365)
438 KOG4242 Predicted myosin-I-bin 60.3 30 0.00064 34.2 6.6 218 48-267 215-481 (553)
439 KOG3763 mRNA export factor TAP 60.1 3.7 7.9E-05 41.0 0.6 15 22-36 217-231 (585)
440 PF08114 PMP1_2: ATPase proteo 59.7 12 0.00027 22.6 2.5 8 430-437 27-34 (43)
441 PF12273 RCR: Chitin synthesis 58.7 8.4 0.00018 31.0 2.5 6 432-437 24-29 (130)
442 PRK09605 bifunctional UGMP fam 58.5 6.7 0.00015 40.4 2.3 32 464-495 389-420 (535)
443 PF15102 TMEM154: TMEM154 prot 57.9 13 0.00028 30.2 3.2 21 424-444 70-90 (146)
444 KOG0605 NDR and related serine 57.7 10 0.00022 37.8 3.2 32 464-495 194-225 (550)
445 KOG4250 TANK binding protein k 57.2 2.7 5.7E-05 43.2 -0.8 31 464-494 64-100 (732)
446 KOG0610 Putative serine/threon 56.6 8.9 0.00019 37.0 2.5 32 464-495 130-161 (459)
447 cd07851 STKc_p38 Catalytic dom 56.4 2.8 6.1E-05 40.3 -0.8 31 464-494 67-103 (343)
448 PF15050 SCIMP: SCIMP protein 55.6 8.3 0.00018 29.7 1.7 18 464-481 98-115 (133)
449 KOG0199 ACK and related non-re 55.6 3.9 8.4E-05 42.2 0.0 30 464-494 164-193 (1039)
450 PRK14879 serine/threonine prot 54.7 6.3 0.00014 34.6 1.2 32 464-495 52-83 (211)
451 KOG0577 Serine/threonine prote 52.7 2.4 5.2E-05 42.7 -1.9 30 464-493 79-108 (948)
452 PF08374 Protocadherin: Protoc 52.6 16 0.00034 31.8 3.1 10 483-492 206-215 (221)
453 KOG4717 Serine/threonine prote 52.3 9.6 0.00021 37.9 2.1 29 464-492 70-98 (864)
454 KOG0660 Mitogen-activated prot 51.9 7.2 0.00016 36.8 1.1 31 464-494 74-109 (359)
455 KOG3763 mRNA export factor TAP 49.9 12 0.00027 37.5 2.4 63 276-340 216-284 (585)
456 cd07857 STKc_MPK1 Catalytic do 49.4 11 0.00024 35.8 2.1 31 464-494 54-89 (332)
457 cd07877 STKc_p38alpha_MAPK14 C 49.3 11 0.00024 36.2 2.1 30 464-493 69-104 (345)
458 PTZ00046 rifin; Provisional 47.3 14 0.0003 35.1 2.2 25 415-439 320-344 (358)
459 TIGR01477 RIFIN variant surfac 46.8 14 0.00031 34.9 2.2 26 414-439 314-339 (353)
460 TIGR03724 arch_bud32 Kae1-asso 46.2 10 0.00023 32.9 1.2 32 464-495 50-81 (199)
461 cd07878 STKc_p38beta_MAPK11 Ca 45.7 6.8 0.00015 37.5 -0.0 31 464-494 67-103 (343)
462 PTZ00283 serine/threonine prot 45.7 16 0.00034 37.3 2.6 32 464-495 84-123 (496)
463 KOG0607 MAP kinase-interacting 45.7 5.4 0.00012 37.1 -0.6 26 469-494 134-159 (463)
464 KOG0668 Casein kinase II, alph 45.3 4.2 9E-05 35.9 -1.4 32 464-495 85-119 (338)
465 KOG3741 Poly(A) ribonuclease s 42.1 12 0.00026 37.5 1.0 32 464-495 326-361 (655)
466 KOG2052 Activin A type IB rece 39.9 37 0.0008 33.3 3.8 29 467-495 261-293 (513)
467 smart00367 LRR_CC Leucine-rich 38.6 21 0.00045 19.2 1.2 12 71-82 2-13 (26)
468 KOG0604 MAP kinase-activated p 37.6 18 0.00039 33.5 1.3 27 469-495 113-143 (400)
469 PF05454 DAG1: Dystroglycan (D 37.2 11 0.00024 34.8 0.0 10 429-438 166-175 (290)
470 PF01102 Glycophorin_A: Glycop 35.9 29 0.00063 27.4 2.1 13 410-422 67-79 (122)
471 TIGR00864 PCC polycystin catio 34.8 27 0.00057 42.5 2.4 32 284-315 1-32 (2740)
472 PF06697 DUF1191: Protein of u 33.8 33 0.00072 31.4 2.4 17 409-425 213-229 (278)
473 KOG0579 Ste20-like serine/thre 31.9 13 0.00027 38.2 -0.6 31 464-494 82-112 (1187)
474 KOG0193 Serine/threonine prote 31.7 33 0.00072 35.0 2.2 28 464-492 441-468 (678)
475 PRK10359 lipopolysaccharide co 31.4 26 0.00057 31.4 1.4 32 464-495 88-127 (232)
476 PF06365 CD34_antigen: CD34/Po 31.2 73 0.0016 27.7 4.0 17 420-436 112-128 (202)
477 KOG0591 NIMA (never in mitosis 30.0 3.4 7.4E-05 37.7 -4.3 30 464-493 71-102 (375)
478 PHA03265 envelope glycoprotein 29.9 48 0.001 31.2 2.7 15 423-437 362-376 (402)
479 KOG0603 Ribosomal protein S6 k 29.5 37 0.0008 34.8 2.2 31 464-494 369-399 (612)
480 PF15330 SIT: SHP2-interacting 27.9 81 0.0018 24.3 3.3 6 431-436 20-25 (107)
481 KOG1989 ARK protein kinase fam 27.7 32 0.0007 36.4 1.5 31 464-494 87-125 (738)
482 KOG0584 Serine/threonine prote 27.7 44 0.00095 34.3 2.3 31 464-494 94-126 (632)
483 cd05120 APH_ChoK_like Aminogly 26.8 30 0.00066 27.7 0.9 32 464-495 44-77 (155)
484 KOG1151 Tousled-like protein k 24.5 63 0.0014 31.8 2.6 32 464-495 520-552 (775)
485 PF02009 Rifin_STEVOR: Rifin/s 24.0 56 0.0012 30.6 2.2 28 412-439 261-288 (299)
486 PF12669 P12: Virus attachment 23.5 1.3E+02 0.0028 20.2 3.3 25 414-438 2-26 (58)
487 PF07213 DAP10: DAP10 membrane 23.5 87 0.0019 22.5 2.5 32 414-445 39-70 (79)
488 PF05568 ASFV_J13L: African sw 23.4 80 0.0017 25.4 2.6 27 414-440 33-59 (189)
489 KOG0576 Mitogen-activated prot 23.1 32 0.00069 35.7 0.4 60 432-492 31-93 (829)
490 PRK12274 serine/threonine prot 22.7 61 0.0013 28.7 2.1 28 464-495 54-82 (218)
491 PF00558 Vpu: Vpu protein; In 22.4 1.2E+02 0.0025 22.0 3.0 33 413-445 6-38 (81)
492 PRK10345 hypothetical protein; 22.4 76 0.0016 28.0 2.6 26 468-493 58-83 (210)
493 KOG4236 Serine/threonine prote 22.3 1.1E+02 0.0024 31.0 3.8 45 451-495 589-647 (888)
494 PF05545 FixQ: Cbb3-type cytoc 22.0 1.1E+02 0.0024 19.5 2.7 26 415-440 12-37 (49)
495 KOG0587 Traf2- and Nck-interac 21.0 96 0.0021 33.4 3.3 24 469-492 74-102 (953)
496 PF01299 Lamp: Lysosome-associ 20.4 60 0.0013 30.7 1.6 31 411-441 271-301 (306)
497 PF15656 Tox-HDC: Toxin with a 20.1 66 0.0014 25.3 1.5 23 468-490 97-119 (119)
No 1
>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional
Probab=100.00 E-value=2.9e-59 Score=510.44 Aligned_cols=489 Identities=31% Similarity=0.488 Sum_probs=351.1
Q ss_pred CcEEEeeCCcccccCCccCcCCccCCeeecccCcccccCCcccccCcccceeecccccccccCCccccCCCCCCeeeccC
Q 041558 1 MALLIIHNNSLSGFIPLNIGNSQFLWGLDLSNNQFSSSIPLSFGNLSNLIFLYLYENSYFASIPSNVGKLKSLGDLQLNG 80 (495)
Q Consensus 1 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~l~~ 80 (495)
|++|++++|.+++.+|..++++++|++|++++|.+++.+|..|+++++|++|++++|.+.+.+|..++++++|++|++++
T Consensus 190 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~ 269 (968)
T PLN00113 190 LEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQ 269 (968)
T ss_pred CCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcC
Confidence 57788888888888888888888888888888888888888888888888888888888878888888888888888888
Q ss_pred CcccccCChhhhcCCCCCEEecCCCcccccCCccccCCCCCCEEee--------ecccccCCCCCCEEEccccccccCCC
Q 041558 81 NQFISYIPSSFGNLTNLSTSRLSKNKLFVSIPNEIGKMRSLNILEV--------LPLSVSNLTNPKELALLYNCLSGSIP 152 (495)
Q Consensus 81 n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l--------~~~~l~~~~~L~~L~l~~n~l~~~~~ 152 (495)
|.+++.+|..+.++++|+.|++++|.+.+.+|..+..+++|+.|++ +|..+..+++|+.|++++|.+.+.+|
T Consensus 270 n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p 349 (968)
T PLN00113 270 NKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIP 349 (968)
T ss_pred CeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCC
Confidence 8887777777888888888888888877777777777777777776 45556666667777776666666666
Q ss_pred ccCcc-cccccccccccccccccCc------------------------cCCCCCCCCEEEccCceeeeccCccccCCCC
Q 041558 153 PSLEN-PMLARLGLDFNHFKRTIPK------------------------SLRSCTSLIRLCRNRNNLTRDISEALGIYPY 207 (495)
Q Consensus 153 ~~~~~-~~L~~L~l~~n~~~~~~~~------------------------~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~ 207 (495)
..+.. ++|+.|++++|.+++.+|. .+..+++|+.|++++|.+++..|..+..+++
T Consensus 350 ~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~ 429 (968)
T PLN00113 350 KNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPL 429 (968)
T ss_pred hHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCC
Confidence 55554 5566666665555544444 4455555555555555555555555566666
Q ss_pred ccEEEccCCcCcccCCCCCCCCCCCCEEecccccccccCCccccCCCCCceeccCCCeeeeecCCCCccccccceeeccc
Q 041558 208 LTFIDLSRNNFHGEIPSNREKCPKLGTLGVLMNTITKGIPREIRNSSQRQALDLSLNHIIGEIPKELGKLNSLIKLILRR 287 (495)
Q Consensus 208 L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~L~~L~L~~ 287 (495)
|+.|++++|.+++.+|..+..+++|+.|++++|.+.+.+|..+ ..++|+.|++++|.+.+.+|..+..+++|+.|++++
T Consensus 430 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~ 508 (968)
T PLN00113 430 VYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSE 508 (968)
T ss_pred CCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcC
Confidence 6666666666666555555566666666666666666555544 346777888888888888888888899999999999
Q ss_pred ccccccCCcccCCCCCCCEEeCCCCcCCCCchhhhhcCCCCCEEeCcCCcCCccchhHhhcCCCCCeEeccCCCC-CCCC
Q 041558 288 NQLVGCLPTEIGSPIELEYLDFSVNRFNNLIPESLENLLKLHYLGLCKNKLVQELPKILEKLVQFSELDLSYNFL-GPIP 366 (495)
Q Consensus 288 n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~ls~n~l-~~~p 366 (495)
|.+++.+|..+..+++|++|+|++|.+++.+|..+..+++|+.|++++|++++.+|..+..++.|+.+++++|++ +.+|
T Consensus 509 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p 588 (968)
T PLN00113 509 NKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLP 588 (968)
T ss_pred CcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCC
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999999 9999
Q ss_pred CcccccCCChhhccCCcCCCCCCC--CCCCccccccccccCCcceeeeeehhHHHHHHHHHHHHHHHHHHhhhcccCCCC
Q 041558 367 NSIAFRGASVEALKGNKRLCVSAK--GLQPCKALRQQKQDCGAKWFTIVFLLVGALFVSIALILIFFIFQKWKSNLGDRQ 444 (495)
Q Consensus 367 ~~~~~~~~~~~~~~~n~~~c~~~~--~~~~c~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 444 (495)
....+..+....+.+|+.+|+.+. ...+|... .....+..+++++++++++++++++++++++++++...++.
T Consensus 589 ~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (968)
T PLN00113 589 STGAFLAINASAVAGNIDLCGGDTTSGLPPCKRV-----RKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRV 663 (968)
T ss_pred CcchhcccChhhhcCCccccCCccccCCCCCccc-----cccceeeeehhHHHHHHHHHHHHHHHHHHHHhhhccccccc
Confidence 988888888889999999997542 23455321 11112333333333333332222222333332221110000
Q ss_pred CC------------C--------------------C-C-CC-----------CceEEEeeccc--------eecccccCC
Q 041558 445 CN------------N--------------------Q-N-PQ-----------GLLSILNFKGK--------LALTETGHR 471 (495)
Q Consensus 445 ~~------------~--------------------~-~-~~-----------~~~~~~~~~~~--------~~l~~~~H~ 471 (495)
.. . + + .+ ..++++.+... ..+++++||
T Consensus 664 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~Hp 743 (968)
T PLN00113 664 ENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHP 743 (968)
T ss_pred ccccccccccccccccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCC
Confidence 00 0 0 0 00 11122211110 068899999
Q ss_pred ceeeeEEEEEeCCeeEEEecccCC
Q 041558 472 NIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 472 NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
|||+++|+|.+++..++|||||++
T Consensus 744 nIv~~~~~~~~~~~~~lv~Ey~~~ 767 (968)
T PLN00113 744 NIVKLIGLCRSEKGAYLIHEYIEG 767 (968)
T ss_pred CcceEEEEEEcCCCCEEEEeCCCC
Confidence 999999999999999999999984
No 2
>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional
Probab=100.00 E-value=2.9e-48 Score=424.04 Aligned_cols=385 Identities=34% Similarity=0.448 Sum_probs=325.0
Q ss_pred CcEEEeeCCcccccCCccCcCCccCCeeecccCcccccCCcccccCcccceeecccccccccCCccccCCCCCCeeeccC
Q 041558 1 MALLIIHNNSLSGFIPLNIGNSQFLWGLDLSNNQFSSSIPLSFGNLSNLIFLYLYENSYFASIPSNVGKLKSLGDLQLNG 80 (495)
Q Consensus 1 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~l~~ 80 (495)
|++|++++|.+.+.+|..|+++++|++|++++|.+.+.+|..++++++|++|++++|.+.+.+|..++++++|++|++++
T Consensus 166 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~ 245 (968)
T PLN00113 166 LKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVY 245 (968)
T ss_pred CCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcC
Confidence 68999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcccccCChhhhcCCCCCEEecCCCcccccCCccccCCCCCCEEee--------ecccccCCCCCCEEEccccccccCCC
Q 041558 81 NQFISYIPSSFGNLTNLSTSRLSKNKLFVSIPNEIGKMRSLNILEV--------LPLSVSNLTNPKELALLYNCLSGSIP 152 (495)
Q Consensus 81 n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l--------~~~~l~~~~~L~~L~l~~n~l~~~~~ 152 (495)
|.+++.+|..+.++++|+.|++++|.+.+.+|..+..+++|+.|++ +|..+..+++|+.|++++|.+.+..|
T Consensus 246 n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~ 325 (968)
T PLN00113 246 NNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIP 325 (968)
T ss_pred ceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCC
Confidence 9999999999999999999999999999999999999999999988 67778899999999999999999999
Q ss_pred ccCcc-cccccccccccccccccCccCCCCCCCCEEEccCceeeeccCccccCCCCccEEEccCCcCcccCCCCCCCCCC
Q 041558 153 PSLEN-PMLARLGLDFNHFKRTIPKSLRSCTSLIRLCRNRNNLTRDISEALGIYPYLTFIDLSRNNFHGEIPSNREKCPK 231 (495)
Q Consensus 153 ~~~~~-~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~ 231 (495)
..+.. ++|+.|++++|.+++.+|..+..+++|+.|++++|.+.+..|..+..+++|+.|++++|.+.+.+|..+..+++
T Consensus 326 ~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~ 405 (968)
T PLN00113 326 VALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRS 405 (968)
T ss_pred hhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCC
Confidence 88887 99999999999999999999999999999999999998888777776666666666666666666666666666
Q ss_pred CCEEecccccccccCCccccCCCCC------------------------ceeccCCCeeeeecCCCCccccccceeeccc
Q 041558 232 LGTLGVLMNTITKGIPREIRNSSQR------------------------QALDLSLNHIIGEIPKELGKLNSLIKLILRR 287 (495)
Q Consensus 232 L~~L~l~~n~l~~~~~~~~~~l~~L------------------------~~L~ls~n~l~~~~~~~~~~~~~L~~L~L~~ 287 (495)
|+.|++++|.+++.+|..+..++.| +.|++++|.+.+.+|..+ ..++|+.|++++
T Consensus 406 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~ 484 (968)
T PLN00113 406 LRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSR 484 (968)
T ss_pred CCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcC
Confidence 6666666666555555555555444 445555555544444433 235677777777
Q ss_pred ccccccCCcccCCCCCCCEEeCCCCcCCCCchhhhhcCCCCCEEeCcCCcCCccchhHhhcCCCCCeEeccCCCC-CCCC
Q 041558 288 NQLVGCLPTEIGSPIELEYLDFSVNRFNNLIPESLENLLKLHYLGLCKNKLVQELPKILEKLVQFSELDLSYNFL-GPIP 366 (495)
Q Consensus 288 n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~ls~n~l-~~~p 366 (495)
|++++.+|..+..+++|+.|+|++|.+.+.+|..+..+++|+.|++++|.+++.+|..+..+++|+.|++++|.+ +.+|
T Consensus 485 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 564 (968)
T PLN00113 485 NQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIP 564 (968)
T ss_pred CccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCC
Confidence 788778888888889999999999999999999999999999999999999999999999999999999999999 7888
Q ss_pred Cccc-ccCCChhhccCCcCCC
Q 041558 367 NSIA-FRGASVEALKGNKRLC 386 (495)
Q Consensus 367 ~~~~-~~~~~~~~~~~n~~~c 386 (495)
.... ........+.+|+..+
T Consensus 565 ~~l~~l~~L~~l~ls~N~l~~ 585 (968)
T PLN00113 565 KNLGNVESLVQVNISHNHLHG 585 (968)
T ss_pred hhHhcCcccCEEeccCCccee
Confidence 6432 2344455566676655
No 3
>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]
Probab=100.00 E-value=4.1e-40 Score=309.13 Aligned_cols=343 Identities=22% Similarity=0.171 Sum_probs=204.5
Q ss_pred EEEeeCCcccccCCccCcCCccCCeeecccCcccccCCcccccCcccceeecccccccccCCccccCCCCCCeeeccCCc
Q 041558 3 LLIIHNNSLSGFIPLNIGNSQFLWGLDLSNNQFSSSIPLSFGNLSNLIFLYLYENSYFASIPSNVGKLKSLGDLQLNGNQ 82 (495)
Q Consensus 3 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~l~~n~ 82 (495)
.|++++|.+...-+..|.++++|+.+.+..|.++ .+|...+...+|+.|+|.+|.|...-.+++..++.|+.|||+.|.
T Consensus 82 ~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~ 160 (873)
T KOG4194|consen 82 TLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNL 160 (873)
T ss_pred eeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhch
Confidence 4555555555444455555566666666555555 445433334445556665555555555555555556666666655
Q ss_pred ccccCChhhhcCCCCCEEecCCCcccccCCccccCCCCCCEEeeecccccCCCCCCEEEccccccccCCCccCcc-cccc
Q 041558 83 FISYIPSSFGNLTNLSTSRLSKNKLFVSIPNEIGKMRSLNILEVLPLSVSNLTNPKELALLYNCLSGSIPPSLEN-PMLA 161 (495)
Q Consensus 83 l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~~~l~~~~~L~~L~l~~n~l~~~~~~~~~~-~~L~ 161 (495)
++.+.-.+|..-.++++|+|++|.++..-... |..+.+|..|.++.|+++...+..|.. ++|+
T Consensus 161 is~i~~~sfp~~~ni~~L~La~N~It~l~~~~----------------F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~ 224 (873)
T KOG4194|consen 161 ISEIPKPSFPAKVNIKKLNLASNRITTLETGH----------------FDSLNSLLTLKLSRNRITTLPQRSFKRLPKLE 224 (873)
T ss_pred hhcccCCCCCCCCCceEEeecccccccccccc----------------ccccchheeeecccCcccccCHHHhhhcchhh
Confidence 55544444555555566666665554333333 444556666666666666555555554 6666
Q ss_pred cccccccccccccCccCCCCCCCCEEEccCceeeeccCccccCCCCccEEEccCCcCcccCCCCCCCCCCCCEEeccccc
Q 041558 162 RLGLDFNHFKRTIPKSLRSCTSLIRLCRNRNNLTRDISEALGIYPYLTFIDLSRNNFHGEIPSNREKCPKLGTLGVLMNT 241 (495)
Q Consensus 162 ~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~ 241 (495)
.|+|..|.+.-.-.-.|.++++|+.|.+..|.+......+|..+.++++|+|+.|+++..-.+++.+++.|+.|++++|.
T Consensus 225 ~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~Na 304 (873)
T KOG4194|consen 225 SLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNA 304 (873)
T ss_pred hhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhh
Confidence 66666666653334456666666666666666666666666666666666666666665556666666666666666666
Q ss_pred ccccCCccccCCCCCceeccCCCeeeeecCCCCccccccceeecccccccccCCcccCCCCCCCEEeCCCCcCCCCchh-
Q 041558 242 ITKGIPREIRNSSQRQALDLSLNHIIGEIPKELGKLNSLIKLILRRNQLVGCLPTEIGSPIELEYLDFSVNRFNNLIPE- 320 (495)
Q Consensus 242 l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~- 320 (495)
|...-+.....+.+|++|+|++|+++...+.+|..+..|+.|+|++|.++..-...|..+++|+.|||++|.+++.+.+
T Consensus 305 I~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDa 384 (873)
T KOG4194|consen 305 IQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDA 384 (873)
T ss_pred hheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecc
Confidence 6665566666666666666666666655555666666666666666666654455566666666666666666554433
Q ss_pred --hhhcCCCCCEEeCcCCcCCccchhHhhcCCCCCeEeccCCCC
Q 041558 321 --SLENLLKLHYLGLCKNKLVQELPKILEKLVQFSELDLSYNFL 362 (495)
Q Consensus 321 --~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~ls~n~l 362 (495)
.|.++++|+.|++.+|++.......|..++.|+.||+.+|.+
T Consensus 385 a~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~Nai 428 (873)
T KOG4194|consen 385 AVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAI 428 (873)
T ss_pred hhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcc
Confidence 355566666666666666555555666666666666666666
No 4
>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]
Probab=100.00 E-value=2.9e-38 Score=296.75 Aligned_cols=352 Identities=23% Similarity=0.179 Sum_probs=256.6
Q ss_pred CcEEEeeCCcccccCCccCcCCccCCeeecccCcccccCCcccccCcccceeecccccccccCCccccCCCCCCeeeccC
Q 041558 1 MALLIIHNNSLSGFIPLNIGNSQFLWGLDLSNNQFSSSIPLSFGNLSNLIFLYLYENSYFASIPSNVGKLKSLGDLQLNG 80 (495)
Q Consensus 1 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~l~~ 80 (495)
|+.++|.+|.++ .+|.......+|+.|+|.+|.|+.+-..++..++.|+.|||+.|.|+...-..|..-.++++|+|++
T Consensus 104 Lq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~ 182 (873)
T KOG4194|consen 104 LQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLAS 182 (873)
T ss_pred ceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeecc
Confidence 577889999998 7898777788899999999999988888899999999999999998876667788888999999999
Q ss_pred CcccccCChhhhcCCCCCEEecCCCcccccCCccccCCCCCCEEeeecccccCCCCCCEEEccccccccCCCccCcc-cc
Q 041558 81 NQFISYIPSSFGNLTNLSTSRLSKNKLFVSIPNEIGKMRSLNILEVLPLSVSNLTNPKELALLYNCLSGSIPPSLEN-PM 159 (495)
Q Consensus 81 n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~~~l~~~~~L~~L~l~~n~l~~~~~~~~~~-~~ 159 (495)
|+|+..-...|.++.+|..|.|++|.++..-+..|.++ ++|+.|++..|++.-.--..|.. ++
T Consensus 183 N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L----------------~~L~~LdLnrN~irive~ltFqgL~S 246 (873)
T KOG4194|consen 183 NRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRL----------------PKLESLDLNRNRIRIVEGLTFQGLPS 246 (873)
T ss_pred ccccccccccccccchheeeecccCcccccCHHHhhhc----------------chhhhhhccccceeeehhhhhcCchh
Confidence 99999888899999999999999999974444455444 55555566666654322223333 66
Q ss_pred cccccccccccccccCccCCCCCCCCEEEccCceeeeccCccccCCCCccEEEccCCcCcccCCCCCCCCCCCCEEeccc
Q 041558 160 LARLGLDFNHFKRTIPKSLRSCTSLIRLCRNRNNLTRDISEALGIYPYLTFIDLSRNNFHGEIPSNREKCPKLGTLGVLM 239 (495)
Q Consensus 160 L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~ 239 (495)
|+.|.|..|.+...--..|..+.++++|+|+.|++...-..++-+++.|+.|++++|.+..+-++.+.-+++|+.|+|++
T Consensus 247 l~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~ 326 (873)
T KOG4194|consen 247 LQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSS 326 (873)
T ss_pred hhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccc
Confidence 66666766666655555666777777777777777766666666777777777777777766666666677777777777
Q ss_pred ccccccCCccccCCCCCceeccCCCeeeeecCCCCccccccceeecccccccccCCc---ccCCCCCCCEEeCCCCcCCC
Q 041558 240 NTITKGIPREIRNSSQRQALDLSLNHIIGEIPKELGKLNSLIKLILRRNQLVGCLPT---EIGSPIELEYLDFSVNRFNN 316 (495)
Q Consensus 240 n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~---~~~~l~~L~~L~Ls~n~l~~ 316 (495)
|+++...+..|..+..|++|+|++|.++..-...|..+++|++|||++|.++..+.+ .|..+++|+.|+|.+|++..
T Consensus 327 N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~ 406 (873)
T KOG4194|consen 327 NRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKS 406 (873)
T ss_pred cccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeee
Confidence 777776666677777777777777777655555666777777777777776654433 35567777777777777776
Q ss_pred CchhhhhcCCCCCEEeCcCCcCCccchhHhhcCCCCCeEeccCCCCCCCCCccc
Q 041558 317 LIPESLENLLKLHYLGLCKNKLVQELPKILEKLVQFSELDLSYNFLGPIPNSIA 370 (495)
Q Consensus 317 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~ls~n~l~~~p~~~~ 370 (495)
+...+|.+++.|+.|||.+|.+...-|..|..+ .|+.|-+..-.+-|.|...|
T Consensus 407 I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSssflCDCql~W 459 (873)
T KOG4194|consen 407 IPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSSSFLCDCQLKW 459 (873)
T ss_pred cchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcccceEEeccHHH
Confidence 666677777777777777777766666666666 66666665555533343333
No 5
>KOG0472 consensus Leucine-rich repeat protein [Function unknown]
Probab=100.00 E-value=1.8e-36 Score=272.92 Aligned_cols=373 Identities=29% Similarity=0.404 Sum_probs=256.8
Q ss_pred CcEEEeeCCcccccCCccCcCCccCCeeecccCcccccCCcccccCcccceeecccccccccCCccccCCCCCCeeeccC
Q 041558 1 MALLIIHNNSLSGFIPLNIGNSQFLWGLDLSNNQFSSSIPLSFGNLSNLIFLYLYENSYFASIPSNVGKLKSLGDLQLNG 80 (495)
Q Consensus 1 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~l~~ 80 (495)
+.+|+++.|+++ ..|++++.+..++.|+.++|+++ .+|.+++.+.+|+.|+.++|.+. .+|+.++.+..|+.++..+
T Consensus 70 l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~ 146 (565)
T KOG0472|consen 70 LTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDATN 146 (565)
T ss_pred eeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhccc
Confidence 356778888887 67888888888888888888888 77888888888888888888855 5677788888888888888
Q ss_pred CcccccCChhhhcCCCCCEEecCCCcccccCCccccCCCCCCEEee-------ecccccCCCCCCEEEccccccccCCCc
Q 041558 81 NQFISYIPSSFGNLTNLSTSRLSKNKLFVSIPNEIGKMRSLNILEV-------LPLSVSNLTNPKELALLYNCLSGSIPP 153 (495)
Q Consensus 81 n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l-------~~~~l~~~~~L~~L~l~~n~l~~~~~~ 153 (495)
|++++ .|+.+.++.+|..+++.+|.+. ..|+...+++.|++++. +|..++.+.+|..|++..|.+. ..|.
T Consensus 147 N~i~s-lp~~~~~~~~l~~l~~~~n~l~-~l~~~~i~m~~L~~ld~~~N~L~tlP~~lg~l~~L~~LyL~~Nki~-~lPe 223 (565)
T KOG0472|consen 147 NQISS-LPEDMVNLSKLSKLDLEGNKLK-ALPENHIAMKRLKHLDCNSNLLETLPPELGGLESLELLYLRRNKIR-FLPE 223 (565)
T ss_pred ccccc-CchHHHHHHHHHHhhccccchh-hCCHHHHHHHHHHhcccchhhhhcCChhhcchhhhHHHHhhhcccc-cCCC
Confidence 88766 6777888888888888888875 45555555888888887 8888999999999999999887 4553
Q ss_pred cCcccccccccccccccccccCccCCCCCCCCEEEccCceeeeccCccccCCCCccEEEccCCcCcccCCCCCCCCCCCC
Q 041558 154 SLENPMLARLGLDFNHFKRTIPKSLRSCTSLIRLCRNRNNLTRDISEALGIYPYLTFIDLSRNNFHGEIPSNREKCPKLG 233 (495)
Q Consensus 154 ~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~ 233 (495)
.-+...|+++.++.|.+.....+...++.++..||+.+|++. ..|+.+.-+.+|+.||+++|.++ .+|.+++++ .|+
T Consensus 224 f~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~ 300 (565)
T KOG0472|consen 224 FPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLK 300 (565)
T ss_pred CCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eee
Confidence 333378888888888887544445568888888999888886 45666777888888999988888 677788888 888
Q ss_pred EEecccccccc----------------------------------------------------------------cCCcc
Q 041558 234 TLGVLMNTITK----------------------------------------------------------------GIPRE 249 (495)
Q Consensus 234 ~L~l~~n~l~~----------------------------------------------------------------~~~~~ 249 (495)
+|.+.+|.+.. .+|..
T Consensus 301 ~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdE 380 (565)
T KOG0472|consen 301 FLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDE 380 (565)
T ss_pred ehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccccCCHH
Confidence 88888887621 00100
Q ss_pred ccCC---CCCceeccCCCeee-----------------------eecCCCCccccccceeecccccccccCCcccCCCCC
Q 041558 250 IRNS---SQRQALDLSLNHII-----------------------GEIPKELGKLNSLIKLILRRNQLVGCLPTEIGSPIE 303 (495)
Q Consensus 250 ~~~l---~~L~~L~ls~n~l~-----------------------~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~ 303 (495)
.+.- .-.+..+++.|++. +.+|..++.+++|..|+|++|.+. .+|.+++.+..
T Consensus 381 Vfea~~~~~Vt~VnfskNqL~elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~ 459 (565)
T KOG0472|consen 381 VFEAAKSEIVTSVNFSKNQLCELPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVR 459 (565)
T ss_pred HHHHhhhcceEEEecccchHhhhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhh-hcchhhhhhhh
Confidence 0000 00122333333322 234445566778888888888877 77888888888
Q ss_pred CCEEeCCCCcCCCCchhhhhcCCCCCEEeCcCCcCCccchhHhhcCCCCCeEeccCCCCCCCCCcc-cccCCChhhccCC
Q 041558 304 LEYLDFSVNRFNNLIPESLENLLKLHYLGLCKNKLVQELPKILEKLVQFSELDLSYNFLGPIPNSI-AFRGASVEALKGN 382 (495)
Q Consensus 304 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~ls~n~l~~~p~~~-~~~~~~~~~~~~n 382 (495)
|+.||++.|.+.. +|.+...+..++.+-.++|++....|+.+.++.+|..||+.+|.+..+|... .........+.||
T Consensus 460 Lq~LnlS~NrFr~-lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gN 538 (565)
T KOG0472|consen 460 LQTLNLSFNRFRM-LPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGN 538 (565)
T ss_pred hheeccccccccc-chHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchhhCChhhccccceeEEEecCC
Confidence 8888888887764 3555444444555555555554444444555555555555555554444322 2223333344444
Q ss_pred cC
Q 041558 383 KR 384 (495)
Q Consensus 383 ~~ 384 (495)
+.
T Consensus 539 pf 540 (565)
T KOG0472|consen 539 PF 540 (565)
T ss_pred cc
Confidence 43
No 6
>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]
Probab=99.97 E-value=2.1e-34 Score=272.96 Aligned_cols=352 Identities=28% Similarity=0.351 Sum_probs=267.7
Q ss_pred cEEEeeCCccc-ccCCccCcCCccCCeeecccCcccccCCcccccCcccceeecccccccccCCccccCCCCCCeeeccC
Q 041558 2 ALLIIHNNSLS-GFIPLNIGNSQFLWGLDLSNNQFSSSIPLSFGNLSNLIFLYLYENSYFASIPSNVGKLKSLGDLQLNG 80 (495)
Q Consensus 2 ~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~l~~ 80 (495)
+-.|+++|.++ +.+|.....+++++-|.|...++. .+|+.++.|.+|++|.+++|+++. +-..++.++.|+.+++++
T Consensus 10 rGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~~-vhGELs~Lp~LRsv~~R~ 87 (1255)
T KOG0444|consen 10 RGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLIS-VHGELSDLPRLRSVIVRD 87 (1255)
T ss_pred ecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhHh-hhhhhccchhhHHHhhhc
Confidence 34678888888 568888888888888888888887 778888888888888888888654 345577788888888888
Q ss_pred Ccccc-cCChhhhcCCCCCEEecCCCcccccCCccccCCCCCCEEee-------eccc-ccCCCCCCEEEccccccccCC
Q 041558 81 NQFIS-YIPSSFGNLTNLSTSRLSKNKLFVSIPNEIGKMRSLNILEV-------LPLS-VSNLTNPKELALLYNCLSGSI 151 (495)
Q Consensus 81 n~l~~-~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l-------~~~~-l~~~~~L~~L~l~~n~l~~~~ 151 (495)
|++.. .+|..+-.+..|+.||||+|++ .+.|..+.+-+++-+|++ ||.. +.+++.|-.||+++|++.. +
T Consensus 88 N~LKnsGiP~diF~l~dLt~lDLShNqL-~EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe~-L 165 (1255)
T KOG0444|consen 88 NNLKNSGIPTDIFRLKDLTILDLSHNQL-REVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLEM-L 165 (1255)
T ss_pred cccccCCCCchhcccccceeeecchhhh-hhcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhhh-c
Confidence 87653 4677777788888888888887 467777766666666665 3432 3456667777888887764 3
Q ss_pred CccCcc-cccccccccccccccccCccCCCCCCCCEEEccCceee-eccCccccCCCCccEEEccCCcCcccCCCCCCCC
Q 041558 152 PPSLEN-PMLARLGLDFNHFKRTIPKSLRSCTSLIRLCRNRNNLT-RDISEALGIYPYLTFIDLSRNNFHGEIPSNREKC 229 (495)
Q Consensus 152 ~~~~~~-~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~ 229 (495)
|+.+.. ..|++|+|++|.+.-.--..+..+++|+.|.+++.+-+ ..+|.++..+.+|..+|+|.|.+. .+|+.+..+
T Consensus 166 PPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l 244 (1255)
T KOG0444|consen 166 PPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKL 244 (1255)
T ss_pred CHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhh
Confidence 444443 77888888887765433344555667777777766544 457788888888888888888888 788888888
Q ss_pred CCCCEEecccccccccCCccccCCCCCceeccCCCeeeeecCCCCccccccceeecccccccc-cCCcccCCCCCCCEEe
Q 041558 230 PKLGTLGVLMNTITKGIPREIRNSSQRQALDLSLNHIIGEIPKELGKLNSLIKLILRRNQLVG-CLPTEIGSPIELEYLD 308 (495)
Q Consensus 230 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~ 308 (495)
++|+.|+|++|.++. +......+.+|++|++|.|+++ .+|+++..+++|+.|.+.+|+++- -+|+.++.+.+|+.+.
T Consensus 245 ~~LrrLNLS~N~ite-L~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~ 322 (1255)
T KOG0444|consen 245 RNLRRLNLSGNKITE-LNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFH 322 (1255)
T ss_pred hhhheeccCcCceee-eeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHH
Confidence 888888888888876 4444556778888888888887 788888888888888888888763 3788888888888888
Q ss_pred CCCCcCCCCchhhhhcCCCCCEEeCcCCcCCccchhHhhcCCCCCeEeccCCCC
Q 041558 309 FSVNRFNNLIPESLENLLKLHYLGLCKNKLVQELPKILEKLVQFSELDLSYNFL 362 (495)
Q Consensus 309 Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~ls~n~l 362 (495)
.++|.+. ..|+.+..|..|+.|.|++|++ -.+|+.+.-++.|+.||+..|+-
T Consensus 323 aanN~LE-lVPEglcRC~kL~kL~L~~NrL-iTLPeaIHlL~~l~vLDlreNpn 374 (1255)
T KOG0444|consen 323 AANNKLE-LVPEGLCRCVKLQKLKLDHNRL-ITLPEAIHLLPDLKVLDLRENPN 374 (1255)
T ss_pred hhccccc-cCchhhhhhHHHHHhcccccce-eechhhhhhcCCcceeeccCCcC
Confidence 8888775 4688888888888888888888 45778888888888888888876
No 7
>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]
Probab=99.97 E-value=6.8e-34 Score=269.53 Aligned_cols=363 Identities=27% Similarity=0.393 Sum_probs=314.6
Q ss_pred cCCccCCeeecccCccc-ccCCcccccCcccceeecccccccccCCccccCCCCCCeeeccCCcccccCChhhhcCCCCC
Q 041558 20 GNSQFLWGLDLSNNQFS-SSIPLSFGNLSNLIFLYLYENSYFASIPSNVGKLKSLGDLQLNGNQFISYIPSSFGNLTNLS 98 (495)
Q Consensus 20 ~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 98 (495)
+-++..+-.|+++|.++ +.+|.....+++++-|.|...++. .+|+.++.+.+|++|.+++|++.. +-..+..++.|+
T Consensus 4 gVLpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~~-vhGELs~Lp~LR 81 (1255)
T KOG0444|consen 4 GVLPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLIS-VHGELSDLPRLR 81 (1255)
T ss_pred cccceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhHh-hhhhhccchhhH
Confidence 34667788999999999 578999999999999999988854 789999999999999999999876 456788899999
Q ss_pred EEecCCCccc-ccCCccccCCCCCCEEee-------ecccccCCCCCCEEEccccccccCCCccCcc--ccccccccccc
Q 041558 99 TSRLSKNKLF-VSIPNEIGKMRSLNILEV-------LPLSVSNLTNPKELALLYNCLSGSIPPSLEN--PMLARLGLDFN 168 (495)
Q Consensus 99 ~L~l~~n~~~-~~~~~~~~~l~~L~~L~l-------~~~~l~~~~~L~~L~l~~n~l~~~~~~~~~~--~~L~~L~l~~n 168 (495)
.+.+..|++. .-+|..+..+..|..|++ .|..+..-+++-.|++++|+|. .+|..+.. +.|-.|+|++|
T Consensus 82 sv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~N 160 (1255)
T KOG0444|consen 82 SVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLREVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNN 160 (1255)
T ss_pred HHhhhccccccCCCCchhcccccceeeecchhhhhhcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccc
Confidence 9999999984 458999999999999998 7888888899999999999988 45554443 88999999999
Q ss_pred ccccccCccCCCCCCCCEEEccCceeeeccCccccCCCCccEEEccCCcCc-ccCCCCCCCCCCCCEEecccccccccCC
Q 041558 169 HFKRTIPKSLRSCTSLIRLCRNRNNLTRDISEALGIYPYLTFIDLSRNNFH-GEIPSNREKCPKLGTLGVLMNTITKGIP 247 (495)
Q Consensus 169 ~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~-~~~~~~~~~~~~L~~L~l~~n~l~~~~~ 247 (495)
++. .+|..+..+..|+.|++++|.+...--..+..+++|+.|.+++.+-+ ..+|.++..+.+|..++++.|.+.. +|
T Consensus 161 rLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp~-vP 238 (1255)
T KOG0444|consen 161 RLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLPI-VP 238 (1255)
T ss_pred hhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCCc-ch
Confidence 997 46667899999999999999887554455566788889999887544 4689999999999999999999987 89
Q ss_pred ccccCCCCCceeccCCCeeeeecCCCCccccccceeecccccccccCCcccCCCCCCCEEeCCCCcCCC-CchhhhhcCC
Q 041558 248 REIRNSSQRQALDLSLNHIIGEIPKELGKLNSLIKLILRRNQLVGCLPTEIGSPIELEYLDFSVNRFNN-LIPESLENLL 326 (495)
Q Consensus 248 ~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~ 326 (495)
+.+..+++|+.|+||+|.++ .+....+...+|++|++++|+++ ..|+++..++.|+.|.+.+|+++- -+|..++.+.
T Consensus 239 ecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~ 316 (1255)
T KOG0444|consen 239 ECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLI 316 (1255)
T ss_pred HHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhh
Confidence 99999999999999999998 56666777889999999999999 899999999999999999998863 3799999999
Q ss_pred CCCEEeCcCCcCCccchhHhhcCCCCCeEeccCCCCCCCCCcccc-cCCChhhccCCcCCCCCCC
Q 041558 327 KLHYLGLCKNKLVQELPKILEKLVQFSELDLSYNFLGPIPNSIAF-RGASVEALKGNKRLCVSAK 390 (495)
Q Consensus 327 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~ls~n~l~~~p~~~~~-~~~~~~~~~~n~~~c~~~~ 390 (495)
+|+.+..++|.+ ...|+.++.+.+|+.|.++.|.+-.+|+.+.+ .......+..|+.+--+|.
T Consensus 317 ~Levf~aanN~L-ElVPEglcRC~kL~kL~L~~NrLiTLPeaIHlL~~l~vLDlreNpnLVMPPK 380 (1255)
T KOG0444|consen 317 QLEVFHAANNKL-ELVPEGLCRCVKLQKLKLDHNRLITLPEAIHLLPDLKVLDLRENPNLVMPPK 380 (1255)
T ss_pred hhHHHHhhcccc-ccCchhhhhhHHHHHhcccccceeechhhhhhcCCcceeeccCCcCccCCCC
Confidence 999999999998 78899999999999999999999999987754 4566677778887775543
No 8
>KOG0472 consensus Leucine-rich repeat protein [Function unknown]
Probab=99.97 E-value=2.5e-34 Score=259.12 Aligned_cols=383 Identities=26% Similarity=0.376 Sum_probs=309.5
Q ss_pred CcEEEeeCCcccccCCccCcCCccCCeeecccCcccccCCcccccCcccceeecccccccccCCccccCCCCCCeeeccC
Q 041558 1 MALLIIHNNSLSGFIPLNIGNSQFLWGLDLSNNQFSSSIPLSFGNLSNLIFLYLYENSYFASIPSNVGKLKSLGDLQLNG 80 (495)
Q Consensus 1 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~l~~ 80 (495)
++.++++.|.+. .+.+.+.++..|.+|++.+|+++ ..|.+++.+..++.++.++|++. .+|+.++.+.+|..+++++
T Consensus 47 l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~ 123 (565)
T KOG0472|consen 47 LQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSS 123 (565)
T ss_pred hhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhccc
Confidence 356788999998 56667899999999999999999 78889999999999999999955 7899999999999999999
Q ss_pred CcccccCChhhhcCCCCCEEecCCCcccccCCccccCCCCCCEEee-------ecccccCCCCCCEEEccccccccCCCc
Q 041558 81 NQFISYIPSSFGNLTNLSTSRLSKNKLFVSIPNEIGKMRSLNILEV-------LPLSVSNLTNPKELALLYNCLSGSIPP 153 (495)
Q Consensus 81 n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l-------~~~~l~~~~~L~~L~l~~n~l~~~~~~ 153 (495)
|.+.. +|+.++.+..|+.++..+|+++ ..|.+++.+.+|..+++ +|+..-.++.|+++|...|.+. .+|+
T Consensus 124 n~~~e-l~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~m~~L~~ld~~~N~L~-tlP~ 200 (565)
T KOG0472|consen 124 NELKE-LPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIAMKRLKHLDCNSNLLE-TLPP 200 (565)
T ss_pred cceee-cCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHHHHHHHhcccchhhhh-cCCh
Confidence 99876 7788999999999999999994 78999998888887776 5555556899999999999876 6777
Q ss_pred cCcc-cccccccccccccccccCccCCCCCCCCEEEccCceeeeccCccccCCCCccEEEccCCcCcccCCCCCCCCCCC
Q 041558 154 SLEN-PMLARLGLDFNHFKRTIPKSLRSCTSLIRLCRNRNNLTRDISEALGIYPYLTFIDLSRNNFHGEIPSNREKCPKL 232 (495)
Q Consensus 154 ~~~~-~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L 232 (495)
.++. .+|+.|++..|++. ..| .|.+|..|+++.++.|++.....+....++++..||+.+|+++ ..|+.+.-+++|
T Consensus 201 ~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL 277 (565)
T KOG0472|consen 201 ELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSL 277 (565)
T ss_pred hhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhh
Confidence 7777 99999999999997 456 7999999999999999998777777779999999999999999 889999999999
Q ss_pred CEEecccccccccCCccccCCCCCceeccCCCeeeee--------------------------------------cCCCC
Q 041558 233 GTLGVLMNTITKGIPREIRNSSQRQALDLSLNHIIGE--------------------------------------IPKEL 274 (495)
Q Consensus 233 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~--------------------------------------~~~~~ 274 (495)
.+||+++|.+++ .|..++++ .|+.|.+.+|.+... .+..|
T Consensus 278 ~rLDlSNN~is~-Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~ 355 (565)
T KOG0472|consen 278 ERLDLSNNDISS-LPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESF 355 (565)
T ss_pred hhhcccCCcccc-CCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcc
Confidence 999999999998 78889988 888888888854200 00001
Q ss_pred cc---ccc--------------------------cceeeccccccc-----------------------ccCCcccCCCC
Q 041558 275 GK---LNS--------------------------LIKLILRRNQLV-----------------------GCLPTEIGSPI 302 (495)
Q Consensus 275 ~~---~~~--------------------------L~~L~L~~n~l~-----------------------~~~~~~~~~l~ 302 (495)
.. +.+ ....+++.|++. +.+|..+..++
T Consensus 356 ~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~ 435 (565)
T KOG0472|consen 356 PDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLCELPKRLVELKELVTDLVLSNNKISFVPLELSQLQ 435 (565)
T ss_pred cchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHhhhhhhhHHHHHHHHHHHhhcCccccchHHHHhhh
Confidence 00 001 234455555432 35666778899
Q ss_pred CCCEEeCCCCcCCCCchhhhhcCCCCCEEeCcCCcCCccchhHhhcCCCCCeEeccCCCCCCCCCcc--cccCCChhhcc
Q 041558 303 ELEYLDFSVNRFNNLIPESLENLLKLHYLGLCKNKLVQELPKILEKLVQFSELDLSYNFLGPIPNSI--AFRGASVEALK 380 (495)
Q Consensus 303 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~ls~n~l~~~p~~~--~~~~~~~~~~~ 380 (495)
+|..|+|++|.+.. +|..++.+..|+.||++.|+| ..+|.++..+..++.+-.++|+++.++.++ -.+......+.
T Consensus 436 kLt~L~L~NN~Ln~-LP~e~~~lv~Lq~LnlS~NrF-r~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~ 513 (565)
T KOG0472|consen 436 KLTFLDLSNNLLND-LPEEMGSLVRLQTLNLSFNRF-RMLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQ 513 (565)
T ss_pred cceeeecccchhhh-cchhhhhhhhhheeccccccc-ccchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccC
Confidence 99999999998876 588889999999999999999 678999999999999999999998888763 23344444454
Q ss_pred CCcCCCCCCCCCCCccc
Q 041558 381 GNKRLCVSAKGLQPCKA 397 (495)
Q Consensus 381 ~n~~~c~~~~~~~~c~~ 397 (495)
.|. +-..|+..+.|..
T Consensus 514 nNd-lq~IPp~Lgnmtn 529 (565)
T KOG0472|consen 514 NND-LQQIPPILGNMTN 529 (565)
T ss_pred CCc-hhhCChhhccccc
Confidence 443 3334444455543
No 9
>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]
Probab=99.96 E-value=6.8e-31 Score=259.82 Aligned_cols=371 Identities=29% Similarity=0.333 Sum_probs=214.5
Q ss_pred CcEEEeeCCcccccCCccCcCCccCCeeecccCcccccCCcccccCcccceeecccccccccCCccccCCCCCCeeeccC
Q 041558 1 MALLIIHNNSLSGFIPLNIGNSQFLWGLDLSNNQFSSSIPLSFGNLSNLIFLYLYENSYFASIPSNVGKLKSLGDLQLNG 80 (495)
Q Consensus 1 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~l~~ 80 (495)
|+.|+|++|++. ..|..+..+++|+.|.++.|.+. ..|.+..++.+|++|+|.+|.+ ...|..+..+.+|++|++++
T Consensus 47 L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l-~~lP~~~~~lknl~~LdlS~ 123 (1081)
T KOG0618|consen 47 LKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRL-QSLPASISELKNLQYLDLSF 123 (1081)
T ss_pred eEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchh-hcCchhHHhhhcccccccch
Confidence 467888888876 67878888888888888888887 5667777888888888888774 46777888888888888888
Q ss_pred CcccccCChhhhcCCCCCEEecCCC-------------------cccccCCccccCCCCCCEEee-----ecccccCCCC
Q 041558 81 NQFISYIPSSFGNLTNLSTSRLSKN-------------------KLFVSIPNEIGKMRSLNILEV-----LPLSVSNLTN 136 (495)
Q Consensus 81 n~l~~~~~~~~~~l~~L~~L~l~~n-------------------~~~~~~~~~~~~l~~L~~L~l-----~~~~l~~~~~ 136 (495)
|++.. +|..+..++.++++..++| .+.+.++.++..++. .|++ +-..+..+.+
T Consensus 124 N~f~~-~Pl~i~~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~~~dls~~~~ 200 (1081)
T KOG0618|consen 124 NHFGP-IPLVIEVLTAEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEMEVLDLSNLAN 200 (1081)
T ss_pred hccCC-CchhHHhhhHHHHHhhhcchhhhhhccccchhhhhhhhhcccchhcchhhhhe--eeecccchhhhhhhhhccc
Confidence 88654 5555554444444444444 333333333333333 2333 1122333444
Q ss_pred CCEEEcccccccc-------------------CCCccCcccccccccccccccccccCccCCCCCCCCEEEccCceeeec
Q 041558 137 PKELALLYNCLSG-------------------SIPPSLENPMLARLGLDFNHFKRTIPKSLRSCTSLIRLCRNRNNLTRD 197 (495)
Q Consensus 137 L~~L~l~~n~l~~-------------------~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~~~~~ 197 (495)
|+.+....|+++. .........+|+.++++.|++++ +|.|+..|.+|+.++..+|.++ .
T Consensus 201 l~~l~c~rn~ls~l~~~g~~l~~L~a~~n~l~~~~~~p~p~nl~~~dis~n~l~~-lp~wi~~~~nle~l~~n~N~l~-~ 278 (1081)
T KOG0618|consen 201 LEVLHCERNQLSELEISGPSLTALYADHNPLTTLDVHPVPLNLQYLDISHNNLSN-LPEWIGACANLEALNANHNRLV-A 278 (1081)
T ss_pred hhhhhhhhcccceEEecCcchheeeeccCcceeeccccccccceeeecchhhhhc-chHHHHhcccceEecccchhHH-h
Confidence 4444444333321 11111122578888888888874 5588888999999999888884 4
Q ss_pred cCccccCCCCccEEEccCCcCcccCCCCCCCCCCCCEEecccccccccCCcccc-------------------------C
Q 041558 198 ISEALGIYPYLTFIDLSRNNFHGEIPSNREKCPKLGTLGVLMNTITKGIPREIR-------------------------N 252 (495)
Q Consensus 198 ~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~-------------------------~ 252 (495)
.|..+....+|+.|.+..|.+. .+|....+.+.|++|+|..|++....+..+. .
T Consensus 279 lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~ 357 (1081)
T KOG0618|consen 279 LPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENN 357 (1081)
T ss_pred hHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchh
Confidence 4444445555555555555555 4555555566666666666665442111110 1
Q ss_pred CCCCceeccCCCeeeeecCCCCccccccceeecccccccccCCcccCCCCCCCEEeCCCCcCCCCchhhhhcCCCCCEEe
Q 041558 253 SSQRQALDLSLNHIIGEIPKELGKLNSLIKLILRRNQLVGCLPTEIGSPIELEYLDFSVNRFNNLIPESLENLLKLHYLG 332 (495)
Q Consensus 253 l~~L~~L~ls~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 332 (495)
.+.|+.|++.+|.+++..-..+.++..|+.|+|++|++.......+.+++.|++|+||+|+++.+ |+++..+..|++|.
T Consensus 358 ~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~~L-p~tva~~~~L~tL~ 436 (1081)
T KOG0618|consen 358 HAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLTTL-PDTVANLGRLHTLR 436 (1081)
T ss_pred hHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhhhh-hHHHHhhhhhHHHh
Confidence 23445556666666555544555666666666666666633333455566666666666666543 45555555555555
Q ss_pred CcCCcCCccchhHhhcCCCCCeEeccCCCC--CCCCCcccccCCChhhccCCc
Q 041558 333 LCKNKLVQELPKILEKLVQFSELDLSYNFL--GPIPNSIAFRGASVEALKGNK 383 (495)
Q Consensus 333 l~~n~l~~~~~~~~~~l~~L~~l~ls~n~l--~~~p~~~~~~~~~~~~~~~n~ 383 (495)
..+|++. ..| .+..++.|+.+|+|.|.+ ..+|....++......+.||.
T Consensus 437 ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 437 AHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNT 487 (1081)
T ss_pred hcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCc
Confidence 5555552 223 444555555555555555 333333322333333444444
No 10
>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]
Probab=99.93 E-value=3.8e-28 Score=240.54 Aligned_cols=346 Identities=27% Similarity=0.311 Sum_probs=180.1
Q ss_pred CcEEEeeCCcccccCCccCcCCccCCeeecccCcccccCCcccccCcccceeecccccccccCCccccCCCC--------
Q 041558 1 MALLIIHNNSLSGFIPLNIGNSQFLWGLDLSNNQFSSSIPLSFGNLSNLIFLYLYENSYFASIPSNVGKLKS-------- 72 (495)
Q Consensus 1 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~l~~-------- 72 (495)
|+.|+++.|.+. ..|.+..++.+|++|.|.+|.+. ..|..+..+++|++|++++|.+. .+|..+..+..
T Consensus 70 L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~ 146 (1081)
T KOG0618|consen 70 LRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASN 146 (1081)
T ss_pred HhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhc
Confidence 456666777666 55666667777777777776666 66666777777777777777643 33333332222
Q ss_pred -----------CCeeeccCCcccccCChhhhcCCCCCEEecCCCcccccCCccccCC-----------------------
Q 041558 73 -----------LGDLQLNGNQFISYIPSSFGNLTNLSTSRLSKNKLFVSIPNEIGKM----------------------- 118 (495)
Q Consensus 73 -----------L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l----------------------- 118 (495)
.+.+++..|.+.+.++..+..++. .|+|++|.+... .+..+
T Consensus 147 N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~~~---dls~~~~l~~l~c~rn~ls~l~~~g~~l 221 (1081)
T KOG0618|consen 147 NEKIQRLGQTSIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEMEVL---DLSNLANLEVLHCERNQLSELEISGPSL 221 (1081)
T ss_pred chhhhhhccccchhhhhhhhhcccchhcchhhhhe--eeecccchhhhh---hhhhccchhhhhhhhcccceEEecCcch
Confidence 233333333333333333333333 355555554311 11111
Q ss_pred -------------------CCCCEEee-------ecccccCCCCCCEEEccccccccCCCccCcc-cccccccccccccc
Q 041558 119 -------------------RSLNILEV-------LPLSVSNLTNPKELALLYNCLSGSIPPSLEN-PMLARLGLDFNHFK 171 (495)
Q Consensus 119 -------------------~~L~~L~l-------~~~~l~~~~~L~~L~l~~n~l~~~~~~~~~~-~~L~~L~l~~n~~~ 171 (495)
.+|+.+++ +|+++..+.+|+.++...|+++ .+|..+.. .+|+.+++..|.++
T Consensus 222 ~~L~a~~n~l~~~~~~p~p~nl~~~dis~n~l~~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~ 300 (1081)
T KOG0618|consen 222 TALYADHNPLTTLDVHPVPLNLQYLDISHNNLSNLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE 300 (1081)
T ss_pred heeeeccCcceeeccccccccceeeecchhhhhcchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh
Confidence 12222322 5566666666666666666664 34443333 66666666666665
Q ss_pred cccCccCCCCCCCCEEEccCceeeeccCccccCCCC-ccEEEccCCcCcccCCC-CCCCCCCCCEEecccccccccCCcc
Q 041558 172 RTIPKSLRSCTSLIRLCRNRNNLTRDISEALGIYPY-LTFIDLSRNNFHGEIPS-NREKCPKLGTLGVLMNTITKGIPRE 249 (495)
Q Consensus 172 ~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~-L~~L~l~~n~l~~~~~~-~~~~~~~L~~L~l~~n~l~~~~~~~ 249 (495)
.+|....+.+.|+.|++..|++....+..+..... |..|..+.|.+. ..|. .=...+.|+.|++.+|.++...-+.
T Consensus 301 -yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~-~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~ 378 (1081)
T KOG0618|consen 301 -YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLS-TLPSYEENNHAALQELYLANNHLTDSCFPV 378 (1081)
T ss_pred -hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhcccc-ccccccchhhHHHHHHHHhcCcccccchhh
Confidence 35555666777777777777776544433332222 333333333332 1111 0112334555555666655555555
Q ss_pred ccCCCCCceeccCCCeeeeecCC-CCccccccceeecccccccccCCcccCCCCCCCEEeCCCCcCCCCchhhhhcCCCC
Q 041558 250 IRNSSQRQALDLSLNHIIGEIPK-ELGKLNSLIKLILRRNQLVGCLPTEIGSPIELEYLDFSVNRFNNLIPESLENLLKL 328 (495)
Q Consensus 250 ~~~l~~L~~L~ls~n~l~~~~~~-~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L 328 (495)
+.+...|+.|+|++|++. .+|+ .+.++..|+.|+|++|+++ .+|+.+..+..|++|...+|.+... | .+..++.|
T Consensus 379 l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~~f-P-e~~~l~qL 454 (1081)
T KOG0618|consen 379 LVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLLSF-P-ELAQLPQL 454 (1081)
T ss_pred hccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCceeec-h-hhhhcCcc
Confidence 555556666666666555 2332 3455555666666666665 4555555555555555555555443 2 45555555
Q ss_pred CEEeCcCCcCCccchhHhhcCCCCCeEeccCCC
Q 041558 329 HYLGLCKNKLVQELPKILEKLVQFSELDLSYNF 361 (495)
Q Consensus 329 ~~L~l~~n~l~~~~~~~~~~l~~L~~l~ls~n~ 361 (495)
+.+|++.|.++...-......++|++||+++|.
T Consensus 455 ~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 455 KVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNT 487 (1081)
T ss_pred eEEecccchhhhhhhhhhCCCcccceeeccCCc
Confidence 666666555544332222233555566666555
No 11
>PLN03210 Resistant to P. syringae 6; Provisional
Probab=99.93 E-value=2.9e-24 Score=235.61 Aligned_cols=334 Identities=19% Similarity=0.220 Sum_probs=250.9
Q ss_pred CCccCcCCccCCeeecccCc------ccccCCcccccCc-ccceeecccccccccCCccccCCCCCCeeeccCCcccccC
Q 041558 15 IPLNIGNSQFLWGLDLSNNQ------FSSSIPLSFGNLS-NLIFLYLYENSYFASIPSNVGKLKSLGDLQLNGNQFISYI 87 (495)
Q Consensus 15 ~~~~~~~l~~L~~L~l~~n~------l~~~~~~~~~~l~-~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 87 (495)
.+.+|..+++|+.|.+..+. +...+|..|..++ +|+.|++.++.+ ..+|..| ...+|++|++++|.+.. +
T Consensus 550 ~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l-~~lP~~f-~~~~L~~L~L~~s~l~~-L 626 (1153)
T PLN03210 550 HENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPL-RCMPSNF-RPENLVKLQMQGSKLEK-L 626 (1153)
T ss_pred cHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCC-CCCCCcC-CccCCcEEECcCccccc-c
Confidence 34568888999999886653 2334677777664 599999988875 4567766 46889999999988765 6
Q ss_pred ChhhhcCCCCCEEecCCCcccccCCccccCCCCCCEEee--------ecccccCCCCCCEEEccccccccCCCccCcccc
Q 041558 88 PSSFGNLTNLSTSRLSKNKLFVSIPNEIGKMRSLNILEV--------LPLSVSNLTNPKELALLYNCLSGSIPPSLENPM 159 (495)
Q Consensus 88 ~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l--------~~~~l~~~~~L~~L~l~~n~l~~~~~~~~~~~~ 159 (495)
+..+..+++|+.|+|+++.....+|. +..+++|+.|++ +|..+..+++|+.|++++|.....+|..+..++
T Consensus 627 ~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i~l~s 705 (1153)
T PLN03210 627 WDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGINLKS 705 (1153)
T ss_pred ccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcCCCCC
Confidence 77788899999999988765566764 777888888887 677888888999999988766667777665588
Q ss_pred cccccccccccccccCccCCCCCCCCEEEccCceeeeccCccccCCCCccEEEccCCcCc-------ccCCCCCCCCCCC
Q 041558 160 LARLGLDFNHFKRTIPKSLRSCTSLIRLCRNRNNLTRDISEALGIYPYLTFIDLSRNNFH-------GEIPSNREKCPKL 232 (495)
Q Consensus 160 L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~-------~~~~~~~~~~~~L 232 (495)
|+.|++++|.....+|.. ..+|+.|++++|.+.. +|..+ .+++|++|.+.++... ...+......++|
T Consensus 706 L~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~~-lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL 780 (1153)
T PLN03210 706 LYRLNLSGCSRLKSFPDI---STNISWLDLDETAIEE-FPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSL 780 (1153)
T ss_pred CCEEeCCCCCCccccccc---cCCcCeeecCCCcccc-ccccc-cccccccccccccchhhccccccccchhhhhccccc
Confidence 899999888655555543 4578888999888764 44433 5678888888764321 1112223345688
Q ss_pred CEEecccccccccCCccccCCCCCceeccCCCeeeeecCCCCccccccceeecccccccccCCcccCCCCCCCEEeCCCC
Q 041558 233 GTLGVLMNTITKGIPREIRNSSQRQALDLSLNHIIGEIPKELGKLNSLIKLILRRNQLVGCLPTEIGSPIELEYLDFSVN 312 (495)
Q Consensus 233 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n 312 (495)
+.|++++|...+.+|..+.++++|+.|++++|...+.+|... .+++|+.|++++|.....+|.. .++|+.|+|++|
T Consensus 781 ~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n 856 (1153)
T PLN03210 781 TRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRT 856 (1153)
T ss_pred hheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCC
Confidence 999999998888888889999999999999876555777665 6888999999988665556543 367889999999
Q ss_pred cCCCCchhhhhcCCCCCEEeCcCCcCCccchhHhhcCCCCCeEeccCCCC
Q 041558 313 RFNNLIPESLENLLKLHYLGLCKNKLVQELPKILEKLVQFSELDLSYNFL 362 (495)
Q Consensus 313 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~ls~n~l 362 (495)
.++. +|..+..+++|+.|++++|+-...+|..+..+++|+.+++++|.-
T Consensus 857 ~i~~-iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C~~ 905 (1153)
T PLN03210 857 GIEE-VPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDCGA 905 (1153)
T ss_pred CCcc-ChHHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCCCcc
Confidence 8875 577888899999999998655455777777888888888888853
No 12
>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]
Probab=99.92 E-value=2.1e-27 Score=214.17 Aligned_cols=264 Identities=23% Similarity=0.219 Sum_probs=181.1
Q ss_pred cEEEeeCCcccccCCccCcCCccCCeeecccCcccccCCcccccCcccceeeccc-ccccccCCccccCCCCCCeeeccC
Q 041558 2 ALLIIHNNSLSGFIPLNIGNSQFLWGLDLSNNQFSSSIPLSFGNLSNLIFLYLYE-NSYFASIPSNVGKLKSLGDLQLNG 80 (495)
Q Consensus 2 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~-n~~~~~~~~~~~~l~~L~~L~l~~ 80 (495)
..++|..|+|+...|.+|+.+++|++||||+|+|+.+.|++|.++++|..|-+.+ |+|+....+.|.++..|+.|.+.-
T Consensus 70 veirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNa 149 (498)
T KOG4237|consen 70 VEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNA 149 (498)
T ss_pred eEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcCh
Confidence 3678899999977778899999999999999999999999999999988887777 888776667899999999999999
Q ss_pred CcccccCChhhhcCCCCCEEecCCCcccccCCc-cccCCCCCCEEee--------------------ecccccCCCCCCE
Q 041558 81 NQFISYIPSSFGNLTNLSTSRLSKNKLFVSIPN-EIGKMRSLNILEV--------------------LPLSVSNLTNPKE 139 (495)
Q Consensus 81 n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~-~~~~l~~L~~L~l--------------------~~~~l~~~~~L~~ 139 (495)
|++..+..+.|..+++|..|.+.+|.+. .++. .|..+..++.+.+ .|.+++.......
T Consensus 150 n~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p 228 (498)
T KOG4237|consen 150 NHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSP 228 (498)
T ss_pred hhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecch
Confidence 9998888899999999999999999885 4444 6666666666655 1122222222222
Q ss_pred EEccccccccCCCccCcc--cccccccccccccccccC-ccCCCCCCCCEEEccCceeeeccCccccCCCCccEEEccCC
Q 041558 140 LALLYNCLSGSIPPSLEN--PMLARLGLDFNHFKRTIP-KSLRSCTSLIRLCRNRNNLTRDISEALGIYPYLTFIDLSRN 216 (495)
Q Consensus 140 L~l~~n~l~~~~~~~~~~--~~L~~L~l~~n~~~~~~~-~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n 216 (495)
..+.++++...-+..+.. ..+..-..+.+...+..| ..|..+++|+.|++++|.++++.+.+|.....++.|.|..|
T Consensus 229 ~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N 308 (498)
T KOG4237|consen 229 YRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRN 308 (498)
T ss_pred HHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcc
Confidence 223333332222222211 111111111121222222 34667777777777777777777777777777777777777
Q ss_pred cCcccCCCCCCCCCCCCEEecccccccccCCccccCCCCCceeccCCCee
Q 041558 217 NFHGEIPSNREKCPKLGTLGVLMNTITKGIPREIRNSSQRQALDLSLNHI 266 (495)
Q Consensus 217 ~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l 266 (495)
++...-...|.++..|+.|+|.+|+|+...|.+|..+.+|.+|.+-.|.+
T Consensus 309 ~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~ 358 (498)
T KOG4237|consen 309 KLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPF 358 (498)
T ss_pred hHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcc
Confidence 77655566666777777777777777776777777777777776665543
No 13
>PLN03210 Resistant to P. syringae 6; Provisional
Probab=99.92 E-value=6.1e-24 Score=233.15 Aligned_cols=323 Identities=22% Similarity=0.223 Sum_probs=243.2
Q ss_pred CcEEEeeCCc------ccccCCccCcCCc-cCCeeecccCcccccCCcccccCcccceeecccccccccCCccccCCCCC
Q 041558 1 MALLIIHNNS------LSGFIPLNIGNSQ-FLWGLDLSNNQFSSSIPLSFGNLSNLIFLYLYENSYFASIPSNVGKLKSL 73 (495)
Q Consensus 1 L~~L~l~~n~------l~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L 73 (495)
|+.|.+..+. +...+|..|..++ +|+.|++.++.+. .+|..| ...+|++|++.+|++. .++..+..+++|
T Consensus 560 L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~L 636 (1153)
T PLN03210 560 LLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGL 636 (1153)
T ss_pred ccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccccccCCCC
Confidence 4566665442 3345677777665 5888888888776 667666 4678888888888865 466667788888
Q ss_pred CeeeccCCcccccCChhhhcCCCCCEEecCCCcccccCCccccCCCCCCEEee--------ecccccCCCCCCEEEcccc
Q 041558 74 GDLQLNGNQFISYIPSSFGNLTNLSTSRLSKNKLFVSIPNEIGKMRSLNILEV--------LPLSVSNLTNPKELALLYN 145 (495)
Q Consensus 74 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l--------~~~~l~~~~~L~~L~l~~n 145 (495)
++|+|+++...+.+|. +..+++|+.|++++|.....+|..++++++|+.|++ +|..+ ++++|+.|++++|
T Consensus 637 k~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc 714 (1153)
T PLN03210 637 RNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGC 714 (1153)
T ss_pred CEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCC
Confidence 8888887764455553 777888888888887766778888888888888877 45444 6788999999998
Q ss_pred ccccCCCccCcccccccccccccccccccCccCCCCCCCCEEEccCceee-------eccCccccCCCCccEEEccCCcC
Q 041558 146 CLSGSIPPSLENPMLARLGLDFNHFKRTIPKSLRSCTSLIRLCRNRNNLT-------RDISEALGIYPYLTFIDLSRNNF 218 (495)
Q Consensus 146 ~l~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~~~-------~~~~~~~~~~~~L~~L~l~~n~l 218 (495)
.....+|... ++|++|++++|.+. .+|..+ .+++|+.|.+.++... ...+..+...++|+.|++++|..
T Consensus 715 ~~L~~~p~~~--~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~ 790 (1153)
T PLN03210 715 SRLKSFPDIS--TNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPS 790 (1153)
T ss_pred CCcccccccc--CCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhhccccchheeCCCCCC
Confidence 6555555432 68899999999876 456544 5788888888764321 12222333457899999999988
Q ss_pred cccCCCCCCCCCCCCEEecccccccccCCccccCCCCCceeccCCCeeeeecCCCCccccccceeecccccccccCCccc
Q 041558 219 HGEIPSNREKCPKLGTLGVLMNTITKGIPREIRNSSQRQALDLSLNHIIGEIPKELGKLNSLIKLILRRNQLVGCLPTEI 298 (495)
Q Consensus 219 ~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~ 298 (495)
.+.+|..++.+++|+.|++++|...+.+|... .+++|+.|++++|.....+|.. ..+|+.|+|++|.++ .+|..+
T Consensus 791 l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si 865 (1153)
T PLN03210 791 LVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWI 865 (1153)
T ss_pred ccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHH
Confidence 87899999999999999999987666677765 6899999999998665555543 367999999999998 788889
Q ss_pred CCCCCCCEEeCCCCcCCCCchhhhhcCCCCCEEeCcCCc
Q 041558 299 GSPIELEYLDFSVNRFNNLIPESLENLLKLHYLGLCKNK 337 (495)
Q Consensus 299 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~ 337 (495)
..+++|++|++++|.-...+|..+..+++|+.+++++|.
T Consensus 866 ~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 866 EKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred hcCCCCCEEECCCCCCcCccCcccccccCCCeeecCCCc
Confidence 999999999999964333456678888999999999885
No 14
>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional
Probab=99.89 E-value=2.4e-22 Score=205.41 Aligned_cols=166 Identities=26% Similarity=0.316 Sum_probs=93.9
Q ss_pred cccccccccccccccccCccCCCCCCCCEEEccCceeeeccCccccCCCCccEEEccCCcCcccCCCCCCCCCCCCEEec
Q 041558 158 PMLARLGLDFNHFKRTIPKSLRSCTSLIRLCRNRNNLTRDISEALGIYPYLTFIDLSRNNFHGEIPSNREKCPKLGTLGV 237 (495)
Q Consensus 158 ~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l 237 (495)
++|+.|++++|.+++ +|.. ...|+.|++++|.+++ +|. ...+|+.|++++|+++ .+|.. .++|+.|++
T Consensus 302 ~~L~~LdLS~N~L~~-Lp~l---p~~L~~L~Ls~N~L~~-LP~---lp~~Lq~LdLS~N~Ls-~LP~l---p~~L~~L~L 369 (788)
T PRK15387 302 PGLQELSVSDNQLAS-LPAL---PSELCKLWAYNNQLTS-LPT---LPSGLQELSVSDNQLA-SLPTL---PSELYKLWA 369 (788)
T ss_pred cccceeECCCCcccc-CCCC---cccccccccccCcccc-ccc---cccccceEecCCCccC-CCCCC---Ccccceehh
Confidence 344555555554443 2221 1234555555555543 221 1135666666666666 34432 235566666
Q ss_pred ccccccccCCccccCCCCCceeccCCCeeeeecCCCCccccccceeecccccccccCCcccCCCCCCCEEeCCCCcCCCC
Q 041558 238 LMNTITKGIPREIRNSSQRQALDLSLNHIIGEIPKELGKLNSLIKLILRRNQLVGCLPTEIGSPIELEYLDFSVNRFNNL 317 (495)
Q Consensus 238 ~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~ 317 (495)
++|.+.. +|.. ..+|+.|++++|.++ .+|.. .++|+.|++++|.++ .+|.. ..+|+.|++++|.++.
T Consensus 370 s~N~L~~-LP~l---~~~L~~LdLs~N~Lt-~LP~l---~s~L~~LdLS~N~Ls-sIP~l---~~~L~~L~Ls~NqLt~- 436 (788)
T PRK15387 370 YNNRLTS-LPAL---PSGLKELIVSGNRLT-SLPVL---PSELKELMVSGNRLT-SLPML---PSGLLSLSVYRNQLTR- 436 (788)
T ss_pred hcccccc-Cccc---ccccceEEecCCccc-CCCCc---ccCCCEEEccCCcCC-CCCcc---hhhhhhhhhccCcccc-
Confidence 6666664 4432 235667777777766 34432 245677777777776 35543 2456677777777764
Q ss_pred chhhhhcCCCCCEEeCcCCcCCccchhHhhc
Q 041558 318 IPESLENLLKLHYLGLCKNKLVQELPKILEK 348 (495)
Q Consensus 318 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 348 (495)
+|..+..+++|+.|+|++|++++..+..+..
T Consensus 437 LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~ 467 (788)
T PRK15387 437 LPESLIHLSSETTVNLEGNPLSERTLQALRE 467 (788)
T ss_pred cChHHhhccCCCeEECCCCCCCchHHHHHHH
Confidence 4666777777777777777777766666543
No 15
>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional
Probab=99.88 E-value=5.8e-22 Score=202.58 Aligned_cols=264 Identities=22% Similarity=0.235 Sum_probs=182.5
Q ss_pred EEEeeCCcccccCCccCcCCccCCeeecccCcccccCCcccccCcccceeecccccccccCCccccCCCCCCeeeccCCc
Q 041558 3 LLIIHNNSLSGFIPLNIGNSQFLWGLDLSNNQFSSSIPLSFGNLSNLIFLYLYENSYFASIPSNVGKLKSLGDLQLNGNQ 82 (495)
Q Consensus 3 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~l~~n~ 82 (495)
.|++++|.++ .+|+.+. ++|+.|++++|+++ .+|. ..++|++|++++|+++. +|.. .++|+.|++++|.
T Consensus 205 ~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~---lp~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~Ls~N~ 273 (788)
T PRK15387 205 VLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTS-LPVL---PPGLLELSIFSNP 273 (788)
T ss_pred EEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCC---CCCCCcEEEecCCccCc-ccCc---ccccceeeccCCc
Confidence 5778888887 5777665 37888888888887 3553 25678888888887764 4432 3577788888887
Q ss_pred ccccCChhhhcCCCCCEEecCCCcccccCCccccCCCCCCEEeeecccccCCCCCCEEEccccccccCCCccCccccccc
Q 041558 83 FISYIPSSFGNLTNLSTSRLSKNKLFVSIPNEIGKMRSLNILEVLPLSVSNLTNPKELALLYNCLSGSIPPSLENPMLAR 162 (495)
Q Consensus 83 l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~~~l~~~~~L~~L~l~~n~l~~~~~~~~~~~~L~~ 162 (495)
++. +|.. ..+|+.|++++|+++ .+|.. .++|+.|++++|++++ +|.. ...|+.
T Consensus 274 L~~-Lp~l---p~~L~~L~Ls~N~Lt-~LP~~-------------------p~~L~~LdLS~N~L~~-Lp~l--p~~L~~ 326 (788)
T PRK15387 274 LTH-LPAL---PSGLCKLWIFGNQLT-SLPVL-------------------PPGLQELSVSDNQLAS-LPAL--PSELCK 326 (788)
T ss_pred hhh-hhhc---hhhcCEEECcCCccc-ccccc-------------------ccccceeECCCCcccc-CCCC--cccccc
Confidence 764 4432 256777888888774 33321 2567888888888775 3331 146778
Q ss_pred ccccccccccccCccCCCCCCCCEEEccCceeeeccCccccCCCCccEEEccCCcCcccCCCCCCCCCCCCEEecccccc
Q 041558 163 LGLDFNHFKRTIPKSLRSCTSLIRLCRNRNNLTRDISEALGIYPYLTFIDLSRNNFHGEIPSNREKCPKLGTLGVLMNTI 242 (495)
Q Consensus 163 L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l 242 (495)
|++++|.+++ +|.. ..+|+.|++++|++++. |.. .++|+.|++++|.++ .+|.. ..+|+.|++++|.+
T Consensus 327 L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~L-P~l---p~~L~~L~Ls~N~L~-~LP~l---~~~L~~LdLs~N~L 394 (788)
T PRK15387 327 LWAYNNQLTS-LPTL---PSGLQELSVSDNQLASL-PTL---PSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRL 394 (788)
T ss_pred cccccCcccc-cccc---ccccceEecCCCccCCC-CCC---Ccccceehhhccccc-cCccc---ccccceEEecCCcc
Confidence 8888888764 4432 24788888888888753 322 356778888888887 45543 24688888888888
Q ss_pred cccCCccccCCCCCceeccCCCeeeeecCCCCccccccceeecccccccccCCcccCCCCCCCEEeCCCCcCCCCchhhh
Q 041558 243 TKGIPREIRNSSQRQALDLSLNHIIGEIPKELGKLNSLIKLILRRNQLVGCLPTEIGSPIELEYLDFSVNRFNNLIPESL 322 (495)
Q Consensus 243 ~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~ 322 (495)
++ +|.. .++|+.|++++|.++ .+|.. ..+|+.|++++|+++ .+|..+..+++|+.|+|++|.+++..+..+
T Consensus 395 t~-LP~l---~s~L~~LdLS~N~Ls-sIP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L 465 (788)
T PRK15387 395 TS-LPVL---PSELKELMVSGNRLT-SLPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQAL 465 (788)
T ss_pred cC-CCCc---ccCCCEEEccCCcCC-CCCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHH
Confidence 76 4443 256888888888887 45643 245777888888888 678888888888888888888888777666
Q ss_pred hcC
Q 041558 323 ENL 325 (495)
Q Consensus 323 ~~l 325 (495)
..+
T Consensus 466 ~~l 468 (788)
T PRK15387 466 REI 468 (788)
T ss_pred HHH
Confidence 443
No 16
>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]
Probab=99.86 E-value=9.2e-24 Score=190.79 Aligned_cols=218 Identities=23% Similarity=0.230 Sum_probs=161.7
Q ss_pred CcEEEeeCCcccccCCccCcCCccCCeeeccc-CcccccCCcccccCcccceeecccccccccCCccccCCCCCCeeecc
Q 041558 1 MALLIIHNNSLSGFIPLNIGNSQFLWGLDLSN-NQFSSSIPLSFGNLSNLIFLYLYENSYFASIPSNVGKLKSLGDLQLN 79 (495)
Q Consensus 1 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~-n~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~l~ 79 (495)
||+||||+|+|+..-|++|..++.|.+|-+-+ |+|+....+.|+++..|+.|.+.-|++.....+.|..+++|..|.+.
T Consensus 93 LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLsly 172 (498)
T KOG4237|consen 93 LRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLY 172 (498)
T ss_pred hceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhccc
Confidence 68999999999999999999999988876655 99997777889999999999999999998888999999999999999
Q ss_pred CCcccccCChhhhcCCCCCEEecCCCccc------------ccCCccccCCCCCCEEee---------------------
Q 041558 80 GNQFISYIPSSFGNLTNLSTSRLSKNKLF------------VSIPNEIGKMRSLNILEV--------------------- 126 (495)
Q Consensus 80 ~n~l~~~~~~~~~~l~~L~~L~l~~n~~~------------~~~~~~~~~l~~L~~L~l--------------------- 126 (495)
+|.+..+--.+|..+..++++.+..|.+- ...|..++.....+-..+
T Consensus 173 Dn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~ 252 (498)
T KOG4237|consen 173 DNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLP 252 (498)
T ss_pred chhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHH
Confidence 99987755568999999999999998841 112222222221111111
Q ss_pred ------------ec-ccccCCCCCCEEEccccccccCCCccCcc-cccccccccccccccccCccCCCCCCCCEEEccCc
Q 041558 127 ------------LP-LSVSNLTNPKELALLYNCLSGSIPPSLEN-PMLARLGLDFNHFKRTIPKSLRSCTSLIRLCRNRN 192 (495)
Q Consensus 127 ------------~~-~~l~~~~~L~~L~l~~n~l~~~~~~~~~~-~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n 192 (495)
.| ..|..+++|++|++++|++++.-+.+|.. ..+++|.|..|++...-...|.++..|+.|+|.+|
T Consensus 253 s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N 332 (498)
T KOG4237|consen 253 SRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDN 332 (498)
T ss_pred HhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCC
Confidence 11 23556677777777777777666666665 67777777777766555566677777777777777
Q ss_pred eeeeccCccccCCCCccEEEccCCcC
Q 041558 193 NLTRDISEALGIYPYLTFIDLSRNNF 218 (495)
Q Consensus 193 ~~~~~~~~~~~~~~~L~~L~l~~n~l 218 (495)
+|+...|.+|..+..|.+|.+-.|.+
T Consensus 333 ~it~~~~~aF~~~~~l~~l~l~~Np~ 358 (498)
T KOG4237|consen 333 QITTVAPGAFQTLFSLSTLNLLSNPF 358 (498)
T ss_pred eeEEEecccccccceeeeeehccCcc
Confidence 77777777777777777776665543
No 17
>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional
Probab=99.84 E-value=7e-21 Score=195.95 Aligned_cols=220 Identities=25% Similarity=0.415 Sum_probs=112.8
Q ss_pred EEEeeCCcccccCCccCcCCccCCeeecccCcccccCCcccccCcccceeecccccccccCCccccCCCCCCeeeccCCc
Q 041558 3 LLIIHNNSLSGFIPLNIGNSQFLWGLDLSNNQFSSSIPLSFGNLSNLIFLYLYENSYFASIPSNVGKLKSLGDLQLNGNQ 82 (495)
Q Consensus 3 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~l~~n~ 82 (495)
.|+++++.++ .+|..+. ++|+.|++++|+++ .+|..+. ++|++|++++|++. .+|..+. .+|+.|+|++|.
T Consensus 182 ~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~ 252 (754)
T PRK15370 182 ELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINR 252 (754)
T ss_pred EEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCc
Confidence 4666666666 4555443 35666677766666 3444332 36666666666655 3444332 356666666666
Q ss_pred ccccCChhhhcCCCCCEEecCCCcccccCCccccCCCCCCEEeeecccccCCCCCCEEEccccccccCCCccCccccccc
Q 041558 83 FISYIPSSFGNLTNLSTSRLSKNKLFVSIPNEIGKMRSLNILEVLPLSVSNLTNPKELALLYNCLSGSIPPSLENPMLAR 162 (495)
Q Consensus 83 l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~~~l~~~~~L~~L~l~~n~l~~~~~~~~~~~~L~~ 162 (495)
+.. +|..+. ++|+.|++++|++. .+|..+ .++|+.|++++|.+++ +|..+. ++|+.
T Consensus 253 L~~-LP~~l~--s~L~~L~Ls~N~L~-~LP~~l------------------~~sL~~L~Ls~N~Lt~-LP~~lp-~sL~~ 308 (754)
T PRK15370 253 ITE-LPERLP--SALQSLDLFHNKIS-CLPENL------------------PEELRYLSVYDNSIRT-LPAHLP-SGITH 308 (754)
T ss_pred cCc-CChhHh--CCCCEEECcCCccC-cccccc------------------CCCCcEEECCCCcccc-Ccccch-hhHHH
Confidence 653 454443 45666666666664 344322 1245666666666653 332221 35666
Q ss_pred ccccccccccccCccCCCCCCCCEEEccCceeeeccCccccCCCCccEEEccCCcCcccCCCCCCCCCCCCEEecccccc
Q 041558 163 LGLDFNHFKRTIPKSLRSCTSLIRLCRNRNNLTRDISEALGIYPYLTFIDLSRNNFHGEIPSNREKCPKLGTLGVLMNTI 242 (495)
Q Consensus 163 L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l 242 (495)
|++++|.++. +|..+ .++|+.|++++|.+++ +|..+ .++|+.|++++|+++ .+|..+. ++|+.|++++|.+
T Consensus 309 L~Ls~N~Lt~-LP~~l--~~sL~~L~Ls~N~Lt~-LP~~l--~~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~L 379 (754)
T PRK15370 309 LNVQSNSLTA-LPETL--PPGLKTLEAGENALTS-LPASL--PPELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNAL 379 (754)
T ss_pred HHhcCCcccc-CCccc--cccceeccccCCcccc-CChhh--cCcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcC
Confidence 6666666553 33222 1455555555555554 23222 245555555555554 3343331 3455555555555
Q ss_pred cccCCccccCCCCCceeccCCCeee
Q 041558 243 TKGIPREIRNSSQRQALDLSLNHII 267 (495)
Q Consensus 243 ~~~~~~~~~~l~~L~~L~ls~n~l~ 267 (495)
.. +|..+. ..|+.|++++|++.
T Consensus 380 t~-LP~~l~--~sL~~LdLs~N~L~ 401 (754)
T PRK15370 380 TN-LPENLP--AALQIMQASRNNLV 401 (754)
T ss_pred CC-CCHhHH--HHHHHHhhccCCcc
Confidence 43 333322 23445555555544
No 18
>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional
Probab=99.82 E-value=2.2e-20 Score=192.26 Aligned_cols=223 Identities=27% Similarity=0.394 Sum_probs=112.7
Q ss_pred cCCeeecccCcccccCCcccccCcccceeecccccccccCCccccCCCCCCeeeccCCcccccCChhhhcCCCCCEEecC
Q 041558 24 FLWGLDLSNNQFSSSIPLSFGNLSNLIFLYLYENSYFASIPSNVGKLKSLGDLQLNGNQFISYIPSSFGNLTNLSTSRLS 103 (495)
Q Consensus 24 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 103 (495)
+...|++++++++ .+|..+. ++|+.|+|++|+++ .+|..+. .+|++|++++|.+++ +|..+. .+|+.|+++
T Consensus 179 ~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lts-LP~~l~--~~L~~L~Ls 249 (754)
T PRK15370 179 NKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLTS-IPATLP--DTIQEMELS 249 (754)
T ss_pred CceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCcccc-CChhhh--ccccEEECc
Confidence 4567777777777 4555442 46777777777766 3454443 467777777777764 455443 367777777
Q ss_pred CCcccccCCccccCCCCCCEEeeecccccCCCCCCEEEccccccccCCCccCcccccccccccccccccccCccCCCCCC
Q 041558 104 KNKLFVSIPNEIGKMRSLNILEVLPLSVSNLTNPKELALLYNCLSGSIPPSLENPMLARLGLDFNHFKRTIPKSLRSCTS 183 (495)
Q Consensus 104 ~n~~~~~~~~~~~~l~~L~~L~l~~~~l~~~~~L~~L~l~~n~l~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~ 183 (495)
+|++. .+|..+. .+|+.|++++|.++ .+|..+. ++|+.|++++|.+++ +|..+. ++
T Consensus 250 ~N~L~-~LP~~l~------------------s~L~~L~Ls~N~L~-~LP~~l~-~sL~~L~Ls~N~Lt~-LP~~lp--~s 305 (754)
T PRK15370 250 INRIT-ELPERLP------------------SALQSLDLFHNKIS-CLPENLP-EELRYLSVYDNSIRT-LPAHLP--SG 305 (754)
T ss_pred CCccC-cCChhHh------------------CCCCEEECcCCccC-ccccccC-CCCcEEECCCCcccc-Ccccch--hh
Confidence 77764 4454321 24566666666665 3443332 355566666655553 232221 24
Q ss_pred CCEEEccCceeeeccCccccCCCCccEEEccCCcCcccCCCCCCCCCCCCEEecccccccccCCccccCCCCCceeccCC
Q 041558 184 LIRLCRNRNNLTRDISEALGIYPYLTFIDLSRNNFHGEIPSNREKCPKLGTLGVLMNTITKGIPREIRNSSQRQALDLSL 263 (495)
Q Consensus 184 L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~ 263 (495)
|+.|++++|.++.. |..+ .++|+.|++++|.+++ +|..+. ++|+.|++++|++.. +|..+. ++|+.|++++
T Consensus 306 L~~L~Ls~N~Lt~L-P~~l--~~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~~-LP~~lp--~~L~~LdLs~ 376 (754)
T PRK15370 306 ITHLNVQSNSLTAL-PETL--PPGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQITV-LPETLP--PTITTLDVSR 376 (754)
T ss_pred HHHHHhcCCccccC-Cccc--cccceeccccCCcccc-CChhhc--CcccEEECCCCCCCc-CChhhc--CCcCEEECCC
Confidence 55555555555432 2111 1345555555555442 333321 344555555554442 333221 3444444444
Q ss_pred CeeeeecCCCCccccccceeeccccccc
Q 041558 264 NHIIGEIPKELGKLNSLIKLILRRNQLV 291 (495)
Q Consensus 264 n~l~~~~~~~~~~~~~L~~L~L~~n~l~ 291 (495)
|.++ .+|..+. ..|+.|++++|+++
T Consensus 377 N~Lt-~LP~~l~--~sL~~LdLs~N~L~ 401 (754)
T PRK15370 377 NALT-NLPENLP--AALQIMQASRNNLV 401 (754)
T ss_pred CcCC-CCCHhHH--HHHHHHhhccCCcc
Confidence 4444 2333222 13444444444444
No 19
>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily. LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).
Probab=99.78 E-value=6.3e-21 Score=182.58 Aligned_cols=281 Identities=25% Similarity=0.233 Sum_probs=160.2
Q ss_pred eeeccccccc-ccCCccccCCCCCCeeeccCCcccc----cCChhhhcCCCCCEEecCCCcccccCCccccCCCCCCEEe
Q 041558 51 FLYLYENSYF-ASIPSNVGKLKSLGDLQLNGNQFIS----YIPSSFGNLTNLSTSRLSKNKLFVSIPNEIGKMRSLNILE 125 (495)
Q Consensus 51 ~L~L~~n~~~-~~~~~~~~~l~~L~~L~l~~n~l~~----~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~ 125 (495)
.|+|..+.+. ...+..+..+.+|++|+++++.++. .++..+...+++++++++++.+.+ .+..+.
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~-~~~~~~--------- 71 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGR-IPRGLQ--------- 71 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCC-cchHHH---------
Confidence 4667777766 3444555667778888888888754 245556677778888888877642 122111
Q ss_pred eecccccCCCCCCEEEccccccccCCCccCcc-cccccccccccccccccCccCCCCCCCCEEEccCceeee----ccCc
Q 041558 126 VLPLSVSNLTNPKELALLYNCLSGSIPPSLEN-PMLARLGLDFNHFKRTIPKSLRSCTSLIRLCRNRNNLTR----DISE 200 (495)
Q Consensus 126 l~~~~l~~~~~L~~L~l~~n~l~~~~~~~~~~-~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~~~~----~~~~ 200 (495)
.++..+..+++|+.|++++|.+.+..+..+.. .. . ++|+.|++++|.+++ .+..
T Consensus 72 ~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~--------------------~-~~L~~L~ls~~~~~~~~~~~l~~ 130 (319)
T cd00116 72 SLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLR--------------------S-SSLQELKLNNNGLGDRGLRLLAK 130 (319)
T ss_pred HHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhc--------------------c-CcccEEEeeCCccchHHHHHHHH
Confidence 12334455667777777777665433322221 11 1 335555555554442 1222
Q ss_pred cccCC-CCccEEEccCCcCccc----CCCCCCCCCCCCEEeccccccccc----CCccccCCCCCceeccCCCeeeee--
Q 041558 201 ALGIY-PYLTFIDLSRNNFHGE----IPSNREKCPKLGTLGVLMNTITKG----IPREIRNSSQRQALDLSLNHIIGE-- 269 (495)
Q Consensus 201 ~~~~~-~~L~~L~l~~n~l~~~----~~~~~~~~~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~ls~n~l~~~-- 269 (495)
.+..+ ++|+.|++++|.+++. ++..+..+++|+.|++++|.+.+. ++..+...++|+.|++++|.+++.
T Consensus 131 ~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~ 210 (319)
T cd00116 131 GLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGA 210 (319)
T ss_pred HHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHH
Confidence 33344 5566666666665521 223344455666666666666532 223344445677777777666422
Q ss_pred --cCCCCccccccceeecccccccccCCcccC-----CCCCCCEEeCCCCcCCCC----chhhhhcCCCCCEEeCcCCcC
Q 041558 270 --IPKELGKLNSLIKLILRRNQLVGCLPTEIG-----SPIELEYLDFSVNRFNNL----IPESLENLLKLHYLGLCKNKL 338 (495)
Q Consensus 270 --~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~-----~l~~L~~L~Ls~n~l~~~----~~~~~~~l~~L~~L~l~~n~l 338 (495)
+...+..+++|+.|++++|.+++.....+. ..+.|++|++++|.+++. +...+..+++|+.+++++|.+
T Consensus 211 ~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l 290 (319)
T cd00116 211 SALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKF 290 (319)
T ss_pred HHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCC
Confidence 223345566777777777777642221111 236788888888877632 234455667788888888888
Q ss_pred Ccc----chhHhhcC-CCCCeEeccCCCC
Q 041558 339 VQE----LPKILEKL-VQFSELDLSYNFL 362 (495)
Q Consensus 339 ~~~----~~~~~~~l-~~L~~l~ls~n~l 362 (495)
+.. ....+... +.|+.+++.+|++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 291 GEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred cHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 644 33444444 5778888877764
No 20
>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily. LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).
Probab=99.78 E-value=7.4e-21 Score=182.09 Aligned_cols=280 Identities=21% Similarity=0.182 Sum_probs=183.3
Q ss_pred eeecccCccc-ccCCcccccCcccceeecccccccc----cCCccccCCCCCCeeeccCCcccc------cCChhhhcCC
Q 041558 27 GLDLSNNQFS-SSIPLSFGNLSNLIFLYLYENSYFA----SIPSNVGKLKSLGDLQLNGNQFIS------YIPSSFGNLT 95 (495)
Q Consensus 27 ~L~l~~n~l~-~~~~~~~~~l~~L~~L~L~~n~~~~----~~~~~~~~l~~L~~L~l~~n~l~~------~~~~~~~~l~ 95 (495)
.|+|..+.++ +.....|..+.+|++|+++++.++. .++..+...++|++|+++++.+.+ .++..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 5788888887 3455567788899999999999754 245556678889999999998762 3445678899
Q ss_pred CCCEEecCCCcccccCCccccCCCCCCEEeeecccccCCCCCCEEEccccccccCCCccCcccccccccccccccccccC
Q 041558 96 NLSTSRLSKNKLFVSIPNEIGKMRSLNILEVLPLSVSNLTNPKELALLYNCLSGSIPPSLENPMLARLGLDFNHFKRTIP 175 (495)
Q Consensus 96 ~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~~~l~~~~~L~~L~l~~n~l~~~~~~~~~~~~L~~L~l~~n~~~~~~~ 175 (495)
+|+.|++++|.+.+..+..+..+. .. ++|++|++++|.+++.... .+.
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~------------~~-~~L~~L~ls~~~~~~~~~~-------------------~l~ 129 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLL------------RS-SSLQELKLNNNGLGDRGLR-------------------LLA 129 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHh------------cc-CcccEEEeeCCccchHHHH-------------------HHH
Confidence 999999999998765555443321 12 5588888888876532111 111
Q ss_pred ccCCCC-CCCCEEEccCceeee----ccCccccCCCCccEEEccCCcCccc----CCCCCCCCCCCCEEeccccccccc-
Q 041558 176 KSLRSC-TSLIRLCRNRNNLTR----DISEALGIYPYLTFIDLSRNNFHGE----IPSNREKCPKLGTLGVLMNTITKG- 245 (495)
Q Consensus 176 ~~~~~l-~~L~~L~l~~n~~~~----~~~~~~~~~~~L~~L~l~~n~l~~~----~~~~~~~~~~L~~L~l~~n~l~~~- 245 (495)
..+..+ ++|+.|++++|.+++ ..+..+..++.|++|++++|.+++. ++..+..+++|+.|++++|.+.+.
T Consensus 130 ~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~ 209 (319)
T cd00116 130 KGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEG 209 (319)
T ss_pred HHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHH
Confidence 122333 556666666666552 2233445556677777776666532 223344456777777777766542
Q ss_pred ---CCccccCCCCCceeccCCCeeeeecCCCCc-----cccccceeecccccccc----cCCcccCCCCCCCEEeCCCCc
Q 041558 246 ---IPREIRNSSQRQALDLSLNHIIGEIPKELG-----KLNSLIKLILRRNQLVG----CLPTEIGSPIELEYLDFSVNR 313 (495)
Q Consensus 246 ---~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~-----~~~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~Ls~n~ 313 (495)
++..+..+++|++|++++|.+++.....+. ..+.|+.|++++|.++. .+...+..+++|+++++++|.
T Consensus 210 ~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~ 289 (319)
T cd00116 210 ASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNK 289 (319)
T ss_pred HHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCC
Confidence 233455667788888888877642222221 23688999999998862 234455566889999999999
Q ss_pred CCCC----chhhhhcC-CCCCEEeCcCCcC
Q 041558 314 FNNL----IPESLENL-LKLHYLGLCKNKL 338 (495)
Q Consensus 314 l~~~----~~~~~~~l-~~L~~L~l~~n~l 338 (495)
++.. ....+... +.|+.+++.+|++
T Consensus 290 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 290 FGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred CcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 9865 33344445 6889999988864
No 21
>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]
Probab=99.71 E-value=3.9e-19 Score=142.96 Aligned_cols=166 Identities=28% Similarity=0.428 Sum_probs=129.8
Q ss_pred CCCCCCCCEEEccCceeeeccCccccCCCCccEEEccCCcCcccCCCCCCCCCCCCEEecccccccccCCccccCCCCCc
Q 041558 178 LRSCTSLIRLCRNRNNLTRDISEALGIYPYLTFIDLSRNNFHGEIPSNREKCPKLGTLGVLMNTITKGIPREIRNSSQRQ 257 (495)
Q Consensus 178 ~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 257 (495)
+.++...+.|.+++|+++...| .++.+.+|+.|++++|++. .+|..++++++|+.|++.-|.+.. .|..|+.++.|+
T Consensus 29 Lf~~s~ITrLtLSHNKl~~vpp-nia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~~-lprgfgs~p~le 105 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLTVVPP-NIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLNI-LPRGFGSFPALE 105 (264)
T ss_pred ccchhhhhhhhcccCceeecCC-cHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhhc-CccccCCCchhh
Confidence 3455666777777777765444 4567777888888888877 677778888888888888777765 788888888888
Q ss_pred eeccCCCeee-eecCCCCccccccceeecccccccccCCcccCCCCCCCEEeCCCCcCCCCchhhhhcCCCCCEEeCcCC
Q 041558 258 ALDLSLNHII-GEIPKELGKLNSLIKLILRRNQLVGCLPTEIGSPIELEYLDFSVNRFNNLIPESLENLLKLHYLGLCKN 336 (495)
Q Consensus 258 ~L~ls~n~l~-~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n 336 (495)
.||+++|++. ..+|..|..+..|+.|+|++|.+. .+|..++.+++|+.|.+.+|.+.. .|..++.++.|+.|.+.+|
T Consensus 106 vldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll~-lpkeig~lt~lrelhiqgn 183 (264)
T KOG0617|consen 106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLLS-LPKEIGDLTRLRELHIQGN 183 (264)
T ss_pred hhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchhh-CcHHHHHHHHHHHHhcccc
Confidence 8888888875 357888888899999999999998 788888999999999999998876 4778888899999999999
Q ss_pred cCCccchhHhhcC
Q 041558 337 KLVQELPKILEKL 349 (495)
Q Consensus 337 ~l~~~~~~~~~~l 349 (495)
+++ .+|..++.+
T Consensus 184 rl~-vlppel~~l 195 (264)
T KOG0617|consen 184 RLT-VLPPELANL 195 (264)
T ss_pred eee-ecChhhhhh
Confidence 884 555555543
No 22
>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]
Probab=99.69 E-value=4.4e-19 Score=142.68 Aligned_cols=169 Identities=27% Similarity=0.449 Sum_probs=147.9
Q ss_pred CCccCcccccccccccccccccccCccCCCCCCCCEEEccCceeeeccCccccCCCCccEEEccCCcCcccCCCCCCCCC
Q 041558 151 IPPSLENPMLARLGLDFNHFKRTIPKSLRSCTSLIRLCRNRNNLTRDISEALGIYPYLTFIDLSRNNFHGEIPSNREKCP 230 (495)
Q Consensus 151 ~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~ 230 (495)
+|..+....++.|-+++|+++ .+|..++.+.+|+.|++.+|++. ..|..++.+++|+.|+++-|++. ..|..|+.++
T Consensus 26 ~~gLf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p 102 (264)
T KOG0617|consen 26 LPGLFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFP 102 (264)
T ss_pred cccccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCc
Confidence 334444477888889999987 56777899999999999999996 56778899999999999999998 8999999999
Q ss_pred CCCEEecccccccc-cCCccccCCCCCceeccCCCeeeeecCCCCccccccceeecccccccccCCcccCCCCCCCEEeC
Q 041558 231 KLGTLGVLMNTITK-GIPREIRNSSQRQALDLSLNHIIGEIPKELGKLNSLIKLILRRNQLVGCLPTEIGSPIELEYLDF 309 (495)
Q Consensus 231 ~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 309 (495)
.|+.||+++|++.. .+|..|..+..|+-|+++.|.+. .+|..++.+++|+.|.+.+|.+. ..|..++.+..|++|++
T Consensus 103 ~levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhi 180 (264)
T KOG0617|consen 103 ALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHI 180 (264)
T ss_pred hhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhc
Confidence 99999999999876 47888989999999999999998 88999999999999999999998 89999999999999999
Q ss_pred CCCcCCCCchhhhhcC
Q 041558 310 SVNRFNNLIPESLENL 325 (495)
Q Consensus 310 s~n~l~~~~~~~~~~l 325 (495)
.+|.++-. |+.++++
T Consensus 181 qgnrl~vl-ppel~~l 195 (264)
T KOG0617|consen 181 QGNRLTVL-PPELANL 195 (264)
T ss_pred ccceeeec-Chhhhhh
Confidence 99999876 4455543
No 23
>PLN03150 hypothetical protein; Provisional
Probab=99.55 E-value=2.8e-14 Score=146.84 Aligned_cols=117 Identities=26% Similarity=0.373 Sum_probs=100.0
Q ss_pred ccceeecccccccccCCcccCCCCCCCEEeCCCCcCCCCchhhhhcCCCCCEEeCcCCcCCccchhHhhcCCCCCeEecc
Q 041558 279 SLIKLILRRNQLVGCLPTEIGSPIELEYLDFSVNRFNNLIPESLENLLKLHYLGLCKNKLVQELPKILEKLVQFSELDLS 358 (495)
Q Consensus 279 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~ls 358 (495)
.++.|+|++|.+.|.+|..+..+++|+.|+|++|.+++.+|..++.+++|+.|+|++|++++.+|+.+..+++|+.|+++
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 37789999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCC-CCCCCcccc--cCCChhhccCCcCCCCCCCCCCCcc
Q 041558 359 YNFL-GPIPNSIAF--RGASVEALKGNKRLCVSAKGLQPCK 396 (495)
Q Consensus 359 ~n~l-~~~p~~~~~--~~~~~~~~~~n~~~c~~~~~~~~c~ 396 (495)
+|.+ +.+|..... .......+.+|+.+|+.+. ...|.
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~-l~~C~ 538 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG-LRACG 538 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCCC-CCCCc
Confidence 9999 888865421 1223456778999997653 35674
No 24
>PLN03150 hypothetical protein; Provisional
Probab=99.41 E-value=1.1e-12 Score=135.09 Aligned_cols=112 Identities=34% Similarity=0.459 Sum_probs=103.1
Q ss_pred CCceeccCCCeeeeecCCCCccccccceeecccccccccCCcccCCCCCCCEEeCCCCcCCCCchhhhhcCCCCCEEeCc
Q 041558 255 QRQALDLSLNHIIGEIPKELGKLNSLIKLILRRNQLVGCLPTEIGSPIELEYLDFSVNRFNNLIPESLENLLKLHYLGLC 334 (495)
Q Consensus 255 ~L~~L~ls~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~ 334 (495)
.++.|+|++|.+.|.+|..+..+++|+.|+|++|.++|.+|..++.+++|+.|+|++|.+++.+|+.++.+++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 37889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcCCccchhHhhcC-CCCCeEeccCCCC-CCCC
Q 041558 335 KNKLVQELPKILEKL-VQFSELDLSYNFL-GPIP 366 (495)
Q Consensus 335 ~n~l~~~~~~~~~~l-~~L~~l~ls~n~l-~~~p 366 (495)
+|++++.+|..+... .++..+++++|+. +..|
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p 532 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCC
Confidence 999999999988764 4678899999987 5444
No 25
>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]
Probab=99.26 E-value=2.5e-13 Score=129.40 Aligned_cols=170 Identities=35% Similarity=0.454 Sum_probs=103.3
Q ss_pred ccccccccccccccCccCCCCCCCCEEEccCceeeeccCccccCCCCccEEEccCCcCcccCCCCCCCCCCCCEEecccc
Q 041558 161 ARLGLDFNHFKRTIPKSLRSCTSLIRLCRNRNNLTRDISEALGIYPYLTFIDLSRNNFHGEIPSNREKCPKLGTLGVLMN 240 (495)
Q Consensus 161 ~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n 240 (495)
...+++.|++. .+|..+..+..|+.+.+..|.+. .+|.+++.+..|++++++.|+++ ..|..+..|+ |+.|.+++|
T Consensus 78 ~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNN 153 (722)
T KOG0532|consen 78 VFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNN 153 (722)
T ss_pred hhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecC
Confidence 44555556554 45555555556666666666554 34555566666666666666666 4555554443 666666666
Q ss_pred cccccCCccccCCCCCceeccCCCeeeeecCCCCccccccceeecccccccccCCcccCCCCCCCEEeCCCCcCCCCchh
Q 041558 241 TITKGIPREIRNSSQRQALDLSLNHIIGEIPKELGKLNSLIKLILRRNQLVGCLPTEIGSPIELEYLDFSVNRFNNLIPE 320 (495)
Q Consensus 241 ~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~ 320 (495)
+++. +|..++....|..||.+.|.+. .+|..++.+.+|+.|.+..|++. .+|.++. .-.|..||+|.|+++. +|.
T Consensus 154 kl~~-lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~-~LpLi~lDfScNkis~-iPv 228 (722)
T KOG0532|consen 154 KLTS-LPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELC-SLPLIRLDFSCNKISY-LPV 228 (722)
T ss_pred cccc-CCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHh-CCceeeeecccCceee-cch
Confidence 6654 5555556666666666666665 55566666666666666666666 4555555 2346666666666654 466
Q ss_pred hhhcCCCCCEEeCcCCcCC
Q 041558 321 SLENLLKLHYLGLCKNKLV 339 (495)
Q Consensus 321 ~~~~l~~L~~L~l~~n~l~ 339 (495)
+|..|..|++|-|.+|.+.
T Consensus 229 ~fr~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 229 DFRKMRHLQVLQLENNPLQ 247 (722)
T ss_pred hhhhhhhheeeeeccCCCC
Confidence 6666666666666666663
No 26
>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]
Probab=99.26 E-value=1.3e-11 Score=121.58 Aligned_cols=198 Identities=33% Similarity=0.419 Sum_probs=129.3
Q ss_pred eeecccCcccccCCcccccCcccceeecccccccccCCccccCCC-CCCeeeccCCcccccCChhhhcCCCCCEEecCCC
Q 041558 27 GLDLSNNQFSSSIPLSFGNLSNLIFLYLYENSYFASIPSNVGKLK-SLGDLQLNGNQFISYIPSSFGNLTNLSTSRLSKN 105 (495)
Q Consensus 27 ~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 105 (495)
.++++.|.+... ...+..++.++.|++.+|.+. .+|.....+. +|+.|++++|.+.. +|..+..+++|+.|++++|
T Consensus 97 ~l~~~~~~~~~~-~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~~-l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLRSN-ISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIES-LPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccccC-chhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchhh-hhhhhhccccccccccCCc
Confidence 477777776422 233455678888888888865 4555566664 88888888888765 4566788888888888888
Q ss_pred cccccCCccccCCCCCCEEeeecccccCCCCCCEEEccccccccCCCccCcc-cccccccccccccccccCccCCCCCCC
Q 041558 106 KLFVSIPNEIGKMRSLNILEVLPLSVSNLTNPKELALLYNCLSGSIPPSLEN-PMLARLGLDFNHFKRTIPKSLRSCTSL 184 (495)
Q Consensus 106 ~~~~~~~~~~~~l~~L~~L~l~~~~l~~~~~L~~L~l~~n~l~~~~~~~~~~-~~L~~L~l~~n~~~~~~~~~~~~l~~L 184 (495)
+++ .+|... ...++|+.|++++|++. .+|..... ..|+++.+++|... ..+..+.++.++
T Consensus 174 ~l~-~l~~~~----------------~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l 234 (394)
T COG4886 174 DLS-DLPKLL----------------SNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNL 234 (394)
T ss_pred hhh-hhhhhh----------------hhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccc
Confidence 874 333322 24566777777777776 34444333 45777777777432 344556677777
Q ss_pred CEEEccCceeeeccCccccCCCCccEEEccCCcCcccCCCCCCCCCCCCEEecccccccccCCcc
Q 041558 185 IRLCRNRNNLTRDISEALGIYPYLTFIDLSRNNFHGEIPSNREKCPKLGTLGVLMNTITKGIPRE 249 (495)
Q Consensus 185 ~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~ 249 (495)
..+.+.+|++... +..++.++++++|++++|.++ .++. ++...+++.|++++|.+....+..
T Consensus 235 ~~l~l~~n~~~~~-~~~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~~s~n~~~~~~~~~ 296 (394)
T COG4886 235 SGLELSNNKLEDL-PESIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLSNALPLI 296 (394)
T ss_pred cccccCCceeeec-cchhccccccceecccccccc-cccc-ccccCccCEEeccCccccccchhh
Confidence 7777777766543 455566666777777777776 3333 666667777777776666644443
No 27
>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]
Probab=99.25 E-value=1.5e-13 Score=130.85 Aligned_cols=179 Identities=26% Similarity=0.360 Sum_probs=157.0
Q ss_pred CCCCCCEEEccCceeeeccCccccCCCCccEEEccCCcCcccCCCCCCCCCCCCEEecccccccccCCccccCCCCCcee
Q 041558 180 SCTSLIRLCRNRNNLTRDISEALGIYPYLTFIDLSRNNFHGEIPSNREKCPKLGTLGVLMNTITKGIPREIRNSSQRQAL 259 (495)
Q Consensus 180 ~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 259 (495)
.+..-...|++.|++. .+|..+..+..|+.+.+..|.+. .+|..+..+..|++++++.|+++. .|..+..++ |+.|
T Consensus 73 ~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS~-lp~~lC~lp-Lkvl 148 (722)
T KOG0532|consen 73 DLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLSH-LPDGLCDLP-LKVL 148 (722)
T ss_pred cccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhhc-CChhhhcCc-ceeE
Confidence 3445567899999987 56677788889999999999998 899999999999999999999987 677777676 8999
Q ss_pred ccCCCeeeeecCCCCccccccceeecccccccccCCcccCCCCCCCEEeCCCCcCCCCchhhhhcCCCCCEEeCcCCcCC
Q 041558 260 DLSLNHIIGEIPKELGKLNSLIKLILRRNQLVGCLPTEIGSPIELEYLDFSVNRFNNLIPESLENLLKLHYLGLCKNKLV 339 (495)
Q Consensus 260 ~ls~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 339 (495)
-+++|+++ .+|..++...+|..|+.+.|.+. .+|..++++.+|+.|.++.|.+... |+.+..+ .|..||++.|++
T Consensus 149 i~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~~l-p~El~~L-pLi~lDfScNki- 223 (722)
T KOG0532|consen 149 IVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLEDL-PEELCSL-PLIRLDFSCNKI- 223 (722)
T ss_pred EEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhhhC-CHHHhCC-ceeeeecccCce-
Confidence 99999998 88999999999999999999998 8899999999999999999999886 5556655 588999999999
Q ss_pred ccchhHhhcCCCCCeEeccCCCCCCCCC
Q 041558 340 QELPKILEKLVQFSELDLSYNFLGPIPN 367 (495)
Q Consensus 340 ~~~~~~~~~l~~L~~l~ls~n~l~~~p~ 367 (495)
..+|-+|..+..|++|-+.+|++..-|.
T Consensus 224 s~iPv~fr~m~~Lq~l~LenNPLqSPPA 251 (722)
T KOG0532|consen 224 SYLPVDFRKMRHLQVLQLENNPLQSPPA 251 (722)
T ss_pred eecchhhhhhhhheeeeeccCCCCCChH
Confidence 6789999999999999999999965553
No 28
>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]
Probab=99.23 E-value=8.6e-13 Score=116.14 Aligned_cols=130 Identities=25% Similarity=0.209 Sum_probs=65.5
Q ss_pred CCEEecccccccccCCccccCCCCCceeccCCCeeeeecCCCCccccccceeecccccccccCCcccCCCCCCCEEeCCC
Q 041558 232 LGTLGVLMNTITKGIPREIRNSSQRQALDLSLNHIIGEIPKELGKLNSLIKLILRRNQLVGCLPTEIGSPIELEYLDFSV 311 (495)
Q Consensus 232 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 311 (495)
|+.+|+++|.|+. +.+...-.|.++.|++|+|.+.. + +.+..+++|+.|||++|.++ .+..+-..+.++++|.|++
T Consensus 286 LtelDLS~N~I~~-iDESvKL~Pkir~L~lS~N~i~~-v-~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~ 361 (490)
T KOG1259|consen 286 LTELDLSGNLITQ-IDESVKLAPKLRRLILSQNRIRT-V-QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQ 361 (490)
T ss_pred hhhccccccchhh-hhhhhhhccceeEEeccccceee-e-hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhh
Confidence 4444444444433 22333334444555555554431 1 12444555555555555554 2333333344555555555
Q ss_pred CcCCCCchhhhhcCCCCCEEeCcCCcCCccc-hhHhhcCCCCCeEeccCCCCCCCCC
Q 041558 312 NRFNNLIPESLENLLKLHYLGLCKNKLVQEL-PKILEKLVQFSELDLSYNFLGPIPN 367 (495)
Q Consensus 312 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~-~~~~~~l~~L~~l~ls~n~l~~~p~ 367 (495)
|.+... ..++.+-+|..||+++|++.... -..++++|.|+.+.+.+|++..+++
T Consensus 362 N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd 416 (490)
T KOG1259|consen 362 NKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD 416 (490)
T ss_pred hhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence 555432 33445555666666666663321 1345677777777888888766554
No 29
>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]
Probab=99.23 E-value=1e-11 Score=122.39 Aligned_cols=153 Identities=34% Similarity=0.422 Sum_probs=67.0
Q ss_pred CCCEEEccCceeeeccCccccCCCCccEEEccCCcCcccCCCCCCCCCCCCEEecccccccccCCccccCCCCCceeccC
Q 041558 183 SLIRLCRNRNNLTRDISEALGIYPYLTFIDLSRNNFHGEIPSNREKCPKLGTLGVLMNTITKGIPREIRNSSQRQALDLS 262 (495)
Q Consensus 183 ~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls 262 (495)
+|+.|++++|.+... |..++.+++|+.|++++|++. .+|...+..+.|+.|++++|++.. +|........|+++.++
T Consensus 141 nL~~L~l~~N~i~~l-~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~~-l~~~~~~~~~L~~l~~~ 217 (394)
T COG4886 141 NLKELDLSDNKIESL-PSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKISD-LPPEIELLSALEELDLS 217 (394)
T ss_pred hcccccccccchhhh-hhhhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCcccc-Cchhhhhhhhhhhhhhc
Confidence 444444444444322 123344444445555544444 333333344444445555544444 23222223334555555
Q ss_pred CCeeeeecCCCCccccccceeecccccccccCCcccCCCCCCCEEeCCCCcCCCCchhhhhcCCCCCEEeCcCCcCCccc
Q 041558 263 LNHIIGEIPKELGKLNSLIKLILRRNQLVGCLPTEIGSPIELEYLDFSVNRFNNLIPESLENLLKLHYLGLCKNKLVQEL 342 (495)
Q Consensus 263 ~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 342 (495)
+|.+. ..+..+..+.++..+.+.+|++. ..+..++.++++++|++++|.++...+ ++.+.+++.|++++|.++...
T Consensus 218 ~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~ 293 (394)
T COG4886 218 NNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNAL 293 (394)
T ss_pred CCcce-ecchhhhhcccccccccCCceee-eccchhccccccceecccccccccccc--ccccCccCEEeccCccccccc
Confidence 55322 23333444444444444444444 223444444445555555555544322 444445555555555444433
No 30
>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]
Probab=99.18 E-value=7.1e-13 Score=119.22 Aligned_cols=251 Identities=22% Similarity=0.242 Sum_probs=145.9
Q ss_pred ccCCCCCCeeeccCCcccc----cCChhhhcCCCCCEEecCCCccccc----CCccccCCCCCCEEeeecccccCCCCCC
Q 041558 67 VGKLKSLGDLQLNGNQFIS----YIPSSFGNLTNLSTSRLSKNKLFVS----IPNEIGKMRSLNILEVLPLSVSNLTNPK 138 (495)
Q Consensus 67 ~~~l~~L~~L~l~~n~l~~----~~~~~~~~l~~L~~L~l~~n~~~~~----~~~~~~~l~~L~~L~l~~~~l~~~~~L~ 138 (495)
...+..++.++|++|.+.. .+...+.+.++|+..++++- ++|. +|+.+ ..+...+..+++|+
T Consensus 26 ~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~-ftGR~~~Ei~e~L---------~~l~~aL~~~~~L~ 95 (382)
T KOG1909|consen 26 LEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDM-FTGRLKDEIPEAL---------KMLSKALLGCPKLQ 95 (382)
T ss_pred hcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhh-hcCCcHHHHHHHH---------HHHHHHHhcCCcee
Confidence 4456788999999998764 24455677788888888764 3333 33332 22345667788999
Q ss_pred EEEccccccccCCCccCcc-----cccccccccccccccccCccCCCCCCCCEEEccCceeeeccCccccCCCCccEEEc
Q 041558 139 ELALLYNCLSGSIPPSLEN-----PMLARLGLDFNHFKRTIPKSLRSCTSLIRLCRNRNNLTRDISEALGIYPYLTFIDL 213 (495)
Q Consensus 139 ~L~l~~n~l~~~~~~~~~~-----~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l 213 (495)
+++||.|.+.-..+..+.. ..|++|.|.+|.+.-.-...++. .|..+. .....+.-+.|+++..
T Consensus 96 ~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~--al~~l~---------~~kk~~~~~~Lrv~i~ 164 (382)
T KOG1909|consen 96 KLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGR--ALFELA---------VNKKAASKPKLRVFIC 164 (382)
T ss_pred EeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHH--HHHHHH---------HHhccCCCcceEEEEe
Confidence 9999999887666555543 66777777777553110000000 000000 0111223455666666
Q ss_pred cCCcCccc----CCCCCCCCCCCCEEeccccccccc----CCccccCCCCCceeccCCCeeeee----cCCCCccccccc
Q 041558 214 SRNNFHGE----IPSNREKCPKLGTLGVLMNTITKG----IPREIRNSSQRQALDLSLNHIIGE----IPKELGKLNSLI 281 (495)
Q Consensus 214 ~~n~l~~~----~~~~~~~~~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~ls~n~l~~~----~~~~~~~~~~L~ 281 (495)
.+|++... +...|..++.|+.+.+..|.|... +...|..+++|+.|||..|.++.. +...++.++.|+
T Consensus 165 ~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~ 244 (382)
T KOG1909|consen 165 GRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLR 244 (382)
T ss_pred eccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchhe
Confidence 66655422 122344455666666666655431 123455667777777777766422 233455666777
Q ss_pred eeecccccccccCCcc----c-CCCCCCCEEeCCCCcCCCC----chhhhhcCCCCCEEeCcCCcC
Q 041558 282 KLILRRNQLVGCLPTE----I-GSPIELEYLDFSVNRFNNL----IPESLENLLKLHYLGLCKNKL 338 (495)
Q Consensus 282 ~L~L~~n~l~~~~~~~----~-~~l~~L~~L~Ls~n~l~~~----~~~~~~~l~~L~~L~l~~n~l 338 (495)
.|++++|.+...-... + ...++|+.|.+.+|.++.. +..+....+.|..|+|++|++
T Consensus 245 El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 245 ELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred eecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 7777777665322111 1 2357788888888877642 333455678888888888888
No 31
>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]
Probab=99.18 E-value=1.8e-11 Score=128.91 Aligned_cols=122 Identities=28% Similarity=0.323 Sum_probs=97.8
Q ss_pred cEEEeeCCcccccCCccCcCCccCCeeecccCc--ccccCCcccccCcccceeecccccccccCCccccCCCCCCeeecc
Q 041558 2 ALLIIHNNSLSGFIPLNIGNSQFLWGLDLSNNQ--FSSSIPLSFGNLSNLIFLYLYENSYFASIPSNVGKLKSLGDLQLN 79 (495)
Q Consensus 2 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~--l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~l~ 79 (495)
+++.+.+|.+. .++.... ++.|++|-+..|. +....++.|..++.|++|||++|.-.+.+|+.++.+-+|++|+++
T Consensus 526 rr~s~~~~~~~-~~~~~~~-~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~ 603 (889)
T KOG4658|consen 526 RRMSLMNNKIE-HIAGSSE-NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLS 603 (889)
T ss_pred eEEEEeccchh-hccCCCC-CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhccccc
Confidence 45566666665 4444433 4589999999986 554445558889999999999988778999999999999999999
Q ss_pred CCcccccCChhhhcCCCCCEEecCCCcccccCCccccCCCCCCEEee
Q 041558 80 GNQFISYIPSSFGNLTNLSTSRLSKNKLFVSIPNEIGKMRSLNILEV 126 (495)
Q Consensus 80 ~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l 126 (495)
+..+. .+|..++++++|.+|++..+.....+|.....+++|++|.+
T Consensus 604 ~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l 649 (889)
T KOG4658|consen 604 DTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRL 649 (889)
T ss_pred CCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEe
Confidence 99987 48999999999999999988765666777777888988887
No 32
>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]
Probab=99.16 E-value=4.6e-12 Score=117.23 Aligned_cols=205 Identities=20% Similarity=0.205 Sum_probs=126.3
Q ss_pred cccccccccccccccccC-ccCCCCCCCCEEEccCceeee--ccCccccCCCCccEEEccCCcCcccCCCC-CCCCCCCC
Q 041558 158 PMLARLGLDFNHFKRTIP-KSLRSCTSLIRLCRNRNNLTR--DISEALGIYPYLTFIDLSRNNFHGEIPSN-REKCPKLG 233 (495)
Q Consensus 158 ~~L~~L~l~~n~~~~~~~-~~~~~l~~L~~L~l~~n~~~~--~~~~~~~~~~~L~~L~l~~n~l~~~~~~~-~~~~~~L~ 233 (495)
.+|+++.|+++....... .....|++++.||++.|-+.. ........+|+|+.|+++.|++.....+. -..++.|+
T Consensus 121 kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK 200 (505)
T KOG3207|consen 121 KKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLK 200 (505)
T ss_pred HhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhh
Confidence 455555565554432111 245567777777777776653 22344456778888888888776322221 12466788
Q ss_pred EEeccccccccc-CCccccCCCCCceeccCCCeeeeecCCCCccccccceeecccccccccC-CcccCCCCCCCEEeCCC
Q 041558 234 TLGVLMNTITKG-IPREIRNSSQRQALDLSLNHIIGEIPKELGKLNSLIKLILRRNQLVGCL-PTEIGSPIELEYLDFSV 311 (495)
Q Consensus 234 ~L~l~~n~l~~~-~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~Ls~ 311 (495)
+|.++.|.++.. +...+..+|+|+.|++..|............+..|+.|+|++|++.... -...+.++.|..|+++.
T Consensus 201 ~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~ 280 (505)
T KOG3207|consen 201 QLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSS 280 (505)
T ss_pred eEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhccc
Confidence 888888887753 2233456788888888888533333334455677888888888776321 13456677888888888
Q ss_pred CcCCCC-chhh-----hhcCCCCCEEeCcCCcCCccc-hhHhhcCCCCCeEeccCCCC
Q 041558 312 NRFNNL-IPES-----LENLLKLHYLGLCKNKLVQEL-PKILEKLVQFSELDLSYNFL 362 (495)
Q Consensus 312 n~l~~~-~~~~-----~~~l~~L~~L~l~~n~l~~~~-~~~~~~l~~L~~l~ls~n~l 362 (495)
+.+..+ .|+. ...+++|++|++..|++...- -..+..+++|+.+.+..|++
T Consensus 281 tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~l 338 (505)
T KOG3207|consen 281 TGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYL 338 (505)
T ss_pred cCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcccccc
Confidence 877654 2322 235678888888888874321 13344556677777777777
No 33
>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A.
Probab=99.14 E-value=3.6e-11 Score=101.60 Aligned_cols=81 Identities=32% Similarity=0.345 Sum_probs=15.2
Q ss_pred CccCCeeecccCcccccCCcccc-cCcccceeecccccccccCCccccCCCCCCeeeccCCcccccCChhh-hcCCCCCE
Q 041558 22 SQFLWGLDLSNNQFSSSIPLSFG-NLSNLIFLYLYENSYFASIPSNVGKLKSLGDLQLNGNQFISYIPSSF-GNLTNLST 99 (495)
Q Consensus 22 l~~L~~L~l~~n~l~~~~~~~~~-~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~-~~l~~L~~ 99 (495)
...++.|+|++|.|+.+ +.++ .+.+|+.|++++|.+.... .+..+++|++|++++|+++.. .+.+ ..+++|++
T Consensus 18 ~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l~--~l~~L~~L~~L~L~~N~I~~i-~~~l~~~lp~L~~ 92 (175)
T PF14580_consen 18 PVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKLE--GLPGLPRLKTLDLSNNRISSI-SEGLDKNLPNLQE 92 (175)
T ss_dssp --------------------S--TT-TT--EEE-TTS--S--T--T----TT--EEE--SS---S--CHHHHHH-TT--E
T ss_pred ccccccccccccccccc--cchhhhhcCCCEEECCCCCCcccc--CccChhhhhhcccCCCCCCcc-ccchHHhCCcCCE
Confidence 33445555555555421 1232 3444555555555544321 244445555555555554432 2222 23455555
Q ss_pred EecCCCcc
Q 041558 100 SRLSKNKL 107 (495)
Q Consensus 100 L~l~~n~~ 107 (495)
|++++|++
T Consensus 93 L~L~~N~I 100 (175)
T PF14580_consen 93 LYLSNNKI 100 (175)
T ss_dssp EE-TTS--
T ss_pred EECcCCcC
Confidence 55555544
No 34
>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]
Probab=99.12 E-value=2.1e-12 Score=116.30 Aligned_cols=248 Identities=21% Similarity=0.226 Sum_probs=164.3
Q ss_pred hhhhcCCCCCEEecCCCcccccCCccccCCCCCCEEeeecccccCCCCCCEEEcccc---ccccCCCccCcccccccccc
Q 041558 89 SSFGNLTNLSTSRLSKNKLFVSIPNEIGKMRSLNILEVLPLSVSNLTNPKELALLYN---CLSGSIPPSLENPMLARLGL 165 (495)
Q Consensus 89 ~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~~~l~~~~~L~~L~l~~n---~l~~~~~~~~~~~~L~~L~l 165 (495)
+....+..++.++||+|.+...-..+++ ..+.+.++|+..+++.- +....+|..+.
T Consensus 24 ~~~~~~~s~~~l~lsgnt~G~EAa~~i~------------~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~--------- 82 (382)
T KOG1909|consen 24 EELEPMDSLTKLDLSGNTFGTEAARAIA------------KVLASKKELREVNLSDMFTGRLKDEIPEALK--------- 82 (382)
T ss_pred HHhcccCceEEEeccCCchhHHHHHHHH------------HHHhhcccceeeehHhhhcCCcHHHHHHHHH---------
Confidence 3455566777777777776444334433 23445556666665532 11111221110
Q ss_pred cccccccccCccCCCCCCCCEEEccCceeeeccCcc----ccCCCCccEEEccCCcCccc-------------CCCCCCC
Q 041558 166 DFNHFKRTIPKSLRSCTSLIRLCRNRNNLTRDISEA----LGIYPYLTFIDLSRNNFHGE-------------IPSNREK 228 (495)
Q Consensus 166 ~~n~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~----~~~~~~L~~L~l~~n~l~~~-------------~~~~~~~ 228 (495)
.+.+++..+++|+.++||+|-+....+.. +.++..|++|.|.+|.+.-. .....+.
T Consensus 83 -------~l~~aL~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~ 155 (382)
T KOG1909|consen 83 -------MLSKALLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAAS 155 (382)
T ss_pred -------HHHHHHhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCC
Confidence 11224556677777777777776444433 34567788888887766421 1122345
Q ss_pred CCCCCEEeccccccccc----CCccccCCCCCceeccCCCeeeee----cCCCCccccccceeeccccccccc----CCc
Q 041558 229 CPKLGTLGVLMNTITKG----IPREIRNSSQRQALDLSLNHIIGE----IPKELGKLNSLIKLILRRNQLVGC----LPT 296 (495)
Q Consensus 229 ~~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~ls~n~l~~~----~~~~~~~~~~L~~L~L~~n~l~~~----~~~ 296 (495)
-+.|+++...+|.+... +...|...+.|+.+.++.|.+... +...|..++.|+.|||.+|-++.. +..
T Consensus 156 ~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~Lak 235 (382)
T KOG1909|consen 156 KPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAK 235 (382)
T ss_pred CcceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHH
Confidence 67899999999998653 234566778999999999988522 223477899999999999988732 445
Q ss_pred ccCCCCCCCEEeCCCCcCCCCchhhhh-----cCCCCCEEeCcCCcCCcc----chhHhhcCCCCCeEeccCCCCCC
Q 041558 297 EIGSPIELEYLDFSVNRFNNLIPESLE-----NLLKLHYLGLCKNKLVQE----LPKILEKLVQFSELDLSYNFLGP 364 (495)
Q Consensus 297 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~-----~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~l~ls~n~l~~ 364 (495)
.+..+++|+.|++++|.+...-...+. ..|+|++|.+.+|.++.. +..++...+.|..|++++|.++.
T Consensus 236 aL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~e 312 (382)
T KOG1909|consen 236 ALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLGE 312 (382)
T ss_pred HhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccccc
Confidence 667788999999999999765433332 468999999999998642 44556678899999999999953
No 35
>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A.
Probab=99.10 E-value=7.1e-11 Score=99.80 Aligned_cols=121 Identities=28% Similarity=0.309 Sum_probs=36.6
Q ss_pred CCCEEecccccccccCCcccc-CCCCCceeccCCCeeeeecCCCCccccccceeecccccccccCCccc-CCCCCCCEEe
Q 041558 231 KLGTLGVLMNTITKGIPREIR-NSSQRQALDLSLNHIIGEIPKELGKLNSLIKLILRRNQLVGCLPTEI-GSPIELEYLD 308 (495)
Q Consensus 231 ~L~~L~l~~n~l~~~~~~~~~-~l~~L~~L~ls~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~-~~l~~L~~L~ 308 (495)
.++.|+|++|.|+.. +.+. .+.+|+.|++++|.++ .++ .+..++.|+.|++++|.++ .+...+ ..+++|++|+
T Consensus 20 ~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~ 94 (175)
T PF14580_consen 20 KLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELY 94 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EEE
T ss_pred ccccccccccccccc--cchhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEE
Confidence 455555555555441 2233 3455666666666665 222 3555666666666666666 333223 2456666666
Q ss_pred CCCCcCCCCc-hhhhhcCCCCCEEeCcCCcCCccc---hhHhhcCCCCCeEe
Q 041558 309 FSVNRFNNLI-PESLENLLKLHYLGLCKNKLVQEL---PKILEKLVQFSELD 356 (495)
Q Consensus 309 Ls~n~l~~~~-~~~~~~l~~L~~L~l~~n~l~~~~---~~~~~~l~~L~~l~ 356 (495)
+++|++.... -..+..+++|+.|++.+|++.... ...+..+|+|+.||
T Consensus 95 L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD 146 (175)
T PF14580_consen 95 LSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLD 146 (175)
T ss_dssp -TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEET
T ss_pred CcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeC
Confidence 6666665431 134556666777777777664321 12345566666665
No 36
>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]
Probab=99.08 E-value=1.1e-11 Score=114.86 Aligned_cols=65 Identities=23% Similarity=0.202 Sum_probs=29.7
Q ss_pred CCCCCCCEEEccCceeeeccCccccCCCCccEEEccCCcCcccCC--CCCCCCCCCCEEecccccccc
Q 041558 179 RSCTSLIRLCRNRNNLTRDISEALGIYPYLTFIDLSRNNFHGEIP--SNREKCPKLGTLGVLMNTITK 244 (495)
Q Consensus 179 ~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~--~~~~~~~~L~~L~l~~n~l~~ 244 (495)
..+++|+.|++..|............+..|+.|||++|.+- ..+ ...+.++.|..|+++.+.+..
T Consensus 219 ~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~~Lnls~tgi~s 285 (505)
T KOG3207|consen 219 LTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPGLNQLNLSSTGIAS 285 (505)
T ss_pred HhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccc-ccccccccccccchhhhhccccCcch
Confidence 34455555555555322222222333445555555555544 122 233445555555555554443
No 37
>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]
Probab=99.05 E-value=3.9e-11 Score=105.88 Aligned_cols=134 Identities=25% Similarity=0.251 Sum_probs=80.9
Q ss_pred CCCCCCCCEEEccCceeeeccCccccCCCCccEEEccCCcCcccCCCCCCCCCCCCEEecccccccccCCccccCCCCCc
Q 041558 178 LRSCTSLIRLCRNRNNLTRDISEALGIYPYLTFIDLSRNNFHGEIPSNREKCPKLGTLGVLMNTITKGIPREIRNSSQRQ 257 (495)
Q Consensus 178 ~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 257 (495)
+..+..|+.+|+++|.|+. +.++..-.|.++.|++++|.+. .+.. +..+++|+.||+++|.++. +..+=..+-+.+
T Consensus 280 ~dTWq~LtelDLS~N~I~~-iDESvKL~Pkir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls~-~~Gwh~KLGNIK 355 (490)
T KOG1259|consen 280 ADTWQELTELDLSGNLITQ-IDESVKLAPKLRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLAE-CVGWHLKLGNIK 355 (490)
T ss_pred cchHhhhhhccccccchhh-hhhhhhhccceeEEecccccee-eehh-hhhcccceEeecccchhHh-hhhhHhhhcCEe
Confidence 3344556666666666642 3344455566666666666665 2222 5566666666666666655 222223455666
Q ss_pred eeccCCCeeeeecCCCCccccccceeeccccccccc-CCcccCCCCCCCEEeCCCCcCCCC
Q 041558 258 ALDLSLNHIIGEIPKELGKLNSLIKLILRRNQLVGC-LPTEIGSPIELEYLDFSVNRFNNL 317 (495)
Q Consensus 258 ~L~ls~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~Ls~n~l~~~ 317 (495)
+|.|+.|.+. .+ ..+..+-+|..||+++|++... .-..+++++-|+++.|.+|.+.+.
T Consensus 356 tL~La~N~iE-~L-SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~ 414 (490)
T KOG1259|consen 356 TLKLAQNKIE-TL-SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS 414 (490)
T ss_pred eeehhhhhHh-hh-hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence 7777777664 11 2455666777777777777632 223577788888888888888764
No 38
>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A ....
Probab=99.02 E-value=2e-10 Score=79.76 Aligned_cols=59 Identities=39% Similarity=0.432 Sum_probs=34.1
Q ss_pred cCCeeecccCcccccCCcccccCcccceeecccccccccCCccccCCCCCCeeeccCCc
Q 041558 24 FLWGLDLSNNQFSSSIPLSFGNLSNLIFLYLYENSYFASIPSNVGKLKSLGDLQLNGNQ 82 (495)
Q Consensus 24 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~l~~n~ 82 (495)
+|++|++++|+++...+..|.++++|++|++++|.+....|..|.++++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 45556666665555544555556666666666555555555555555566666655554
No 39
>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A ....
Probab=98.95 E-value=6.1e-10 Score=77.35 Aligned_cols=61 Identities=36% Similarity=0.440 Sum_probs=55.2
Q ss_pred cccceeecccccccccCCccccCCCCCCeeeccCCcccccCChhhhcCCCCCEEecCCCcc
Q 041558 47 SNLIFLYLYENSYFASIPSNVGKLKSLGDLQLNGNQFISYIPSSFGNLTNLSTSRLSKNKL 107 (495)
Q Consensus 47 ~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~ 107 (495)
++|++|++++|++....+..|.++++|++|++++|.++...|.+|.++++|++|++++|++
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 5789999999998888778899999999999999999988888999999999999999874
No 40
>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]
Probab=98.94 E-value=9e-10 Score=116.25 Aligned_cols=241 Identities=22% Similarity=0.212 Sum_probs=146.1
Q ss_pred CcEEEeeCCc--ccccCCccCcCCccCCeeecccCcccccCCcccccCcccceeecccccccccCCccccCCCCCCeeec
Q 041558 1 MALLIIHNNS--LSGFIPLNIGNSQFLWGLDLSNNQFSSSIPLSFGNLSNLIFLYLYENSYFASIPSNVGKLKSLGDLQL 78 (495)
Q Consensus 1 L~~L~l~~n~--l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~l 78 (495)
|++|-+.+|. +....++.|..++.|++|||++|.=-+.+|..++.+-+||+|++++..+. .+|..+.++..|.+|++
T Consensus 547 L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl 625 (889)
T KOG4658|consen 547 LRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLNL 625 (889)
T ss_pred cceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheecc
Confidence 5678888886 55344445788999999999998776789999999999999999999966 78999999999999999
Q ss_pred cCCcccccCChhhhcCCCCCEEecCCCcc--cccCCccccCCCCCCEEee-e-----cccccCCCCCC----EEEccccc
Q 041558 79 NGNQFISYIPSSFGNLTNLSTSRLSKNKL--FVSIPNEIGKMRSLNILEV-L-----PLSVSNLTNPK----ELALLYNC 146 (495)
Q Consensus 79 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~~--~~~~~~~~~~l~~L~~L~l-~-----~~~l~~~~~L~----~L~l~~n~ 146 (495)
..+.-...+|.....+++|++|.+..... +...-..+.++..|+.+.. . -..+..+..|. .+.+..+.
T Consensus 626 ~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~~~~e~l~~~~~L~~~~~~l~~~~~~ 705 (889)
T KOG4658|consen 626 EVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSVLLLEDLLGMTRLRSLLQSLSIEGCS 705 (889)
T ss_pred ccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecchhHhHhhhhhhHHHHHHhHhhhhcccc
Confidence 98876555677777899999999977642 1122223334444444333 0 01122222222 11111111
Q ss_pred cccCCCccCcc-cccccccccccccccccCccCCCCC------CCCEEEccCceeeeccCccccCCCCccEEEccCCcCc
Q 041558 147 LSGSIPPSLEN-PMLARLGLDFNHFKRTIPKSLRSCT------SLIRLCRNRNNLTRDISEALGIYPYLTFIDLSRNNFH 219 (495)
Q Consensus 147 l~~~~~~~~~~-~~L~~L~l~~n~~~~~~~~~~~~l~------~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~ 219 (495)
.. ..+..+.. .+|+.|.+.++.+......+..... ++..+...++... ..+.+.-..++|+.|.+..+...
T Consensus 706 ~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~~~~~~-r~l~~~~f~~~L~~l~l~~~~~~ 783 (889)
T KOG4658|consen 706 KR-TLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSILNCHML-RDLTWLLFAPHLTSLSLVSCRLL 783 (889)
T ss_pred cc-eeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHhhccccc-cccchhhccCcccEEEEeccccc
Confidence 11 12222222 7778888877766533222222111 2222222221111 11222235678899999888776
Q ss_pred ccCCCCCCCCCCCCEEecccccccc
Q 041558 220 GEIPSNREKCPKLGTLGVLMNTITK 244 (495)
Q Consensus 220 ~~~~~~~~~~~~L~~L~l~~n~l~~ 244 (495)
..+.+....+..++.+.+..+.+.+
T Consensus 784 e~~i~~~k~~~~l~~~i~~f~~~~~ 808 (889)
T KOG4658|consen 784 EDIIPKLKALLELKELILPFNKLEG 808 (889)
T ss_pred ccCCCHHHHhhhcccEEeccccccc
Confidence 6665555555566655555555555
No 41
>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]
Probab=98.94 E-value=1.1e-10 Score=115.22 Aligned_cols=241 Identities=28% Similarity=0.235 Sum_probs=107.6
Q ss_pred CCCCCCeeeccCCcccccCChhhhcCCCCCEEecCCCcccccCCccccCCCCCCEEeeecccccCCCCCCEEEccccccc
Q 041558 69 KLKSLGDLQLNGNQFISYIPSSFGNLTNLSTSRLSKNKLFVSIPNEIGKMRSLNILEVLPLSVSNLTNPKELALLYNCLS 148 (495)
Q Consensus 69 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~~~l~~~~~L~~L~l~~n~l~ 148 (495)
.+..++.++++.|.+.. +-..+..+++|+.|++.+|.+..... .+..+++|+.|++++|.|+
T Consensus 70 ~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i~~-----------------~l~~~~~L~~L~ls~N~I~ 131 (414)
T KOG0531|consen 70 SLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKIEN-----------------LLSSLVNLQVLDLSFNKIT 131 (414)
T ss_pred HhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhhccc-----------------chhhhhcchheeccccccc
Confidence 34445555555555443 12234455556666666655532111 0223444455555555444
Q ss_pred cCCCccCcccccccccccccccccccCccCCCCCCCCEEEccCceeeeccC-ccccCCCCccEEEccCCcCcccCCCCCC
Q 041558 149 GSIPPSLENPMLARLGLDFNHFKRTIPKSLRSCTSLIRLCRNRNNLTRDIS-EALGIYPYLTFIDLSRNNFHGEIPSNRE 227 (495)
Q Consensus 149 ~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~-~~~~~~~~L~~L~l~~n~l~~~~~~~~~ 227 (495)
...+- -..+.|+.|++++|.++.. ..+..++.|+.+++++|++....+ . ...+.+++.+++++|.+
T Consensus 132 ~i~~l-~~l~~L~~L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i--------- 198 (414)
T KOG0531|consen 132 KLEGL-STLTLLKELNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSI--------- 198 (414)
T ss_pred cccch-hhccchhhheeccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCch---------
Confidence 22110 0002345555555554421 233345555555555555554433 1 23344444444444444
Q ss_pred CCCCCCEEecccccccccCCccccCCCCCceeccCCCeeeeecCCCCcccc--ccceeecccccccccCCcccCCCCCCC
Q 041558 228 KCPKLGTLGVLMNTITKGIPREIRNSSQRQALDLSLNHIIGEIPKELGKLN--SLIKLILRRNQLVGCLPTEIGSPIELE 305 (495)
Q Consensus 228 ~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~--~L~~L~L~~n~l~~~~~~~~~~l~~L~ 305 (495)
.. ...+..+..+..+++..|.++..-+ +..+. .|+.+++++|.+. ..+..+..+..+.
T Consensus 199 ---------------~~--i~~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~ 258 (414)
T KOG0531|consen 199 ---------------RE--IEGLDLLKKLVLLSLLDNKISKLEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLP 258 (414)
T ss_pred ---------------hc--ccchHHHHHHHHhhcccccceeccC--cccchhHHHHHHhcccCccc-ccccccccccccc
Confidence 33 1112222223333445554442111 11111 2556666666665 3334445556666
Q ss_pred EEeCCCCcCCCCchhhhhcCCCCCEEeCcCCcCCcc---chhH-hhcCCCCCeEeccCCCC
Q 041558 306 YLDFSVNRFNNLIPESLENLLKLHYLGLCKNKLVQE---LPKI-LEKLVQFSELDLSYNFL 362 (495)
Q Consensus 306 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~-~~~l~~L~~l~ls~n~l 362 (495)
.|++++|.+... ..+...+.+..+....|.+... .... ....+.+..+.+.+|+.
T Consensus 259 ~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (414)
T KOG0531|consen 259 VLDLSSNRISNL--EGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPI 317 (414)
T ss_pred ccchhhcccccc--ccccccchHHHhccCcchhcchhhhhccccccccccccccccccCcc
Confidence 666666665543 2234444555555555555321 1111 33445566666666666
No 42
>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]
Probab=98.87 E-value=3.4e-10 Score=111.73 Aligned_cols=265 Identities=28% Similarity=0.223 Sum_probs=148.8
Q ss_pred cCCeeecccCcccccCCcccccCcccceeecccccccccCCccccCCCCCCeeeccCCcccccCChhhhcCCCCCEEecC
Q 041558 24 FLWGLDLSNNQFSSSIPLSFGNLSNLIFLYLYENSYFASIPSNVGKLKSLGDLQLNGNQFISYIPSSFGNLTNLSTSRLS 103 (495)
Q Consensus 24 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 103 (495)
.++.++..++.....-.. ...+..++.+++..|.+.. +-..+..+.+|+.|++.+|.+... ...+..+++|++|+++
T Consensus 50 ~~~~~~~~~~~~~~~~~~-~~~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls 126 (414)
T KOG0531|consen 50 DLEEIDLIFNLDGSDEDL-VESLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLS 126 (414)
T ss_pred hhhhhcchhccccchhhh-HHHhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhhc-ccchhhhhcchheecc
Confidence 344455544443321111 1345566666666666443 223355666677777777766552 2225566677777777
Q ss_pred CCcccccCCccccCCCCCCEEeeecccccCCCCCCEEEccccccccCCCccCc-ccccccccccccccccccC-ccCCCC
Q 041558 104 KNKLFVSIPNEIGKMRSLNILEVLPLSVSNLTNPKELALLYNCLSGSIPPSLE-NPMLARLGLDFNHFKRTIP-KSLRSC 181 (495)
Q Consensus 104 ~n~~~~~~~~~~~~l~~L~~L~l~~~~l~~~~~L~~L~l~~n~l~~~~~~~~~-~~~L~~L~l~~n~~~~~~~-~~~~~l 181 (495)
+|.++...+ +..++.|+.|++++|.++.. ..+. .+.|+.+++++|.+...-+ . ...+
T Consensus 127 ~N~I~~i~~------------------l~~l~~L~~L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~ 185 (414)
T KOG0531|consen 127 FNKITKLEG------------------LSTLTLLKELNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSEL 185 (414)
T ss_pred ccccccccc------------------hhhccchhhheeccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhc
Confidence 776642111 22334466666666665421 1122 2666777777776654332 1 4667
Q ss_pred CCCCEEEccCceeeeccCccccCCCCccEEEccCCcCcccCCCCCCCCC--CCCEEecccccccccCCccccCCCCCcee
Q 041558 182 TSLIRLCRNRNNLTRDISEALGIYPYLTFIDLSRNNFHGEIPSNREKCP--KLGTLGVLMNTITKGIPREIRNSSQRQAL 259 (495)
Q Consensus 182 ~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~--~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 259 (495)
.+++.+++.+|.+.... .+..+..+..+++..|.++..-+. .... .|+.+++++|.+.. .+..+..+..+..+
T Consensus 186 ~~l~~l~l~~n~i~~i~--~~~~~~~l~~~~l~~n~i~~~~~l--~~~~~~~L~~l~l~~n~i~~-~~~~~~~~~~l~~l 260 (414)
T KOG0531|consen 186 ISLEELDLGGNSIREIE--GLDLLKKLVLLSLLDNKISKLEGL--NELVMLHLRELYLSGNRISR-SPEGLENLKNLPVL 260 (414)
T ss_pred cchHHHhccCCchhccc--chHHHHHHHHhhcccccceeccCc--ccchhHHHHHHhcccCcccc-cccccccccccccc
Confidence 77777777777775432 233344455557777776632221 1222 37788888888765 22556677788888
Q ss_pred ccCCCeeeeecCCCCccccccceeeccccccccc---CCc-ccCCCCCCCEEeCCCCcCCCCch
Q 041558 260 DLSLNHIIGEIPKELGKLNSLIKLILRRNQLVGC---LPT-EIGSPIELEYLDFSVNRFNNLIP 319 (495)
Q Consensus 260 ~ls~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~---~~~-~~~~l~~L~~L~Ls~n~l~~~~~ 319 (495)
++..|.+...- .+.....+..+....|.+... ... .....+.++...+..|.+....+
T Consensus 261 ~~~~n~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (414)
T KOG0531|consen 261 DLSSNRISNLE--GLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKISS 322 (414)
T ss_pred chhhccccccc--cccccchHHHhccCcchhcchhhhhccccccccccccccccccCccccccc
Confidence 88888775321 234455666677777766521 111 14456788888888887766533
No 43
>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=98.71 E-value=6.2e-09 Score=99.89 Aligned_cols=32 Identities=34% Similarity=0.686 Sum_probs=30.7
Q ss_pred ecccccCCceeeeEEEEEeCC-eeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHAR-HSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~-~~~LVyeym~n 495 (495)
++++++|||||+|+|||.+++ +++||||||+|
T Consensus 124 ~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~n 156 (361)
T KOG1187|consen 124 ILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPN 156 (361)
T ss_pred HHhcCCCcCcccEEEEEecCCceEEEEEEccCC
Confidence 899999999999999999999 59999999997
No 44
>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]
Probab=98.57 E-value=2.6e-09 Score=105.28 Aligned_cols=163 Identities=23% Similarity=0.174 Sum_probs=97.3
Q ss_pred CccccCCCCccEEEccCCcCccc---CC--CC-----------------------CCC---CCCCCEEecccccccccCC
Q 041558 199 SEALGIYPYLTFIDLSRNNFHGE---IP--SN-----------------------REK---CPKLGTLGVLMNTITKGIP 247 (495)
Q Consensus 199 ~~~~~~~~~L~~L~l~~n~l~~~---~~--~~-----------------------~~~---~~~L~~L~l~~n~l~~~~~ 247 (495)
|-.+..+.+|+.|.+.++.+... .+ .. +.+ ...|.+.+.+.|.+.- ..
T Consensus 102 pi~ifpF~sLr~LElrg~~L~~~~GL~~lr~qLe~LIC~~Sl~Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~~-mD 180 (1096)
T KOG1859|consen 102 PISIFPFRSLRVLELRGCDLSTAKGLQELRHQLEKLICHNSLDALRHVFASCGGDISNSPVWNKLATASFSYNRLVL-MD 180 (1096)
T ss_pred CceeccccceeeEEecCcchhhhhhhHHHHHhhhhhhhhccHHHHHHHHHHhccccccchhhhhHhhhhcchhhHHh-HH
Confidence 55566788999999999877521 00 00 000 0133444445555443 33
Q ss_pred ccccCCCCCceeccCCCeeeeecCCCCccccccceeecccccccccCCcccCCCCCCCEEeCCCCcCCCCchhhhhcCCC
Q 041558 248 REIRNSSQRQALDLSLNHIIGEIPKELGKLNSLIKLILRRNQLVGCLPTEIGSPIELEYLDFSVNRFNNLIPESLENLLK 327 (495)
Q Consensus 248 ~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~ 327 (495)
..+.-++.++.|+|++|+++..- .+..++.|+.|||+.|.+. .+|..-..--.|+.|.+++|.++.. ..+.++.+
T Consensus 181 ~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~L~~L~lrnN~l~tL--~gie~Lks 255 (1096)
T KOG1859|consen 181 ESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCKLQLLNLRNNALTTL--RGIENLKS 255 (1096)
T ss_pred HHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhhhheeeeecccHHHhh--hhHHhhhh
Confidence 44555666777777777776322 5667777777777777776 4443211112377777777777654 45667777
Q ss_pred CCEEeCcCCcCCccc-hhHhhcCCCCCeEeccCCCCCCCCC
Q 041558 328 LHYLGLCKNKLVQEL-PKILEKLVQFSELDLSYNFLGPIPN 367 (495)
Q Consensus 328 L~~L~l~~n~l~~~~-~~~~~~l~~L~~l~ls~n~l~~~p~ 367 (495)
|+.||+++|-+.+.- -..+..+..|+.|++.+|++.|-|.
T Consensus 256 L~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p~ 296 (1096)
T KOG1859|consen 256 LYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAPW 296 (1096)
T ss_pred hhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCHH
Confidence 777777777765531 1234455667777777777776663
No 45
>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]
Probab=98.52 E-value=3.2e-09 Score=104.60 Aligned_cols=157 Identities=27% Similarity=0.252 Sum_probs=118.2
Q ss_pred CccCCCCCCCCEEEccCceeeecc---------------------Ccccc----------CCCCccEEEccCCcCcccCC
Q 041558 175 PKSLRSCTSLIRLCRNRNNLTRDI---------------------SEALG----------IYPYLTFIDLSRNNFHGEIP 223 (495)
Q Consensus 175 ~~~~~~l~~L~~L~l~~n~~~~~~---------------------~~~~~----------~~~~L~~L~l~~n~l~~~~~ 223 (495)
|-.+..+.+|++|.+.++.+.... .+.|. ....|...+.+.|++. ...
T Consensus 102 pi~ifpF~sLr~LElrg~~L~~~~GL~~lr~qLe~LIC~~Sl~Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~-~mD 180 (1096)
T KOG1859|consen 102 PISIFPFRSLRVLELRGCDLSTAKGLQELRHQLEKLICHNSLDALRHVFASCGGDISNSPVWNKLATASFSYNRLV-LMD 180 (1096)
T ss_pred CceeccccceeeEEecCcchhhhhhhHHHHHhhhhhhhhccHHHHHHHHHHhccccccchhhhhHhhhhcchhhHH-hHH
Confidence 446677889999999998775210 00000 0124677788888887 667
Q ss_pred CCCCCCCCCCEEecccccccccCCccccCCCCCceeccCCCeeeeecCCC-CccccccceeecccccccccCCcccCCCC
Q 041558 224 SNREKCPKLGTLGVLMNTITKGIPREIRNSSQRQALDLSLNHIIGEIPKE-LGKLNSLIKLILRRNQLVGCLPTEIGSPI 302 (495)
Q Consensus 224 ~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~-~~~~~~L~~L~L~~n~l~~~~~~~~~~l~ 302 (495)
.++.-++.++.|+|+.|++... ..+..++.|+.|||++|.+. .+|.. ...+. |..|.+++|.++. . ..+.++.
T Consensus 181 ~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~lrnN~l~t-L-~gie~Lk 254 (1096)
T KOG1859|consen 181 ESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNLRNNALTT-L-RGIENLK 254 (1096)
T ss_pred HHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhhh-heeeeecccHHHh-h-hhHHhhh
Confidence 7777788999999999999884 37788999999999999997 55542 33444 9999999999973 2 3467899
Q ss_pred CCCEEeCCCCcCCCCc-hhhhhcCCCCCEEeCcCCcC
Q 041558 303 ELEYLDFSVNRFNNLI-PESLENLLKLHYLGLCKNKL 338 (495)
Q Consensus 303 ~L~~L~Ls~n~l~~~~-~~~~~~l~~L~~L~l~~n~l 338 (495)
+|..||+++|-+.+.- -..+..+..|+.|+|.+|++
T Consensus 255 sL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl 291 (1096)
T KOG1859|consen 255 SLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPL 291 (1096)
T ss_pred hhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcc
Confidence 9999999999887642 13456678899999999998
No 46
>KOG2982 consensus Uncharacterized conserved protein [Function unknown]
Probab=98.49 E-value=1.6e-08 Score=89.52 Aligned_cols=39 Identities=31% Similarity=0.370 Sum_probs=20.3
Q ss_pred CCCCCeeeccCCcccc--cCChhhhcCCCCCEEecCCCccc
Q 041558 70 LKSLGDLQLNGNQFIS--YIPSSFGNLTNLSTSRLSKNKLF 108 (495)
Q Consensus 70 l~~L~~L~l~~n~l~~--~~~~~~~~l~~L~~L~l~~n~~~ 108 (495)
++.++.+||.+|.++. .+...+.+++.|++|+++.|.+.
T Consensus 70 ~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~ 110 (418)
T KOG2982|consen 70 VTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLS 110 (418)
T ss_pred hhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCC
Confidence 4455555555555543 23333445555566666555553
No 47
>KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones]
Probab=98.37 E-value=6.4e-09 Score=92.06 Aligned_cols=145 Identities=23% Similarity=0.261 Sum_probs=65.6
Q ss_pred CCCeeeccCCcccc-cCChhhhcCCCCCEEecCCCcccccCCccccCCCCCCEEee----------ecccccCCCCCCEE
Q 041558 72 SLGDLQLNGNQFIS-YIPSSFGNLTNLSTSRLSKNKLFVSIPNEIGKMRSLNILEV----------LPLSVSNLTNPKEL 140 (495)
Q Consensus 72 ~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l----------~~~~l~~~~~L~~L 140 (495)
.||+|||+...++. .+...+..+.+|+.|.+.+++++..+...++.-.+|+.|++ ....+.+|+.|.+|
T Consensus 186 Rlq~lDLS~s~it~stl~~iLs~C~kLk~lSlEg~~LdD~I~~~iAkN~~L~~lnlsm~sG~t~n~~~ll~~scs~L~~L 265 (419)
T KOG2120|consen 186 RLQHLDLSNSVITVSTLHGILSQCSKLKNLSLEGLRLDDPIVNTIAKNSNLVRLNLSMCSGFTENALQLLLSSCSRLDEL 265 (419)
T ss_pred hhHHhhcchhheeHHHHHHHHHHHHhhhhccccccccCcHHHHHHhccccceeeccccccccchhHHHHHHHhhhhHhhc
Confidence 36666666555442 23334555666666666666665554444444444444443 11124455666666
Q ss_pred EccccccccCCCccC-cc--ccccccccccccc---ccccCccCCCCCCCCEEEccCc-eeeeccCccccCCCCccEEEc
Q 041558 141 ALLYNCLSGSIPPSL-EN--PMLARLGLDFNHF---KRTIPKSLRSCTSLIRLCRNRN-NLTRDISEALGIYPYLTFIDL 213 (495)
Q Consensus 141 ~l~~n~l~~~~~~~~-~~--~~L~~L~l~~n~~---~~~~~~~~~~l~~L~~L~l~~n-~~~~~~~~~~~~~~~L~~L~l 213 (495)
+++.+.+....-... .. ++|..|+++++.- ...+..-...|++|..||+++| .++......|-.++.|++|.+
T Consensus 266 NlsWc~l~~~~Vtv~V~hise~l~~LNlsG~rrnl~~sh~~tL~~rcp~l~~LDLSD~v~l~~~~~~~~~kf~~L~~lSl 345 (419)
T KOG2120|consen 266 NLSWCFLFTEKVTVAVAHISETLTQLNLSGYRRNLQKSHLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFKFNYLQHLSL 345 (419)
T ss_pred CchHhhccchhhhHHHhhhchhhhhhhhhhhHhhhhhhHHHHHHHhCCceeeeccccccccCchHHHHHHhcchheeeeh
Confidence 666665443221111 11 5555566655321 1111111234555555555543 222222233334444444444
Q ss_pred cCC
Q 041558 214 SRN 216 (495)
Q Consensus 214 ~~n 216 (495)
+.|
T Consensus 346 sRC 348 (419)
T KOG2120|consen 346 SRC 348 (419)
T ss_pred hhh
Confidence 444
No 48
>KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones]
Probab=98.33 E-value=5.5e-09 Score=92.44 Aligned_cols=177 Identities=23% Similarity=0.134 Sum_probs=112.7
Q ss_pred cCCeeecccCccccc-CCcccccCcccceeecccccccccCCccccCCCCCCeeeccCCc-ccc-cCChhhhcCCCCCEE
Q 041558 24 FLWGLDLSNNQFSSS-IPLSFGNLSNLIFLYLYENSYFASIPSNVGKLKSLGDLQLNGNQ-FIS-YIPSSFGNLTNLSTS 100 (495)
Q Consensus 24 ~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~l~~n~-l~~-~~~~~~~~l~~L~~L 100 (495)
.|++||||+..|+.. ....++.|.+|+.|.|.++++.+.+...+..-.+|+.|+++.+. ++. ...-.+.+++.|..|
T Consensus 186 Rlq~lDLS~s~it~stl~~iLs~C~kLk~lSlEg~~LdD~I~~~iAkN~~L~~lnlsm~sG~t~n~~~ll~~scs~L~~L 265 (419)
T KOG2120|consen 186 RLQHLDLSNSVITVSTLHGILSQCSKLKNLSLEGLRLDDPIVNTIAKNSNLVRLNLSMCSGFTENALQLLLSSCSRLDEL 265 (419)
T ss_pred hhHHhhcchhheeHHHHHHHHHHHHhhhhccccccccCcHHHHHHhccccceeeccccccccchhHHHHHHHhhhhHhhc
Confidence 488899998887632 33446788999999999999888777788888899999998874 332 122346788999999
Q ss_pred ecCCCcccccCCccccCCCCCCEEeeecccccCCCCCCEEEccccc--cccCCCccCcc--cccccccccccc-cccccC
Q 041558 101 RLSKNKLFVSIPNEIGKMRSLNILEVLPLSVSNLTNPKELALLYNC--LSGSIPPSLEN--PMLARLGLDFNH-FKRTIP 175 (495)
Q Consensus 101 ~l~~n~~~~~~~~~~~~l~~L~~L~l~~~~l~~~~~L~~L~l~~n~--l~~~~~~~~~~--~~L~~L~l~~n~-~~~~~~ 175 (495)
+++.+.++...-..+.. .--++|+.|++++.. +...--+.+.. |+|..|||++|. ++....
T Consensus 266 NlsWc~l~~~~Vtv~V~--------------hise~l~~LNlsG~rrnl~~sh~~tL~~rcp~l~~LDLSD~v~l~~~~~ 331 (419)
T KOG2120|consen 266 NLSWCFLFTEKVTVAVA--------------HISETLTQLNLSGYRRNLQKSHLSTLVRRCPNLVHLDLSDSVMLKNDCF 331 (419)
T ss_pred CchHhhccchhhhHHHh--------------hhchhhhhhhhhhhHhhhhhhHHHHHHHhCCceeeeccccccccCchHH
Confidence 99998775433221110 001345566666542 11111112222 777777777753 333344
Q ss_pred ccCCCCCCCCEEEccCceeeeccCc---cccCCCCccEEEccCC
Q 041558 176 KSLRSCTSLIRLCRNRNNLTRDISE---ALGIYPYLTFIDLSRN 216 (495)
Q Consensus 176 ~~~~~l~~L~~L~l~~n~~~~~~~~---~~~~~~~L~~L~l~~n 216 (495)
..|..++.|++|.++.|-. ++|. .+...|+|.+|++.++
T Consensus 332 ~~~~kf~~L~~lSlsRCY~--i~p~~~~~l~s~psl~yLdv~g~ 373 (419)
T KOG2120|consen 332 QEFFKFNYLQHLSLSRCYD--IIPETLLELNSKPSLVYLDVFGC 373 (419)
T ss_pred HHHHhcchheeeehhhhcC--CChHHeeeeccCcceEEEEeccc
Confidence 4566778888888877632 3343 3456677888877654
No 49
>COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification]
Probab=98.25 E-value=1.9e-08 Score=87.90 Aligned_cols=86 Identities=23% Similarity=0.251 Sum_probs=56.9
Q ss_pred CCccCCeeecccCcccccCCccc----ccCcccceeecccccccc----cCC-------ccccCCCCCCeeeccCCcccc
Q 041558 21 NSQFLWGLDLSNNQFSSSIPLSF----GNLSNLIFLYLYENSYFA----SIP-------SNVGKLKSLGDLQLNGNQFIS 85 (495)
Q Consensus 21 ~l~~L~~L~l~~n~l~~~~~~~~----~~l~~L~~L~L~~n~~~~----~~~-------~~~~~l~~L~~L~l~~n~l~~ 85 (495)
.+..++.+|||+|.|......++ .+-.+|++.+++.-- +| .++ .++.+|++|+..+|++|.+..
T Consensus 28 ~~d~~~evdLSGNtigtEA~e~l~~~ia~~~~L~vvnfsd~f-tgr~kde~~~~L~~Ll~aLlkcp~l~~v~LSDNAfg~ 106 (388)
T COG5238 28 MMDELVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDAF-TGRDKDELYSNLVMLLKALLKCPRLQKVDLSDNAFGS 106 (388)
T ss_pred hhcceeEEeccCCcccHHHHHHHHHHHhhhcceeEeehhhhh-hcccHHHHHHHHHHHHHHHhcCCcceeeeccccccCc
Confidence 35678888888888875444443 445677777776532 22 222 233467888888888888776
Q ss_pred cCChh----hhcCCCCCEEecCCCcc
Q 041558 86 YIPSS----FGNLTNLSTSRLSKNKL 107 (495)
Q Consensus 86 ~~~~~----~~~l~~L~~L~l~~n~~ 107 (495)
..|+. +..-+.|++|.+++|.+
T Consensus 107 ~~~e~L~d~is~~t~l~HL~l~NnGl 132 (388)
T COG5238 107 EFPEELGDLISSSTDLVHLKLNNNGL 132 (388)
T ss_pred ccchHHHHHHhcCCCceeEEeecCCC
Confidence 55544 34557888888888866
No 50
>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]
Probab=98.20 E-value=2.4e-08 Score=78.18 Aligned_cols=82 Identities=26% Similarity=0.347 Sum_probs=42.8
Q ss_pred CCCceeccCCCeeeeecCCCCc-cccccceeecccccccccCCcccCCCCCCCEEeCCCCcCCCCchhhhhcCCCCCEEe
Q 041558 254 SQRQALDLSLNHIIGEIPKELG-KLNSLIKLILRRNQLVGCLPTEIGSPIELEYLDFSVNRFNNLIPESLENLLKLHYLG 332 (495)
Q Consensus 254 ~~L~~L~ls~n~l~~~~~~~~~-~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 332 (495)
..|+..+|++|.+. .+|..|. ..+.++.+++++|.++ .+|.++..++.|+.|+++.|.+.-. |..+..+.++..|+
T Consensus 53 ~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~~~-p~vi~~L~~l~~Ld 129 (177)
T KOG4579|consen 53 YELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLNAE-PRVIAPLIKLDMLD 129 (177)
T ss_pred ceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccccc-hHHHHHHHhHHHhc
Confidence 33444455555554 3333332 2335555566666655 4555555556666666666655543 34444455666666
Q ss_pred CcCCcC
Q 041558 333 LCKNKL 338 (495)
Q Consensus 333 l~~n~l 338 (495)
..+|.+
T Consensus 130 s~~na~ 135 (177)
T KOG4579|consen 130 SPENAR 135 (177)
T ss_pred CCCCcc
Confidence 666655
No 51
>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]
Probab=98.19 E-value=1.3e-07 Score=74.06 Aligned_cols=125 Identities=24% Similarity=0.294 Sum_probs=94.4
Q ss_pred CCceeccCCCeeeeecCCC---CccccccceeecccccccccCCcccCC-CCCCCEEeCCCCcCCCCchhhhhcCCCCCE
Q 041558 255 QRQALDLSLNHIIGEIPKE---LGKLNSLIKLILRRNQLVGCLPTEIGS-PIELEYLDFSVNRFNNLIPESLENLLKLHY 330 (495)
Q Consensus 255 ~L~~L~ls~n~l~~~~~~~---~~~~~~L~~L~L~~n~l~~~~~~~~~~-l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~ 330 (495)
.+-.++|+.|.+. -+++. +.....|+..+|++|.+. ..|..|.. .+.++.|++++|.+++. |..+..++.|+.
T Consensus 28 E~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neisdv-PeE~Aam~aLr~ 104 (177)
T KOG4579|consen 28 ELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEISDV-PEELAAMPALRS 104 (177)
T ss_pred Hhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhhhc-hHHHhhhHHhhh
Confidence 3456677887764 33333 445566888899999998 56665654 45899999999999986 666999999999
Q ss_pred EeCcCCcCCccchhHhhcCCCCCeEeccCCCCCCCCCcccccCCChhhccCCc
Q 041558 331 LGLCKNKLVQELPKILEKLVQFSELDLSYNFLGPIPNSIAFRGASVEALKGNK 383 (495)
Q Consensus 331 L~l~~n~l~~~~~~~~~~l~~L~~l~ls~n~l~~~p~~~~~~~~~~~~~~~n~ 383 (495)
|+++.|.+. ..|..+..+.++..||..+|....+|.....+......-.||.
T Consensus 105 lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~eid~dl~~s~~~al~~lgne 156 (177)
T KOG4579|consen 105 LNLRFNPLN-AEPRVIAPLIKLDMLDSPENARAEIDVDLFYSSLPALIKLGNE 156 (177)
T ss_pred cccccCccc-cchHHHHHHHhHHHhcCCCCccccCcHHHhccccHHHHHhcCC
Confidence 999999995 4566677799999999999999888877555555544433544
No 52
>COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification]
Probab=98.10 E-value=8.2e-08 Score=84.06 Aligned_cols=252 Identities=20% Similarity=0.114 Sum_probs=140.0
Q ss_pred cCCCCCCeeeccCCcccccCC----hhhhcCCCCCEEecCCCcccccCCccccCCCCCCEEeeecccccCCCCCCEEEcc
Q 041558 68 GKLKSLGDLQLNGNQFISYIP----SSFGNLTNLSTSRLSKNKLFVSIPNEIGKMRSLNILEVLPLSVSNLTNPKELALL 143 (495)
Q Consensus 68 ~~l~~L~~L~l~~n~l~~~~~----~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~~~l~~~~~L~~L~l~ 143 (495)
..+..++.++|++|.+...-. ..+.+-.+|+..++++-. +|...+.+.. .|.++...+.+|++|+..+++
T Consensus 27 ~~~d~~~evdLSGNtigtEA~e~l~~~ia~~~~L~vvnfsd~f-tgr~kde~~~-----~L~~Ll~aLlkcp~l~~v~LS 100 (388)
T COG5238 27 EMMDELVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDAF-TGRDKDELYS-----NLVMLLKALLKCPRLQKVDLS 100 (388)
T ss_pred HhhcceeEEeccCCcccHHHHHHHHHHHhhhcceeEeehhhhh-hcccHHHHHH-----HHHHHHHHHhcCCcceeeecc
Confidence 346778888888887765322 334445677777776542 2332221110 011134467789999999999
Q ss_pred ccccccCCCccCcc-----ccccccccccccccc----ccCccCCCCCCCCEEEccCceeeeccCccccCCCCccEEEcc
Q 041558 144 YNCLSGSIPPSLEN-----PMLARLGLDFNHFKR----TIPKSLRSCTSLIRLCRNRNNLTRDISEALGIYPYLTFIDLS 214 (495)
Q Consensus 144 ~n~l~~~~~~~~~~-----~~L~~L~l~~n~~~~----~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~ 214 (495)
.|.+....|..+.. +.|+.|.+++|.+.- .+..++..+ ..| .....-|.|+..+..
T Consensus 101 DNAfg~~~~e~L~d~is~~t~l~HL~l~NnGlGp~aG~rigkal~~l--------a~n-------KKaa~kp~Le~vicg 165 (388)
T COG5238 101 DNAFGSEFPEELGDLISSSTDLVHLKLNNNGLGPIAGGRIGKALFHL--------AYN-------KKAADKPKLEVVICG 165 (388)
T ss_pred ccccCcccchHHHHHHhcCCCceeEEeecCCCCccchhHHHHHHHHH--------HHH-------hhhccCCCceEEEec
Confidence 99888776665433 556666666654420 011111000 000 111234667777777
Q ss_pred CCcCcccC----CCCCCCCCCCCEEecccccccccC-----CccccCCCCCceeccCCCeeeee----cCCCCccccccc
Q 041558 215 RNNFHGEI----PSNREKCPKLGTLGVLMNTITKGI-----PREIRNSSQRQALDLSLNHIIGE----IPKELGKLNSLI 281 (495)
Q Consensus 215 ~n~l~~~~----~~~~~~~~~L~~L~l~~n~l~~~~-----~~~~~~l~~L~~L~ls~n~l~~~----~~~~~~~~~~L~ 281 (495)
.|++..-. ...+..-.+|+.+.+..|.|...- -..+..+.+|+.||+..|.++-. +...+...+.|+
T Consensus 166 rNRlengs~~~~a~~l~sh~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~La~al~~W~~lr 245 (388)
T COG5238 166 RNRLENGSKELSAALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYLADALCEWNLLR 245 (388)
T ss_pred cchhccCcHHHHHHHHHhhcCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHHHHHHhcccchhh
Confidence 77665211 112233356777777777765321 11234467788888888877522 222344556678
Q ss_pred eeecccccccccCCc----ccC--CCCCCCEEeCCCCcCCCCchh-----h--hhcCCCCCEEeCcCCcCCc
Q 041558 282 KLILRRNQLVGCLPT----EIG--SPIELEYLDFSVNRFNNLIPE-----S--LENLLKLHYLGLCKNKLVQ 340 (495)
Q Consensus 282 ~L~L~~n~l~~~~~~----~~~--~l~~L~~L~Ls~n~l~~~~~~-----~--~~~l~~L~~L~l~~n~l~~ 340 (495)
.|.+.+|-++..-.. .|. ..++|..|...+|...+.+-. . -..+|-|..|.+.+|++..
T Consensus 246 EL~lnDClls~~G~~~v~~~f~e~~~p~l~~L~~~Yne~~~~~i~~~~l~~~e~~~~p~L~~le~ngNr~~E 317 (388)
T COG5238 246 ELRLNDCLLSNEGVKSVLRRFNEKFVPNLMPLPGDYNERRGGIILDISLNEFEQDAVPLLVDLERNGNRIKE 317 (388)
T ss_pred hccccchhhccccHHHHHHHhhhhcCCCccccccchhhhcCceeeeechhhhhhcccHHHHHHHHccCcchh
Confidence 888888876633221 111 246777888888866543211 1 2356778888889999854
No 53
>KOG2982 consensus Uncharacterized conserved protein [Function unknown]
Probab=98.04 E-value=1.2e-06 Score=78.03 Aligned_cols=18 Identities=28% Similarity=0.207 Sum_probs=12.8
Q ss_pred eeeEEEEEeCCeeEEEec
Q 041558 474 VKFYGFCSHARHSFSVYE 491 (495)
Q Consensus 474 V~l~G~c~~~~~~~LVye 491 (495)
.+|+-|-+++++.+||-|
T Consensus 399 ~~L~~fkIedGDs~lvqe 416 (418)
T KOG2982|consen 399 MPLHYFKIEDGDSFLVQE 416 (418)
T ss_pred CcceEEeccCCCEeeeec
Confidence 457777777777777765
No 54
>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]
Probab=98.03 E-value=4.7e-06 Score=80.88 Aligned_cols=32 Identities=28% Similarity=0.467 Sum_probs=31.0
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.|++++|||||+|+|.|..++-.++|.|||+|
T Consensus 588 iLsqLkhPNIveLvGVC~~DePicmI~EYmEn 619 (807)
T KOG1094|consen 588 ILSRLKHPNIVELLGVCVQDDPLCMITEYMEN 619 (807)
T ss_pred HHhccCCCCeeEEEeeeecCCchHHHHHHHhc
Confidence 89999999999999999999999999999997
No 55
>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B ....
Probab=97.95 E-value=4.2e-06 Score=53.03 Aligned_cols=35 Identities=46% Similarity=0.524 Sum_probs=14.2
Q ss_pred cCCeeecccCcccccCCcccccCcccceeecccccc
Q 041558 24 FLWGLDLSNNQFSSSIPLSFGNLSNLIFLYLYENSY 59 (495)
Q Consensus 24 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~~ 59 (495)
+|++|++++|+|+ .+|..+++|++|++|++++|++
T Consensus 2 ~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i 36 (44)
T PF12799_consen 2 NLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPI 36 (44)
T ss_dssp T-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCC
T ss_pred cceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCC
Confidence 3444444444444 2233344444444444444443
No 56
>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B ....
Probab=97.87 E-value=1.2e-05 Score=50.95 Aligned_cols=36 Identities=42% Similarity=0.594 Sum_probs=19.2
Q ss_pred CCCEEeCCCCcCCCCchhhhhcCCCCCEEeCcCCcCC
Q 041558 303 ELEYLDFSVNRFNNLIPESLENLLKLHYLGLCKNKLV 339 (495)
Q Consensus 303 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 339 (495)
+|++|++++|.++.. |..++.+++|+.|++++|+++
T Consensus 2 ~L~~L~l~~N~i~~l-~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 2 NLEELDLSNNQITDL-PPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp T-SEEEETSSS-SSH-GGHGTTCTTSSEEEETSSCCS
T ss_pred cceEEEccCCCCccc-CchHhCCCCCCEEEecCCCCC
Confidence 455566666665543 334556666666666666554
No 57
>KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification]
Probab=97.78 E-value=2.9e-05 Score=65.45 Aligned_cols=104 Identities=27% Similarity=0.262 Sum_probs=64.0
Q ss_pred CCceeccCCCeeeeecCCCCccccccceeecccccccccCCcccCCCCCCCEEeCCCCcCCCC-chhhhhcCCCCCEEeC
Q 041558 255 QRQALDLSLNHIIGEIPKELGKLNSLIKLILRRNQLVGCLPTEIGSPIELEYLDFSVNRFNNL-IPESLENLLKLHYLGL 333 (495)
Q Consensus 255 ~L~~L~ls~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~~~~~~~l~~L~~L~l 333 (495)
+...+||++|.+. . ...|..++.|.+|.|.+|+|+...|.--..+++|+.|.|.+|+|... .-+.+..+|+|+.|.+
T Consensus 43 ~~d~iDLtdNdl~-~-l~~lp~l~rL~tLll~nNrIt~I~p~L~~~~p~l~~L~LtnNsi~~l~dl~pLa~~p~L~~Ltl 120 (233)
T KOG1644|consen 43 QFDAIDLTDNDLR-K-LDNLPHLPRLHTLLLNNNRITRIDPDLDTFLPNLKTLILTNNSIQELGDLDPLASCPKLEYLTL 120 (233)
T ss_pred ccceecccccchh-h-cccCCCccccceEEecCCcceeeccchhhhccccceEEecCcchhhhhhcchhccCCccceeee
Confidence 4456677777664 2 23466667777777777777755555444556677777777766543 1133566777777777
Q ss_pred cCCcCCccc---hhHhhcCCCCCeEeccCC
Q 041558 334 CKNKLVQEL---PKILEKLVQFSELDLSYN 360 (495)
Q Consensus 334 ~~n~l~~~~---~~~~~~l~~L~~l~ls~n 360 (495)
-+|+.+..- ...+..+++|+.||.+.=
T Consensus 121 l~Npv~~k~~YR~yvl~klp~l~~LDF~kV 150 (233)
T KOG1644|consen 121 LGNPVEHKKNYRLYVLYKLPSLRTLDFQKV 150 (233)
T ss_pred cCCchhcccCceeEEEEecCcceEeehhhh
Confidence 777764321 123456777777776653
No 58
>KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification]
Probab=97.78 E-value=2.8e-05 Score=65.61 Aligned_cols=84 Identities=20% Similarity=0.141 Sum_probs=65.6
Q ss_pred ccCCeeecccCcccccCCcccccCcccceeecccccccccCCccccCCCCCCeeeccCCccccc-CChhhhcCCCCCEEe
Q 041558 23 QFLWGLDLSNNQFSSSIPLSFGNLSNLIFLYLYENSYFASIPSNVGKLKSLGDLQLNGNQFISY-IPSSFGNLTNLSTSR 101 (495)
Q Consensus 23 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~ 101 (495)
.+...+||++|.+... ..|..++.|..|.+.+|.|+.+.|.--..+++|+.|.|.+|.+... .-.-+..+++|+.|.
T Consensus 42 d~~d~iDLtdNdl~~l--~~lp~l~rL~tLll~nNrIt~I~p~L~~~~p~l~~L~LtnNsi~~l~dl~pLa~~p~L~~Lt 119 (233)
T KOG1644|consen 42 DQFDAIDLTDNDLRKL--DNLPHLPRLHTLLLNNNRITRIDPDLDTFLPNLKTLILTNNSIQELGDLDPLASCPKLEYLT 119 (233)
T ss_pred cccceecccccchhhc--ccCCCccccceEEecCCcceeeccchhhhccccceEEecCcchhhhhhcchhccCCccceee
Confidence 3567789999988733 3577888999999999998887777666788899999999987651 123466788999999
Q ss_pred cCCCccc
Q 041558 102 LSKNKLF 108 (495)
Q Consensus 102 l~~n~~~ 108 (495)
+-+|..+
T Consensus 120 ll~Npv~ 126 (233)
T KOG1644|consen 120 LLGNPVE 126 (233)
T ss_pred ecCCchh
Confidence 9888874
No 59
>PF13306 LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_A 3V47_B 3V44_A 3ZYN_A 3ZYO_A 3SB4_A.
Probab=97.75 E-value=0.00012 Score=59.42 Aligned_cols=38 Identities=13% Similarity=0.217 Sum_probs=13.1
Q ss_pred cCCCCCCCCEEEccCceeeeccCccccCCCCccEEEccC
Q 041558 177 SLRSCTSLIRLCRNRNNLTRDISEALGIYPYLTFIDLSR 215 (495)
Q Consensus 177 ~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~ 215 (495)
.|.++.+|+.+.+.. .+......+|..+++|+.+.+.+
T Consensus 7 ~F~~~~~l~~i~~~~-~~~~I~~~~F~~~~~l~~i~~~~ 44 (129)
T PF13306_consen 7 AFYNCSNLESITFPN-TIKKIGENAFSNCTSLKSINFPN 44 (129)
T ss_dssp TTTT-TT--EEEETS-T--EE-TTTTTT-TT-SEEEESS
T ss_pred HHhCCCCCCEEEECC-CeeEeChhhcccccccccccccc
Confidence 344444444444442 23333344444444444444443
No 60
>PF13306 LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_A 3V47_B 3V44_A 3ZYN_A 3ZYO_A 3SB4_A.
Probab=97.73 E-value=0.00016 Score=58.75 Aligned_cols=126 Identities=11% Similarity=0.118 Sum_probs=67.6
Q ss_pred cCccccCCCCccEEEccCCcCcccCCCCCCCCCCCCEEecccccccccCCccccCCCCCceeccCCCeeeeecCCCCccc
Q 041558 198 ISEALGIYPYLTFIDLSRNNFHGEIPSNREKCPKLGTLGVLMNTITKGIPREIRNSSQRQALDLSLNHIIGEIPKELGKL 277 (495)
Q Consensus 198 ~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~ 277 (495)
...+|..+++|+.+.+.. .+...-...|..+++|+.+.+.++ +.......|.++..++.+.+.+ .+.......|..+
T Consensus 4 ~~~~F~~~~~l~~i~~~~-~~~~I~~~~F~~~~~l~~i~~~~~-~~~i~~~~F~~~~~l~~i~~~~-~~~~i~~~~F~~~ 80 (129)
T PF13306_consen 4 GNNAFYNCSNLESITFPN-TIKKIGENAFSNCTSLKSINFPNN-LTSIGDNAFSNCKSLESITFPN-NLKSIGDNAFSNC 80 (129)
T ss_dssp -TTTTTT-TT--EEEETS-T--EE-TTTTTT-TT-SEEEESST-TSCE-TTTTTT-TT-EEEEETS-TT-EE-TTTTTT-
T ss_pred CHHHHhCCCCCCEEEECC-CeeEeChhhccccccccccccccc-ccccceeeeecccccccccccc-ccccccccccccc
Confidence 345677888888888875 466566677888888888888775 5554556677787888888866 3333445567778
Q ss_pred cccceeecccccccccCCcccCCCCCCCEEeCCCCcCCCCchhhhhcCCCCC
Q 041558 278 NSLIKLILRRNQLVGCLPTEIGSPIELEYLDFSVNRFNNLIPESLENLLKLH 329 (495)
Q Consensus 278 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 329 (495)
++|+.+++..+ +.......|.++ +|+.+.+.. .++......|.++++|+
T Consensus 81 ~~l~~i~~~~~-~~~i~~~~f~~~-~l~~i~~~~-~~~~i~~~~F~~~~~l~ 129 (129)
T PF13306_consen 81 TNLKNIDIPSN-ITEIGSSSFSNC-NLKEINIPS-NITKIEENAFKNCTKLK 129 (129)
T ss_dssp TTECEEEETTT--BEEHTTTTTT--T--EEE-TT-B-SS----GGG------
T ss_pred ccccccccCcc-ccEEchhhhcCC-CceEEEECC-CccEECCccccccccCC
Confidence 88888888765 554455567776 888888876 45555566777777664
No 61
>KOG3665 consensus ZYG-1-like serine/threonine protein kinases [General function prediction only]
Probab=97.71 E-value=4.2e-06 Score=86.64 Aligned_cols=152 Identities=23% Similarity=0.174 Sum_probs=78.7
Q ss_pred CcEEEeeCCcc-cccCCccCc-CCccCCeeecccCcccc-cCCcccccCcccceeecccccccccCCccccCCCCCCeee
Q 041558 1 MALLIIHNNSL-SGFIPLNIG-NSQFLWGLDLSNNQFSS-SIPLSFGNLSNLIFLYLYENSYFASIPSNVGKLKSLGDLQ 77 (495)
Q Consensus 1 L~~L~l~~n~l-~~~~~~~~~-~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~ 77 (495)
|++|++++... ....|..++ -+|.|++|.+++-.+.. .+.....++++|..||+++.+++.. ..++.+++|++|.
T Consensus 124 L~~LdI~G~~~~s~~W~~kig~~LPsL~sL~i~~~~~~~~dF~~lc~sFpNL~sLDIS~TnI~nl--~GIS~LknLq~L~ 201 (699)
T KOG3665|consen 124 LQHLDISGSELFSNGWPKKIGTMLPSLRSLVISGRQFDNDDFSQLCASFPNLRSLDISGTNISNL--SGISRLKNLQVLS 201 (699)
T ss_pred hhhcCccccchhhccHHHHHhhhCcccceEEecCceecchhHHHHhhccCccceeecCCCCccCc--HHHhccccHHHHh
Confidence 45666666442 223333333 35777777776654431 1222235667777777777665533 3456667777776
Q ss_pred ccCCcccc-cCChhhhcCCCCCEEecCCCcccccCCccccCCCCCCEEeeecccccCCCCCCEEEccccccccCCCccCc
Q 041558 78 LNGNQFIS-YIPSSFGNLTNLSTSRLSKNKLFVSIPNEIGKMRSLNILEVLPLSVSNLTNPKELALLYNCLSGSIPPSLE 156 (495)
Q Consensus 78 l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~~~l~~~~~L~~L~l~~n~l~~~~~~~~~ 156 (495)
+.+=.+.. ..-..+-+|++|++||+|....... +..+.. .-+.-..+|+|+.||.+++.+...+-..+-
T Consensus 202 mrnLe~e~~~~l~~LF~L~~L~vLDIS~~~~~~~-~~ii~q---------Ylec~~~LpeLrfLDcSgTdi~~~~le~ll 271 (699)
T KOG3665|consen 202 MRNLEFESYQDLIDLFNLKKLRVLDISRDKNNDD-TKIIEQ---------YLECGMVLPELRFLDCSGTDINEEILEELL 271 (699)
T ss_pred ccCCCCCchhhHHHHhcccCCCeeeccccccccc-hHHHHH---------HHHhcccCccccEEecCCcchhHHHHHHHH
Confidence 66544432 1112345677777777776654211 110000 011123467888888887766654443333
Q ss_pred c--ccccccc
Q 041558 157 N--PMLARLG 164 (495)
Q Consensus 157 ~--~~L~~L~ 164 (495)
. ++|+.+.
T Consensus 272 ~sH~~L~~i~ 281 (699)
T KOG3665|consen 272 NSHPNLQQIA 281 (699)
T ss_pred HhCccHhhhh
Confidence 2 4454444
No 62
>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]
Probab=97.68 E-value=0.00012 Score=74.72 Aligned_cols=31 Identities=32% Similarity=0.588 Sum_probs=30.3
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~ 494 (495)
++++++|+|||+|+|.|.+++-.++|+|||.
T Consensus 542 Lla~l~H~nIVrLlGVC~~~~P~~MvFEYm~ 572 (774)
T KOG1026|consen 542 LLAELQHPNIVRLLGVCREGDPLCMVFEYMD 572 (774)
T ss_pred HHHhccCCCeEEEEEEEccCCeeEEEEEecc
Confidence 8999999999999999999999999999996
No 63
>PRK15386 type III secretion protein GogB; Provisional
Probab=97.48 E-value=0.0002 Score=68.63 Aligned_cols=54 Identities=19% Similarity=0.063 Sum_probs=23.2
Q ss_pred CCCCCEEEccCceeeeccCccccCCCCccEEEccCCcCcccCCCCCCCCCCCCEEecccc
Q 041558 181 CTSLIRLCRNRNNLTRDISEALGIYPYLTFIDLSRNNFHGEIPSNREKCPKLGTLGVLMN 240 (495)
Q Consensus 181 l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n 240 (495)
+.+++.|++++|.+... |. -.++|+.|.++++.-...+|+.+ .++|+.|++++|
T Consensus 51 ~~~l~~L~Is~c~L~sL-P~---LP~sLtsL~Lsnc~nLtsLP~~L--P~nLe~L~Ls~C 104 (426)
T PRK15386 51 ARASGRLYIKDCDIESL-PV---LPNELTEITIENCNNLTTLPGSI--PEGLEKLTVCHC 104 (426)
T ss_pred hcCCCEEEeCCCCCccc-CC---CCCCCcEEEccCCCCcccCCchh--hhhhhheEccCc
Confidence 34455555555544322 21 12245555555432222334332 134555555555
No 64
>PRK15386 type III secretion protein GogB; Provisional
Probab=97.43 E-value=0.00055 Score=65.68 Aligned_cols=135 Identities=16% Similarity=0.136 Sum_probs=83.7
Q ss_pred ccCCCCccEEEccCCcCcccCCCCCCCCCCCCEEecccccccccCCccccCCCCCceeccCCC-eeeeecCCCCcccccc
Q 041558 202 LGIYPYLTFIDLSRNNFHGEIPSNREKCPKLGTLGVLMNTITKGIPREIRNSSQRQALDLSLN-HIIGEIPKELGKLNSL 280 (495)
Q Consensus 202 ~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~n-~l~~~~~~~~~~~~~L 280 (495)
+..+.+++.|++++|.++ .+|. + .++|+.|.++++.-...+|..+. ++|+.|++++| .+. .+|. +|
T Consensus 48 ~~~~~~l~~L~Is~c~L~-sLP~-L--P~sLtsL~Lsnc~nLtsLP~~LP--~nLe~L~Ls~Cs~L~-sLP~------sL 114 (426)
T PRK15386 48 IEEARASGRLYIKDCDIE-SLPV-L--PNELTEITIENCNNLTTLPGSIP--EGLEKLTVCHCPEIS-GLPE------SV 114 (426)
T ss_pred HHHhcCCCEEEeCCCCCc-ccCC-C--CCCCcEEEccCCCCcccCCchhh--hhhhheEccCccccc-cccc------cc
Confidence 345688999999999887 5563 2 24699999998655455666553 68999999998 443 4554 46
Q ss_pred ceeecccccccc--cCCcccCCCCCCCEEeCCCCc-CC-CCchhhhhcCCCCCEEeCcCCcCCccchhHhhcCCCCCeEe
Q 041558 281 IKLILRRNQLVG--CLPTEIGSPIELEYLDFSVNR-FN-NLIPESLENLLKLHYLGLCKNKLVQELPKILEKLVQFSELD 356 (495)
Q Consensus 281 ~~L~L~~n~l~~--~~~~~~~~l~~L~~L~Ls~n~-l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~ 356 (495)
+.|++..+.... .+| ++|+.|.+.++. .. ..+|.. -.++|+.|++++|.... .|..+. .+|+.|+
T Consensus 115 e~L~L~~n~~~~L~~LP------ssLk~L~I~~~n~~~~~~lp~~--LPsSLk~L~Is~c~~i~-LP~~LP--~SLk~L~ 183 (426)
T PRK15386 115 RSLEIKGSATDSIKNVP------NGLTSLSINSYNPENQARIDNL--ISPSLKTLSLTGCSNII-LPEKLP--ESLQSIT 183 (426)
T ss_pred ceEEeCCCCCcccccCc------chHhheeccccccccccccccc--cCCcccEEEecCCCccc-Cccccc--ccCcEEE
Confidence 677777665431 233 356677765432 11 111111 12578888888777532 333332 4677777
Q ss_pred ccCC
Q 041558 357 LSYN 360 (495)
Q Consensus 357 ls~n 360 (495)
++.+
T Consensus 184 ls~n 187 (426)
T PRK15386 184 LHIE 187 (426)
T ss_pred eccc
Confidence 7766
No 65
>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]
Probab=97.36 E-value=0.00011 Score=70.42 Aligned_cols=32 Identities=34% Similarity=0.532 Sum_probs=30.1
Q ss_pred ecccccCCceeeeEEEEEeCC-eeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHAR-HSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~-~~~LVyeym~n 495 (495)
++++++|||+|+++|+|.+.. ..++|.|||++
T Consensus 92 il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 92 LLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred HHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 899999999999999999987 79999999986
No 66
>KOG2739 consensus Leucine-rich acidic nuclear protein [Cell cycle control, cell division, chromosome partitioning; General function prediction only]
Probab=97.18 E-value=0.00019 Score=63.34 Aligned_cols=93 Identities=20% Similarity=0.124 Sum_probs=65.3
Q ss_pred CCccCcCCccCCeeecccCcccccCCcccccCcccceeecccc--cccccCCccccCCCCCCeeeccCCccccc-CChhh
Q 041558 15 IPLNIGNSQFLWGLDLSNNQFSSSIPLSFGNLSNLIFLYLYEN--SYFASIPSNVGKLKSLGDLQLNGNQFISY-IPSSF 91 (495)
Q Consensus 15 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n--~~~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~ 91 (495)
+....-.+..|+.|++.+..++.. ..|-.+++|+.|.++.| .+.+..+-....+++|++|++++|++.-. --..+
T Consensus 35 ~~gl~d~~~~le~ls~~n~gltt~--~~~P~Lp~LkkL~lsdn~~~~~~~l~vl~e~~P~l~~l~ls~Nki~~lstl~pl 112 (260)
T KOG2739|consen 35 LGGLTDEFVELELLSVINVGLTTL--TNFPKLPKLKKLELSDNYRRVSGGLEVLAEKAPNLKVLNLSGNKIKDLSTLRPL 112 (260)
T ss_pred cccccccccchhhhhhhccceeec--ccCCCcchhhhhcccCCcccccccceehhhhCCceeEEeecCCccccccccchh
Confidence 444555667778888877777632 34667889999999999 66665555556679999999999987631 11235
Q ss_pred hcCCCCCEEecCCCcccc
Q 041558 92 GNLTNLSTSRLSKNKLFV 109 (495)
Q Consensus 92 ~~l~~L~~L~l~~n~~~~ 109 (495)
..+.+|..|++.+|..+.
T Consensus 113 ~~l~nL~~Ldl~n~~~~~ 130 (260)
T KOG2739|consen 113 KELENLKSLDLFNCSVTN 130 (260)
T ss_pred hhhcchhhhhcccCCccc
Confidence 567778888888886543
No 67
>KOG2739 consensus Leucine-rich acidic nuclear protein [Cell cycle control, cell division, chromosome partitioning; General function prediction only]
Probab=97.17 E-value=0.00021 Score=63.06 Aligned_cols=65 Identities=29% Similarity=0.351 Sum_probs=27.3
Q ss_pred cccccceeecccc--cccccCCcccCCCCCCCEEeCCCCcCCCC-chhhhhcCCCCCEEeCcCCcCCc
Q 041558 276 KLNSLIKLILRRN--QLVGCLPTEIGSPIELEYLDFSVNRFNNL-IPESLENLLKLHYLGLCKNKLVQ 340 (495)
Q Consensus 276 ~~~~L~~L~L~~n--~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~~~~~~~l~~L~~L~l~~n~l~~ 340 (495)
.+++|+.|.++.| +..+.++.....+++|+++++++|++..+ .-..+..+.+|..|++.+|..+.
T Consensus 63 ~Lp~LkkL~lsdn~~~~~~~l~vl~e~~P~l~~l~ls~Nki~~lstl~pl~~l~nL~~Ldl~n~~~~~ 130 (260)
T KOG2739|consen 63 KLPKLKKLELSDNYRRVSGGLEVLAEKAPNLKVLNLSGNKIKDLSTLRPLKELENLKSLDLFNCSVTN 130 (260)
T ss_pred CcchhhhhcccCCcccccccceehhhhCCceeEEeecCCccccccccchhhhhcchhhhhcccCCccc
Confidence 3444444444444 33322222223334555555555544321 00123334455555555555443
No 68
>KOG3665 consensus ZYG-1-like serine/threonine protein kinases [General function prediction only]
Probab=97.10 E-value=0.00019 Score=74.57 Aligned_cols=113 Identities=19% Similarity=0.178 Sum_probs=56.5
Q ss_pred CCCCCEEeccccccccc-CCccccCCCCCceeccCCCeeeeecCCCCccccccceeecccccccc-cCCcccCCCCCCCE
Q 041558 229 CPKLGTLGVLMNTITKG-IPREIRNSSQRQALDLSLNHIIGEIPKELGKLNSLIKLILRRNQLVG-CLPTEIGSPIELEY 306 (495)
Q Consensus 229 ~~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~ 306 (495)
+|+|+.|.+++-.+... ......++++|..||+|+.+++.. ..++.+++|+.|.+.+=.+.. ..-..+..+++|+.
T Consensus 147 LPsL~sL~i~~~~~~~~dF~~lc~sFpNL~sLDIS~TnI~nl--~GIS~LknLq~L~mrnLe~e~~~~l~~LF~L~~L~v 224 (699)
T KOG3665|consen 147 LPSLRSLVISGRQFDNDDFSQLCASFPNLRSLDISGTNISNL--SGISRLKNLQVLSMRNLEFESYQDLIDLFNLKKLRV 224 (699)
T ss_pred CcccceEEecCceecchhHHHHhhccCccceeecCCCCccCc--HHHhccccHHHHhccCCCCCchhhHHHHhcccCCCe
Confidence 45555555555444321 112233455566666666555422 344555556655555544431 11123445666666
Q ss_pred EeCCCCcCCCCc--h----hhhhcCCCCCEEeCcCCcCCccch
Q 041558 307 LDFSVNRFNNLI--P----ESLENLLKLHYLGLCKNKLVQELP 343 (495)
Q Consensus 307 L~Ls~n~l~~~~--~----~~~~~l~~L~~L~l~~n~l~~~~~ 343 (495)
||+|........ . ++-..+|+|+.||.|+..+...+-
T Consensus 225 LDIS~~~~~~~~~ii~qYlec~~~LpeLrfLDcSgTdi~~~~l 267 (699)
T KOG3665|consen 225 LDISRDKNNDDTKIIEQYLECGMVLPELRFLDCSGTDINEEIL 267 (699)
T ss_pred eeccccccccchHHHHHHHHhcccCccccEEecCCcchhHHHH
Confidence 666665443321 1 122346777777777776655433
No 69
>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]
Probab=97.05 E-value=0.0011 Score=67.34 Aligned_cols=32 Identities=19% Similarity=0.406 Sum_probs=31.1
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++++..||||++|-|.-....-.|+|.|||+|
T Consensus 683 IMGQFdHPNIIrLEGVVTks~PvMIiTEyMEN 714 (996)
T KOG0196|consen 683 IMGQFDHPNIIRLEGVVTKSKPVMIITEYMEN 714 (996)
T ss_pred hcccCCCCcEEEEEEEEecCceeEEEhhhhhC
Confidence 89999999999999999999999999999998
No 70
>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]
Probab=96.99 E-value=0.00048 Score=66.63 Aligned_cols=32 Identities=28% Similarity=0.594 Sum_probs=30.6
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|+|||+++|+|..++..++|.|||++
T Consensus 254 iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~ 285 (468)
T KOG0197|consen 254 IMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK 285 (468)
T ss_pred HHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence 89999999999999999998889999999985
No 71
>KOG2123 consensus Uncharacterized conserved protein [Function unknown]
Probab=96.90 E-value=6.3e-05 Score=66.62 Aligned_cols=87 Identities=18% Similarity=0.046 Sum_probs=50.4
Q ss_pred CccCCeeecccCcccccCCcccccCcccceeecccccccccCCccccCCCCCCeeeccCCcccccC-ChhhhcCCCCCEE
Q 041558 22 SQFLWGLDLSNNQFSSSIPLSFGNLSNLIFLYLYENSYFASIPSNVGKLKSLGDLQLNGNQFISYI-PSSFGNLTNLSTS 100 (495)
Q Consensus 22 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~-~~~~~~l~~L~~L 100 (495)
+.+.++|++.++.++++ .....++.|++|.|+-|+|+..- .|..|++|++|.|+.|.|.... -.-+.++++|+.|
T Consensus 18 l~~vkKLNcwg~~L~DI--sic~kMp~lEVLsLSvNkIssL~--pl~rCtrLkElYLRkN~I~sldEL~YLknlpsLr~L 93 (388)
T KOG2123|consen 18 LENVKKLNCWGCGLDDI--SICEKMPLLEVLSLSVNKISSLA--PLQRCTRLKELYLRKNCIESLDELEYLKNLPSLRTL 93 (388)
T ss_pred HHHhhhhcccCCCccHH--HHHHhcccceeEEeeccccccch--hHHHHHHHHHHHHHhcccccHHHHHHHhcCchhhhH
Confidence 44556666666666633 12345666777777777665433 2556666777777776665421 1234566667777
Q ss_pred ecCCCcccccCC
Q 041558 101 RLSKNKLFVSIP 112 (495)
Q Consensus 101 ~l~~n~~~~~~~ 112 (495)
-|..|.-.+..+
T Consensus 94 WL~ENPCc~~ag 105 (388)
T KOG2123|consen 94 WLDENPCCGEAG 105 (388)
T ss_pred hhccCCcccccc
Confidence 776666554444
No 72
>KOG2123 consensus Uncharacterized conserved protein [Function unknown]
Probab=96.71 E-value=7.4e-05 Score=66.19 Aligned_cols=95 Identities=24% Similarity=0.136 Sum_probs=68.2
Q ss_pred cEEEeeCCcccccCCccCcCCccCCeeecccCcccccCCcccccCcccceeecccccccccCC-ccccCCCCCCeeeccC
Q 041558 2 ALLIIHNNSLSGFIPLNIGNSQFLWGLDLSNNQFSSSIPLSFGNLSNLIFLYLYENSYFASIP-SNVGKLKSLGDLQLNG 80 (495)
Q Consensus 2 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~-~~~~~l~~L~~L~l~~ 80 (495)
+.|+..++.++.. ....+++.|++|.||-|+|+... .|..|++|++|+|..|.|..... ..+.++++|+.|.|..
T Consensus 22 kKLNcwg~~L~DI--sic~kMp~lEVLsLSvNkIssL~--pl~rCtrLkElYLRkN~I~sldEL~YLknlpsLr~LWL~E 97 (388)
T KOG2123|consen 22 KKLNCWGCGLDDI--SICEKMPLLEVLSLSVNKISSLA--PLQRCTRLKELYLRKNCIESLDELEYLKNLPSLRTLWLDE 97 (388)
T ss_pred hhhcccCCCccHH--HHHHhcccceeEEeeccccccch--hHHHHHHHHHHHHHhcccccHHHHHHHhcCchhhhHhhcc
Confidence 3566777777643 23567899999999999998554 47899999999999998765221 3356899999999999
Q ss_pred CcccccCCh-----hhhcCCCCCEE
Q 041558 81 NQFISYIPS-----SFGNLTNLSTS 100 (495)
Q Consensus 81 n~l~~~~~~-----~~~~l~~L~~L 100 (495)
|.-.+.-+. .+.-|++|+.|
T Consensus 98 NPCc~~ag~nYR~~VLR~LPnLkKL 122 (388)
T KOG2123|consen 98 NPCCGEAGQNYRRKVLRVLPNLKKL 122 (388)
T ss_pred CCcccccchhHHHHHHHHcccchhc
Confidence 876654332 24446666655
No 73
>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]
Probab=96.64 E-value=0.0004 Score=70.64 Aligned_cols=30 Identities=17% Similarity=0.361 Sum_probs=27.9
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~ 494 (495)
.|++++|+||+||+|+|.... .+||.+|||
T Consensus 751 ~masldHpnl~RLLgvc~~s~-~qlvtq~mP 780 (1177)
T KOG1025|consen 751 RMASLDHPNLLRLLGVCMLST-LQLVTQLMP 780 (1177)
T ss_pred HHhcCCCchHHHHhhhcccch-HHHHHHhcc
Confidence 899999999999999998765 899999998
No 74
>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]
Probab=96.62 E-value=0.00046 Score=68.01 Aligned_cols=32 Identities=25% Similarity=0.495 Sum_probs=30.5
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++..|+|||||+|+|.|.++.-.++|.|||.+
T Consensus 316 vMKeikHpNLVqLLGVCT~EpPFYIiTEfM~y 347 (1157)
T KOG4278|consen 316 VMKEIKHPNLVQLLGVCTHEPPFYIITEFMCY 347 (1157)
T ss_pred HHHhhcCccHHHHhhhhccCCCeEEEEecccC
Confidence 89999999999999999999999999999974
No 75
>KOG4341 consensus F-box protein containing LRR [General function prediction only]
Probab=96.57 E-value=0.00012 Score=68.59 Aligned_cols=14 Identities=21% Similarity=0.297 Sum_probs=7.1
Q ss_pred CCCCCCEEeccccc
Q 041558 228 KCPKLGTLGVLMNT 241 (495)
Q Consensus 228 ~~~~L~~L~l~~n~ 241 (495)
++.+|+++-++.++
T Consensus 318 ~~~~L~~l~l~~c~ 331 (483)
T KOG4341|consen 318 HCHNLQVLELSGCQ 331 (483)
T ss_pred CCCceEEEeccccc
Confidence 34555555555543
No 76
>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt
Probab=96.44 E-value=0.0024 Score=59.50 Aligned_cols=32 Identities=19% Similarity=0.355 Sum_probs=30.0
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+++++|+|+|+++|+|.+++..++|+||+++
T Consensus 69 ~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~ 100 (274)
T cd05076 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEH 100 (274)
T ss_pred HHhcCCCCCeeeEEEEEEeCCceEEEEecCCC
Confidence 67889999999999999999999999999974
No 77
>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity. Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....
Probab=96.20 E-value=0.003 Score=58.22 Aligned_cols=32 Identities=41% Similarity=0.610 Sum_probs=26.8
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+++++|+|+|+++|+|.+.+..++||||+++
T Consensus 54 ~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~ 85 (259)
T PF07714_consen 54 ILRKLRHPNIVKLYGFCIENEPLFLVMEYCPG 85 (259)
T ss_dssp HHHTHSBTTBE-EEEEEESSSSEEEEEE--TT
T ss_pred cccccccccccccccccccccccccccccccc
Confidence 78899999999999999988889999999974
No 78
>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=95.99 E-value=0.0045 Score=59.78 Aligned_cols=32 Identities=22% Similarity=0.398 Sum_probs=29.3
Q ss_pred ecccccCCceeeeEEEEEeC--CeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHA--RHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~--~~~~LVyeym~n 495 (495)
+|.++.|||||+|.|...+. ...+||+|||+.
T Consensus 169 ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh 202 (560)
T KOG0600|consen 169 ILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH 202 (560)
T ss_pred HHHhcCCCcccceeeEEEecCCceEEEEEecccc
Confidence 89999999999999999876 688999999974
No 79
>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]
Probab=95.97 E-value=0.0049 Score=58.02 Aligned_cols=32 Identities=31% Similarity=0.429 Sum_probs=30.5
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
+|.+++|||||++.+|....+..++|.|||+.
T Consensus 229 ILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~G 260 (475)
T KOG0615|consen 229 ILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEG 260 (475)
T ss_pred HHHhcCCCCEEEEeeeeecCCceEEEEEEecC
Confidence 89999999999999999999999999999974
No 80
>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]
Probab=95.90 E-value=0.0044 Score=66.04 Aligned_cols=32 Identities=25% Similarity=0.468 Sum_probs=30.6
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
+|+++.|||+|+++|.|.+....++|.|||+.
T Consensus 748 ~m~~f~HpNiv~liGv~l~~~~~~i~leyM~g 779 (1025)
T KOG1095|consen 748 LMSKFDHPNIVSLIGVCLDSGPPLILLEYMEG 779 (1025)
T ss_pred HHhcCCCcceeeEEEeecCCCCcEEEehhccc
Confidence 89999999999999999999999999999974
No 81
>PF00560 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []. LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. ; GO: 0005515 protein binding; PDB: 4ECO_B 2A0Z_A 3ULU_A 1ZIW_A 3ULV_A 1DCE_C 1LTX_A 3J0A_B 3A79_B 4FCG_A ....
Probab=95.80 E-value=0.0037 Score=32.80 Aligned_cols=12 Identities=42% Similarity=0.631 Sum_probs=5.3
Q ss_pred CCeeeccCCccc
Q 041558 73 LGDLQLNGNQFI 84 (495)
Q Consensus 73 L~~L~l~~n~l~ 84 (495)
|++|++++|+++
T Consensus 2 L~~Ldls~n~l~ 13 (22)
T PF00560_consen 2 LEYLDLSGNNLT 13 (22)
T ss_dssp ESEEEETSSEES
T ss_pred ccEEECCCCcCE
Confidence 344444444444
No 82
>PF00560 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []. LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. ; GO: 0005515 protein binding; PDB: 4ECO_B 2A0Z_A 3ULU_A 1ZIW_A 3ULV_A 1DCE_C 1LTX_A 3J0A_B 3A79_B 4FCG_A ....
Probab=95.73 E-value=0.0032 Score=33.03 Aligned_cols=12 Identities=50% Similarity=0.529 Sum_probs=4.9
Q ss_pred CCeeecccCccc
Q 041558 25 LWGLDLSNNQFS 36 (495)
Q Consensus 25 L~~L~l~~n~l~ 36 (495)
|++||+++|+++
T Consensus 2 L~~Ldls~n~l~ 13 (22)
T PF00560_consen 2 LEYLDLSGNNLT 13 (22)
T ss_dssp ESEEEETSSEES
T ss_pred ccEEECCCCcCE
Confidence 334444444444
No 83
>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]
Probab=95.55 E-value=0.011 Score=55.74 Aligned_cols=31 Identities=26% Similarity=0.314 Sum_probs=29.8
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~ 494 (495)
+|.+++|+|||+|+-|++.++...||+||..
T Consensus 62 iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~ 92 (429)
T KOG0595|consen 62 ILKELKHPNIVRLLDCIEDDDFIYLVMEYCN 92 (429)
T ss_pred HHHhcCCcceeeEEEEEecCCeEEEEEEeCC
Confidence 8999999999999999999999999999975
No 84
>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor
Probab=95.42 E-value=0.011 Score=54.66 Aligned_cols=32 Identities=25% Similarity=0.373 Sum_probs=29.7
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+.+++|+|+|++.|++..++..++||||+++
T Consensus 59 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 90 (266)
T cd05064 59 TLGQFDHSNIVRLEGVITRGNTMMIVTEYMSN 90 (266)
T ss_pred HHhcCCCCCcCeEEEEEecCCCcEEEEEeCCC
Confidence 78889999999999999999999999999974
No 85
>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha. Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-
Probab=95.40 E-value=0.01 Score=58.51 Aligned_cols=32 Identities=28% Similarity=0.436 Sum_probs=29.4
Q ss_pred eccccc-CCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETG-HRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~-H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++++++ |||+|+++|+|.+++..++|+|||++
T Consensus 93 ~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~ 125 (400)
T cd05105 93 IMTHLGPHLNIVNLLGACTKSGPIYIITEYCFY 125 (400)
T ss_pred HHHhcCCCCCeeeEEEEEccCCceEEEEEecCC
Confidence 788885 99999999999999999999999974
No 86
>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]
Probab=95.38 E-value=0.011 Score=58.31 Aligned_cols=32 Identities=25% Similarity=0.422 Sum_probs=30.4
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++..++|+|+|+++|+|....-.++|.|+|++
T Consensus 214 vMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~g 245 (474)
T KOG0194|consen 214 VMRQLNHPNVVRFYGVAVLEEPLMLVMELCNG 245 (474)
T ss_pred HHHhCCCCCEEEEEEEEcCCCccEEEEEecCC
Confidence 88899999999999999999999999999975
No 87
>PTZ00267 NIMA-related protein kinase; Provisional
Probab=95.37 E-value=0.014 Score=59.23 Aligned_cols=32 Identities=19% Similarity=0.161 Sum_probs=30.4
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+++++|||||+++++|..++..++|||||++
T Consensus 118 ~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~g 149 (478)
T PTZ00267 118 CLAACDHFGIVKHFDDFKSDDKLLLIMEYGSG 149 (478)
T ss_pred HHHhCCCCCEeEEEEEEEECCEEEEEEECCCC
Confidence 78999999999999999999999999999974
No 88
>PHA02988 hypothetical protein; Provisional
Probab=95.36 E-value=0.013 Score=54.83 Aligned_cols=32 Identities=25% Similarity=0.351 Sum_probs=28.0
Q ss_pred ecccccCCceeeeEEEEEe----CCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSH----ARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~----~~~~~LVyeym~n 495 (495)
++.+++|||+|+++|+|.+ .....+|+|||++
T Consensus 71 ~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~ 106 (283)
T PHA02988 71 NLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTR 106 (283)
T ss_pred HHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCC
Confidence 8999999999999999987 3456899999974
No 89
>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3. Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells
Probab=95.32 E-value=0.011 Score=54.69 Aligned_cols=32 Identities=19% Similarity=0.283 Sum_probs=29.8
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+.+++|+|+|+++|+|.+.+..++|+|||++
T Consensus 48 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 48 PYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred HHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 78899999999999999999999999999974
No 90
>KOG4308 consensus LRR-containing protein [Function unknown]
Probab=95.27 E-value=0.00013 Score=72.39 Aligned_cols=83 Identities=24% Similarity=0.301 Sum_probs=45.8
Q ss_pred cccccccccccccc----cCccCCCCCCCCEEEccCceeeeccC----ccccCC-CCccEEEccCCcCccc----CCCCC
Q 041558 160 LARLGLDFNHFKRT----IPKSLRSCTSLIRLCRNRNNLTRDIS----EALGIY-PYLTFIDLSRNNFHGE----IPSNR 226 (495)
Q Consensus 160 L~~L~l~~n~~~~~----~~~~~~~l~~L~~L~l~~n~~~~~~~----~~~~~~-~~L~~L~l~~n~l~~~----~~~~~ 226 (495)
+..+.|.+|.+... +...+...+.|..|++++|.+.+... ..+... ..+++|++..|.+++. +...+
T Consensus 89 l~~L~L~~~~l~~~~~~~l~~~l~t~~~L~~L~l~~n~l~~~g~~~l~~~l~~~~~~l~~L~l~~c~l~~~g~~~l~~~L 168 (478)
T KOG4308|consen 89 LLHLSLANNRLGDRGAEELAQALKTLPTLGQLDLSGNNLGDEGARLLCEGLRLPQCLLQTLELVSCSLTSEGAAPLAAVL 168 (478)
T ss_pred HHHhhhhhCccccchHHHHHHHhcccccHhHhhcccCCCccHhHHHHHhhcccchHHHHHHHhhcccccccchHHHHHHH
Confidence 66777777766532 22345666777777777777763221 112221 3455566666655532 23334
Q ss_pred CCCCCCCEEecccccc
Q 041558 227 EKCPKLGTLGVLMNTI 242 (495)
Q Consensus 227 ~~~~~L~~L~l~~n~l 242 (495)
.....++.++++.|.+
T Consensus 169 ~~~~~l~~l~l~~n~l 184 (478)
T KOG4308|consen 169 EKNEHLTELDLSLNGL 184 (478)
T ss_pred hcccchhHHHHHhccc
Confidence 4455666666666655
No 91
>KOG4341 consensus F-box protein containing LRR [General function prediction only]
Probab=95.26 E-value=0.00064 Score=63.88 Aligned_cols=263 Identities=16% Similarity=0.049 Sum_probs=140.6
Q ss_pred CcEEEeeCCcccccCC--ccCcCCccCCeeecccCcc-cccCCccc-ccCcccceeeccccc-ccccCCcc-ccCCCCCC
Q 041558 1 MALLIIHNNSLSGFIP--LNIGNSQFLWGLDLSNNQF-SSSIPLSF-GNLSNLIFLYLYENS-YFASIPSN-VGKLKSLG 74 (495)
Q Consensus 1 L~~L~l~~n~l~~~~~--~~~~~l~~L~~L~l~~n~l-~~~~~~~~-~~l~~L~~L~L~~n~-~~~~~~~~-~~~l~~L~ 74 (495)
|+.|.+.++.-.+.-+ ..-.+++++++|++.++.- ++..-..+ ..|++|++|+|..+. ++...-.. -.++++|+
T Consensus 140 lk~LSlrG~r~v~~sslrt~~~~CpnIehL~l~gc~~iTd~s~~sla~~C~~l~~l~L~~c~~iT~~~Lk~la~gC~kL~ 219 (483)
T KOG4341|consen 140 LKELSLRGCRAVGDSSLRTFASNCPNIEHLALYGCKKITDSSLLSLARYCRKLRHLNLHSCSSITDVSLKYLAEGCRKLK 219 (483)
T ss_pred cccccccccccCCcchhhHHhhhCCchhhhhhhcceeccHHHHHHHHHhcchhhhhhhcccchhHHHHHHHHHHhhhhHH
Confidence 3556666655433222 2235789999998888762 22111122 468999999998853 33322221 23789999
Q ss_pred eeeccCCc-ccc-cCChhhhcCCCCCEEecCCCcccccCCc-cc----cCCCCCCEEee-----e-c----ccccCCCCC
Q 041558 75 DLQLNGNQ-FIS-YIPSSFGNLTNLSTSRLSKNKLFVSIPN-EI----GKMRSLNILEV-----L-P----LSVSNLTNP 137 (495)
Q Consensus 75 ~L~l~~n~-l~~-~~~~~~~~l~~L~~L~l~~n~~~~~~~~-~~----~~l~~L~~L~l-----~-~----~~l~~~~~L 137 (495)
+|+++++. +++ .+...+.+++.++.+.+.++.- .+. .+ +.+.-+-.+++ + . ..-..+..|
T Consensus 220 ~lNlSwc~qi~~~gv~~~~rG~~~l~~~~~kGC~e---~~le~l~~~~~~~~~i~~lnl~~c~~lTD~~~~~i~~~c~~l 296 (483)
T KOG4341|consen 220 YLNLSWCPQISGNGVQALQRGCKELEKLSLKGCLE---LELEALLKAAAYCLEILKLNLQHCNQLTDEDLWLIACGCHAL 296 (483)
T ss_pred HhhhccCchhhcCcchHHhccchhhhhhhhccccc---ccHHHHHHHhccChHhhccchhhhccccchHHHHHhhhhhHh
Confidence 99999986 333 1223345566666665554321 110 11 11111112221 0 0 011235667
Q ss_pred CEEEcccccc-ccCCCccCcc--cccccccccccc-cccccCccC-CCCCCCCEEEccCceeeec--cCccccCCCCccE
Q 041558 138 KELALLYNCL-SGSIPPSLEN--PMLARLGLDFNH-FKRTIPKSL-RSCTSLIRLCRNRNNLTRD--ISEALGIYPYLTF 210 (495)
Q Consensus 138 ~~L~l~~n~l-~~~~~~~~~~--~~L~~L~l~~n~-~~~~~~~~~-~~l~~L~~L~l~~n~~~~~--~~~~~~~~~~L~~ 210 (495)
+.++.+++.. ++.....+.. ++|+.+.++.++ |+..-...+ .+++.|+.+++..+..... +...-..++.|+.
T Consensus 297 q~l~~s~~t~~~d~~l~aLg~~~~~L~~l~l~~c~~fsd~~ft~l~rn~~~Le~l~~e~~~~~~d~tL~sls~~C~~lr~ 376 (483)
T KOG4341|consen 297 QVLCYSSCTDITDEVLWALGQHCHNLQVLELSGCQQFSDRGFTMLGRNCPHLERLDLEECGLITDGTLASLSRNCPRLRV 376 (483)
T ss_pred hhhcccCCCCCchHHHHHHhcCCCceEEEeccccchhhhhhhhhhhcCChhhhhhcccccceehhhhHhhhccCCchhcc
Confidence 7777766532 2222233333 777777777764 322211122 3567788887777654322 2333345677888
Q ss_pred EEccCCcCcccC-----CCCCCCCCCCCEEecccccccc-cCCccccCCCCCceeccCCCee
Q 041558 211 IDLSRNNFHGEI-----PSNREKCPKLGTLGVLMNTITK-GIPREIRNSSQRQALDLSLNHI 266 (495)
Q Consensus 211 L~l~~n~l~~~~-----~~~~~~~~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~ls~n~l 266 (495)
+.++++...... ...-.....+..+.++++.... ..-..+..+++|+.+++-.+.-
T Consensus 377 lslshce~itD~gi~~l~~~~c~~~~l~~lEL~n~p~i~d~~Le~l~~c~~Leri~l~~~q~ 438 (483)
T KOG4341|consen 377 LSLSHCELITDEGIRHLSSSSCSLEGLEVLELDNCPLITDATLEHLSICRNLERIELIDCQD 438 (483)
T ss_pred CChhhhhhhhhhhhhhhhhccccccccceeeecCCCCchHHHHHHHhhCcccceeeeechhh
Confidence 888877543111 2222345677788888776543 2334456677788877766543
No 92
>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1. Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom
Probab=95.18 E-value=0.014 Score=53.93 Aligned_cols=32 Identities=28% Similarity=0.511 Sum_probs=29.6
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+++++|||+|+++|+|......++|+||+++
T Consensus 57 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 88 (262)
T cd05077 57 MMRQVSHKHIVLLYGVCVRDVENIMVEEFVEF 88 (262)
T ss_pred HHHhCCCCCEeeEEEEEecCCCCEEEEecccC
Confidence 78889999999999999999999999999973
No 93
>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1. Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k
Probab=94.82 E-value=0.023 Score=53.68 Aligned_cols=32 Identities=22% Similarity=0.416 Sum_probs=29.8
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|+|+|+++|+|.+.+..++|+|||++
T Consensus 72 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 103 (304)
T cd05096 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMEN 103 (304)
T ss_pred HHhhcCCCCeeEEEEEEecCCceEEEEecCCC
Confidence 78899999999999999999999999999974
No 94
>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1. Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst
Probab=94.80 E-value=0.022 Score=54.66 Aligned_cols=32 Identities=25% Similarity=0.289 Sum_probs=29.9
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|+|+|+++|+|.+++..++||||+++
T Consensus 56 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 87 (333)
T cd06650 56 VLHECNSPYIVGFYGAFYSDGEISICMEHMDG 87 (333)
T ss_pred HHHHCCCCcccceeEEEEECCEEEEEEecCCC
Confidence 78889999999999999999999999999973
No 95
>KOG1947 consensus Leucine rich repeat proteins, some proteins contain F-box [General function prediction only]
Probab=94.78 E-value=0.0023 Score=64.94 Aligned_cols=64 Identities=27% Similarity=0.266 Sum_probs=27.8
Q ss_pred CCCCCCCEEEccCce-eeeccCccccC-CCCccEEEccCCc-Cccc-CCCCCCCCCCCCEEecccccc
Q 041558 179 RSCTSLIRLCRNRNN-LTRDISEALGI-YPYLTFIDLSRNN-FHGE-IPSNREKCPKLGTLGVLMNTI 242 (495)
Q Consensus 179 ~~l~~L~~L~l~~n~-~~~~~~~~~~~-~~~L~~L~l~~n~-l~~~-~~~~~~~~~~L~~L~l~~n~l 242 (495)
..+.+|+.++++.+. +++..-..+.. +++|+.|.+.++. +++. +-.....++.|+.|+++++..
T Consensus 240 ~~~~~L~~l~l~~~~~isd~~l~~l~~~c~~L~~L~l~~c~~lt~~gl~~i~~~~~~L~~L~l~~c~~ 307 (482)
T KOG1947|consen 240 SICRKLKSLDLSGCGLVTDIGLSALASRCPNLETLSLSNCSNLTDEGLVSIAERCPSLRELDLSGCHG 307 (482)
T ss_pred hhcCCcCccchhhhhccCchhHHHHHhhCCCcceEccCCCCccchhHHHHHHHhcCcccEEeeecCcc
Confidence 344555555555554 33322222222 4555555554444 2211 111223345555555554443
No 96
>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit. Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce
Probab=94.74 E-value=0.015 Score=56.87 Aligned_cols=32 Identities=25% Similarity=0.336 Sum_probs=29.2
Q ss_pred ecccc-cCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTET-GHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~-~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.++ +|||+|+++|+|.+++..++|+|||++
T Consensus 91 il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~ 123 (375)
T cd05104 91 VLSYLGNHINIVNLLGACTVGGPTLVITEYCCY 123 (375)
T ss_pred HHHHhcCCcceeeeeeeeccCCcceeeehhccC
Confidence 67777 899999999999999999999999974
No 97
>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2. Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage
Probab=94.72 E-value=0.02 Score=53.05 Aligned_cols=32 Identities=28% Similarity=0.340 Sum_probs=29.5
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+++++|||+|+++|+|......++|+||+++
T Consensus 48 ~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 48 PYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred HHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 67889999999999999999999999999973
No 98
>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional
Probab=94.63 E-value=0.027 Score=54.27 Aligned_cols=32 Identities=22% Similarity=0.209 Sum_probs=29.9
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|||+|+++|++.+++..++|+|||++
T Consensus 84 ~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~ 115 (340)
T PTZ00426 84 ILNYINHPFCVNLYGSFKDESYLYLVLEFVIG 115 (340)
T ss_pred HHHhCCCCCCcceEEEEEeCCEEEEEEeCCCC
Confidence 78899999999999999999999999999973
No 99
>KOG1947 consensus Leucine rich repeat proteins, some proteins contain F-box [General function prediction only]
Probab=94.59 E-value=0.0047 Score=62.69 Aligned_cols=85 Identities=22% Similarity=0.115 Sum_probs=38.7
Q ss_pred CccCCeeecccCccccc--CCcccccCcccceeecccc-cccccCC----ccccCCCCCCeeeccCCc-ccccCChhhh-
Q 041558 22 SQFLWGLDLSNNQFSSS--IPLSFGNLSNLIFLYLYEN-SYFASIP----SNVGKLKSLGDLQLNGNQ-FISYIPSSFG- 92 (495)
Q Consensus 22 l~~L~~L~l~~n~l~~~--~~~~~~~l~~L~~L~L~~n-~~~~~~~----~~~~~l~~L~~L~l~~n~-l~~~~~~~~~- 92 (495)
++.|+.|.+..+.-... .-.....+++|+.|+++++ ......+ .....+.+|+.|+++++. ++...-..+.
T Consensus 187 ~~~L~~l~l~~~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~L~~l~l~~~~~isd~~l~~l~~ 266 (482)
T KOG1947|consen 187 CPLLKRLSLSGCSKITDDSLDALALKCPNLEELDLSGCCLLITLSPLLLLLLLSICRKLKSLDLSGCGLVTDIGLSALAS 266 (482)
T ss_pred CchhhHhhhcccccCChhhHHHHHhhCchhheecccCcccccccchhHhhhhhhhcCCcCccchhhhhccCchhHHHHHh
Confidence 45566666655432211 1123345666666666652 1111111 122345666666666665 3322222222
Q ss_pred cCCCCCEEecCCCc
Q 041558 93 NLTNLSTSRLSKNK 106 (495)
Q Consensus 93 ~l~~L~~L~l~~n~ 106 (495)
.+++|+.|.+.++.
T Consensus 267 ~c~~L~~L~l~~c~ 280 (482)
T KOG1947|consen 267 RCPNLETLSLSNCS 280 (482)
T ss_pred hCCCcceEccCCCC
Confidence 25566666655443
No 100
>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include
Probab=94.57 E-value=0.027 Score=52.66 Aligned_cols=32 Identities=22% Similarity=0.283 Sum_probs=30.0
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|+|+|+++|+|...+..++||||+++
T Consensus 56 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (284)
T cd06620 56 IMHECRSPYIVSFYGAFLNENNICMCMEFMDC 87 (284)
T ss_pred HHHHcCCCCcceEeeeEecCCEEEEEEecCCC
Confidence 68889999999999999999999999999974
No 101
>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase. Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina
Probab=94.56 E-value=0.026 Score=52.15 Aligned_cols=32 Identities=25% Similarity=0.206 Sum_probs=29.9
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++++++|+|+|+++|+|..++..++|+||+++
T Consensus 58 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 89 (268)
T cd06624 58 LHSYLKHRNIVQYLGSDSENGFFKIFMEQVPG 89 (268)
T ss_pred HHHhcCCCCeeeeeeeeccCCEEEEEEecCCC
Confidence 78899999999999999999999999999974
No 102
>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha. Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype
Probab=94.55 E-value=0.032 Score=53.44 Aligned_cols=32 Identities=16% Similarity=0.085 Sum_probs=29.6
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++..++|||||+++|+|..++..++|+|||++
T Consensus 52 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 83 (327)
T cd08227 52 VSKLFNHPNIVPYRATFIADNELWVVTSFMAY 83 (327)
T ss_pred HHHhcCCCCeeeEEEEEEECCEEEEEEeccCC
Confidence 67788999999999999999999999999974
No 103
>KOG4308 consensus LRR-containing protein [Function unknown]
Probab=94.53 E-value=9.6e-05 Score=73.39 Aligned_cols=38 Identities=32% Similarity=0.275 Sum_probs=16.9
Q ss_pred cccceeeccccccccc----CCcccCCCCCCCEEeCCCCcCC
Q 041558 278 NSLIKLILRRNQLVGC----LPTEIGSPIELEYLDFSVNRFN 315 (495)
Q Consensus 278 ~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~Ls~n~l~ 315 (495)
..++.++++.|.++.. ....+..++.++.+.++.|.+.
T Consensus 262 ~~l~~l~l~~nsi~~~~~~~L~~~l~~~~~l~~l~l~~n~l~ 303 (478)
T KOG4308|consen 262 ETLRVLDLSRNSITEKGVRDLAEVLVSCRQLEELSLSNNPLT 303 (478)
T ss_pred hhhhhhhhhcCCccccchHHHHHHHhhhHHHHHhhcccCccc
Confidence 3445555555555432 1222333444555555555444
No 104
>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase. Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down
Probab=94.48 E-value=0.03 Score=53.05 Aligned_cols=32 Identities=25% Similarity=0.289 Sum_probs=29.9
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|+|+|+++|+|..+++.++|+||+++
T Consensus 52 ~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~ 83 (308)
T cd06615 52 VLHECNSPYIVGFYGAFYSDGEISICMEHMDG 83 (308)
T ss_pred HHHhCCCCCCCeEEEEEeeCCEEEEEeeccCC
Confidence 78889999999999999999999999999974
No 105
>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including
Probab=94.41 E-value=0.026 Score=53.07 Aligned_cols=32 Identities=19% Similarity=0.402 Sum_probs=30.1
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|+|+|+++|+|..++..++|||||++
T Consensus 70 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (295)
T cd05097 70 IMSRLKNPNIIRLLGVCVSDDPLCMITEYMEN 101 (295)
T ss_pred HHHhCCCCCcCeEEEEEcCCCccEEEEecCCC
Confidence 78899999999999999999999999999974
No 106
>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul
Probab=94.34 E-value=0.031 Score=51.65 Aligned_cols=32 Identities=22% Similarity=0.388 Sum_probs=29.6
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+.+++|||+|++.|++.+++..++|+||+++
T Consensus 58 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 89 (267)
T cd05066 58 IMGQFDHPNIIHLEGVVTKSKPVMIVTEYMEN 89 (267)
T ss_pred HHHhCCCCCcceEEEEEecCCccEEEEEcCCC
Confidence 78889999999999999999999999999974
No 107
>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2. Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst
Probab=94.23 E-value=0.037 Score=53.08 Aligned_cols=32 Identities=25% Similarity=0.289 Sum_probs=30.0
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|+|+|+++|++..++..++|+|||++
T Consensus 56 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 87 (331)
T cd06649 56 VLHECNSPYIVGFYGAFYSDGEISICMEHMDG 87 (331)
T ss_pred HHHHCCCCCCCeEEEEEEECCEEEEEeecCCC
Confidence 78899999999999999999999999999974
No 108
>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h
Probab=94.14 E-value=0.035 Score=50.88 Aligned_cols=32 Identities=25% Similarity=0.615 Sum_probs=30.0
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+.+++|+|+|+++|+|.+++..++||||+++
T Consensus 52 ~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 52 VMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred HHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 88999999999999999999999999999974
No 109
>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase. Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate
Probab=94.12 E-value=0.04 Score=52.49 Aligned_cols=32 Identities=22% Similarity=0.208 Sum_probs=29.8
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++++++|+|+|++++++.+++..++|+||+++
T Consensus 51 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 82 (318)
T cd05582 51 ILAEVNHPFIVKLHYAFQTEGKLYLILDFLRG 82 (318)
T ss_pred HHHhCCCCCcccEEEEEEcCCEEEEEEcCCCC
Confidence 78899999999999999999999999999974
No 110
>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n
Probab=94.09 E-value=0.038 Score=51.81 Aligned_cols=32 Identities=38% Similarity=0.701 Sum_probs=29.9
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+++++|+|+|+++|+|..++..++||||+++
T Consensus 60 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 91 (291)
T cd05094 60 LLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKH 91 (291)
T ss_pred HHhcCCCCCcceEEEEEccCCceEEEEecCCC
Confidence 78899999999999999999999999999974
No 111
>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros. Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male
Probab=94.05 E-value=0.035 Score=51.26 Aligned_cols=32 Identities=28% Similarity=0.523 Sum_probs=29.8
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+++++|+|+|+++|+|...+..++|+||+++
T Consensus 52 ~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (269)
T cd05044 52 LMSNFNHPNIVKLLGVCLLNEPQYIIMELMEG 83 (269)
T ss_pred HHHhcCCCCeeeEeeeecCCCCeEEEEeccCC
Confidence 78899999999999999999999999999974
No 112
>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa
Probab=93.99 E-value=0.047 Score=49.99 Aligned_cols=32 Identities=19% Similarity=0.237 Sum_probs=29.9
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++++++|+|+|++++++.+++..++||||+++
T Consensus 52 ~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (256)
T cd08221 52 ILSLLQHPNIIAYYNHFMDDNTLLIEMEYANG 83 (256)
T ss_pred HHHhCCCCCeeEEEeEEecCCeEEEEEEecCC
Confidence 78899999999999999999999999999973
No 113
>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins. Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily
Probab=93.85 E-value=0.042 Score=52.05 Aligned_cols=32 Identities=19% Similarity=0.240 Sum_probs=29.7
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+.+++|+|+|++.|+|.+++..++|+||+++
T Consensus 68 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~g 99 (307)
T cd06607 68 FLQQLRHPNTIEYKGCYLREHTAWLVMEYCLG 99 (307)
T ss_pred HHHhCCCCCEEEEEEEEEeCCeEEEEHHhhCC
Confidence 68889999999999999999999999999863
No 114
>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases. Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina
Probab=93.84 E-value=0.042 Score=50.81 Aligned_cols=32 Identities=22% Similarity=0.284 Sum_probs=29.3
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+.+++|+|+|+++|+|.+++..++|+|||+.
T Consensus 48 ~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 48 PYRELNHPNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred HHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence 67788999999999999999999999999973
No 115
>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta. Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D
Probab=93.81 E-value=0.042 Score=54.18 Aligned_cols=32 Identities=25% Similarity=0.464 Sum_probs=29.3
Q ss_pred eccccc-CCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETG-HRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~-H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.++. |+|+|+++|+|...+..++|+||+++
T Consensus 93 ~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~ 125 (401)
T cd05107 93 IMSHLGPHLNIVNLLGACTKGGPIYIITEYCRY 125 (401)
T ss_pred HHHhcCCCCCeEEEEEEEccCCCcEEEEeccCC
Confidence 788886 99999999999999999999999974
No 116
>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains. Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc
Probab=93.81 E-value=0.04 Score=50.38 Aligned_cols=32 Identities=19% Similarity=0.208 Sum_probs=29.9
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+++++|+|+++++++|.+++..++|+||+++
T Consensus 52 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd08529 52 VLAKLDSSYIIRYYESFLDKGKLNIVMEYAEN 83 (256)
T ss_pred HHHhcCCCCeehheeeeccCCEEEEEEEeCCC
Confidence 68899999999999999999999999999974
No 117
>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome. Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds
Probab=93.71 E-value=0.05 Score=49.93 Aligned_cols=31 Identities=26% Similarity=0.632 Sum_probs=29.0
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~ 494 (495)
.+.+++|||+|+++|+|.+.+..++|+||++
T Consensus 52 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 52 VMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 7889999999999999998888999999986
No 118
>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int
Probab=93.68 E-value=0.062 Score=49.93 Aligned_cols=32 Identities=19% Similarity=0.334 Sum_probs=29.7
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+++++|+|+|+++|++..++..++|+||+++
T Consensus 55 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 86 (277)
T cd06641 55 VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGG 86 (277)
T ss_pred HHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCC
Confidence 78889999999999999999999999999864
No 119
>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85. Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.
Probab=93.67 E-value=0.048 Score=50.81 Aligned_cols=32 Identities=25% Similarity=0.405 Sum_probs=29.9
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+.+++|+|+++++++|.+++..++|+||+++
T Consensus 51 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 82 (284)
T cd07836 51 LMKELKHENIVRLHDVIHTENKLMLVFEYMDK 82 (284)
T ss_pred HHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc
Confidence 78899999999999999999999999999974
No 120
>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly
Probab=93.65 E-value=0.049 Score=51.01 Aligned_cols=32 Identities=38% Similarity=0.687 Sum_probs=29.9
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|+|+|++.|+|..++..++|||||++
T Consensus 60 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 91 (288)
T cd05093 60 LLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKH 91 (288)
T ss_pred HHHhCCCCCcceEEEEEecCCccEEEEEcCCC
Confidence 78899999999999999999999999999973
No 121
>KOG0473 consensus Leucine-rich repeat protein [Function unknown]
Probab=93.65 E-value=0.0028 Score=55.00 Aligned_cols=90 Identities=20% Similarity=0.218 Sum_probs=74.5
Q ss_pred ccCcCCccCCeeecccCcccccCCcccccCcccceeecccccccccCCccccCCCCCCeeeccCCcccccCChhhhcCCC
Q 041558 17 LNIGNSQFLWGLDLSNNQFSSSIPLSFGNLSNLIFLYLYENSYFASIPSNVGKLKSLGDLQLNGNQFISYIPSSFGNLTN 96 (495)
Q Consensus 17 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~ 96 (495)
.++..+...+.||++.|++. ..-..|+-++.|..|+++.|.+. ..|.+++....+..+++..|..+. .|.+++..+.
T Consensus 36 ~ei~~~kr~tvld~~s~r~v-n~~~n~s~~t~~~rl~~sknq~~-~~~~d~~q~~e~~~~~~~~n~~~~-~p~s~~k~~~ 112 (326)
T KOG0473|consen 36 REIASFKRVTVLDLSSNRLV-NLGKNFSILTRLVRLDLSKNQIK-FLPKDAKQQRETVNAASHKNNHSQ-QPKSQKKEPH 112 (326)
T ss_pred hhhhccceeeeehhhhhHHH-hhccchHHHHHHHHHhccHhhHh-hChhhHHHHHHHHHHHhhccchhh-CCccccccCC
Confidence 44667788899999999887 45567888889999999999854 678889999999999998888654 7899999999
Q ss_pred CCEEecCCCcccc
Q 041558 97 LSTSRLSKNKLFV 109 (495)
Q Consensus 97 L~~L~l~~n~~~~ 109 (495)
++.+++-.|.+..
T Consensus 113 ~k~~e~k~~~~~~ 125 (326)
T KOG0473|consen 113 PKKNEQKKTEFFR 125 (326)
T ss_pred cchhhhccCcchH
Confidence 9999999888753
No 122
>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases. Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki
Probab=93.63 E-value=0.043 Score=50.30 Aligned_cols=31 Identities=26% Similarity=0.576 Sum_probs=28.6
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++++++|+|+|+++|+|.. +..++|+||+++
T Consensus 54 ~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~ 84 (259)
T cd05037 54 LMSQLSHKHLVKLYGVCVR-DENIMVEEYVKF 84 (259)
T ss_pred HHHcCCCcchhheeeEEec-CCcEEEEEcCCC
Confidence 7889999999999999998 788999999974
No 123
>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1. Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25
Probab=93.62 E-value=0.029 Score=52.21 Aligned_cols=32 Identities=19% Similarity=0.346 Sum_probs=29.9
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+++++|+|+|+++|++..++..++|+||+++
T Consensus 55 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (277)
T cd06642 55 VLSQCDSPYITRYYGSYLKGTKLWIIMEYLGG 86 (277)
T ss_pred HHHcCCCCccHhhhcccccCCceEEEEEccCC
Confidence 78899999999999999999999999999974
No 124
>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1. Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly
Probab=93.62 E-value=0.058 Score=50.33 Aligned_cols=31 Identities=26% Similarity=0.417 Sum_probs=29.4
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~ 494 (495)
.+++++|+|+|+++|++..++..++||||++
T Consensus 60 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 90 (283)
T cd05090 60 LMAELHHPNIVCLLGVVTQEQPVCMLFEYLN 90 (283)
T ss_pred HHhhCCCCCeeeEEEEEecCCceEEEEEcCC
Confidence 7899999999999999999999999999986
No 125
>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N. Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved
Probab=93.58 E-value=0.063 Score=51.32 Aligned_cols=32 Identities=16% Similarity=0.185 Sum_probs=28.9
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+++++|+|+|+++|++..++..++|+||+++
T Consensus 55 ~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~ 86 (324)
T cd05589 55 TANSERHPFLVNLFACFQTEDHVCFVMEYAAG 86 (324)
T ss_pred hccccCCCChhceeeEEEcCCEEEEEEcCCCC
Confidence 45788999999999999999999999999974
No 126
>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases. Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include
Probab=93.54 E-value=0.06 Score=50.38 Aligned_cols=32 Identities=22% Similarity=0.118 Sum_probs=27.4
Q ss_pred ecccccCCceeeeEEEEEeC--CeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHA--RHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~--~~~~LVyeym~n 495 (495)
.+++++|+|+|+++|+|.+. +..++||||+++
T Consensus 52 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 85 (287)
T cd06621 52 INKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEG 85 (287)
T ss_pred HHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCC
Confidence 78899999999999999764 357899999974
No 127
>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4. Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.
Probab=93.52 E-value=0.06 Score=49.62 Aligned_cols=32 Identities=25% Similarity=0.323 Sum_probs=29.8
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+.+++|+|+|+++|+|.+++..++||||+++
T Consensus 55 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (265)
T cd06631 55 LLKSLKHVNIVQYLGTCLDDNTISIFMEFVPG 86 (265)
T ss_pred HHHhcCCCCEeeEeeEeecCCeEEEEEecCCC
Confidence 78899999999999999999999999999973
No 128
>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter
Probab=93.50 E-value=0.07 Score=49.59 Aligned_cols=32 Identities=19% Similarity=0.342 Sum_probs=29.8
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+++++|+|+|+++++|..++..++||||+++
T Consensus 55 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (277)
T cd06640 55 VLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGG 86 (277)
T ss_pred HHHhCCCCCEeeEEEEEEECCEEEEEEecCCC
Confidence 68889999999999999999999999999974
No 129
>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5. Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p
Probab=93.48 E-value=0.069 Score=49.71 Aligned_cols=32 Identities=19% Similarity=0.178 Sum_probs=29.7
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|+|+|+++|+|...+...+|+||+++
T Consensus 52 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 83 (279)
T cd06619 52 ILYKCDSPYIIGFYGAFFVENRISICTEFMDG 83 (279)
T ss_pred HHHhCCCCCeeeEEEEEEECCEEEEEEecCCC
Confidence 67889999999999999999999999999974
No 130
>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase. Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M
Probab=93.47 E-value=0.047 Score=51.05 Aligned_cols=32 Identities=28% Similarity=0.517 Sum_probs=29.6
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++++++|+|+|+++|+|..++..++|+||+++
T Consensus 61 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 92 (288)
T cd05050 61 LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAY 92 (288)
T ss_pred HHHhcCCCchheEEEEEcCCCccEEEEecCCC
Confidence 78899999999999999999999999999873
No 131
>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor. Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh
Probab=93.46 E-value=0.058 Score=50.14 Aligned_cols=32 Identities=16% Similarity=0.416 Sum_probs=29.5
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+.+++|+|+|+++|+|.+++..++|+||+++
T Consensus 62 ~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~ 93 (277)
T cd05062 62 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTR 93 (277)
T ss_pred HHHhCCCCCeeeEEEEEcCCCCeEEEEecCCC
Confidence 67889999999999999999999999999974
No 132
>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.
Probab=93.45 E-value=0.062 Score=51.27 Aligned_cols=32 Identities=16% Similarity=0.106 Sum_probs=29.2
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|+|+|++++++.+.+..++|+|||++
T Consensus 49 ~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 49 LLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred HHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 56788999999999999999999999999974
No 133
>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1. Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops
Probab=93.44 E-value=0.054 Score=49.59 Aligned_cols=32 Identities=22% Similarity=0.331 Sum_probs=29.9
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++++++|+|+|++.|+|..++..++||||+++
T Consensus 55 ~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (258)
T cd06632 55 LLSKLQHPNIVQYLGTEREEDNLYIFLELVPG 86 (258)
T ss_pred HHHhcCCCCchheeeeEecCCeEEEEEEecCC
Confidence 78899999999999999999999999999974
No 134
>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio
Probab=93.43 E-value=0.065 Score=49.95 Aligned_cols=32 Identities=22% Similarity=0.328 Sum_probs=29.9
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|+|+|++++++..++...+|+|||++
T Consensus 53 ~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~ 84 (286)
T cd07847 53 MLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDH 84 (286)
T ss_pred HHHhCCCCCEeeeeeEEeeCCEEEEEEeccCc
Confidence 78899999999999999999999999999974
No 135
>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding
Probab=93.41 E-value=0.072 Score=50.13 Aligned_cols=32 Identities=22% Similarity=0.259 Sum_probs=29.7
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|+|+|+++|++..++..++|||||++
T Consensus 70 ~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~ 101 (296)
T cd06654 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101 (296)
T ss_pred HHHhCCCCCEeeEEEEEEeCCEEEEeecccCC
Confidence 67888999999999999999999999999974
No 136
>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase. Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play
Probab=93.38 E-value=0.064 Score=50.81 Aligned_cols=32 Identities=28% Similarity=0.378 Sum_probs=29.8
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+.+++|+|+|++++++..++..++||||+++
T Consensus 57 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 88 (309)
T cd07872 57 LLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK 88 (309)
T ss_pred HHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC
Confidence 78899999999999999999999999999863
No 137
>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in
Probab=93.38 E-value=0.062 Score=51.34 Aligned_cols=32 Identities=16% Similarity=0.012 Sum_probs=29.7
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|||+|++.+++...+..++|+|||++
T Consensus 48 ~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (323)
T cd05595 48 VLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 79 (323)
T ss_pred HHHhCCCCCCcceeeEEecCCEEEEEEeCCCC
Confidence 78889999999999999999999999999974
No 138
>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2. Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po
Probab=93.36 E-value=0.067 Score=52.46 Aligned_cols=32 Identities=19% Similarity=0.257 Sum_probs=30.0
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|+|+|++++++.+++..++|+||+++
T Consensus 54 il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~g 85 (381)
T cd05626 54 ILAEADNEWVVKLYYSFQDKDNLYFVMDYIPG 85 (381)
T ss_pred HHHhcCCCCeeeeEEEEecCCEEEEEEecCCC
Confidence 78899999999999999999999999999974
No 139
>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored
Probab=93.34 E-value=0.066 Score=49.42 Aligned_cols=32 Identities=19% Similarity=0.412 Sum_probs=29.8
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+.+++|+|++++.|++...+..++||||+++
T Consensus 59 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 90 (268)
T cd05063 59 IMGQFSHHNIIRLEGVVTKFKPAMIITEYMEN 90 (268)
T ss_pred HHhcCCCCCeeEEEEEEccCCCcEEEEEcCCC
Confidence 78899999999999999999999999999974
No 140
>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3. Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity
Probab=93.32 E-value=0.054 Score=49.73 Aligned_cols=32 Identities=25% Similarity=0.464 Sum_probs=29.6
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+.+++|+|+|+++|+|..++..++|+||++.
T Consensus 52 ~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 83 (258)
T cd05078 52 MMSQLSHKHLVLNYGVCVCGDESIMVQEYVKF 83 (258)
T ss_pred HHHhCCCCChhheeeEEEeCCCcEEEEecCCC
Confidence 78889999999999999999999999999963
No 141
>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding
Probab=93.29 E-value=0.071 Score=50.19 Aligned_cols=32 Identities=22% Similarity=0.259 Sum_probs=29.9
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++++++|+|+|+++|+|..++..++|+||+++
T Consensus 69 ~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 100 (297)
T cd06656 69 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 100 (297)
T ss_pred HHHhCCCCCEeeEEEEEecCCEEEEeecccCC
Confidence 78889999999999999999999999999974
No 142
>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of
Probab=93.29 E-value=0.068 Score=52.32 Aligned_cols=32 Identities=22% Similarity=0.244 Sum_probs=29.8
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|+|+|++++++.+++..++|+||+++
T Consensus 54 il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~g 85 (377)
T cd05629 54 VLAESDSPWVVSLYYSFQDAQYLYLIMEFLPG 85 (377)
T ss_pred HHHhCCCCCcceEEEEEEcCCeeEEEEeCCCC
Confidence 67889999999999999999999999999974
No 143
>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer. Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c
Probab=93.26 E-value=0.064 Score=48.89 Aligned_cols=32 Identities=31% Similarity=0.533 Sum_probs=29.4
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+.+++|+|+++++++|...+..++|+||++.
T Consensus 45 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (250)
T cd05085 45 ILKQYDHPNIVKLIGVCTQRQPIYIVMELVPG 76 (250)
T ss_pred HHHhCCCCCcCeEEEEEecCCccEEEEECCCC
Confidence 78889999999999999999999999999863
No 144
>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1. Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron
Probab=93.24 E-value=0.077 Score=50.50 Aligned_cols=31 Identities=19% Similarity=0.239 Sum_probs=29.4
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~ 494 (495)
.+++++|+|+|+++|+|.+++..++|+||++
T Consensus 78 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 108 (317)
T cd06635 78 FLQRIKHPNSIEYKGCYLREHTAWLVMEYCL 108 (317)
T ss_pred HHHhCCCCCEEEEEEEEeeCCeEEEEEeCCC
Confidence 7889999999999999999999999999986
No 145
>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein. Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi
Probab=93.21 E-value=0.066 Score=50.17 Aligned_cols=32 Identities=25% Similarity=0.487 Sum_probs=29.6
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+++++|+|||+++|+|..++..++|+||+++
T Consensus 56 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 87 (290)
T cd05045 56 LLKQVNHPHVIKLYGACSQDGPLLLIVEYAKY 87 (290)
T ss_pred HHhhCCCCCEeeEEEEEecCCCcEEEEEecCC
Confidence 78899999999999999999999999999873
No 146
>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.
Probab=93.21 E-value=0.087 Score=48.62 Aligned_cols=30 Identities=23% Similarity=0.398 Sum_probs=27.4
Q ss_pred ccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 466 TETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 466 ~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+++|+|+|+++|+|.+++..++|+||+++
T Consensus 64 ~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 93 (269)
T cd08528 64 EQLRHPNIVRYYKTFLENDRLYIVMDLIEG 93 (269)
T ss_pred hcCCCCCeeeEEeeEccCCeEEEEEecCCC
Confidence 458999999999999999999999999974
No 147
>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]
Probab=93.20 E-value=0.023 Score=52.82 Aligned_cols=32 Identities=28% Similarity=0.354 Sum_probs=26.2
Q ss_pred ecccccCCceeeeEEEEEeCCee-----EEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHS-----FSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~-----~LVyeym~n 495 (495)
+|+++.|||||+|+-|..+..+. .||+||||.
T Consensus 70 im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~ 106 (364)
T KOG0658|consen 70 IMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE 106 (364)
T ss_pred HHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH
Confidence 88999999999999887763322 489999984
No 148
>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase. Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in
Probab=93.18 E-value=0.064 Score=51.23 Aligned_cols=32 Identities=19% Similarity=0.157 Sum_probs=29.7
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|||+|++++++..++..++|+||+++
T Consensus 53 il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 84 (323)
T cd05584 53 ILEAVKHPFIVDLIYAFQTGGKLYLILEYLSG 84 (323)
T ss_pred HHHhCCCCchhceeeEEecCCeEEEEEeCCCC
Confidence 78899999999999999999999999999974
No 149
>PLN00034 mitogen-activated protein kinase kinase; Provisional
Probab=93.17 E-value=0.063 Score=52.01 Aligned_cols=32 Identities=22% Similarity=0.312 Sum_probs=29.9
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|+|||++++++.+++...+|+|||++
T Consensus 125 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 156 (353)
T PLN00034 125 ILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDG 156 (353)
T ss_pred HHHhCCCCCcceeeeEeccCCeEEEEEecCCC
Confidence 78899999999999999999999999999974
No 150
>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl
Probab=93.16 E-value=0.073 Score=50.55 Aligned_cols=32 Identities=13% Similarity=0.052 Sum_probs=29.7
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|||+|++.+++.+++..++|+||+++
T Consensus 46 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 77 (312)
T cd05585 46 VLAQVNCPFIVPLKFSFQSPEKLYLVLAFING 77 (312)
T ss_pred HHHhCCCCcEeceeeEEecCCeEEEEEcCCCC
Confidence 78889999999999999999999999999974
No 151
>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t
Probab=93.12 E-value=0.077 Score=48.75 Aligned_cols=32 Identities=22% Similarity=0.318 Sum_probs=29.7
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|+|+|+++|++.+++..++||||+++
T Consensus 57 ~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 88 (263)
T cd06625 57 LLKNLQHERIVQYYGCLRDDETLSIFMEYMPG 88 (263)
T ss_pred HHHhCCCCCeeeeEEEEccCCeEEEEEEECCC
Confidence 68889999999999999999999999999974
No 152
>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor. Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti
Probab=93.10 E-value=0.05 Score=53.17 Aligned_cols=32 Identities=28% Similarity=0.454 Sum_probs=29.2
Q ss_pred ecccc-cCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTET-GHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~-~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
+++++ +|+|+|+++|+|.+++..++|+||+++
T Consensus 94 il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~ 126 (374)
T cd05106 94 ILSHLGQHKNIVNLLGACTHGGPVLVITEYCCY 126 (374)
T ss_pred HHHhhccCCceeeEeeEecCCCCeEEeHhhccC
Confidence 67788 899999999999999999999999963
No 153
>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the
Probab=93.08 E-value=0.082 Score=49.50 Aligned_cols=32 Identities=25% Similarity=0.333 Sum_probs=29.9
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|+|++++++++.+++..++|+|||++
T Consensus 56 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (291)
T cd07844 56 LLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT 87 (291)
T ss_pred HHhhCCCcceeeEEEEEecCCeEEEEEecCCC
Confidence 78899999999999999999999999999973
No 154
>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte
Probab=93.08 E-value=0.07 Score=49.37 Aligned_cols=32 Identities=25% Similarity=0.346 Sum_probs=29.8
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+.+++|+|+|+++|+|..++..++|+||+++
T Consensus 61 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 92 (272)
T cd06629 61 TLKDLDHLNIVQYLGFETTEEYLSIFLEYVPG 92 (272)
T ss_pred HHHhcCCCCcceEEEEeccCCceEEEEecCCC
Confidence 78899999999999999999999999999863
No 155
>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes. Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular
Probab=93.06 E-value=0.066 Score=48.88 Aligned_cols=32 Identities=28% Similarity=0.556 Sum_probs=29.4
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|+|+|+++++|..++..++|+||+++
T Consensus 46 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (252)
T cd05084 46 ILKQYSHPNIVRLIGVCTQKQPIYIVMELVQG 77 (252)
T ss_pred HHHhCCCCCcceEEEEEcCCCCeEEEEeeccC
Confidence 68889999999999999999999999999864
No 156
>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.
Probab=93.05 E-value=0.079 Score=50.82 Aligned_cols=32 Identities=19% Similarity=0.097 Sum_probs=29.7
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|+|+|++++++.+++..++|+|||++
T Consensus 54 ~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g 85 (333)
T cd05600 54 ILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPG 85 (333)
T ss_pred HHHhCCCCCCccEEEEEEcCCEEEEEEeCCCC
Confidence 68888999999999999999999999999974
No 157
>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding
Probab=93.05 E-value=0.078 Score=49.91 Aligned_cols=32 Identities=28% Similarity=0.295 Sum_probs=29.8
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+++++|+|+|+++|++..++..++||||+++
T Consensus 69 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 100 (296)
T cd06655 69 VMKELKNPNIVNFLDSFLVGDELFVVMEYLAG 100 (296)
T ss_pred HHHhcCCCceeeeeeeEecCceEEEEEEecCC
Confidence 78899999999999999999999999999863
No 158
>PTZ00263 protein kinase A catalytic subunit; Provisional
Probab=93.03 E-value=0.077 Score=50.82 Aligned_cols=32 Identities=19% Similarity=0.163 Sum_probs=29.8
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|+|+|++++++.+++..++|+||+++
T Consensus 71 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 102 (329)
T PTZ00263 71 ILMELSHPFIVNMMCSFQDENRVYFLLEFVVG 102 (329)
T ss_pred HHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCC
Confidence 78899999999999999999999999999863
No 159
>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor. Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta
Probab=93.02 E-value=0.071 Score=49.90 Aligned_cols=32 Identities=16% Similarity=0.331 Sum_probs=29.6
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+.+++|+|+|+++|++..++..++|+||+++
T Consensus 62 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 93 (288)
T cd05061 62 VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAH 93 (288)
T ss_pred HHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCC
Confidence 68889999999999999999999999999974
No 160
>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase. Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays
Probab=92.99 E-value=0.058 Score=49.66 Aligned_cols=32 Identities=22% Similarity=0.469 Sum_probs=29.6
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+.+++|+|+|+++|+|..++..++|+|||++
T Consensus 55 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (263)
T cd05052 55 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTY 86 (263)
T ss_pred HHHhCCCCChhheEEEEcCCCCcEEEEEeCCC
Confidence 78889999999999999999999999999974
No 161
>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate
Probab=92.98 E-value=0.078 Score=48.86 Aligned_cols=32 Identities=31% Similarity=0.352 Sum_probs=29.8
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|+|+++++|++.+.+..++|+||+++
T Consensus 59 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 90 (267)
T cd06628 59 LLKELQHENIVQYLGSSLDADHLNIFLEYVPG 90 (267)
T ss_pred HHHhcCCCCeeeEEEEEEeCCccEEEEEecCC
Confidence 78899999999999999999999999999874
No 162
>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the
Probab=92.93 E-value=0.076 Score=50.38 Aligned_cols=32 Identities=19% Similarity=0.342 Sum_probs=29.2
Q ss_pred ecccccCCceeeeEEEEEeC--CeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHA--RHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~--~~~~LVyeym~n 495 (495)
++.+++|||+|+++|+|... +..++||||+++
T Consensus 55 ~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~ 88 (316)
T cd07842 55 LLRELKHENVVSLVEVFLEHADKSVYLLFDYAEH 88 (316)
T ss_pred HHHhcCCCCccceEEEEeCCCCceEEEEEeCCCc
Confidence 78899999999999999987 789999999863
No 163
>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,
Probab=92.92 E-value=0.073 Score=49.77 Aligned_cols=32 Identities=13% Similarity=0.033 Sum_probs=29.7
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|+|+|++.+++..++..++|+|||+.
T Consensus 53 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 84 (285)
T cd05605 53 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 84 (285)
T ss_pred HHHhcCCCCEeeeeeeecCCCeEEEEEeccCC
Confidence 78899999999999999999999999999973
No 164
>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn. Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa
Probab=92.92 E-value=0.073 Score=48.90 Aligned_cols=32 Identities=16% Similarity=0.386 Sum_probs=29.6
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|+|+|++++++..++..++|||||++
T Consensus 54 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (261)
T cd05072 54 LMKTLQHDKLVRLYAVVTKEEPIYIITEYMAK 85 (261)
T ss_pred HHHhCCCCCeeeEEEEEcCCCCcEEEEecCCC
Confidence 78889999999999999999999999999974
No 165
>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti
Probab=92.91 E-value=0.088 Score=48.96 Aligned_cols=32 Identities=25% Similarity=0.269 Sum_probs=29.9
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++++++|+|+|+++|++.+++..++|+||+++
T Consensus 55 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (280)
T cd06611 55 ILSECKHPNIVGLYEAYFYENKLWILIEFCDG 86 (280)
T ss_pred HHHhCCCCceeEEEEEEecCCeEEEEeeccCC
Confidence 78899999999999999999999999999974
No 166
>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1. Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an
Probab=92.89 E-value=0.085 Score=51.73 Aligned_cols=32 Identities=16% Similarity=0.252 Sum_probs=29.9
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++++++|+|+|++++++.+++..++|+|||++
T Consensus 54 il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~g 85 (382)
T cd05625 54 ILAEADNEWVVRLYYSFQDKDNLYFVMDYIPG 85 (382)
T ss_pred HHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCC
Confidence 78889999999999999999999999999974
No 167
>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]
Probab=92.87 E-value=0.076 Score=52.52 Aligned_cols=31 Identities=26% Similarity=0.434 Sum_probs=29.3
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~ 494 (495)
-|.+++|+||+++.|+|.....-++|+||.+
T Consensus 165 HLRkLkH~NII~FkGVCtqsPcyCIiMEfCa 195 (904)
T KOG4721|consen 165 HLRKLKHPNIITFKGVCTQSPCYCIIMEFCA 195 (904)
T ss_pred HHHhccCcceeeEeeeecCCceeEEeeeccc
Confidence 6999999999999999999999999999975
No 168
>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase. Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an
Probab=92.87 E-value=0.086 Score=49.78 Aligned_cols=31 Identities=23% Similarity=0.208 Sum_probs=29.4
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~ 494 (495)
++++++|+|+|++.+++..++..++|+|||+
T Consensus 56 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 86 (303)
T cd07869 56 LLKGLKHANIVLLHDIIHTKETLTLVFEYVH 86 (303)
T ss_pred HHhhCCCCCcCeEEEEEecCCeEEEEEECCC
Confidence 7889999999999999999999999999996
No 169
>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors. Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept
Probab=92.85 E-value=0.079 Score=50.04 Aligned_cols=31 Identities=23% Similarity=0.372 Sum_probs=28.9
Q ss_pred ecccc-cCCceeeeEEEEEeCCeeEEEecccC
Q 041558 464 ALTET-GHRNIVKFYGFCSHARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~-~H~NlV~l~G~c~~~~~~~LVyeym~ 494 (495)
++.++ +|+|+|+++|+|...+..++|+||++
T Consensus 91 ~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 122 (302)
T cd05055 91 IMSHLGNHENIVNLLGACTIGGPILVITEYCC 122 (302)
T ss_pred HHHhccCCCCcceEEEEEecCCceEEEEEcCC
Confidence 77888 79999999999999999999999997
No 170
>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti
Probab=92.84 E-value=0.086 Score=48.22 Aligned_cols=32 Identities=22% Similarity=0.296 Sum_probs=29.7
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++++++|+|++++.+++.+.+..++|+||++.
T Consensus 52 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd08218 52 VLSNMKHPNIVQYQESFEENGNLYIVMDYCEG 83 (256)
T ss_pred HHHhCCCCCeeeeEeeecCCCeEEEEEecCCC
Confidence 78899999999999999999999999999963
No 171
>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be
Probab=92.84 E-value=0.087 Score=50.31 Aligned_cols=32 Identities=16% Similarity=0.007 Sum_probs=29.8
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|+|+|++.+++..++..++|+||+++
T Consensus 48 ~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~ 79 (323)
T cd05571 48 VLQNTRHPFLTALKYSFQTHDRLCFVMEYANG 79 (323)
T ss_pred HHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence 78899999999999999999999999999974
No 172
>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their
Probab=92.78 E-value=0.056 Score=49.83 Aligned_cols=31 Identities=16% Similarity=0.252 Sum_probs=29.4
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~ 494 (495)
.+++++|+|+|+++|+|.+++..++||||++
T Consensus 56 ~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 86 (268)
T cd06630 56 LMARLNHPHIIRMLGATCEDSHFNLFVEWMA 86 (268)
T ss_pred HHHHcCCCceehhhceeccCCeEEEEEeccC
Confidence 7888999999999999999999999999997
No 173
>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase. Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well
Probab=92.76 E-value=0.083 Score=49.08 Aligned_cols=32 Identities=22% Similarity=0.377 Sum_probs=29.5
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+++++|+|+|+++|++.+.+..++|+|||++
T Consensus 62 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g 93 (277)
T cd05036 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAG 93 (277)
T ss_pred HHHhCCCCCEeeEEEEEccCCCcEEEEecCCC
Confidence 78899999999999999999999999999963
No 174
>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase. Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl
Probab=92.75 E-value=0.086 Score=49.69 Aligned_cols=31 Identities=26% Similarity=0.348 Sum_probs=29.3
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~ 494 (495)
.+.+++|+|+|++++++..++..++|+|||+
T Consensus 57 ~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~ 87 (301)
T cd07873 57 LLKDLKHANIVTLHDIIHTEKSLTLVFEYLD 87 (301)
T ss_pred HHHhcCCCCcceEEEEEecCCeEEEEEeccc
Confidence 7889999999999999999999999999986
No 175
>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g
Probab=92.75 E-value=0.092 Score=48.94 Aligned_cols=32 Identities=16% Similarity=0.042 Sum_probs=29.6
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|+|+|++.+++..++..++|+|||++
T Consensus 46 il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (280)
T cd05608 46 ILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNG 77 (280)
T ss_pred HHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCC
Confidence 78899999999999999999999999999974
No 176
>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate
Probab=92.66 E-value=0.096 Score=50.17 Aligned_cols=32 Identities=16% Similarity=0.048 Sum_probs=29.7
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|+|+|++.+++..++..++|+||+++
T Consensus 48 ~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~ 79 (328)
T cd05593 48 VLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNG 79 (328)
T ss_pred HHHhCCCCCCcceEEEEEcCCEEEEEEeCCCC
Confidence 68889999999999999999999999999974
No 177
>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l
Probab=92.66 E-value=0.083 Score=48.87 Aligned_cols=32 Identities=25% Similarity=0.418 Sum_probs=29.0
Q ss_pred ecccc-cCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTET-GHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~-~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.++ +|||+|+++|+|...+..++|+||+++
T Consensus 48 ~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 48 VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred HHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 67788 899999999999999899999999974
No 178
>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes
Probab=92.62 E-value=0.056 Score=50.49 Aligned_cols=32 Identities=25% Similarity=0.311 Sum_probs=29.8
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|+|+|++.++|.+++..++|+||+++
T Consensus 53 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 84 (287)
T cd07848 53 MLRTLKQENIVELKEAFRRRGKLYLVFEYVEK 84 (287)
T ss_pred HHHhCCCccccchhhhEecCCEEEEEEecCCC
Confidence 78899999999999999999999999999974
No 179
>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase. Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.
Probab=92.60 E-value=0.1 Score=48.60 Aligned_cols=32 Identities=22% Similarity=0.195 Sum_probs=29.6
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+.+++|+|+|+++|+|..++..++||||+++
T Consensus 55 ~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 55 ILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 67889999999999999999999999999873
No 180
>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex
Probab=92.56 E-value=0.046 Score=51.01 Aligned_cols=31 Identities=32% Similarity=0.444 Sum_probs=29.4
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~ 494 (495)
.+.+++|+|+|+++|++.+++..++|+||++
T Consensus 52 ~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (284)
T cd07860 52 LLKELNHPNIVKLLDVIHTENKLYLVFEFLH 82 (284)
T ss_pred HHHhcCCCCCcchhhhcccCCcEEEEeeccc
Confidence 7899999999999999999999999999985
No 181
>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk. Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom
Probab=92.55 E-value=0.082 Score=48.54 Aligned_cols=32 Identities=25% Similarity=0.566 Sum_probs=29.7
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+.+++|+|+++++++|..++..++|+||+++
T Consensus 55 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (261)
T cd05148 55 ALKRLRHKHLISLFAVCSVGEPVYIITELMEK 86 (261)
T ss_pred HHhcCCCcchhheeeeEecCCCeEEEEeeccc
Confidence 78899999999999999999999999999973
No 182
>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.
Probab=92.53 E-value=0.057 Score=49.41 Aligned_cols=32 Identities=28% Similarity=0.379 Sum_probs=29.7
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+++++|+|+|+++|+|.+++..++||||+++
T Consensus 52 ~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (257)
T cd08225 52 LLAKMKHPNIVTFFASFQENGRLFIVMEYCDG 83 (257)
T ss_pred HHHhCCCCChhhhhheeccCCeEEEEEecCCC
Confidence 78899999999999999999999999999963
No 183
>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,
Probab=92.53 E-value=0.1 Score=49.79 Aligned_cols=32 Identities=13% Similarity=0.092 Sum_probs=29.1
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++..++|+|+|++++++..++..++|+|||++
T Consensus 49 ~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 49 LLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred HHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46778999999999999999999999999974
No 184
>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase. Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in
Probab=92.49 E-value=0.11 Score=50.83 Aligned_cols=32 Identities=13% Similarity=0.114 Sum_probs=29.7
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++++++|+|+|++++++.+++..++|+|||++
T Consensus 96 il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~g 127 (370)
T cd05596 96 IMAHANSEWIVQLHYAFQDDKYLYMVMEYMPG 127 (370)
T ss_pred HHHhCCCCCcceEEEEEecCCEEEEEEcCCCC
Confidence 78889999999999999999999999999974
No 185
>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase. Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament
Probab=92.47 E-value=0.1 Score=48.78 Aligned_cols=32 Identities=28% Similarity=0.328 Sum_probs=29.5
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|+|+|+++|+...++...+|+||++.
T Consensus 56 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 87 (288)
T cd07871 56 LLKNLKHANIVTLHDIIHTERCLTLVFEYLDS 87 (288)
T ss_pred HHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc
Confidence 78899999999999999988899999999863
No 186
>PLN00009 cyclin-dependent kinase A; Provisional
Probab=92.47 E-value=0.1 Score=49.00 Aligned_cols=31 Identities=29% Similarity=0.485 Sum_probs=29.4
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~ 494 (495)
.+.+++|+|+|+++|++..++..++|+|||+
T Consensus 54 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (294)
T PLN00009 54 LLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD 84 (294)
T ss_pred HHHhccCCCEeeEEEEEecCCeEEEEEeccc
Confidence 7889999999999999999999999999996
No 187
>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory
Probab=92.41 E-value=0.11 Score=48.40 Aligned_cols=32 Identities=38% Similarity=0.744 Sum_probs=29.7
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+++++|+|+|+++|++.+++..++|+||+++
T Consensus 60 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 91 (280)
T cd05092 60 LLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRH 91 (280)
T ss_pred HHhcCCCCCCceEEEEEecCCceEEEEecCCC
Confidence 78899999999999999999999999999973
No 188
>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment
Probab=92.40 E-value=0.1 Score=48.16 Aligned_cols=32 Identities=22% Similarity=0.427 Sum_probs=29.8
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+.+++|+|+++++|++.+++..++|+||+++
T Consensus 58 ~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 89 (266)
T cd05033 58 IMGQFDHPNIIRLEGVVTKSRPVMIITEYMEN 89 (266)
T ss_pred HHHhCCCCCcceEeEEEecCCceEEEEEcCCC
Confidence 78899999999999999999999999999974
No 189
>KOG0473 consensus Leucine-rich repeat protein [Function unknown]
Probab=92.34 E-value=0.0046 Score=53.68 Aligned_cols=87 Identities=15% Similarity=0.147 Sum_probs=60.0
Q ss_pred CCCCCCCCEEecccccccccCCccccCCCCCceeccCCCeeeeecCCCCccccccceeecccccccccCCcccCCCCCCC
Q 041558 226 REKCPKLGTLGVLMNTITKGIPREIRNSSQRQALDLSLNHIIGEIPKELGKLNSLIKLILRRNQLVGCLPTEIGSPIELE 305 (495)
Q Consensus 226 ~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 305 (495)
+......+.||++.|++.. ....|+-++.+..++++.|.+. ..|..+++...++.+++..|..+ ..|..++..+.++
T Consensus 38 i~~~kr~tvld~~s~r~vn-~~~n~s~~t~~~rl~~sknq~~-~~~~d~~q~~e~~~~~~~~n~~~-~~p~s~~k~~~~k 114 (326)
T KOG0473|consen 38 IASFKRVTVLDLSSNRLVN-LGKNFSILTRLVRLDLSKNQIK-FLPKDAKQQRETVNAASHKNNHS-QQPKSQKKEPHPK 114 (326)
T ss_pred hhccceeeeehhhhhHHHh-hccchHHHHHHHHHhccHhhHh-hChhhHHHHHHHHHHHhhccchh-hCCccccccCCcc
Confidence 3445556666666666543 3345556667777777777776 67777777777777777777777 6777777777788
Q ss_pred EEeCCCCcCC
Q 041558 306 YLDFSVNRFN 315 (495)
Q Consensus 306 ~L~Ls~n~l~ 315 (495)
++++.+|.+.
T Consensus 115 ~~e~k~~~~~ 124 (326)
T KOG0473|consen 115 KNEQKKTEFF 124 (326)
T ss_pred hhhhccCcch
Confidence 8777777654
No 190
>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4. Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s
Probab=92.32 E-value=0.088 Score=48.79 Aligned_cols=31 Identities=23% Similarity=0.611 Sum_probs=29.4
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~ 494 (495)
++.+++|+|+|+++++|.+.+..++|+||++
T Consensus 61 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 91 (275)
T cd05046 61 MFRKLSHKNVVRLLGLCREAEPHYMILEYTD 91 (275)
T ss_pred HHHhcCCcceeeeEEEECCCCcceEEEEecC
Confidence 7899999999999999999899999999986
No 191
>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]
Probab=92.32 E-value=0.026 Score=51.22 Aligned_cols=44 Identities=20% Similarity=0.307 Sum_probs=36.7
Q ss_pred CCceEEEeeccce--------------ecccccCCceeeeEEEEEeCCeeEEEecccC
Q 041558 451 QGLLSILNFKGKL--------------ALTETGHRNIVKFYGFCSHARHSFSVYESLE 494 (495)
Q Consensus 451 ~~~~~~~~~~~~~--------------~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~ 494 (495)
+..+|++.|.+.- +|..++|+|||.|+-.|.......||+||.+
T Consensus 27 gqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~d 84 (396)
T KOG0593|consen 27 GQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCD 84 (396)
T ss_pred ccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecc
Confidence 4566777775432 8999999999999999999999999999975
No 192
>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase. Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi
Probab=92.31 E-value=0.095 Score=48.17 Aligned_cols=32 Identities=25% Similarity=0.266 Sum_probs=29.7
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|+|++++++++.+++..++|+||+++
T Consensus 46 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (262)
T cd05572 46 ILEECNHPFIVKLYRTFKDKKYIYMLMEYCLG 77 (262)
T ss_pred HHHhCCCCCEeeeeeeEEcCCccEEEEecCCC
Confidence 68899999999999999999999999999974
No 193
>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr
Probab=92.24 E-value=0.13 Score=47.88 Aligned_cols=32 Identities=16% Similarity=0.062 Sum_probs=29.7
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|||+|++.+++.+++..++|+||+++
T Consensus 46 il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g 77 (277)
T cd05607 46 ILEKVNSPFIVNLAYAFESKTHLCLVMSLMNG 77 (277)
T ss_pred HHHhcCCCcEEEEEEEEecCCeEEEEEecCCC
Confidence 78899999999999999999999999999974
No 194
>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors. Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer
Probab=92.22 E-value=0.11 Score=48.49 Aligned_cols=32 Identities=25% Similarity=0.544 Sum_probs=29.5
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+++++|+|+++++|++...+..++||||+++
T Consensus 61 ~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 92 (283)
T cd05048 61 LMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAH 92 (283)
T ss_pred HHHhcCCcccceEEEEEcCCCceEEEEecCCC
Confidence 68889999999999999998899999999974
No 195
>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated
Probab=92.20 E-value=0.13 Score=47.44 Aligned_cols=32 Identities=22% Similarity=0.285 Sum_probs=29.7
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+.+++|+|+|++.++|..++..++|+|||++
T Consensus 59 ~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~ 90 (267)
T cd06646 59 MVKECKHCNIVAYFGSYLSREKLWICMEYCGG 90 (267)
T ss_pred HHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCC
Confidence 78889999999999999999999999999973
No 196
>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk
Probab=92.20 E-value=0.1 Score=47.75 Aligned_cols=32 Identities=25% Similarity=0.392 Sum_probs=29.7
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+.+++|+|+|+++|++..++...+|+||+++
T Consensus 53 ~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 84 (256)
T cd05039 53 VMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK 84 (256)
T ss_pred HHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence 78899999999999999999999999999973
No 197
>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa. Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho
Probab=92.20 E-value=0.12 Score=47.53 Aligned_cols=31 Identities=23% Similarity=0.358 Sum_probs=27.0
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|+|+|+++|+|. .+..++|+||+++
T Consensus 48 ~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~ 78 (257)
T cd05115 48 IMHQLDNPYIVRMIGVCE-AEALMLVMEMASG 78 (257)
T ss_pred HHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCC
Confidence 788999999999999984 5577899999974
No 198
>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3. Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th
Probab=92.19 E-value=0.11 Score=48.44 Aligned_cols=32 Identities=41% Similarity=0.497 Sum_probs=27.3
Q ss_pred ecccccCCceeeeEEEEEeC--CeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHA--RHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~--~~~~LVyeym~n 495 (495)
++++++|+|+|++.|+|... ...++|+|||++
T Consensus 58 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 91 (284)
T cd05081 58 ILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPY 91 (284)
T ss_pred HHHhCCCCCeeEEEEEEccCCCCceEEEEEecCC
Confidence 78899999999999998653 457899999974
No 199
>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase. Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi
Probab=92.17 E-value=0.087 Score=49.48 Aligned_cols=32 Identities=25% Similarity=0.309 Sum_probs=29.7
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+.+++|+|+|++.|+|..++..++|+||+++
T Consensus 69 ~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~ 100 (293)
T cd06647 69 VMRENKHPNIVNYLDSYLVGDELWVVMEYLAG 100 (293)
T ss_pred HHhhcCCCCeeehhheeeeCCcEEEEEecCCC
Confidence 68889999999999999999999999999974
No 200
>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati
Probab=92.16 E-value=0.13 Score=46.95 Aligned_cols=32 Identities=28% Similarity=0.310 Sum_probs=29.7
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+++++|+|+|++.+++..++..++|+||+++
T Consensus 51 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 82 (255)
T cd08219 51 LLAKMKHPNIVAFKESFEADGHLYIVMEYCDG 82 (255)
T ss_pred HHHhCCCCCcceEEEEEEECCEEEEEEeeCCC
Confidence 68889999999999999999999999999973
No 201
>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows
Probab=92.15 E-value=0.12 Score=47.36 Aligned_cols=32 Identities=31% Similarity=0.655 Sum_probs=29.5
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+.+++|+|+++++|++...+..++|+||+++
T Consensus 52 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 52 VMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 78889999999999999999999999999973
No 202
>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien
Probab=92.12 E-value=0.12 Score=49.32 Aligned_cols=32 Identities=13% Similarity=-0.004 Sum_probs=29.4
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|+|+|++.+++...+..++|+||+++
T Consensus 48 ~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (325)
T cd05594 48 VLQNSRHPFLTALKYSFQTHDRLCFVMEYANG 79 (325)
T ss_pred HHHhCCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 67888999999999999999999999999974
No 203
>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a
Probab=92.10 E-value=0.13 Score=48.53 Aligned_cols=32 Identities=25% Similarity=0.227 Sum_probs=29.4
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|+|+|++++++.+++..++|+|||++
T Consensus 54 ~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g 85 (305)
T cd05609 54 ILTFAENPFVVSMFCSFETKRHLCMVMEYVEG 85 (305)
T ss_pred HHHhCCCCCeeeeEEEEecCCEEEEEEecCCC
Confidence 67889999999999999999999999999974
No 204
>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]
Probab=92.09 E-value=0.45 Score=46.16 Aligned_cols=32 Identities=28% Similarity=0.334 Sum_probs=26.6
Q ss_pred ecccccCCceeeeEEEEEeCC----eeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHAR----HSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~----~~~LVyeym~n 495 (495)
.+=.++|+|||+++|+=..++ +-.||.||-|+
T Consensus 257 ~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~k 292 (534)
T KOG3653|consen 257 SLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPK 292 (534)
T ss_pred hccCccchhHHHhhchhccCCccccceeEEeeeccC
Confidence 455899999999999977666 67899998764
No 205
>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr
Probab=92.03 E-value=0.11 Score=47.98 Aligned_cols=32 Identities=22% Similarity=0.396 Sum_probs=29.4
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+.+++|+|++++.+++.+++..++|+||+++
T Consensus 58 ~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~ 89 (269)
T cd05065 58 IMGQFDHPNIIHLEGVVTKSRPVMIITEFMEN 89 (269)
T ss_pred HHHhCCCcCcceEEEEECCCCceEEEEecCCC
Confidence 68889999999999999999999999999863
No 206
>PF13504 LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OOK_G 1QYY_G 1SQ0_B 1P9A_G 1GWB_A 1P8V_A 1M0Z_A 1U0N_D ....
Probab=91.92 E-value=0.087 Score=25.50 Aligned_cols=12 Identities=42% Similarity=0.639 Sum_probs=5.6
Q ss_pred CCCEEeCcCCcC
Q 041558 327 KLHYLGLCKNKL 338 (495)
Q Consensus 327 ~L~~L~l~~n~l 338 (495)
+|+.|++++|++
T Consensus 2 ~L~~L~l~~n~L 13 (17)
T PF13504_consen 2 NLRTLDLSNNRL 13 (17)
T ss_dssp T-SEEEETSS--
T ss_pred ccCEEECCCCCC
Confidence 456666666665
No 207
>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2. Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit
Probab=91.91 E-value=0.12 Score=48.50 Aligned_cols=32 Identities=16% Similarity=0.336 Sum_probs=29.7
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+.+++|+|+|++++++..++..++|+||+++
T Consensus 72 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 103 (296)
T cd05095 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMEN 103 (296)
T ss_pred HHHhCCCCCcceEEEEEecCCccEEEEEeCCC
Confidence 78899999999999999999999999999973
No 208
>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2. Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A
Probab=91.87 E-value=0.1 Score=49.31 Aligned_cols=32 Identities=25% Similarity=0.418 Sum_probs=29.2
Q ss_pred ecccc-cCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTET-GHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~-~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.++ +|+|+|+++|+|.+++..++|+||+++
T Consensus 60 ~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 92 (303)
T cd05088 60 VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 92 (303)
T ss_pred HHHHhcCCCCcceEEEEECCCCCceEEEEeCCC
Confidence 67788 899999999999999999999999974
No 209
>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]
Probab=91.86 E-value=0.083 Score=48.77 Aligned_cols=42 Identities=21% Similarity=0.215 Sum_probs=30.4
Q ss_pred ceEEEeeccceecccccCCceeeeEEEEEe--CCeeEEEecccC
Q 041558 453 LLSILNFKGKLALTETGHRNIVKFYGFCSH--ARHSFSVYESLE 494 (495)
Q Consensus 453 ~~~~~~~~~~~~l~~~~H~NlV~l~G~c~~--~~~~~LVyeym~ 494 (495)
.|.+....+..+|.++||||||.+--.-.. -+..++|+|||+
T Consensus 117 GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~E 160 (419)
T KOG0663|consen 117 GFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVE 160 (419)
T ss_pred CCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHH
Confidence 333333333338999999999988776543 467899999996
No 210
>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica
Probab=91.81 E-value=0.13 Score=49.94 Aligned_cols=32 Identities=22% Similarity=0.244 Sum_probs=29.8
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|+|+|++++++.+++..++|+||+++
T Consensus 54 il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~ 85 (364)
T cd05599 54 ILAEADNPWVVKLYYSFQDENYLYLIMEYLPG 85 (364)
T ss_pred HHHhCCCCCCcceEEEEEcCCeEEEEECCCCC
Confidence 78889999999999999999999999999974
No 211
>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI
Probab=91.80 E-value=0.051 Score=50.69 Aligned_cols=32 Identities=19% Similarity=0.401 Sum_probs=29.8
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++++++|+|+++++|+|..++..++|+|||++
T Consensus 53 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 84 (286)
T cd07846 53 MLKQLRHENLVNLIEVFRRKKRLYLVFEFVDH 84 (286)
T ss_pred HHHhcCCcchhhHHHhcccCCeEEEEEecCCc
Confidence 78899999999999999999999999999973
No 212
>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3. Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V
Probab=91.79 E-value=0.11 Score=49.89 Aligned_cols=32 Identities=22% Similarity=0.376 Sum_probs=27.0
Q ss_pred ecccc-cCCceeeeEEEEEeCC-eeEEEecccCC
Q 041558 464 ALTET-GHRNIVKFYGFCSHAR-HSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~-~H~NlV~l~G~c~~~~-~~~LVyeym~n 495 (495)
++.++ +|||+|+++|+|.+.+ ..++|+||+++
T Consensus 63 ~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~ 96 (338)
T cd05102 63 ILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKY 96 (338)
T ss_pred HHHHhccCcceeeEEeEecCCCCceEEEEecCCC
Confidence 67777 8999999999998754 57899999974
No 213
>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2. Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found
Probab=91.77 E-value=0.15 Score=49.73 Aligned_cols=32 Identities=9% Similarity=0.143 Sum_probs=29.6
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
+++.++|||+|++++++.+++..++|+|||++
T Consensus 96 i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~g 127 (370)
T cd05621 96 IMAFANSPWVVQLFCAFQDDKYLYMVMEYMPG 127 (370)
T ss_pred HHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCC
Confidence 67889999999999999999999999999974
No 214
>PHA03211 serine/threonine kinase US3; Provisional
Probab=91.73 E-value=0.14 Score=51.43 Aligned_cols=31 Identities=10% Similarity=0.088 Sum_probs=29.2
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~ 494 (495)
++++++|+|||+++++|..++..++|+||+.
T Consensus 213 iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~ 243 (461)
T PHA03211 213 LLRRLSHPAVLALLDVRVVGGLTCLVLPKYR 243 (461)
T ss_pred HHHHCCCCCCCcEEEEEEECCEEEEEEEccC
Confidence 8999999999999999999999999999874
No 215
>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check
Probab=91.71 E-value=0.035 Score=50.97 Aligned_cols=32 Identities=25% Similarity=0.174 Sum_probs=29.6
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++++++|||++++++++.+.+..++||||+++
T Consensus 55 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (260)
T cd08222 55 LLSKLDHPAIVKFHASFLERDAFCIITEYCEG 86 (260)
T ss_pred HHHhCCCCcHHHHHHHHhcCCceEEEEEeCCC
Confidence 78899999999999999998899999999974
No 216
>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3. Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co
Probab=91.62 E-value=0.16 Score=48.31 Aligned_cols=31 Identities=19% Similarity=0.259 Sum_probs=29.3
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~ 494 (495)
.+.+++|+|+|+++|+|.+++..++|+||++
T Consensus 74 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 104 (313)
T cd06633 74 FLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL 104 (313)
T ss_pred HHHhCCCCCCccEEEEEEeCCEEEEEEecCC
Confidence 7889999999999999999999999999985
No 217
>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt
Probab=91.59 E-value=0.12 Score=48.01 Aligned_cols=32 Identities=44% Similarity=0.781 Sum_probs=29.9
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|+|++++.+++..++...+|+|||++
T Consensus 61 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 92 (280)
T cd05049 61 LLTNFQHENIVKFYGVCTEGDPPIMVFEYMEH 92 (280)
T ss_pred HHHhcCCCCchheeeEEecCCCeEEEEecCCC
Confidence 78899999999999999999999999999973
No 218
>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase. Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess
Probab=91.58 E-value=0.16 Score=47.47 Aligned_cols=31 Identities=23% Similarity=0.211 Sum_probs=29.2
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~ 494 (495)
.+.+++|+|+|++.+++..++..++|+|||+
T Consensus 56 ~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~ 86 (291)
T cd07870 56 LLKGLKHANIVLLHDIIHTKETLTFVFEYMH 86 (291)
T ss_pred HHHhcCCCCEeEEEEEEecCCeEEEEEeccc
Confidence 7889999999999999999999999999996
No 219
>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a
Probab=91.56 E-value=0.12 Score=47.46 Aligned_cols=31 Identities=16% Similarity=0.470 Sum_probs=29.2
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~ 494 (495)
.+.+++|+|+|++.++|..++..++|+||++
T Consensus 54 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05068 54 IMKKLRHPKLIQLYAVCTLEEPIYIVTELMK 84 (261)
T ss_pred HHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence 7889999999999999999999999999985
No 220
>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]
Probab=91.56 E-value=0.08 Score=46.66 Aligned_cols=32 Identities=16% Similarity=0.254 Sum_probs=29.4
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
+...++|||||+|.--..+...+.+|+|+|..
T Consensus 63 IC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G 94 (355)
T KOG0033|consen 63 ICRKLQHPNIVRLHDSIQEESFHYLVFDLVTG 94 (355)
T ss_pred HHHhcCCCcEeehhhhhcccceeEEEEecccc
Confidence 77889999999999998899999999999974
No 221
>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt
Probab=91.54 E-value=0.062 Score=50.43 Aligned_cols=32 Identities=19% Similarity=0.289 Sum_probs=29.6
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|||+|++++++.+++..++|+|||++
T Consensus 54 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 85 (291)
T cd05612 54 VLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPG 85 (291)
T ss_pred HHHhCCCCcHhhhHhhhccCCeEEEEEeCCCC
Confidence 78899999999999999999999999999974
No 222
>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1. Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the
Probab=91.51 E-value=0.15 Score=47.75 Aligned_cols=31 Identities=26% Similarity=0.278 Sum_probs=28.5
Q ss_pred ecccccCCceeeeEEEEEeC--CeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHA--RHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~--~~~~LVyeym~ 494 (495)
.+.+++|+|++++.|++... +..++||||++
T Consensus 57 ~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~ 89 (293)
T cd07843 57 ILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE 89 (293)
T ss_pred HHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC
Confidence 78899999999999999887 78999999986
No 223
>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6. Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs
Probab=91.48 E-value=0.13 Score=47.77 Aligned_cols=32 Identities=16% Similarity=0.282 Sum_probs=28.3
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+...+|+|+|+++|+|..++..++|+|||++
T Consensus 53 ~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~ 84 (283)
T cd06617 53 SMRSVDCPYTVTFYGALFREGDVWICMEVMDT 84 (283)
T ss_pred HHHHcCCCCeeeeeEEEecCCcEEEEhhhhcc
Confidence 35567899999999999999999999999974
No 224
>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota. Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o
Probab=91.40 E-value=0.19 Score=48.19 Aligned_cols=28 Identities=18% Similarity=0.192 Sum_probs=25.9
Q ss_pred ccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 468 TGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 468 ~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+|||+|++++++..++..++|||||++
T Consensus 53 ~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 53 SNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 3899999999999999999999999974
No 225
>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2
Probab=91.39 E-value=0.16 Score=47.21 Aligned_cols=31 Identities=26% Similarity=0.335 Sum_probs=29.2
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~ 494 (495)
.+.+++|+|+++++|++.+++..++|+|||+
T Consensus 52 ~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (285)
T cd07861 52 LLKELQHPNIVCLQDVLMQESRLYLIFEFLS 82 (285)
T ss_pred HHHhcCCCCEeeeEEEEeeCCeEEEEEecCC
Confidence 7888999999999999999999999999986
No 226
>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i
Probab=91.38 E-value=0.17 Score=47.33 Aligned_cols=32 Identities=13% Similarity=0.036 Sum_probs=29.9
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|+|+|++.+++.+++..++|+|||++
T Consensus 53 il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~ 84 (285)
T cd05631 53 ILEKVNSRFVVSLAYAYETKDALCLVLTIMNG 84 (285)
T ss_pred HHHhcCCCcEEEEEEEEccCCeEEEEEEecCC
Confidence 78899999999999999999999999999974
No 227
>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr
Probab=91.38 E-value=0.17 Score=48.25 Aligned_cols=32 Identities=16% Similarity=0.113 Sum_probs=28.9
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+.+++|+|+|++.+++.+++..++|+||+++
T Consensus 49 ~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 49 LLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred HHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46788999999999999999999999999974
No 228
>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors. Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke
Probab=91.35 E-value=0.15 Score=47.76 Aligned_cols=32 Identities=22% Similarity=0.409 Sum_probs=29.6
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|+|+|+++|+|..++..++|+||+++
T Consensus 72 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 103 (296)
T cd05051 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMEN 103 (296)
T ss_pred HHHhcCCCCEeEEEEEEecCCCcEEEEecCCC
Confidence 78899999999999999999999999999863
No 229
>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=91.32 E-value=0.14 Score=49.23 Aligned_cols=32 Identities=22% Similarity=0.455 Sum_probs=29.0
Q ss_pred ecccc-cCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTET-GHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~-~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.++ +|+|+|+++|+|.+++..++|+||+++
T Consensus 70 ~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 102 (334)
T cd05100 70 MMKMIGKHKNIINLLGACTQDGPLYVLVEYASK 102 (334)
T ss_pred HHHhhcCCCCeeeeeEEEccCCceEEEEecCCC
Confidence 67778 899999999999999999999999974
No 230
>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=91.30 E-value=0.16 Score=47.99 Aligned_cols=32 Identities=22% Similarity=0.469 Sum_probs=28.8
Q ss_pred ecccc-cCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTET-GHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~-~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.++ +|+|+|+++|+|..++..++|+||+++
T Consensus 76 ~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 108 (307)
T cd05098 76 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 108 (307)
T ss_pred HHHHhcCCCCEeeEEEEEecCCceEEEEecCCC
Confidence 67777 799999999999999999999999974
No 231
>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea
Probab=91.29 E-value=0.16 Score=47.26 Aligned_cols=30 Identities=13% Similarity=0.407 Sum_probs=27.5
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~ 494 (495)
.+++++|+|+|+++|+|.. +..++|+||++
T Consensus 62 ~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~ 91 (279)
T cd05057 62 VMASVDHPHVVRLLGICLS-SQVQLITQLMP 91 (279)
T ss_pred HHHhCCCCCcceEEEEEec-CceEEEEecCC
Confidence 7888999999999999987 78899999986
No 232
>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase. Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi
Probab=91.27 E-value=0.16 Score=47.49 Aligned_cols=32 Identities=22% Similarity=0.323 Sum_probs=29.6
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|+|+|++++++.+++..++|+||+++
T Consensus 54 ~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 85 (290)
T cd05580 54 ILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPG 85 (290)
T ss_pred HHHhCCCCCccceeeEEEcCCeEEEEEecCCC
Confidence 78899999999999999999999999999963
No 233
>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)
Probab=91.23 E-value=0.18 Score=46.73 Aligned_cols=32 Identities=19% Similarity=0.255 Sum_probs=29.5
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++++++|+|+|++++++.++...++||||++.
T Consensus 52 ~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (274)
T cd06609 52 FLSQCRSPYITKYYGSFLKGSKLWIIMEYCGG 83 (274)
T ss_pred HHHHcCCCCeeeeeEEEEECCeEEEEEEeeCC
Confidence 68889999999999999999999999999863
No 234
>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor. Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.
Probab=91.20 E-value=0.18 Score=49.36 Aligned_cols=32 Identities=19% Similarity=0.257 Sum_probs=29.8
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|+|+|++++++.+++..++|+||+++
T Consensus 54 il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~ 85 (376)
T cd05598 54 ILAEADNEWVVKLYYSFQDKDNLYFVMDYIPG 85 (376)
T ss_pred HHHhCCCCCcceEEEEEEcCCEEEEEEeCCCC
Confidence 78899999999999999999999999999974
No 235
>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological
Probab=91.20 E-value=0.15 Score=47.24 Aligned_cols=31 Identities=19% Similarity=0.388 Sum_probs=29.0
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~ 494 (495)
.+.+++|+|+|+++|++..++..++|+||++
T Consensus 62 ~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 92 (277)
T cd05032 62 VMKEFNCHHVVRLLGVVSTGQPTLVVMELMA 92 (277)
T ss_pred HHHhCCCCceeEEEEEEcCCCCcEEEEecCC
Confidence 6788999999999999999999999999986
No 236
>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2. Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin
Probab=91.19 E-value=0.17 Score=47.93 Aligned_cols=31 Identities=19% Similarity=0.261 Sum_probs=29.2
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~ 494 (495)
.+.+++|+|+|++.|+|.+++..++|+||++
T Consensus 68 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 98 (308)
T cd06634 68 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCL 98 (308)
T ss_pred HHHhCCCCCcccEEEEEEcCCeeEEEEEccC
Confidence 7889999999999999999999999999985
No 237
>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i
Probab=91.18 E-value=0.098 Score=49.25 Aligned_cols=32 Identities=19% Similarity=0.317 Sum_probs=29.7
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+.+++|+|+|+++|++..++..++|+||+++
T Consensus 71 ~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 71 IMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 68889999999999999999999999999974
No 238
>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ
Probab=91.14 E-value=0.19 Score=46.08 Aligned_cols=31 Identities=29% Similarity=0.382 Sum_probs=29.2
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~ 494 (495)
.+++++|+|+|++.|+...++..++|+||++
T Consensus 53 ~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~ 83 (262)
T cd06613 53 MLKECRHPNIVAYFGSYLRRDKLWIVMEYCG 83 (262)
T ss_pred HHHhCCCCChhceEEEEEeCCEEEEEEeCCC
Confidence 7889999999999999999999999999986
No 239
>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning
Probab=91.10 E-value=0.14 Score=47.66 Aligned_cols=32 Identities=25% Similarity=0.381 Sum_probs=29.9
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++++++|+|+++++|+|..++..++||||+++
T Consensus 53 ~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~ 84 (288)
T cd07833 53 VLRQLRHENIVNLKEAFRRKGRLYLVFEYVER 84 (288)
T ss_pred HHHhcCCCCeeehhheEEECCEEEEEEecCCC
Confidence 78899999999999999999999999999974
No 240
>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of
Probab=91.05 E-value=0.19 Score=46.64 Aligned_cols=32 Identities=16% Similarity=0.049 Sum_probs=29.5
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|+|+|++.+++...+..++|+||+++
T Consensus 46 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (277)
T cd05577 46 ILEKVSSRFIVSLAYAFETKDDLCLVMTLMNG 77 (277)
T ss_pred HHHhCCCCCEeeeeeEEecCCeEEEEEecCCC
Confidence 78899999999999999989999999999973
No 241
>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4
Probab=91.04 E-value=0.16 Score=46.63 Aligned_cols=32 Identities=28% Similarity=0.424 Sum_probs=29.8
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|+|+++++|++...+..++|+||+++
T Consensus 52 ~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (264)
T cd06626 52 VLELLKHPNLVKYYGVEVHREKVYIFMEYCSG 83 (264)
T ss_pred HHHhCCCCChhheeeeEecCCEEEEEEecCCC
Confidence 78899999999999999999999999999873
No 242
>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is
Probab=91.02 E-value=0.12 Score=48.51 Aligned_cols=30 Identities=27% Similarity=0.361 Sum_probs=28.6
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEeccc
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESL 493 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym 493 (495)
.+.+++|+|+|++++++.+++..++|||||
T Consensus 55 ~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (298)
T cd07841 55 LLQELKHPNIIGLLDVFGHKSNINLVFEFM 84 (298)
T ss_pred HHhhcCCCCChhhhheeecCCEEEEEEccc
Confidence 788999999999999999999999999998
No 243
>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase
Probab=91.00 E-value=0.19 Score=46.28 Aligned_cols=32 Identities=19% Similarity=0.227 Sum_probs=29.6
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+.+++|+|+++++|++...+...+|+||++.
T Consensus 55 ~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 86 (267)
T cd08228 55 LLKQLNHPNVIKYLDSFIEDNELNIVLELADA 86 (267)
T ss_pred HHHhCCCcceeeeeeeEEECCeEEEEEEecCC
Confidence 78899999999999999999999999999873
No 244
>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely
Probab=90.99 E-value=0.14 Score=48.28 Aligned_cols=32 Identities=25% Similarity=0.473 Sum_probs=28.2
Q ss_pred ecccccCCceeeeEEEEEeCC----------eeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHAR----------HSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~----------~~~LVyeym~n 495 (495)
++.+++|||+|+++|++.+.+ ..++|+|||++
T Consensus 59 ~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~ 100 (302)
T cd07864 59 ILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH 100 (302)
T ss_pred HHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc
Confidence 788999999999999998755 67899999974
No 245
>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=90.99 E-value=0.11 Score=45.74 Aligned_cols=32 Identities=19% Similarity=0.489 Sum_probs=29.3
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
+-+.++||||.+++||-.+....+|+.||-++
T Consensus 75 Iqs~L~hpnilrlY~~fhd~~riyLilEya~~ 106 (281)
T KOG0580|consen 75 IQSHLRHPNILRLYGYFHDSKRIYLILEYAPR 106 (281)
T ss_pred eecccCCccHHhhhhheeccceeEEEEEecCC
Confidence 67889999999999999999999999999763
No 246
>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc
Probab=90.92 E-value=0.1 Score=48.53 Aligned_cols=31 Identities=29% Similarity=0.476 Sum_probs=29.3
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~ 494 (495)
.+++++|+|+|+++++|.+++..++||||++
T Consensus 51 ~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~ 81 (283)
T cd07835 51 LLKELNHPNIVRLLDVVHSENKLYLVFEFLD 81 (283)
T ss_pred HHHhcCCCCccCHhheeccCCeEEEEEeccC
Confidence 7889999999999999999999999999985
No 247
>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a
Probab=90.92 E-value=0.18 Score=45.98 Aligned_cols=32 Identities=25% Similarity=0.298 Sum_probs=29.3
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+.+++|+|+++++|++.+++..++||||+++
T Consensus 51 ~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 82 (256)
T cd06612 51 ILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGA 82 (256)
T ss_pred HHHhCCCCcEeeeeeeeecCCcEEEEEecCCC
Confidence 67788999999999999999999999999873
No 248
>PTZ00024 cyclin-dependent protein kinase; Provisional
Probab=90.87 E-value=0.18 Score=48.40 Aligned_cols=32 Identities=16% Similarity=0.202 Sum_probs=29.8
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|+|+|++++++..++..++|+|||++
T Consensus 73 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 104 (335)
T PTZ00024 73 IMNEIKHENIMGLVDVYVEGDFINLVMDIMAS 104 (335)
T ss_pred HHHhCCCcceeeeeEEEecCCcEEEEEecccc
Confidence 78899999999999999999999999999863
No 249
>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase. Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio
Probab=90.86 E-value=0.17 Score=46.39 Aligned_cols=31 Identities=26% Similarity=0.393 Sum_probs=26.9
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++++++|+|+|+++|+|. ++..++|+||++.
T Consensus 49 ~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 49 VMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred HHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 788899999999999984 5677999999873
No 250
>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt
Probab=90.86 E-value=0.2 Score=47.89 Aligned_cols=32 Identities=16% Similarity=0.110 Sum_probs=29.0
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++..++|+|+|++++++.+++..++|+|||++
T Consensus 49 ~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 49 LLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred HHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46778999999999999999999999999974
No 251
>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1. Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.
Probab=90.83 E-value=0.07 Score=48.94 Aligned_cols=32 Identities=19% Similarity=0.212 Sum_probs=29.6
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+++++|+|+|++.+++.+++..++|+||+++
T Consensus 53 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 84 (258)
T cd05578 53 ILQELNHPFLVNLWYSFQDEENMYLVVDLLLG 84 (258)
T ss_pred HHHhCCCCChHHHHHhhcCCCeEEEEEeCCCC
Confidence 78899999999999999999999999999963
No 252
>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C. Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl
Probab=90.82 E-value=0.19 Score=48.10 Aligned_cols=32 Identities=16% Similarity=0.162 Sum_probs=27.8
Q ss_pred ecccc-cCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTET-GHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~-~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.++ +|||+|++++++...+..++|+|||++
T Consensus 48 il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 48 VFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred HHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 45555 799999999999999999999999974
No 253
>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of
Probab=90.80 E-value=0.2 Score=45.94 Aligned_cols=31 Identities=23% Similarity=0.252 Sum_probs=29.3
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~ 494 (495)
.+.+++|+|++++.+++.+++..++|+||++
T Consensus 52 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (264)
T cd06623 52 TLRSCESPYVVKCYGAFYKEGEISIVLEYMD 82 (264)
T ss_pred HHHhcCCCCeeeEEEEEccCCeEEEEEEecC
Confidence 6888999999999999999999999999997
No 254
>smart00370 LRR Leucine-rich repeats, outliers.
Probab=90.77 E-value=0.26 Score=26.83 Aligned_cols=15 Identities=40% Similarity=0.587 Sum_probs=7.3
Q ss_pred CCCEEeCCCCcCCCC
Q 041558 303 ELEYLDFSVNRFNNL 317 (495)
Q Consensus 303 ~L~~L~Ls~n~l~~~ 317 (495)
+|++|+|++|.++.+
T Consensus 3 ~L~~L~L~~N~l~~l 17 (26)
T smart00370 3 NLRELDLSNNQLSSL 17 (26)
T ss_pred CCCEEECCCCcCCcC
Confidence 445555555554444
No 255
>smart00369 LRR_TYP Leucine-rich repeats, typical (most populated) subfamily.
Probab=90.77 E-value=0.26 Score=26.83 Aligned_cols=15 Identities=40% Similarity=0.587 Sum_probs=7.3
Q ss_pred CCCEEeCCCCcCCCC
Q 041558 303 ELEYLDFSVNRFNNL 317 (495)
Q Consensus 303 ~L~~L~Ls~n~l~~~ 317 (495)
+|++|+|++|.++.+
T Consensus 3 ~L~~L~L~~N~l~~l 17 (26)
T smart00369 3 NLRELDLSNNQLSSL 17 (26)
T ss_pred CCCEEECCCCcCCcC
Confidence 445555555554444
No 256
>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=90.76 E-value=0.19 Score=47.73 Aligned_cols=32 Identities=22% Similarity=0.481 Sum_probs=28.2
Q ss_pred ecccc-cCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTET-GHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~-~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+.++ +|+|+|+++|+|..++..++|+|||++
T Consensus 70 ~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 102 (314)
T cd05099 70 LMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAK 102 (314)
T ss_pred HHHhccCCCCeeeEEEEEccCCceEEEEecCCC
Confidence 56667 699999999999998889999999973
No 257
>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=90.71 E-value=0.17 Score=47.74 Aligned_cols=32 Identities=22% Similarity=0.469 Sum_probs=28.9
Q ss_pred ecccc-cCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTET-GHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~-~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+.++ +|+|+|+++|+|...+..++||||+++
T Consensus 73 ~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 105 (304)
T cd05101 73 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 105 (304)
T ss_pred HHHhhccCCCchheeEEEecCCceEEEEecCCC
Confidence 67777 899999999999999999999999974
No 258
>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein. Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc
Probab=90.67 E-value=0.12 Score=48.91 Aligned_cols=31 Identities=13% Similarity=0.119 Sum_probs=29.2
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~ 494 (495)
.+++++|+|+|+++|++...+..++||||++
T Consensus 52 ~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (314)
T cd08216 52 TSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82 (314)
T ss_pred HHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence 7889999999999999999999999999997
No 259
>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor. Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor
Probab=90.61 E-value=0.16 Score=48.34 Aligned_cols=31 Identities=6% Similarity=0.267 Sum_probs=27.0
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+.+++|+|+|+++|+|..+ ...+|+|||++
T Consensus 62 ~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~ 92 (316)
T cd05108 62 VMASVDNPHVCRLLGICLTS-TVQLITQLMPF 92 (316)
T ss_pred HHHhCCCCCCCeEEEEEcCC-CceeeeecCCC
Confidence 78899999999999999864 56799999974
No 260
>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k
Probab=90.57 E-value=0.23 Score=45.26 Aligned_cols=31 Identities=32% Similarity=0.537 Sum_probs=29.1
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~ 494 (495)
++.+++|+|+++++++|.+.+..++|+||++
T Consensus 45 ~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 75 (251)
T cd05041 45 ILKQYDHPNIVKLIGVCVQKQPIYIVMELVP 75 (251)
T ss_pred HHHhCCCCCeEEEEEEEecCCCeEEEEEcCC
Confidence 6788999999999999999999999999986
No 261
>smart00369 LRR_TYP Leucine-rich repeats, typical (most populated) subfamily.
Probab=90.55 E-value=0.22 Score=27.15 Aligned_cols=16 Identities=38% Similarity=0.524 Sum_probs=8.6
Q ss_pred CCCCeeeccCCccccc
Q 041558 71 KSLGDLQLNGNQFISY 86 (495)
Q Consensus 71 ~~L~~L~l~~n~l~~~ 86 (495)
++|++|+|++|++...
T Consensus 2 ~~L~~L~L~~N~l~~l 17 (26)
T smart00369 2 PNLRELDLSNNQLSSL 17 (26)
T ss_pred CCCCEEECCCCcCCcC
Confidence 4455555555555543
No 262
>smart00370 LRR Leucine-rich repeats, outliers.
Probab=90.55 E-value=0.22 Score=27.15 Aligned_cols=16 Identities=38% Similarity=0.524 Sum_probs=8.6
Q ss_pred CCCCeeeccCCccccc
Q 041558 71 KSLGDLQLNGNQFISY 86 (495)
Q Consensus 71 ~~L~~L~l~~n~l~~~ 86 (495)
++|++|+|++|++...
T Consensus 2 ~~L~~L~L~~N~l~~l 17 (26)
T smart00370 2 PNLRELDLSNNQLSSL 17 (26)
T ss_pred CCCCEEECCCCcCCcC
Confidence 4455555555555543
No 263
>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase. Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.
Probab=90.51 E-value=0.24 Score=46.42 Aligned_cols=32 Identities=22% Similarity=0.192 Sum_probs=29.4
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+++++|+|++++.|++..++..++|+||+++
T Consensus 62 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 93 (292)
T cd06644 62 ILATCNHPYIVKLLGAFYWDGKLWIMIEFCPG 93 (292)
T ss_pred HHHhCCCCcEeeeEEEEEeCCeEEEEEecCCC
Confidence 68889999999999999988999999999874
No 264
>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta. Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig
Probab=90.49 E-value=0.2 Score=47.97 Aligned_cols=31 Identities=10% Similarity=0.059 Sum_probs=28.6
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~ 494 (495)
++.+++|+|+|++++++..++..++|+|||+
T Consensus 52 ~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 52 LSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 5667899999999999999999999999986
No 265
>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.
Probab=90.48 E-value=0.15 Score=47.03 Aligned_cols=32 Identities=22% Similarity=0.312 Sum_probs=29.5
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+.+++|+|+|++++++.+++...+||||++.
T Consensus 55 ~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~ 86 (267)
T cd08229 55 LLKQLNHPNVIKYYASFIEDNELNIVLELADA 86 (267)
T ss_pred HHHHccCCchhhhhheeEeCCeEEEEEEecCC
Confidence 78889999999999999999999999999863
No 266
>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1. Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.
Probab=90.47 E-value=0.15 Score=47.86 Aligned_cols=32 Identities=22% Similarity=0.343 Sum_probs=28.7
Q ss_pred ecccc-cCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTET-GHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~-~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
+++++ +|||+|++.|+|.+.+..++|+||+++
T Consensus 55 ~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 87 (297)
T cd05089 55 VLCKLGHHPNIINLLGACENRGYLYIAIEYAPY 87 (297)
T ss_pred HHHhhcCCCchhheEEEEccCCcceEEEEecCC
Confidence 67777 799999999999998899999999974
No 267
>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express
Probab=90.47 E-value=0.095 Score=49.21 Aligned_cols=32 Identities=25% Similarity=0.339 Sum_probs=29.7
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+.+++|+|+|++++++..++..++|||||++
T Consensus 72 ~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 72 IMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 67888999999999999999999999999974
No 268
>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=90.47 E-value=0.19 Score=48.70 Aligned_cols=31 Identities=23% Similarity=0.286 Sum_probs=27.1
Q ss_pred ecccccCCceeeeEEEEEe--CCeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSH--ARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~--~~~~~LVyeym~ 494 (495)
++.|++|+|+|+|+-+--+ .+..+||+|||.
T Consensus 161 ilKkl~H~nVV~LiEvLDDP~s~~~YlVley~s 193 (576)
T KOG0585|consen 161 ILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCS 193 (576)
T ss_pred HHHhcCCcCeeEEEEeecCcccCceEEEEEecc
Confidence 8999999999999998765 456799999985
No 269
>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2. Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly
Probab=90.42 E-value=0.21 Score=46.43 Aligned_cols=31 Identities=16% Similarity=0.220 Sum_probs=28.8
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~ 494 (495)
++++++|+|+|+++|+|.+.+...+|+||++
T Consensus 61 ~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~ 91 (283)
T cd05091 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCS 91 (283)
T ss_pred HHhcCCCCCcCeEEEEEcCCCceEEEEEcCC
Confidence 6788999999999999999999999999986
No 270
>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3. Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r
Probab=90.40 E-value=0.21 Score=46.39 Aligned_cols=31 Identities=23% Similarity=0.303 Sum_probs=26.1
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+++++|+|+|+++|+|. +....+|+||+++
T Consensus 62 ~l~~l~h~~iv~~~~~~~-~~~~~~i~e~~~~ 92 (279)
T cd05111 62 AMGSLDHAYIVRLLGICP-GASLQLVTQLSPL 92 (279)
T ss_pred HHhcCCCCCcceEEEEEC-CCccEEEEEeCCC
Confidence 678899999999999985 4456789999974
No 271
>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po
Probab=90.34 E-value=0.18 Score=46.85 Aligned_cols=32 Identities=22% Similarity=0.404 Sum_probs=29.1
Q ss_pred ecccccCCceeeeEEEEEeC--CeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHA--RHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~--~~~~LVyeym~n 495 (495)
++.+++|+|+|+++|+|... +..++|+|||++
T Consensus 51 ~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~ 84 (287)
T cd07840 51 LLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH 84 (287)
T ss_pred HHHhccCCCeeeheeeEecCCCCcEEEEeccccc
Confidence 78889999999999999987 789999999973
No 272
>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin. Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear
Probab=90.32 E-value=0.18 Score=46.99 Aligned_cols=32 Identities=31% Similarity=0.479 Sum_probs=26.1
Q ss_pred ecccc-cCCceeeeEEEEEe-----CCeeEEEecccCC
Q 041558 464 ALTET-GHRNIVKFYGFCSH-----ARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~-~H~NlV~l~G~c~~-----~~~~~LVyeym~n 495 (495)
++.++ +|+|+|+++|+|.. ++..++||||+++
T Consensus 67 ~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~ 104 (286)
T cd06638 67 ILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNG 104 (286)
T ss_pred HHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCC
Confidence 56777 69999999999863 3467999999974
No 273
>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase. Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun
Probab=90.24 E-value=0.23 Score=46.34 Aligned_cols=32 Identities=28% Similarity=0.346 Sum_probs=29.5
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|+|+|+++|++..++..++|+||+++
T Consensus 69 ~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 69 IMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred HHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 67888999999999999999999999999964
No 274
>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated
Probab=90.23 E-value=0.27 Score=45.23 Aligned_cols=32 Identities=19% Similarity=0.298 Sum_probs=29.6
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+.+++|+|++++++++..++..++|+||+++
T Consensus 59 ~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 90 (267)
T cd06645 59 MMKDCKHSNIVAYFGSYLRRDKLWICMEFCGG 90 (267)
T ss_pred HHHhCCCCCeeeEEEEEEeCCEEEEEEeccCC
Confidence 78888999999999999999999999999874
No 275
>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1. Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an
Probab=90.21 E-value=0.25 Score=48.24 Aligned_cols=32 Identities=13% Similarity=0.143 Sum_probs=29.4
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++..++|||+|++++++.+++..++|+|||++
T Consensus 96 i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~g 127 (371)
T cd05622 96 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPG 127 (371)
T ss_pred HHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCC
Confidence 67788999999999999999999999999974
No 276
>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase. Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou
Probab=90.20 E-value=0.28 Score=45.78 Aligned_cols=31 Identities=23% Similarity=0.400 Sum_probs=29.4
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~ 494 (495)
.+.+++|+|++++++++..++..++|+||++
T Consensus 68 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 98 (286)
T cd06614 68 IMKDCKHPNIVDYYDSYLVGDELWVVMEYMD 98 (286)
T ss_pred HHHHCCCCCeeEEEEEEEECCEEEEEEeccC
Confidence 7889999999999999999999999999987
No 277
>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]
Probab=90.19 E-value=0.088 Score=46.99 Aligned_cols=31 Identities=26% Similarity=0.361 Sum_probs=29.7
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~ 494 (495)
.|.+++|+|+|.|+-+--+.+..-||+|||+
T Consensus 54 ~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~ 84 (318)
T KOG0659|consen 54 LLQELKHPNIIELIDVFPHKSNLSLVFEFMP 84 (318)
T ss_pred HHHHccCcchhhhhhhccCCCceEEEEEecc
Confidence 8999999999999999999999999999997
No 278
>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase). Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It
Probab=90.17 E-value=0.22 Score=46.30 Aligned_cols=31 Identities=23% Similarity=0.459 Sum_probs=27.8
Q ss_pred ecccccCCceeeeEEEEEe-CCeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSH-ARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~-~~~~~LVyeym~ 494 (495)
.+.+++|+|+++++|+|.+ ++..+++|||++
T Consensus 61 ~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~ 92 (280)
T cd05043 61 LLYGLSHQNILPILHVCIEDGEPPFVLYPYMN 92 (280)
T ss_pred HHHhCCCCCCCeEEEEEecCCCCCEEEEEcCC
Confidence 6888999999999999987 567899999986
No 279
>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase. Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor
Probab=90.16 E-value=0.23 Score=47.57 Aligned_cols=32 Identities=13% Similarity=0.000 Sum_probs=29.2
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|+|+|++.+++.+++..++|+||+++
T Consensus 54 i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (330)
T cd05601 54 ILSISNSPWIPQLQYAFQDKDNLYLVMEYQPG 85 (330)
T ss_pred HHHhCCCCCCcceeeEEecCCeEEEEECCCCC
Confidence 67788999999999999999999999999974
No 280
>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include
Probab=90.16 E-value=0.11 Score=48.59 Aligned_cols=32 Identities=22% Similarity=0.289 Sum_probs=29.7
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+.+++|+|+|+++|++...+..++|+||+++
T Consensus 52 ~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (286)
T cd06622 52 ILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDA 83 (286)
T ss_pred HHHhcCCCcHHhhhhheecCCeEEEEEeecCC
Confidence 78889999999999999999999999999974
No 281
>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase. Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and
Probab=90.16 E-value=0.22 Score=45.50 Aligned_cols=30 Identities=20% Similarity=0.362 Sum_probs=28.0
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~ 494 (495)
.+++++|+|+|+++|++.. ...++|+||++
T Consensus 49 ~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 49 IMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred HHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 7899999999999999988 88899999986
No 282
>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron. Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca
Probab=90.15 E-value=0.24 Score=45.41 Aligned_cols=32 Identities=16% Similarity=0.424 Sum_probs=27.2
Q ss_pred ecccccCCceeeeEEEEEe-CCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSH-ARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~-~~~~~LVyeym~n 495 (495)
++++++|+|+|+++|+|.. ++..++|+||+++
T Consensus 49 ~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~ 81 (262)
T cd05058 49 IMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKH 81 (262)
T ss_pred HHccCCCCCcceEEEEeecCCCCcEEEEecCCC
Confidence 6788999999999999975 4567899999863
No 283
>PHA03212 serine/threonine kinase US3; Provisional
Probab=90.13 E-value=0.24 Score=48.71 Aligned_cols=31 Identities=13% Similarity=0.267 Sum_probs=29.0
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~ 494 (495)
++++++|||||+++|++..++..++|+||+.
T Consensus 136 il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~ 166 (391)
T PHA03212 136 ILRAINHPSIIQLKGTFTYNKFTCLILPRYK 166 (391)
T ss_pred HHHhCCCCCCCCEeEEEEECCeeEEEEecCC
Confidence 8999999999999999999999999999875
No 284
>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1. Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus
Probab=90.11 E-value=0.25 Score=48.07 Aligned_cols=32 Identities=19% Similarity=0.174 Sum_probs=29.6
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|+|+|++++++.+++..++|+|||++
T Consensus 54 il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~g 85 (363)
T cd05628 54 ILVEADSLWVVKMFYSFQDKLNLYLIMEFLPG 85 (363)
T ss_pred HHHhCCCCCcceEEEEEecCCeEEEEEcCCCC
Confidence 67888999999999999999999999999974
No 285
>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t
Probab=90.08 E-value=0.24 Score=45.42 Aligned_cols=32 Identities=25% Similarity=0.521 Sum_probs=29.4
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+.+++|+|++++++++..++..++|+|||+.
T Consensus 54 ~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 85 (261)
T cd05034 54 IMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSK 85 (261)
T ss_pred HHhhCCCCCEeeeeeeeecCCceEEEEeccCC
Confidence 78899999999999999988899999999963
No 286
>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo
Probab=90.06 E-value=0.21 Score=46.89 Aligned_cols=32 Identities=25% Similarity=0.350 Sum_probs=29.7
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+++++|+|+|++++++..++..++|+||+++
T Consensus 70 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (292)
T cd06657 70 IMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101 (292)
T ss_pred HHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence 68889999999999999999999999999974
No 287
>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent
Probab=90.02 E-value=0.25 Score=45.80 Aligned_cols=32 Identities=25% Similarity=0.347 Sum_probs=27.6
Q ss_pred eccccc---CCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETG---HRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~---H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+++++ |+|+++++|+|..++..++|+||+++
T Consensus 52 ~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~ 86 (277)
T cd06917 52 LLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEG 86 (277)
T ss_pred HHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCC
Confidence 455555 99999999999999999999999974
No 288
>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do
Probab=89.94 E-value=0.28 Score=44.90 Aligned_cols=31 Identities=16% Similarity=0.161 Sum_probs=27.4
Q ss_pred cccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 465 LTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 465 l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
....+|+|+|++++++.+++..++|+||+++
T Consensus 51 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 51 MIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred hhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4456899999999999999999999999974
No 289
>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1. Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a
Probab=89.93 E-value=0.24 Score=46.16 Aligned_cols=32 Identities=31% Similarity=0.440 Sum_probs=28.0
Q ss_pred ecccccCCceeeeEEEEEeC--CeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHA--RHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~--~~~~LVyeym~n 495 (495)
++++++|+|+|++.|+|... +..++|+||+++
T Consensus 59 ~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g 92 (284)
T cd05079 59 ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 92 (284)
T ss_pred HHHhCCCCCeeeeeeEEecCCCCceEEEEEccCC
Confidence 78899999999999999875 567899999974
No 290
>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu
Probab=89.88 E-value=0.22 Score=45.99 Aligned_cols=32 Identities=19% Similarity=0.473 Sum_probs=27.6
Q ss_pred ecccccCCceeeeEEEEEeCCe------eEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARH------SFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~------~~LVyeym~n 495 (495)
.+.+++|+|+|+++|+|.+.+. .++|+||+++
T Consensus 54 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~ 91 (273)
T cd05035 54 CMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKH 91 (273)
T ss_pred HHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCC
Confidence 6888999999999999987654 6899999873
No 291
>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as
Probab=89.85 E-value=0.29 Score=45.75 Aligned_cols=32 Identities=13% Similarity=0.033 Sum_probs=29.7
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|+|+|++.+++.+++..++|+|||++
T Consensus 53 il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g 84 (285)
T cd05630 53 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 84 (285)
T ss_pred HHHhCCCCCeeeeeEEEecCCEEEEEEEecCC
Confidence 78889999999999999999999999999974
No 292
>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants. Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos
Probab=89.82 E-value=0.22 Score=47.75 Aligned_cols=32 Identities=22% Similarity=0.284 Sum_probs=26.9
Q ss_pred ecccccCCceeeeEEEEEeCC-----eeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHAR-----HSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~-----~~~LVyeym~n 495 (495)
++.+++|+|+|++.+++...+ ..++|+|||++
T Consensus 52 ~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~ 88 (338)
T cd07859 52 LLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES 88 (338)
T ss_pred HHHhCCCCCEeeecceEeccCCCCCceEEEEEecCCC
Confidence 788999999999999987533 46899999963
No 293
>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re
Probab=89.73 E-value=0.12 Score=47.50 Aligned_cols=32 Identities=22% Similarity=0.271 Sum_probs=29.4
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+.+++|+|++++.+++..++..++|||||++
T Consensus 46 ~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (265)
T cd05579 46 ILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPG 77 (265)
T ss_pred HHHhCCCcchhHHHHheecCcEEEEEEecCCC
Confidence 68889999999999999999999999999973
No 294
>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a
Probab=89.71 E-value=0.26 Score=45.27 Aligned_cols=32 Identities=19% Similarity=0.228 Sum_probs=29.8
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|+|+++.++++..++...+|+||+++
T Consensus 55 ~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (267)
T cd08224 55 LLKQLDHPNVIKYLASFIENNELNIVLELADA 86 (267)
T ss_pred HHHhCCCCCeeeeeeeeecCCeEEEEEecCCC
Confidence 78899999999999999999999999999973
No 295
>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign
Probab=89.68 E-value=0.31 Score=45.39 Aligned_cols=32 Identities=31% Similarity=0.415 Sum_probs=27.4
Q ss_pred ecccccCCceeeeEEEEEeC--CeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHA--RHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~--~~~~LVyeym~n 495 (495)
++.+++|+|+|++.|+|... ...++|+||++.
T Consensus 59 ~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~ 92 (283)
T cd05080 59 ILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPL 92 (283)
T ss_pred HHHhCCCCCEeeEEEEEecCCCceEEEEecCCCC
Confidence 78899999999999999764 357899999863
No 296
>PHA03209 serine/threonine kinase US3; Provisional
Probab=89.67 E-value=0.2 Score=48.62 Aligned_cols=31 Identities=10% Similarity=0.148 Sum_probs=29.3
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~ 494 (495)
++.+++|+|+|+++|+|.+++..++|+||+.
T Consensus 110 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 140 (357)
T PHA03209 110 LLQNVNHPSVIRMKDTLVSGAITCMVLPHYS 140 (357)
T ss_pred HHHhCCCCCCcChhheEEeCCeeEEEEEccC
Confidence 7999999999999999999999999999975
No 297
>PRK13184 pknD serine/threonine-protein kinase; Reviewed
Probab=89.66 E-value=0.28 Score=52.91 Aligned_cols=32 Identities=22% Similarity=0.368 Sum_probs=30.0
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++++++|||+|+++++|.+++..++|+|||++
T Consensus 55 ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eG 86 (932)
T PRK13184 55 IAADLIHPGIVPVYSICSDGDPVYYTMPYIEG 86 (932)
T ss_pred HHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCC
Confidence 78899999999999999999999999999974
No 298
>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,
Probab=89.62 E-value=0.26 Score=46.12 Aligned_cols=32 Identities=22% Similarity=0.471 Sum_probs=28.3
Q ss_pred ecccc-cCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTET-GHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~-~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.++ +|+|+|+++|+|.+++..++|+||+++
T Consensus 68 ~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~ 100 (293)
T cd05053 68 MMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAH 100 (293)
T ss_pred HHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCC
Confidence 56677 799999999999999999999999863
No 299
>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,
Probab=89.61 E-value=0.28 Score=46.99 Aligned_cols=32 Identities=13% Similarity=0.077 Sum_probs=29.2
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|+|+|++.+++.+++..++|+|||++
T Consensus 54 ~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g 85 (331)
T cd05597 54 VLVNGDRRWITNLHYAFQDENNLYLVMDYYVG 85 (331)
T ss_pred HHHhCCCCCCCceEEEEecCCeEEEEEecCCC
Confidence 67778999999999999999999999999974
No 300
>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta. Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.
Probab=89.29 E-value=0.35 Score=46.36 Aligned_cols=32 Identities=9% Similarity=-0.018 Sum_probs=29.3
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|+|++++.+++.+++..++|+|||++
T Consensus 54 ~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~g 85 (331)
T cd05624 54 VLVNGDCQWITTLHYAFQDENYLYLVMDYYVG 85 (331)
T ss_pred HHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCC
Confidence 67778999999999999999999999999974
No 301
>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl. Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor
Probab=89.27 E-value=0.26 Score=45.46 Aligned_cols=32 Identities=16% Similarity=0.451 Sum_probs=26.5
Q ss_pred ecccccCCceeeeEEEEEeC------CeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHA------RHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~------~~~~LVyeym~n 495 (495)
.+.+++|+|+|+++|+|... ...++|+|||+.
T Consensus 53 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~ 90 (272)
T cd05075 53 CMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKH 90 (272)
T ss_pred HHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCC
Confidence 78889999999999999653 246899999973
No 302
>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha. Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw
Probab=89.19 E-value=0.36 Score=46.24 Aligned_cols=32 Identities=9% Similarity=0.043 Sum_probs=29.2
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|+|++++.+++.+.+..++|+||+++
T Consensus 54 ~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~ 85 (332)
T cd05623 54 VLVNGDNQWITTLHYAFQDENNLYLVMDYYVG 85 (332)
T ss_pred HHhhCCCCCEeeEEEEEecCCEEEEEEeccCC
Confidence 67788999999999999999999999999974
No 303
>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl
Probab=89.14 E-value=0.27 Score=46.35 Aligned_cols=31 Identities=26% Similarity=0.413 Sum_probs=26.9
Q ss_pred ecccccCCceeeeEEEEEeCCe--------eEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHARH--------SFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~--------~~LVyeym~ 494 (495)
++++++|+|+|+++++|...+. .++|+||++
T Consensus 64 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~ 102 (310)
T cd07865 64 ILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE 102 (310)
T ss_pred HHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCC
Confidence 7889999999999999987543 499999986
No 304
>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4. Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin
Probab=89.11 E-value=0.24 Score=46.74 Aligned_cols=31 Identities=16% Similarity=0.355 Sum_probs=26.6
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++++++|+|+|+++|+|... ...+|+||+++
T Consensus 62 ~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~ 92 (303)
T cd05110 62 IMASMDHPHLVRLLGVCLSP-TIQLVTQLMPH 92 (303)
T ss_pred HHHhCCCCCcccEEEEEcCC-CceeeehhcCC
Confidence 77889999999999999764 46799999974
No 305
>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2. Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul
Probab=89.04 E-value=0.36 Score=46.84 Aligned_cols=32 Identities=22% Similarity=0.250 Sum_probs=29.5
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|+|+|++++++.+++..++|+|||++
T Consensus 54 ~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~g 85 (360)
T cd05627 54 ILVEADGAWVVKMFYSFQDKRNLYLIMEFLPG 85 (360)
T ss_pred HHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCC
Confidence 67888999999999999999999999999974
No 306
>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in
Probab=88.92 E-value=0.42 Score=45.42 Aligned_cols=28 Identities=21% Similarity=0.214 Sum_probs=26.0
Q ss_pred ccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 468 TGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 468 ~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+|||+|++++++.+.+..++|+||+++
T Consensus 53 ~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 53 WEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred cCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 5899999999999999999999999974
No 307
>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with
Probab=88.91 E-value=0.35 Score=45.15 Aligned_cols=32 Identities=9% Similarity=0.010 Sum_probs=29.6
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|+|+|++.+++..++..++|+|||++
T Consensus 53 il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 84 (285)
T cd05632 53 ILEKVNSQFVVNLAYAYETKDALCLVLTIMNG 84 (285)
T ss_pred HHHHcCCcCceeEEEEEecCCEEEEEEEeccC
Confidence 78899999999999999999999999999973
No 308
>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with
Probab=88.91 E-value=0.31 Score=44.48 Aligned_cols=32 Identities=22% Similarity=0.268 Sum_probs=29.4
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+++++|+|+++++++...++..++|+||++.
T Consensus 52 ~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd08220 52 VLKLLSHPNIIEYYENFLEDKALMIVMEYAPG 83 (256)
T ss_pred HHhhCCCCchhheeeeEecCCEEEEEEecCCC
Confidence 78899999999999999889999999999973
No 309
>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6. Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as
Probab=88.84 E-value=0.33 Score=46.05 Aligned_cols=32 Identities=19% Similarity=0.323 Sum_probs=27.2
Q ss_pred ecccccCCceeeeEEEEEe--CCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSH--ARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~--~~~~~LVyeym~n 495 (495)
++.+++|+|+|++.+++.. +...++|+||+++
T Consensus 51 ~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 51 LLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred HHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 7889999999999999864 4566899999863
No 310
>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase. Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ
Probab=88.80 E-value=0.35 Score=44.16 Aligned_cols=32 Identities=25% Similarity=0.582 Sum_probs=29.4
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+.+++|+|+|++++++.......+|+||++.
T Consensus 52 ~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 52 VMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred HHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 78889999999999999999999999999863
No 311
>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase. Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re
Probab=88.30 E-value=0.42 Score=43.66 Aligned_cols=32 Identities=25% Similarity=0.384 Sum_probs=27.6
Q ss_pred ecccccCCceeeeEEEEEe-CCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSH-ARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~-~~~~~LVyeym~n 495 (495)
.+++++|+|+|+++|++.+ ++..++|+|||++
T Consensus 52 ~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~ 84 (256)
T cd05082 52 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 84 (256)
T ss_pred HHHhCCCCCeeeEEEEEEcCCCceEEEEECCCC
Confidence 7889999999999998765 4567899999974
No 312
>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast
Probab=88.19 E-value=0.46 Score=43.13 Aligned_cols=32 Identities=28% Similarity=0.394 Sum_probs=29.5
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+++++|+|++++++++.+++..++|+||+++
T Consensus 52 ~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (254)
T cd06627 52 LLKNLKHPNIVKYIGSIETSDSLYIILEYAEN 83 (254)
T ss_pred HHHhCCCCCccEEEEEEEeCCEEEEEEecCCC
Confidence 68899999999999999999999999999863
No 313
>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase. Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ
Probab=88.06 E-value=0.43 Score=44.00 Aligned_cols=32 Identities=28% Similarity=0.380 Sum_probs=26.0
Q ss_pred ecccc-cCCceeeeEEEEEeC------CeeEEEecccCC
Q 041558 464 ALTET-GHRNIVKFYGFCSHA------RHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~-~H~NlV~l~G~c~~~------~~~~LVyeym~n 495 (495)
.+.++ +|+|+|++.|+|... +..++||||+++
T Consensus 55 ~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~ 93 (272)
T cd06637 55 MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGA 93 (272)
T ss_pred HHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCC
Confidence 56666 799999999999763 357899999973
No 314
>PF13516 LRR_6: Leucine Rich repeat; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1DFJ_I 2BNH_A 3VQ1_A 3VQ2_A 2Z64_A 2OMX_A ....
Probab=87.98 E-value=0.14 Score=27.26 Aligned_cols=13 Identities=38% Similarity=0.544 Sum_probs=4.8
Q ss_pred CCCeeeccCCccc
Q 041558 72 SLGDLQLNGNQFI 84 (495)
Q Consensus 72 ~L~~L~l~~n~l~ 84 (495)
+|++|+|++|.++
T Consensus 3 ~L~~L~l~~n~i~ 15 (24)
T PF13516_consen 3 NLETLDLSNNQIT 15 (24)
T ss_dssp T-SEEE-TSSBEH
T ss_pred CCCEEEccCCcCC
Confidence 3444444444443
No 315
>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]
Probab=87.98 E-value=0.43 Score=44.73 Aligned_cols=31 Identities=23% Similarity=0.232 Sum_probs=28.7
Q ss_pred ecccccCCceeeeEEEEEeCC-eeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHAR-HSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~-~~~LVyeym~ 494 (495)
++.+.+||+||+.+|.+.+.. +..+++|||.
T Consensus 130 il~~~~spyIV~~ygaF~~~~~~isI~mEYMD 161 (364)
T KOG0581|consen 130 ILRSCQSPYIVGFYGAFYSNGEEISICMEYMD 161 (364)
T ss_pred HHhhCCCCCeeeEeEEEEeCCceEEeehhhcC
Confidence 788899999999999999887 5999999996
No 316
>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes. Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an
Probab=87.86 E-value=0.4 Score=43.91 Aligned_cols=31 Identities=23% Similarity=0.367 Sum_probs=26.8
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|+|+|++.|++. ++..++||||+++
T Consensus 54 ~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~ 84 (260)
T cd05069 54 IMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGK 84 (260)
T ss_pred HHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCC
Confidence 788899999999999874 5668899999974
No 317
>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=87.82 E-value=0.63 Score=46.56 Aligned_cols=32 Identities=28% Similarity=0.462 Sum_probs=29.6
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
+.++++|||||++++|-.+.+..++|-|+.+|
T Consensus 71 IHr~L~HpnIV~f~~~FEDs~nVYivLELC~~ 102 (592)
T KOG0575|consen 71 IHRSLKHPNIVQFYHFFEDSNNVYIVLELCHR 102 (592)
T ss_pred HHHhcCCCcEEeeeeEeecCCceEEEEEecCC
Confidence 88999999999999999999999999998764
No 318
>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase. Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1
Probab=87.81 E-value=0.53 Score=43.17 Aligned_cols=32 Identities=25% Similarity=0.376 Sum_probs=29.5
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+.+++|+|+|+++|.+..++..++|+||+++
T Consensus 52 ~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (267)
T cd06610 52 AMSQCNHPNVVKYYTSFVVGDELWLVMPYLSG 83 (267)
T ss_pred HHHhcCCCCEEEEEEEEeeCCEEEEEEeccCC
Confidence 67889999999999999999999999999964
No 319
>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase. Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.
Probab=87.77 E-value=0.41 Score=44.38 Aligned_cols=31 Identities=23% Similarity=0.300 Sum_probs=27.2
Q ss_pred eccccc-CCceeeeEEEEEeC--CeeEEEecccC
Q 041558 464 ALTETG-HRNIVKFYGFCSHA--RHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~-H~NlV~l~G~c~~~--~~~~LVyeym~ 494 (495)
.+.++. |+|+++++|+|.++ +..++|+|||+
T Consensus 50 ~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~ 83 (282)
T cd07831 50 ALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD 83 (282)
T ss_pred HHhhcCCCCCccceEEEEecCCCCcEEEEEecCC
Confidence 566775 99999999999987 88899999996
No 320
>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the
Probab=87.63 E-value=0.27 Score=47.40 Aligned_cols=32 Identities=25% Similarity=0.307 Sum_probs=29.5
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|+|+|++++++.+++..++|+||+++
T Consensus 54 ~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (350)
T cd05573 54 ILADADSPWIVKLYYSFQDEEHLYLVMEYMPG 85 (350)
T ss_pred HHHhcCCCCccchhhheecCCeEEEEEcCCCC
Confidence 78888999999999999999999999999973
No 321
>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases. Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut
Probab=87.63 E-value=0.4 Score=44.51 Aligned_cols=32 Identities=34% Similarity=0.525 Sum_probs=28.1
Q ss_pred ecccccCCceeeeEEEEEe--CCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSH--ARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~--~~~~~LVyeym~n 495 (495)
.+.+++|+|++++.|+|.. +....+|+||++.
T Consensus 59 ~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~ 92 (284)
T cd05038 59 ILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPS 92 (284)
T ss_pred HHHhCCCCChheEEeeeecCCCCceEEEEecCCC
Confidence 6889999999999999987 5578999999863
No 322
>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]
Probab=87.61 E-value=0.13 Score=49.86 Aligned_cols=31 Identities=23% Similarity=0.377 Sum_probs=28.8
Q ss_pred eccccc-CCceeeeEEEEEeCC-eeEEEecccC
Q 041558 464 ALTETG-HRNIVKFYGFCSHAR-HSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~-H~NlV~l~G~c~~~~-~~~LVyeym~ 494 (495)
.|.|+. |+|||+|.-.-.+.+ ..++|+|||+
T Consensus 61 sL~kln~hpniikL~Evi~d~~~~L~fVfE~Md 93 (538)
T KOG0661|consen 61 SLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMD 93 (538)
T ss_pred HHHhcCCCCcchhhHHHhhccCceEeeeHHhhh
Confidence 799999 999999999998877 8899999996
No 323
>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional
Probab=87.57 E-value=0.63 Score=42.94 Aligned_cols=27 Identities=11% Similarity=0.271 Sum_probs=25.2
Q ss_pred cCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 469 GHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 469 ~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
+|+|+|++++++..++..++|+||+++
T Consensus 67 ~h~~iv~~~~~~~~~~~~~iv~e~~~~ 93 (267)
T PHA03390 67 DNPNFIKLYYSVTTLKGHVLIMDYIKD 93 (267)
T ss_pred cCCCEEEEEEEEecCCeeEEEEEcCCC
Confidence 699999999999999999999999974
No 324
>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re
Probab=87.51 E-value=0.47 Score=43.60 Aligned_cols=32 Identities=25% Similarity=0.351 Sum_probs=26.7
Q ss_pred ecccccCCceeeeEEEEEeC--CeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHA--RHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~--~~~~LVyeym~n 495 (495)
.+.+++|+|+|+.+|++.+. ....+|+||+++
T Consensus 57 ~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~ 90 (265)
T cd06652 57 LLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPG 90 (265)
T ss_pred HHHhcCCCCeeeEEeEeccCCCceEEEEEEecCC
Confidence 78899999999999987664 356789999874
No 325
>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C. Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re
Probab=87.42 E-value=0.54 Score=44.69 Aligned_cols=27 Identities=15% Similarity=0.153 Sum_probs=25.2
Q ss_pred cCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 469 GHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 469 ~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
+|+|+|+++|++...+..++|+||+++
T Consensus 54 ~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 54 KHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 799999999999999999999999974
No 326
>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1. Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U
Probab=87.40 E-value=0.43 Score=45.63 Aligned_cols=31 Identities=23% Similarity=0.250 Sum_probs=27.3
Q ss_pred ecccccCCceeeeEEEEEe-CCeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSH-ARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~-~~~~~LVyeym~ 494 (495)
++.+++|||+|++.+++.. ++..++|+|||.
T Consensus 62 ~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~~ 93 (328)
T cd07856 62 LLKHLRHENIISLSDIFISPLEDIYFVTELLG 93 (328)
T ss_pred HHHhcCCCCeeeEeeeEecCCCcEEEEeehhc
Confidence 7889999999999999876 567889999985
No 327
>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla
Probab=87.26 E-value=0.59 Score=43.61 Aligned_cols=31 Identities=23% Similarity=0.504 Sum_probs=24.7
Q ss_pred ecccccCCceeeeEEEEEe-----CCeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSH-----ARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~-----~~~~~LVyeym~ 494 (495)
.+.+++|||+|+++|+|.. ....++|+||++
T Consensus 57 ~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~ 92 (290)
T cd07862 57 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD 92 (290)
T ss_pred hhcccCCCCcceEEEEEecccCCCCCcEEEEEccCC
Confidence 4556789999999999963 345789999986
No 328
>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase. Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea
Probab=87.20 E-value=0.45 Score=44.26 Aligned_cols=30 Identities=27% Similarity=0.311 Sum_probs=28.4
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEeccc
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESL 493 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym 493 (495)
++.+++|+|+|++++++..++..++||||+
T Consensus 52 ~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (286)
T cd07832 52 ALQACQHPYVVKLLDVFPHGSGFVLVMEYM 81 (286)
T ss_pred HHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence 788899999999999999999999999998
No 329
>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15. Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul
Probab=87.09 E-value=0.38 Score=46.14 Aligned_cols=31 Identities=32% Similarity=0.487 Sum_probs=26.8
Q ss_pred ecccc-cCCceeeeEEEEEeC--CeeEEEecccC
Q 041558 464 ALTET-GHRNIVKFYGFCSHA--RHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~-~H~NlV~l~G~c~~~--~~~~LVyeym~ 494 (495)
+++++ +|+|+|+++|+|... ...++|+||++
T Consensus 59 ~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~ 92 (337)
T cd07852 59 FLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME 92 (337)
T ss_pred HHHHhcCCCCccceeeeeccCCCceEEEEecccc
Confidence 78899 999999999998754 36799999986
No 330
>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains. Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an
Probab=87.07 E-value=0.23 Score=45.26 Aligned_cols=32 Identities=19% Similarity=0.153 Sum_probs=29.5
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+++++|+|++++.+++.+++..++||||+++
T Consensus 52 ~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd08530 52 ILASVNHPNIISYKEAFLDGNKLCIVMEYAPF 83 (256)
T ss_pred HHHhCCCCCchhhhhhhccCCEEEEEehhcCC
Confidence 78899999999999999999999999999863
No 331
>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK
Probab=87.00 E-value=0.56 Score=42.60 Aligned_cols=31 Identities=26% Similarity=0.349 Sum_probs=28.7
Q ss_pred ecccccCCceeeeEEEEEeC--CeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHA--RHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~--~~~~LVyeym~ 494 (495)
.+++++|+|+++.++++.+. +...+|+||++
T Consensus 52 ~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~ 84 (260)
T cd06606 52 ILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVS 84 (260)
T ss_pred HHHHcCCCCEeeEEEEEecCCCCeEEEEEEecC
Confidence 78889999999999999988 88999999985
No 332
>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan
Probab=86.88 E-value=0.44 Score=43.43 Aligned_cols=31 Identities=29% Similarity=0.660 Sum_probs=28.9
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~ 494 (495)
.+.+++|+|++++++++..++..++|+||++
T Consensus 49 ~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 49 VMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred HHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 7888899999999999999999999999985
No 333
>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to
Probab=86.87 E-value=0.62 Score=44.36 Aligned_cols=28 Identities=14% Similarity=0.103 Sum_probs=25.7
Q ss_pred ccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 468 TGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 468 ~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+|+|+|++.+++.+++..++|+||+++
T Consensus 53 ~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 53 AKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred cCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 3799999999999999999999999974
No 334
>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7. Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it
Probab=86.78 E-value=0.32 Score=45.63 Aligned_cols=30 Identities=23% Similarity=0.385 Sum_probs=26.3
Q ss_pred cccc-cCCceeeeEEEEEeCCeeEEEecccC
Q 041558 465 LTET-GHRNIVKFYGFCSHARHSFSVYESLE 494 (495)
Q Consensus 465 l~~~-~H~NlV~l~G~c~~~~~~~LVyeym~ 494 (495)
+.+. .|+|+|+++|+|.++...++|+||++
T Consensus 67 ~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 97 (296)
T cd06618 67 VLKSHDCPYIVKCYGYFITDSDVFICMELMS 97 (296)
T ss_pred HHhccCCCchHhhheeeecCCeEEEEeeccC
Confidence 4444 49999999999999999999999986
No 335
>PHA03207 serine/threonine kinase US3; Provisional
Probab=86.69 E-value=0.5 Score=46.51 Aligned_cols=31 Identities=16% Similarity=0.188 Sum_probs=28.8
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~ 494 (495)
++.+++|+|+|++++++...+..++|+||+.
T Consensus 139 il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 169 (392)
T PHA03207 139 ILKTISHRAIINLIHAYRWKSTVCMVMPKYK 169 (392)
T ss_pred HHHhcCCCCccceeeeEeeCCEEEEEehhcC
Confidence 8999999999999999998889999999975
No 336
>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase. Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa
Probab=86.68 E-value=0.47 Score=43.47 Aligned_cols=31 Identities=16% Similarity=0.300 Sum_probs=27.8
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|+|+|++.+++.+ +..++|+||+++
T Consensus 54 ~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~ 84 (260)
T cd05073 54 VMKTLQHDKLVKLHAVVTK-EPIYIITEFMAK 84 (260)
T ss_pred HHHhcCCCCcceEEEEEcC-CCeEEEEEeCCC
Confidence 7889999999999999887 678999999974
No 337
>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase. Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription
Probab=86.64 E-value=0.31 Score=47.59 Aligned_cols=32 Identities=16% Similarity=0.186 Sum_probs=28.3
Q ss_pred ecccccCCceeeeEEEEEeCC-----eeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHAR-----HSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~-----~~~LVyeym~n 495 (495)
++.+++|+|+|++++++...+ ..++|+|||++
T Consensus 52 ~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~ 88 (372)
T cd07853 52 MLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQS 88 (372)
T ss_pred HHHhCCCCCcCCHhheecCCCccccceEEEEeecccc
Confidence 788899999999999998776 78999999863
No 338
>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi
Probab=86.59 E-value=0.55 Score=42.91 Aligned_cols=30 Identities=23% Similarity=0.414 Sum_probs=26.4
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~ 494 (495)
.+.++.|+|+|+++|+|. ++...+|+||++
T Consensus 49 ~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~ 78 (257)
T cd05060 49 VMAQLDHPCIVRLIGVCK-GEPLMLVMELAP 78 (257)
T ss_pred HHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence 788899999999999985 567899999986
No 339
>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin. Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre
Probab=86.57 E-value=0.54 Score=43.90 Aligned_cols=32 Identities=34% Similarity=0.500 Sum_probs=25.7
Q ss_pred ecccc-cCCceeeeEEEEEeCC-----eeEEEecccCC
Q 041558 464 ALTET-GHRNIVKFYGFCSHAR-----HSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~-~H~NlV~l~G~c~~~~-----~~~LVyeym~n 495 (495)
.+.++ +|+|+++++|+|...+ ..++|+||+++
T Consensus 71 ~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~ 108 (291)
T cd06639 71 ILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNG 108 (291)
T ss_pred HHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCC
Confidence 45556 7999999999998643 57899999974
No 340
>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I
Probab=86.51 E-value=0.51 Score=43.46 Aligned_cols=32 Identities=28% Similarity=0.363 Sum_probs=26.4
Q ss_pred ecccc-cCCceeeeEEEEEeCC------eeEEEecccCC
Q 041558 464 ALTET-GHRNIVKFYGFCSHAR------HSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~-~H~NlV~l~G~c~~~~------~~~LVyeym~n 495 (495)
++.++ +|+|+|+++|+|.... ..++|+||+++
T Consensus 55 ~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~ 93 (275)
T cd06608 55 ILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGG 93 (275)
T ss_pred HHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCC
Confidence 56777 6999999999997644 47899999973
No 341
>smart00219 TyrKc Tyrosine kinase, catalytic domain. Phosphotransferases. Tyrosine-specific kinase subfamily.
Probab=86.51 E-value=0.51 Score=42.98 Aligned_cols=32 Identities=31% Similarity=0.528 Sum_probs=29.2
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+.+++|+|+|++++++.+.+..++|+||++.
T Consensus 54 ~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~ 85 (258)
T smart00219 54 IMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEG 85 (258)
T ss_pred HHHhcCCCchheEEEEEcCCCeeEEEEeccCC
Confidence 67788999999999999999999999999863
No 342
>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp
Probab=86.46 E-value=0.7 Score=43.89 Aligned_cols=29 Identities=21% Similarity=0.230 Sum_probs=26.2
Q ss_pred cccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 467 ETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 467 ~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
..+|+|+|++++++..++..++|+||+++
T Consensus 52 ~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 52 AWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred ccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 35899999999999999999999999974
No 343
>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481
Probab=86.36 E-value=0.61 Score=49.47 Aligned_cols=32 Identities=28% Similarity=0.219 Sum_probs=29.3
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+..++|+|||++++++..++..++|+|||++
T Consensus 57 ~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g 88 (669)
T cd05610 57 ALALSKSPFIVHLYYSLQSANNVYLVMEYLIG 88 (669)
T ss_pred HHHhcCCCCcCeEEEEEEECCEEEEEEeCCCC
Confidence 67888999999999999999999999999963
No 344
>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk. Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r
Probab=86.35 E-value=0.54 Score=43.03 Aligned_cols=31 Identities=23% Similarity=0.410 Sum_probs=26.9
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|+|++++++++. .+..++|||||+.
T Consensus 54 ~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~ 84 (260)
T cd05070 54 IMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSK 84 (260)
T ss_pred HHHhcCCCceEEEEeEEC-CCCcEEEEEecCC
Confidence 788999999999999984 5568999999963
No 345
>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity
Probab=86.26 E-value=0.38 Score=44.12 Aligned_cols=31 Identities=23% Similarity=0.271 Sum_probs=29.1
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~ 494 (495)
.+.+++|+|++++.|+|..++..++|+||++
T Consensus 52 ~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (265)
T cd06605 52 ILHKCNSPYIVGFYGAFYNNGDISICMEYMD 82 (265)
T ss_pred HHHHCCCCchhhhheeeecCCEEEEEEEecC
Confidence 6788899999999999999999999999997
No 346
>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal
Probab=86.13 E-value=0.66 Score=44.18 Aligned_cols=27 Identities=19% Similarity=0.262 Sum_probs=25.1
Q ss_pred cCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 469 GHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 469 ~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
+|+|+|++++++..++..++|+|||++
T Consensus 54 ~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 54 NHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 699999999999999999999999974
No 347
>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase. Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions
Probab=86.03 E-value=0.47 Score=43.77 Aligned_cols=30 Identities=23% Similarity=0.336 Sum_probs=26.2
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~ 494 (495)
.+.+++|+|+|+++|+|.. +..++|+||++
T Consensus 60 ~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~ 89 (270)
T cd05056 60 IMRQFDHPHIVKLIGVITE-NPVWIVMELAP 89 (270)
T ss_pred HHHhCCCCchhceeEEEcC-CCcEEEEEcCC
Confidence 7888999999999999864 56789999986
No 348
>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase. Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki
Probab=86.02 E-value=0.57 Score=42.69 Aligned_cols=31 Identities=29% Similarity=0.515 Sum_probs=26.7
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|+|++++.|++.+ +..++|+||++.
T Consensus 52 ~l~~~~~~~i~~~~~~~~~-~~~~~v~e~~~~ 82 (254)
T cd05083 52 VMTKLHHKNLVRLLGVILH-NGLYIVMELMSK 82 (254)
T ss_pred HHHhCCCCCcCeEEEEEcC-CCcEEEEECCCC
Confidence 7889999999999999865 457999999973
No 349
>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases. Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core
Probab=86.01 E-value=0.74 Score=41.61 Aligned_cols=31 Identities=32% Similarity=0.423 Sum_probs=29.2
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~ 494 (495)
.+++++|+|++++++++..++..++|+||++
T Consensus 50 ~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 50 ILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred HHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 7888999999999999999999999999997
No 350
>KOG3864 consensus Uncharacterized conserved protein [Function unknown]
Probab=85.84 E-value=0.12 Score=44.26 Aligned_cols=83 Identities=22% Similarity=0.165 Sum_probs=53.0
Q ss_pred ccCCeeecccCcccccCCcccccCcccceeecccccccccCC-cccc-CCCCCCeeeccCCc-ccccCChhhhcCCCCCE
Q 041558 23 QFLWGLDLSNNQFSSSIPLSFGNLSNLIFLYLYENSYFASIP-SNVG-KLKSLGDLQLNGNQ-FISYIPSSFGNLTNLST 99 (495)
Q Consensus 23 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~-~~~~-~l~~L~~L~l~~n~-l~~~~~~~~~~l~~L~~ 99 (495)
..++.+|-++..|..+.-+.+..++.++.|.+.+++-.+... +-++ -.++|+.|++++|. ||..--..+..+++|+.
T Consensus 101 ~~IeaVDAsds~I~~eGle~L~~l~~i~~l~l~~ck~~dD~~L~~l~~~~~~L~~L~lsgC~rIT~~GL~~L~~lknLr~ 180 (221)
T KOG3864|consen 101 VKIEAVDASDSSIMYEGLEHLRDLRSIKSLSLANCKYFDDWCLERLGGLAPSLQDLDLSGCPRITDGGLACLLKLKNLRR 180 (221)
T ss_pred ceEEEEecCCchHHHHHHHHHhccchhhhheeccccchhhHHHHHhcccccchheeeccCCCeechhHHHHHHHhhhhHH
Confidence 346778888887776655667778888888887775332111 0111 34678888888775 55433345667777877
Q ss_pred EecCCC
Q 041558 100 SRLSKN 105 (495)
Q Consensus 100 L~l~~n 105 (495)
|.+++-
T Consensus 181 L~l~~l 186 (221)
T KOG3864|consen 181 LHLYDL 186 (221)
T ss_pred HHhcCc
Confidence 777654
No 351
>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]
Probab=85.72 E-value=0.62 Score=46.66 Aligned_cols=31 Identities=23% Similarity=0.337 Sum_probs=29.0
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~ 494 (495)
++-.+.|||||||+++........||.||..
T Consensus 108 imk~l~HPnIvkl~~v~~t~~~lylV~eya~ 138 (596)
T KOG0586|consen 108 IMKSLNHPNIVKLFSVIETEATLYLVMEYAS 138 (596)
T ss_pred HHHhcCCcceeeeeeeeeecceeEEEEEecc
Confidence 7889999999999999999999999999964
No 352
>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase. Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm
Probab=85.69 E-value=0.54 Score=44.01 Aligned_cols=32 Identities=19% Similarity=0.230 Sum_probs=26.7
Q ss_pred eccccc-CCceeeeEEEEEeCCe-----eEEEecccCC
Q 041558 464 ALTETG-HRNIVKFYGFCSHARH-----SFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~-H~NlV~l~G~c~~~~~-----~~LVyeym~n 495 (495)
++++++ |+|+|++++++...+. .++|||||++
T Consensus 53 ~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~ 90 (295)
T cd07837 53 LLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS 90 (295)
T ss_pred HHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc
Confidence 677774 6999999999987665 7999999974
No 353
>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development
Probab=85.54 E-value=0.77 Score=42.22 Aligned_cols=32 Identities=22% Similarity=0.351 Sum_probs=27.0
Q ss_pred ecccccCCceeeeEEEEEe--CCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSH--ARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~--~~~~~LVyeym~n 495 (495)
++.+++|+|++++.|++.+ ++...+|+||+++
T Consensus 57 ~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~ 90 (266)
T cd06651 57 LLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPG 90 (266)
T ss_pred HHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCC
Confidence 7889999999999999875 3556799999863
No 354
>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin
Probab=85.48 E-value=0.59 Score=44.32 Aligned_cols=31 Identities=13% Similarity=0.075 Sum_probs=29.0
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~ 494 (495)
.+.+++|+|+|++++++.+++..++||||++
T Consensus 54 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (316)
T cd05574 54 ILATLDHPFLPTLYASFQTETYLCLVMDYCP 84 (316)
T ss_pred HHHhCCCCCchhheeeeecCCEEEEEEEecC
Confidence 7888999999999999999999999999985
No 355
>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src. Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo
Probab=85.48 E-value=0.59 Score=42.92 Aligned_cols=31 Identities=23% Similarity=0.427 Sum_probs=26.4
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|+|++++.|++. .+..++|+|||+.
T Consensus 54 ~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~ 84 (262)
T cd05071 54 VMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSK 84 (262)
T ss_pred HHHhCCCCCcceEEEEEC-CCCcEEEEEcCCC
Confidence 788899999999999874 4567899999973
No 356
>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both
Probab=85.18 E-value=0.78 Score=42.59 Aligned_cols=31 Identities=29% Similarity=0.503 Sum_probs=26.5
Q ss_pred ecccccCCceeeeEEEEEeCCe-----eEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHARH-----SFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~-----~~LVyeym~ 494 (495)
.++++.|+|+++++|+|...+. ..+||||++
T Consensus 54 ~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~ 89 (287)
T cd07838 54 QLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD 89 (287)
T ss_pred HhhccCCCCcceEEEEEeeccCCCCceeEEEehhcc
Confidence 3566679999999999998776 899999985
No 357
>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta. Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways
Probab=85.13 E-value=0.99 Score=43.11 Aligned_cols=32 Identities=13% Similarity=0.161 Sum_probs=27.3
Q ss_pred ecccc-cCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTET-GHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~-~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.++ +|+|+|++.+++...+..++|+|||++
T Consensus 48 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 48 VFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred HHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 34455 699999999999999999999999974
No 358
>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4. Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates
Probab=84.97 E-value=0.65 Score=43.27 Aligned_cols=31 Identities=23% Similarity=0.368 Sum_probs=27.7
Q ss_pred eccccc-CCceeeeEEEEEeCCeeEEEecccC
Q 041558 464 ALTETG-HRNIVKFYGFCSHARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~-H~NlV~l~G~c~~~~~~~LVyeym~ 494 (495)
.+.++. |+|+|+++|++..++..++|+|||+
T Consensus 55 ~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~ 86 (288)
T cd06616 55 VVMRSSDCPYIVKFYGALFREGDCWICMELMD 86 (288)
T ss_pred HHHHhcCCCCEeeeeeEEecCCcEEEEEeccc
Confidence 677776 9999999999999999999999985
No 359
>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1. Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph
Probab=84.95 E-value=0.66 Score=43.29 Aligned_cols=32 Identities=6% Similarity=0.000 Sum_probs=28.0
Q ss_pred ecccc-cCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTET-GHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~-~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.++ +|+|+|++.+++..++..++|+|||++
T Consensus 57 ~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 89 (290)
T cd05613 57 VLEHIRQSPFLVTLHYAFQTDTKLHLILDYING 89 (290)
T ss_pred HHHhcccCCChhceeeEeecCCeEEEEEecCCC
Confidence 67777 599999999998888888999999974
No 360
>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They
Probab=84.95 E-value=0.29 Score=45.41 Aligned_cols=32 Identities=28% Similarity=0.488 Sum_probs=29.6
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+.+++|+|+|++++++..++..++|+||++.
T Consensus 51 ~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 82 (283)
T cd05118 51 LLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT 82 (283)
T ss_pred HHHHhcCCCcchHHHhhccCCCEEEEEeccCC
Confidence 78889999999999999999999999999863
No 361
>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also
Probab=84.86 E-value=0.32 Score=45.26 Aligned_cols=31 Identities=29% Similarity=0.461 Sum_probs=29.1
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~ 494 (495)
++.+++|+|+|+++++..+.+...+|+||++
T Consensus 52 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (284)
T cd07839 52 LLKELKHKNIVRLYDVLHSDKKLTLVFEYCD 82 (284)
T ss_pred HHHhcCCCCeeeHHHHhccCCceEEEEecCC
Confidence 7888999999999999999999999999986
No 362
>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2. Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp
Probab=84.63 E-value=0.47 Score=45.72 Aligned_cols=32 Identities=22% Similarity=0.332 Sum_probs=26.4
Q ss_pred ecccc-cCCceeeeEEEEEeC-CeeEEEecccCC
Q 041558 464 ALTET-GHRNIVKFYGFCSHA-RHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~-~H~NlV~l~G~c~~~-~~~~LVyeym~n 495 (495)
++.++ +|+|+|+++|+|... ...++|+||+++
T Consensus 63 ~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~ 96 (343)
T cd05103 63 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKF 96 (343)
T ss_pred HHHhccCCccHhhhcceeecCCCceEEEEeccCC
Confidence 67777 789999999999764 456899999974
No 363
>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]
Probab=84.41 E-value=0.93 Score=41.43 Aligned_cols=32 Identities=25% Similarity=0.390 Sum_probs=30.4
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
+|.+++||.+|+|.|-|.+.+..++|+||++.
T Consensus 97 vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~G 128 (355)
T KOG0616|consen 97 VLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPG 128 (355)
T ss_pred HHhhccCceeEEEEEeeccCCeEEEEEeccCC
Confidence 89999999999999999999999999999874
No 364
>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]
Probab=84.38 E-value=0.26 Score=41.17 Aligned_cols=30 Identities=27% Similarity=0.326 Sum_probs=27.3
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEeccc
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESL 493 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym 493 (495)
++.+++|+|+|+|+-.-.++...-||+||.
T Consensus 54 llkelkhknivrl~dvlhsdkkltlvfe~c 83 (292)
T KOG0662|consen 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_pred HHHHhhhcceeehhhhhccCceeEEeHHHh
Confidence 889999999999999988888888999985
No 365
>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]
Probab=84.32 E-value=2.9 Score=39.87 Aligned_cols=30 Identities=20% Similarity=0.382 Sum_probs=26.0
Q ss_pred ecccccCCceeeeEEEEEeC-CeeEEEeccc
Q 041558 464 ALTETGHRNIVKFYGFCSHA-RHSFSVYESL 493 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~-~~~~LVyeym 493 (495)
.+-.+.|||+.+..|.|+++ +..+..|.||
T Consensus 340 lly~~sH~nll~V~~V~ie~~~~P~V~y~~~ 370 (563)
T KOG1024|consen 340 LLYGASHPNLLSVLGVSIEDYATPFVLYPAT 370 (563)
T ss_pred HHhcCcCCCccceeEEEeeccCcceEEEecc
Confidence 67889999999999999984 5678889887
No 366
>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain. Phosphotransferases. Serine or threonine-specific kinase subfamily.
Probab=84.22 E-value=0.41 Score=42.93 Aligned_cols=32 Identities=25% Similarity=0.388 Sum_probs=29.3
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+++++|+|+++++|+|..++..++||||++.
T Consensus 40 ~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 71 (244)
T smart00220 40 ILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDG 71 (244)
T ss_pred HHHhCCCCcHHHHHhheeeCCEEEEEEeCCCC
Confidence 67788999999999999999999999999863
No 367
>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p
Probab=84.16 E-value=0.68 Score=43.92 Aligned_cols=32 Identities=19% Similarity=0.328 Sum_probs=26.8
Q ss_pred ecccccCCceeeeEEEEEe--CCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSH--ARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~--~~~~~LVyeym~n 495 (495)
++.+++|+|+|++++++.+ +...++|+||+++
T Consensus 51 ~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 51 LLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred HHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 7899999999999998865 4457899999863
No 368
>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi
Probab=83.96 E-value=0.79 Score=41.86 Aligned_cols=32 Identities=31% Similarity=0.402 Sum_probs=26.7
Q ss_pred ecccccCCceeeeEEEEEe--CCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSH--ARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~--~~~~~LVyeym~n 495 (495)
.+.+++|+|+|++++++.. +...++||||+++
T Consensus 52 ~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~ 85 (265)
T cd08217 52 ILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEG 85 (265)
T ss_pred HHHhcCCCccceeeeeeecCCCCEEEEEehhccC
Confidence 7889999999999998864 3456899999863
No 369
>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn
Probab=83.92 E-value=0.82 Score=44.34 Aligned_cols=32 Identities=19% Similarity=0.385 Sum_probs=26.7
Q ss_pred ecccccCCceeeeEEEEEeCC------eeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHAR------HSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~------~~~LVyeym~n 495 (495)
++.+++|+|+|++++++...+ ..++|+|||+.
T Consensus 73 ~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~ 110 (359)
T cd07876 73 LLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA 110 (359)
T ss_pred HHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCc
Confidence 788899999999999986543 46899999863
No 370
>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=83.92 E-value=0.91 Score=44.08 Aligned_cols=32 Identities=19% Similarity=0.270 Sum_probs=29.8
Q ss_pred eccccc-CCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETG-HRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~-H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++ |||||++.-+.......++|+||.++
T Consensus 72 ~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~g 104 (370)
T KOG0583|consen 72 ILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSG 104 (370)
T ss_pred HHHHhccCCCEeEEEEEEecCCeEEEEEEecCC
Confidence 899999 99999999999999999999999864
No 371
>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10. Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing
Probab=83.28 E-value=0.98 Score=42.66 Aligned_cols=31 Identities=29% Similarity=0.255 Sum_probs=27.0
Q ss_pred ecccccCCceeeeEEEEEeC--CeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHA--RHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~--~~~~LVyeym~ 494 (495)
++.+++|+|+|++.+++.+. +..++|+||++
T Consensus 59 ~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~ 91 (309)
T cd07845 59 LLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE 91 (309)
T ss_pred HHHhCCCCCCcceEEEEecCCCCeEEEEEecCC
Confidence 78899999999999998764 46799999986
No 372
>KOG3864 consensus Uncharacterized conserved protein [Function unknown]
Probab=83.27 E-value=0.18 Score=43.21 Aligned_cols=80 Identities=26% Similarity=0.185 Sum_probs=40.1
Q ss_pred CceeccCCCeeeeecCCCCccccccceeeccccccccc-CCccc-CCCCCCCEEeCCCC-cCCCCchhhhhcCCCCCEEe
Q 041558 256 RQALDLSLNHIIGEIPKELGKLNSLIKLILRRNQLVGC-LPTEI-GSPIELEYLDFSVN-RFNNLIPESLENLLKLHYLG 332 (495)
Q Consensus 256 L~~L~ls~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~-~~~~~-~~l~~L~~L~Ls~n-~l~~~~~~~~~~l~~L~~L~ 332 (495)
++.+|-++..+...--..+..++.++.|.+.+|.--+. --+.+ +-.++|+.|++++| .|++.--..+..+++|+.|.
T Consensus 103 IeaVDAsds~I~~eGle~L~~l~~i~~l~l~~ck~~dD~~L~~l~~~~~~L~~L~lsgC~rIT~~GL~~L~~lknLr~L~ 182 (221)
T KOG3864|consen 103 IEAVDASDSSIMYEGLEHLRDLRSIKSLSLANCKYFDDWCLERLGGLAPSLQDLDLSGCPRITDGGLACLLKLKNLRRLH 182 (221)
T ss_pred EEEEecCCchHHHHHHHHHhccchhhhheeccccchhhHHHHHhcccccchheeeccCCCeechhHHHHHHHhhhhHHHH
Confidence 44555555555444334445555555555555532110 00000 02356777777766 55555445566666666666
Q ss_pred CcC
Q 041558 333 LCK 335 (495)
Q Consensus 333 l~~ 335 (495)
+.+
T Consensus 183 l~~ 185 (221)
T KOG3864|consen 183 LYD 185 (221)
T ss_pred hcC
Confidence 644
No 373
>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.
Probab=83.14 E-value=0.91 Score=41.35 Aligned_cols=32 Identities=22% Similarity=0.175 Sum_probs=26.4
Q ss_pred ecccccCCceeeeEEEEEeCC-eeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHAR-HSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~-~~~LVyeym~n 495 (495)
++++++|+|+|++.+++...+ ..++||||+++
T Consensus 52 ~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~ 84 (257)
T cd08223 52 LLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEG 84 (257)
T ss_pred HHHhCCCCCeeeeeeeecCCCCEEEEEecccCC
Confidence 788999999999999876444 56899999873
No 374
>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea
Probab=83.01 E-value=0.82 Score=42.43 Aligned_cols=32 Identities=28% Similarity=0.381 Sum_probs=25.7
Q ss_pred ecccc-cCCceeeeEEEEEe------CCeeEEEecccCC
Q 041558 464 ALTET-GHRNIVKFYGFCSH------ARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~-~H~NlV~l~G~c~~------~~~~~LVyeym~n 495 (495)
++.++ +|+|+|+++|++.. ++..++|+||++.
T Consensus 65 ~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~ 103 (282)
T cd06636 65 MLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGA 103 (282)
T ss_pred HHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCC
Confidence 45555 69999999999963 4577999999963
No 375
>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase
Probab=82.94 E-value=0.6 Score=44.79 Aligned_cols=32 Identities=22% Similarity=0.298 Sum_probs=27.1
Q ss_pred ecccccCCceeeeEEEEEeCC-----eeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHAR-----HSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~-----~~~LVyeym~n 495 (495)
++.+++|+|+|++++++...+ ..++|+|||++
T Consensus 56 ~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~ 92 (336)
T cd07849 56 ILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET 92 (336)
T ss_pred HHHhCCCCCcCchhheeecccccccceEEEEehhccc
Confidence 788999999999999987643 47899999963
No 376
>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I
Probab=82.88 E-value=1.3 Score=42.03 Aligned_cols=29 Identities=21% Similarity=0.196 Sum_probs=26.2
Q ss_pred cccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 467 ETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 467 ~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
..+|+|+|++++++.+.+..++|+||+++
T Consensus 52 ~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 52 AWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred ccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 35899999999999999999999999973
No 377
>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors. Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto
Probab=82.77 E-value=0.8 Score=44.01 Aligned_cols=32 Identities=22% Similarity=0.341 Sum_probs=26.5
Q ss_pred ecccc-cCCceeeeEEEEEeC-CeeEEEecccCC
Q 041558 464 ALTET-GHRNIVKFYGFCSHA-RHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~-~H~NlV~l~G~c~~~-~~~~LVyeym~n 495 (495)
++.++ +|+|+|+++|+|... ...++|+||+++
T Consensus 63 ~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~ 96 (337)
T cd05054 63 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKF 96 (337)
T ss_pred HHHhhccCcchhheeeeEecCCCCEEEEEecCCC
Confidence 66777 899999999999764 457799999974
No 378
>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk. Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr
Probab=82.73 E-value=0.96 Score=41.35 Aligned_cols=31 Identities=16% Similarity=0.390 Sum_probs=26.8
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|+|++++.++. ..+..++|+||+++
T Consensus 54 ~l~~l~h~~i~~~~~~~-~~~~~~~v~e~~~~ 84 (260)
T cd05067 54 LMKQLQHPRLVRLYAVV-TQEPIYIITEYMEN 84 (260)
T ss_pred HHHhcCCcCeeeEEEEE-ccCCcEEEEEcCCC
Confidence 78899999999999986 45678999999963
No 379
>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho
Probab=82.60 E-value=1 Score=41.25 Aligned_cols=32 Identities=22% Similarity=0.341 Sum_probs=26.8
Q ss_pred ecccccCCceeeeEEEEEeC--CeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHA--RHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~--~~~~LVyeym~n 495 (495)
++.+++|+|+++++|++.+. ....+|+||+++
T Consensus 57 ~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~ 90 (264)
T cd06653 57 LLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPG 90 (264)
T ss_pred HHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCC
Confidence 78899999999999998764 356789999863
No 380
>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity. Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....
Probab=82.60 E-value=0.88 Score=41.48 Aligned_cols=32 Identities=22% Similarity=0.217 Sum_probs=29.5
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+.+++|+|+++++++..+.+..++|+||++.
T Consensus 51 ~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~ 82 (260)
T PF00069_consen 51 ILRRLRHPNIVQILDVFQDDNYLYIVMEYCPG 82 (260)
T ss_dssp HHHHHTBTTBCHEEEEEEESSEEEEEEEEETT
T ss_pred cccccccccccccccccccccccccccccccc
Confidence 78888999999999999999999999999863
No 381
>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins. Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha
Probab=82.47 E-value=0.77 Score=41.42 Aligned_cols=32 Identities=16% Similarity=0.159 Sum_probs=27.6
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+....|||+|++++++.+++..++|+||+++
T Consensus 38 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 69 (237)
T cd05576 38 TIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEG 69 (237)
T ss_pred HHHhcCCCceeehhhheecCCeEEEEEecCCC
Confidence 34455799999999999999999999999974
No 382
>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2. Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve
Probab=82.45 E-value=0.96 Score=41.92 Aligned_cols=31 Identities=13% Similarity=0.285 Sum_probs=26.6
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+.+++|+|+++++|+|.. ....+|+|||+.
T Consensus 62 ~l~~~~~~~i~~~~~~~~~-~~~~l~~~~~~~ 92 (279)
T cd05109 62 VMAGVGSPYVCRLLGICLT-STVQLVTQLMPY 92 (279)
T ss_pred HHHhcCCCCCceEEEEEcC-CCcEEEEEcCCC
Confidence 6788999999999999975 457799999974
No 383
>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta. Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and
Probab=82.23 E-value=1.5 Score=41.78 Aligned_cols=27 Identities=7% Similarity=0.038 Sum_probs=24.6
Q ss_pred cCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 469 GHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 469 ~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
+|++++++.+++.+.+..++|+|||++
T Consensus 59 ~~~~i~~~~~~~~~~~~~~lv~E~~~~ 85 (323)
T cd05616 59 KPPFLTQLHSCFQTMDRLYFVMEYVNG 85 (323)
T ss_pred CCCeEeeEEEEEecCCEEEEEEcCCCC
Confidence 689999999999999999999999974
No 384
>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=82.03 E-value=0.38 Score=49.08 Aligned_cols=32 Identities=22% Similarity=0.259 Sum_probs=28.7
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
+-+++||+|||+.+|.|++++..-+.+|-+|+
T Consensus 625 LH~~LrHkNIVrYLGs~senGf~kIFMEqVPG 656 (1226)
T KOG4279|consen 625 LHSTLRHKNIVRYLGSVSENGFFKIFMEQVPG 656 (1226)
T ss_pred HHHHHhhHhHHHHhhccCCCCeEEEEeecCCC
Confidence 67899999999999999999988888888774
No 385
>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]
Probab=82.00 E-value=0.41 Score=47.62 Aligned_cols=31 Identities=26% Similarity=0.244 Sum_probs=29.1
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~ 494 (495)
++++++|||||.++.+.....+..+|.||..
T Consensus 54 i~r~lkHpniv~m~esfEt~~~~~vVte~a~ 84 (808)
T KOG0597|consen 54 ILRSLKHPNIVEMLESFETSAHLWVVTEYAV 84 (808)
T ss_pred HHHhcCCcchhhHHHhhcccceEEEEehhhh
Confidence 8999999999999999999999999999963
No 386
>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They
Probab=81.99 E-value=1.1 Score=40.65 Aligned_cols=32 Identities=25% Similarity=0.332 Sum_probs=29.3
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+.+++|+|+++..++...++..++|+||+++
T Consensus 52 ~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~ 83 (258)
T cd08215 52 ILKKLNHPNIIKYYESFEEKGKLCIVMEYADG 83 (258)
T ss_pred HHHhcCCCChhheEEEEecCCEEEEEEEecCC
Confidence 78889999999999999999999999999873
No 387
>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3. Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac
Probab=81.79 E-value=1.1 Score=41.18 Aligned_cols=31 Identities=19% Similarity=0.412 Sum_probs=25.5
Q ss_pred ecccccCCceeeeEEEEEeCC------eeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHAR------HSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~------~~~LVyeym~ 494 (495)
.+++++|||+|+++|++...+ ..++|+||++
T Consensus 54 ~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 90 (273)
T cd05074 54 CMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMK 90 (273)
T ss_pred HHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCC
Confidence 789999999999999987643 2378888886
No 388
>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili
Probab=81.76 E-value=0.4 Score=44.54 Aligned_cols=31 Identities=29% Similarity=0.430 Sum_probs=28.6
Q ss_pred eccccc-CCceeeeEEEEEeCCeeEEEecccC
Q 041558 464 ALTETG-HRNIVKFYGFCSHARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~-H~NlV~l~G~c~~~~~~~LVyeym~ 494 (495)
.+.+++ |+|+++++|+|..++..++|+||++
T Consensus 50 ~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (283)
T cd07830 50 SLRKLNEHPNIVKLKEVFRENDELYFVFEYME 81 (283)
T ss_pred HHHhccCCCCchhHHHHhhcCCcEEEEEecCC
Confidence 677888 9999999999999999999999984
No 389
>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi
Probab=81.74 E-value=1.5 Score=40.71 Aligned_cols=32 Identities=6% Similarity=-0.064 Sum_probs=27.4
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+...+|+|++++.+++..++..++|+|||++
T Consensus 50 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (279)
T cd05633 50 LVSTGDCPFIVCMTYAFHTPDKLCFILDLMNG 81 (279)
T ss_pred HHhhCCCCcEeEEEEEEecCCeEEEEEecCCC
Confidence 34445799999999999999999999999974
No 390
>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]
Probab=81.64 E-value=1.2 Score=41.61 Aligned_cols=31 Identities=26% Similarity=0.420 Sum_probs=28.0
Q ss_pred ecccccCCc-eeeeEEEEEeCC------eeEEEecccC
Q 041558 464 ALTETGHRN-IVKFYGFCSHAR------HSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~N-lV~l~G~c~~~~------~~~LVyeym~ 494 (495)
++.+++|+| +|+|..++...+ ...|||||+.
T Consensus 63 llk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d 100 (323)
T KOG0594|consen 63 LLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLD 100 (323)
T ss_pred HHHHhCCCcceEEEEeeeeecccccccceEEEEEEeec
Confidence 899999999 999999999877 5679999985
No 391
>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the
Probab=81.57 E-value=0.41 Score=44.36 Aligned_cols=31 Identities=32% Similarity=0.450 Sum_probs=29.0
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~ 494 (495)
.+.+++|+|+++++|++.+.+..++||||++
T Consensus 51 ~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (282)
T cd07829 51 LLKELKHPNIVKLLDVIHTERKLYLVFEYCD 81 (282)
T ss_pred HHHhcCCCCHHHHHhhhhcCCceEEEecCcC
Confidence 7888899999999999999999999999986
No 392
>smart00221 STYKc Protein kinase; unclassified specificity. Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.
Probab=81.24 E-value=0.99 Score=39.93 Aligned_cols=32 Identities=34% Similarity=0.462 Sum_probs=28.9
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+.+++|+|++++++++...+...+|+||++.
T Consensus 50 ~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~ 81 (225)
T smart00221 50 ILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEG 81 (225)
T ss_pred HHHhCCCCChhhheeeeecCCceEEEEeccCC
Confidence 67788999999999999999999999999863
No 393
>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou
Probab=81.23 E-value=1.3 Score=41.26 Aligned_cols=31 Identities=26% Similarity=0.507 Sum_probs=24.5
Q ss_pred ecccccCCceeeeEEEEEeC-----CeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHA-----RHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~-----~~~~LVyeym~ 494 (495)
.+..++|+|+|+++++|... ...++|+||++
T Consensus 55 ~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~ 90 (288)
T cd07863 55 RLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVD 90 (288)
T ss_pred HhhhcCCCCeeeeeeeeccccCCCCceEEEEEcccc
Confidence 34556899999999998752 34689999986
No 394
>PLN03224 probable serine/threonine protein kinase; Provisional
Probab=81.23 E-value=0.54 Score=47.62 Aligned_cols=32 Identities=9% Similarity=0.256 Sum_probs=25.3
Q ss_pred ecccccCCce-----eeeEEEEEe--------CCeeEEEecccCC
Q 041558 464 ALTETGHRNI-----VKFYGFCSH--------ARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~Nl-----V~l~G~c~~--------~~~~~LVyeym~n 495 (495)
++++++|+++ ++++|||.. .++.+||||||++
T Consensus 225 ~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~ 269 (507)
T PLN03224 225 MCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESD 269 (507)
T ss_pred HHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCC
Confidence 6777777766 789999864 3568999999985
No 395
>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=81.12 E-value=0.86 Score=42.80 Aligned_cols=32 Identities=28% Similarity=0.345 Sum_probs=27.0
Q ss_pred ecccccCCceeeeEEEEEeCC--eeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHAR--HSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~--~~~LVyeym~n 495 (495)
+|.+++|||||+..|.-...+ ...+..||+++
T Consensus 67 iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~ 100 (313)
T KOG0198|consen 67 ILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPG 100 (313)
T ss_pred HHHhCCCCCEEeeCCccccccCeeeEeeeeccCC
Confidence 899999999999999855544 57899999974
No 396
>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2. Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph
Probab=81.02 E-value=1.4 Score=42.21 Aligned_cols=32 Identities=6% Similarity=-0.012 Sum_probs=27.8
Q ss_pred ecccc-cCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTET-GHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~-~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.++ +|+|+|++.+++.+++..++|+||+++
T Consensus 57 ~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 89 (332)
T cd05614 57 VLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSG 89 (332)
T ss_pred HHHhccCCCCcccEEEEEecCCEEEEEEeCCCC
Confidence 56677 599999999999888899999999974
No 397
>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the
Probab=80.55 E-value=0.55 Score=42.57 Aligned_cols=31 Identities=23% Similarity=0.167 Sum_probs=28.9
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~ 494 (495)
++.+++|+|++++++.+..++..++||||++
T Consensus 46 ~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 76 (250)
T cd05123 46 ILSRINHPFIVKLHYAFQTEEKLYLVLEYAP 76 (250)
T ss_pred HHHHcCCCcHHHHHHHeecCCeeEEEEecCC
Confidence 7888999999999999999999999999985
No 398
>PTZ00036 glycogen synthase kinase; Provisional
Probab=80.40 E-value=1.3 Score=44.39 Aligned_cols=31 Identities=16% Similarity=0.145 Sum_probs=24.6
Q ss_pred ecccccCCceeeeEEEEEeC--------CeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHA--------RHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~--------~~~~LVyeym~ 494 (495)
++.+++|+|+|++.+|.... ....+|+|||+
T Consensus 112 il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~ 150 (440)
T PTZ00036 112 IMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIP 150 (440)
T ss_pred HHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCC
Confidence 88999999999999986432 13458999997
No 399
>PHA03210 serine/threonine kinase US3; Provisional
Probab=80.36 E-value=1.3 Score=45.17 Aligned_cols=30 Identities=20% Similarity=0.328 Sum_probs=27.7
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEeccc
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESL 493 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym 493 (495)
++.+++|+|||++++++.+.+..++|.||+
T Consensus 216 il~~l~HpnIv~l~~~~~~~~~~~lv~e~~ 245 (501)
T PHA03210 216 ALGRLNHENILKIEEILRSEANTYMITQKY 245 (501)
T ss_pred HHHhCCCCCcCcEeEEEEECCeeEEEEecc
Confidence 789999999999999999999999998865
No 400
>smart00364 LRR_BAC Leucine-rich repeats, bacterial type.
Probab=80.00 E-value=1.3 Score=24.09 Aligned_cols=19 Identities=32% Similarity=0.468 Sum_probs=13.8
Q ss_pred CCCCeEeccCCCCCCCCCc
Q 041558 350 VQFSELDLSYNFLGPIPNS 368 (495)
Q Consensus 350 ~~L~~l~ls~n~l~~~p~~ 368 (495)
++|+.|++++|++..+|+.
T Consensus 2 ~~L~~L~vs~N~Lt~LPeL 20 (26)
T smart00364 2 PSLKELNVSNNQLTSLPEL 20 (26)
T ss_pred cccceeecCCCccccCccc
Confidence 3577788888888777753
No 401
>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co
Probab=79.73 E-value=1.8 Score=40.14 Aligned_cols=31 Identities=6% Similarity=-0.075 Sum_probs=26.9
Q ss_pred cccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 465 LTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 465 l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
+...+|+|++++.+++.+++..++|+|||++
T Consensus 51 ~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g 81 (278)
T cd05606 51 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNG 81 (278)
T ss_pred HHhCCCCcEeeeeeeeecCCEEEEEEecCCC
Confidence 4446799999999999999999999999974
No 402
>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase. Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines
Probab=79.39 E-value=1 Score=41.91 Aligned_cols=32 Identities=6% Similarity=-0.019 Sum_probs=28.0
Q ss_pred ecccc-cCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTET-GHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~-~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.++ +|+|++++.++...++...+||||+++
T Consensus 57 ~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 89 (288)
T cd05583 57 VLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNG 89 (288)
T ss_pred HHHhccCCcchhhhheeeecCCEEEEEEecCCC
Confidence 67778 599999999998888889999999974
No 403
>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants. Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati
Probab=78.88 E-value=0.8 Score=43.97 Aligned_cols=31 Identities=19% Similarity=0.410 Sum_probs=26.4
Q ss_pred ecccccCCceeeeEEEEEeCC-----eeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHAR-----HSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~-----~~~LVyeym~ 494 (495)
++.+++|+|+|+++|++...+ ..++|||||.
T Consensus 57 ~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~ 92 (337)
T cd07858 57 LLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD 92 (337)
T ss_pred HHHhcCCCCccchHHheecccccccCcEEEEEeCCC
Confidence 788899999999999987543 4799999985
No 404
>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]
Probab=78.84 E-value=0.23 Score=45.52 Aligned_cols=31 Identities=16% Similarity=0.318 Sum_probs=26.8
Q ss_pred ecccccCCceeeeEEEEEe-CCeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSH-ARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~-~~~~~LVyeym~ 494 (495)
++.+++|+|+|+|.-.-.+ +....|||||-|
T Consensus 80 L~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAE 111 (438)
T KOG0666|consen 80 LLRELKHPNVISLVKVFLSHDKKVWLLFDYAE 111 (438)
T ss_pred HHHHhcCCcchhHHHHHhccCceEEEEehhhh
Confidence 7899999999999988776 556789999976
No 405
>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]
Probab=78.79 E-value=0.75 Score=45.63 Aligned_cols=32 Identities=25% Similarity=0.322 Sum_probs=29.4
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++...+|+|||.++--.+.+++...|+|||+.
T Consensus 323 Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~g 354 (550)
T KOG0578|consen 323 VMRDLHHPNIVNFLDSYLVGDELWVVMEYMEG 354 (550)
T ss_pred HHHhccchHHHHHHHHhcccceeEEEEeecCC
Confidence 89999999999999888888999999999974
No 406
>PTZ00266 NIMA-related protein kinase; Provisional
Probab=78.75 E-value=1.6 Score=47.79 Aligned_cols=32 Identities=19% Similarity=0.338 Sum_probs=27.0
Q ss_pred ecccccCCceeeeEEEEEe--CCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSH--ARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~--~~~~~LVyeym~n 495 (495)
++.+++|||||++++++.+ .+..++|+||++.
T Consensus 65 IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~g 98 (1021)
T PTZ00266 65 VMRELKHKNIVRYIDRFLNKANQKLYILMEFCDA 98 (1021)
T ss_pred HHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCC
Confidence 7889999999999998765 3457899999873
No 407
>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1. Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto
Probab=78.51 E-value=0.58 Score=43.27 Aligned_cols=31 Identities=26% Similarity=0.329 Sum_probs=28.3
Q ss_pred eccccc-CCceeeeEEEEEeCCeeEEEecccC
Q 041558 464 ALTETG-HRNIVKFYGFCSHARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~-H~NlV~l~G~c~~~~~~~LVyeym~ 494 (495)
++.+++ |+|++++++++..++..++|+||++
T Consensus 54 ~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~ 85 (280)
T cd05581 54 VLTRLNGHPGIIKLYYTFQDEENLYFVLEYAP 85 (280)
T ss_pred HHHhcccCCCchhHHHHhcCCceEEEEEcCCC
Confidence 677788 9999999999999999999999985
No 408
>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn
Probab=78.17 E-value=1.4 Score=42.86 Aligned_cols=32 Identities=16% Similarity=0.350 Sum_probs=26.3
Q ss_pred ecccccCCceeeeEEEEEeC------CeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHA------RHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~------~~~~LVyeym~n 495 (495)
++.+++|+|+|++++++... ...++|+|||+.
T Consensus 76 ~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~ 113 (364)
T cd07875 76 LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA 113 (364)
T ss_pred HHHhcCCCCccccceeecccccccccCeEEEEEeCCCC
Confidence 78889999999999987643 246899999963
No 409
>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]
Probab=77.67 E-value=2 Score=40.42 Aligned_cols=32 Identities=22% Similarity=0.213 Sum_probs=28.3
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
+|.+++||-||+|.---.+++..+||.|||.+
T Consensus 78 IL~~v~hPFiv~l~ysFQt~~kLylVld~~~G 109 (357)
T KOG0598|consen 78 ILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNG 109 (357)
T ss_pred HHHhCCCCcEeeeEEecccCCeEEEEEeccCC
Confidence 89999999999998666678888999999975
No 410
>TIGR00864 PCC polycystin cation channel protein. Note: this model has been restricted to the amino half because for technical reasons.
Probab=77.43 E-value=1.3 Score=52.56 Aligned_cols=37 Identities=27% Similarity=0.178 Sum_probs=18.0
Q ss_pred CcCCcCCccchhHhhcCCCCCeEeccCCCCCCCCCcc
Q 041558 333 LCKNKLVQELPKILEKLVQFSELDLSYNFLGPIPNSI 369 (495)
Q Consensus 333 l~~n~l~~~~~~~~~~l~~L~~l~ls~n~l~~~p~~~ 369 (495)
|++|+|+...+..|..+++|+.|+|++|++.|-|...
T Consensus 2 LSnN~LstLp~g~F~~L~sL~~LdLsgNPw~CDC~L~ 38 (2740)
T TIGR00864 2 ISNNKISTIEEGICANLCNLSEIDLSGNPFECDCGLA 38 (2740)
T ss_pred CCCCcCCccChHHhccCCCceEEEeeCCccccccccH
Confidence 4445554444444444555555555555554444433
No 411
>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]
Probab=77.20 E-value=1.5 Score=44.35 Aligned_cols=30 Identities=23% Similarity=0.426 Sum_probs=24.5
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~ 494 (495)
++.+++|||||+|+|.|.+. -.-+|+|..|
T Consensus 444 iMrnfdHphIikLIGv~~e~-P~WivmEL~~ 473 (974)
T KOG4257|consen 444 IMRNFDHPHIIKLIGVCVEQ-PMWIVMELAP 473 (974)
T ss_pred HHHhCCCcchhheeeeeecc-ceeEEEeccc
Confidence 89999999999999999754 4567777543
No 412
>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok
Probab=77.13 E-value=1.3 Score=42.81 Aligned_cols=31 Identities=16% Similarity=0.388 Sum_probs=25.8
Q ss_pred ecccccCCceeeeEEEEEeCC------eeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHAR------HSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~------~~~LVyeym~ 494 (495)
++.+++|+|+|++++++...+ ..++|+|||+
T Consensus 69 ~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~ 105 (355)
T cd07874 69 LMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD 105 (355)
T ss_pred HHHHhCCCchhceeeeeeccccccccceeEEEhhhhc
Confidence 678899999999999886532 4689999986
No 413
>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of
Probab=76.74 E-value=2.5 Score=40.30 Aligned_cols=27 Identities=11% Similarity=-0.031 Sum_probs=25.0
Q ss_pred cCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 469 GHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 469 ~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
+|+|+|++.+++.+++..++|+||+++
T Consensus 54 ~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 54 ESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999999999999999974
No 414
>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins. Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic
Probab=76.26 E-value=1.1 Score=42.10 Aligned_cols=31 Identities=16% Similarity=0.275 Sum_probs=26.0
Q ss_pred ecccccCCceeeeEEEEEeCC--------eeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHAR--------HSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~--------~~~LVyeym~ 494 (495)
.+.+++|+|+|++++++.+.. ..++|+||++
T Consensus 60 ~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~ 98 (311)
T cd07866 60 ILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD 98 (311)
T ss_pred HHHhcCCCCccchhhheecccccccccCceEEEEEecCC
Confidence 788999999999999876533 4589999986
No 415
>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]
Probab=76.14 E-value=1.7 Score=45.58 Aligned_cols=31 Identities=26% Similarity=0.396 Sum_probs=26.5
Q ss_pred cccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 465 LTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 465 l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
-.-.+|+|+|.++|+|...+..++|.||.++
T Consensus 356 ~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~ 386 (609)
T KOG0200|consen 356 KELGKHPNIVNLLGACTQDGPLYVIVEYAEH 386 (609)
T ss_pred HHhcCCcchhhheeeeccCCceEEEEEeccC
Confidence 3345699999999999998899999999763
No 416
>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=76.13 E-value=2 Score=43.77 Aligned_cols=32 Identities=19% Similarity=0.398 Sum_probs=29.5
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
+|.-|.|||+++|+-.-.+..+.+||.|||+.
T Consensus 65 iMkLi~HpnVl~LydVwe~~~~lylvlEyv~g 96 (786)
T KOG0588|consen 65 IMKLIEHPNVLRLYDVWENKQHLYLVLEYVPG 96 (786)
T ss_pred HHHHhcCCCeeeeeeeeccCceEEEEEEecCC
Confidence 77889999999999998889999999999984
No 417
>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13
Probab=75.19 E-value=1.4 Score=42.36 Aligned_cols=31 Identities=16% Similarity=0.319 Sum_probs=26.3
Q ss_pred ecccccCCceeeeEEEEEeC------CeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHA------RHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~------~~~~LVyeym~ 494 (495)
++.+++|+|+|+++|++... .+.++|+|||+
T Consensus 67 ~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~ 103 (342)
T cd07879 67 LLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ 103 (342)
T ss_pred HHHhcCCCCccchhheecccccCCCCceEEEEecccc
Confidence 78899999999999998754 24589999985
No 418
>smart00365 LRR_SD22 Leucine-rich repeat, SDS22-like subfamily.
Probab=75.15 E-value=2.4 Score=23.14 Aligned_cols=12 Identities=33% Similarity=0.609 Sum_probs=5.8
Q ss_pred CCCeeeccCCcc
Q 041558 72 SLGDLQLNGNQF 83 (495)
Q Consensus 72 ~L~~L~l~~n~l 83 (495)
+|++|++++|+|
T Consensus 3 ~L~~L~L~~NkI 14 (26)
T smart00365 3 NLEELDLSQNKI 14 (26)
T ss_pred ccCEEECCCCcc
Confidence 444455555444
No 419
>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and
Probab=74.74 E-value=0.88 Score=43.41 Aligned_cols=31 Identities=23% Similarity=0.318 Sum_probs=27.7
Q ss_pred ecccccCCceeeeEEEEEeCC-----eeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHAR-----HSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~-----~~~LVyeym~ 494 (495)
.+.+++|+|++++.|++...+ ..++|+|||+
T Consensus 52 ~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~ 87 (330)
T cd07834 52 LLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME 87 (330)
T ss_pred HHHhcCCcchhhhhhhhcccCcccccceEEEecchh
Confidence 788889999999999998875 7799999986
No 420
>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK
Probab=74.51 E-value=2.2 Score=41.21 Aligned_cols=31 Identities=16% Similarity=0.365 Sum_probs=25.9
Q ss_pred ecccccCCceeeeEEEEEeC------CeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHA------RHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~------~~~~LVyeym~ 494 (495)
++.+++|+|+|++++++... ...++|+|||+
T Consensus 68 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~ 104 (353)
T cd07850 68 LMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD 104 (353)
T ss_pred HHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccC
Confidence 78889999999999988643 24689999986
No 421
>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha. Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a
Probab=74.11 E-value=3 Score=39.74 Aligned_cols=32 Identities=9% Similarity=0.061 Sum_probs=24.8
Q ss_pred ecccc-cCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTET-GHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~-~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.++ +|++++++.+++.+.+..++|+||+++
T Consensus 53 ~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~ 85 (323)
T cd05615 53 VLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNG 85 (323)
T ss_pred HHHhccCCCchhheeeEEecCCEEEEEEcCCCC
Confidence 34444 467788888888888889999999974
No 422
>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5. Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the
Probab=73.93 E-value=1.1 Score=43.01 Aligned_cols=31 Identities=19% Similarity=0.301 Sum_probs=26.2
Q ss_pred ecccccCCceeeeEEEEEe----CCeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSH----ARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~----~~~~~LVyeym~ 494 (495)
++.+++|+|+|++.+++.. +...++|+||++
T Consensus 57 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~ 91 (334)
T cd07855 57 ILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME 91 (334)
T ss_pred HHHhcCCCCccCHHHhccccCCCCceEEEEEehhh
Confidence 7889999999999998763 346799999985
No 423
>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12
Probab=73.38 E-value=2.1 Score=41.13 Aligned_cols=31 Identities=13% Similarity=0.203 Sum_probs=26.0
Q ss_pred ecccccCCceeeeEEEEEeCC------eeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHAR------HSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~------~~~LVyeym~ 494 (495)
++.+++|+|+|++++++..++ +.++|+||+.
T Consensus 67 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~ 103 (343)
T cd07880 67 LLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMG 103 (343)
T ss_pred HHHhcCCCCccceeeeecCCccccccceEEEEEecCC
Confidence 788999999999999987543 4589999984
No 424
>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]
Probab=71.59 E-value=2.3 Score=41.56 Aligned_cols=32 Identities=25% Similarity=0.195 Sum_probs=27.1
Q ss_pred ecccccCCceeeeEEEEEeCCe-eEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARH-SFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~-~~LVyeym~n 495 (495)
++++++|||||....--.+++. .++|.||.++
T Consensus 56 lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eG 88 (426)
T KOG0589|consen 56 LLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEG 88 (426)
T ss_pred HHHhccCCCeeeeccchhcCCceEEEEEeecCC
Confidence 8999999999988876666666 7899999864
No 425
>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]
Probab=70.60 E-value=3.9 Score=39.74 Aligned_cols=31 Identities=16% Similarity=0.168 Sum_probs=28.4
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~ 494 (495)
.++-++|||||+.+..-..+++..+|+-||.
T Consensus 77 ~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa 107 (516)
T KOG0582|consen 77 TMSLIDHPNIVTYHCSFVVDSELWVVMPFMA 107 (516)
T ss_pred HhhhcCCCCcceEEEEEEecceeEEeehhhc
Confidence 8999999999998888888999999999996
No 426
>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C. Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory
Probab=70.52 E-value=4.9 Score=38.19 Aligned_cols=32 Identities=13% Similarity=0.151 Sum_probs=25.5
Q ss_pred ecccccC-CceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGH-RNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H-~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++..++| ++++++.+++.+.+..++|+||+++
T Consensus 53 ~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 85 (324)
T cd05587 53 VLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNG 85 (324)
T ss_pred HHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCC
Confidence 4556655 5688888888888999999999974
No 427
>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]
Probab=70.19 E-value=4.2 Score=39.64 Aligned_cols=31 Identities=26% Similarity=0.301 Sum_probs=28.9
Q ss_pred eccccc-CCceeeeEEEEEeCCeeEEEecccC
Q 041558 464 ALTETG-HRNIVKFYGFCSHARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~-H~NlV~l~G~c~~~~~~~LVyeym~ 494 (495)
+|.++. |||+|.+.+.....+...+|.|+..
T Consensus 88 il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~ 119 (382)
T KOG0032|consen 88 ILQQLSGHPNIVQLKDAFEDPDSVYLVMELCE 119 (382)
T ss_pred HHHhccCCCCEEEEEEEEEcCCeEEEEEEecC
Confidence 788888 9999999999999999999999875
No 428
>cd00180 PKc Catalytic domain of Protein Kinases. Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which
Probab=69.97 E-value=4.3 Score=35.03 Aligned_cols=31 Identities=39% Similarity=0.577 Sum_probs=29.1
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~ 494 (495)
.+.+++|++++++++++...+..++|+||++
T Consensus 44 ~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~ 74 (215)
T cd00180 44 ILKKLNHPNIVKLYGVFEDENHLYLVMEYCE 74 (215)
T ss_pred HHHhcCCCCeeeEeeeeecCCeEEEEEecCC
Confidence 7888899999999999999999999999987
No 429
>smart00368 LRR_RI Leucine rich repeat, ribonuclease inhibitor type.
Probab=67.99 E-value=3.7 Score=22.76 Aligned_cols=14 Identities=50% Similarity=0.596 Sum_probs=9.6
Q ss_pred ccCCeeecccCccc
Q 041558 23 QFLWGLDLSNNQFS 36 (495)
Q Consensus 23 ~~L~~L~l~~n~l~ 36 (495)
++|++|||++|.+.
T Consensus 2 ~~L~~LdL~~N~i~ 15 (28)
T smart00368 2 PSLRELDLSNNKLG 15 (28)
T ss_pred CccCEEECCCCCCC
Confidence 45677777777765
No 430
>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]
Probab=67.78 E-value=2 Score=38.77 Aligned_cols=31 Identities=23% Similarity=0.351 Sum_probs=28.6
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~ 494 (495)
.|.-..|||+.+.+|.|.+.....++..|||
T Consensus 240 ~lrifshpnilpvlgacnsppnlv~isq~mp 270 (448)
T KOG0195|consen 240 ALRIFSHPNILPVLGACNSPPNLVIISQYMP 270 (448)
T ss_pred ceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence 6777789999999999999999999999998
No 431
>PF02009 Rifin_STEVOR: Rifin/stevor family; InterPro: IPR002858 Malaria is still a major cause of mortality in many areas of the world. Plasmodium falciparum causes the most severe human form of the disease and is responsible for most fatalities. Severe cases of malaria can occur when the parasite invades and then proliferates within red blood cell erythrocytes. The parasite produces many variant antigenic proteins, encoded by multigene families, which are present on the surface of the infected erythrocyte and play important roles in virulence. A crucial survival mechanism for the malaria parasite is its ability to evade the immune response by switching these variant surface antigens. The high virulence of P. falciparum relative to other malarial parasites is in large part due to the fact that in this organism many of these surface antigens mediate the binding of infected erythrocytes to the vascular endothelium (cytoadherence) and non-infected erythrocytes (rosetting). This can lead to the accumulation of infected cells in the vasculature of a variety of organs, blocking the blood flow and reducing the oxygen supply. Clinical symptoms of severe infection can include fever, progressive anaemia, multi-organ dysfunction and coma. For more information see []. Several multicopy gene families have been described in Plasmodium falciparum, including the stevor family of subtelomeric open reading frames and the rif interspersed repetitive elements. Both families contain three predicted transmembrane segments. It has been proposed that stevor and rif are members of a larger superfamily that code for variant surface antigens [].
Probab=66.48 E-value=4.1 Score=37.89 Aligned_cols=25 Identities=12% Similarity=0.531 Sum_probs=11.3
Q ss_pred hhHHHHHHHHHHHHHHHHHHhhhcc
Q 041558 415 LLVGALFVSIALILIFFIFQKWKSN 439 (495)
Q Consensus 415 ~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (495)
+++++++++++++.++.++|.||++
T Consensus 261 SiiaIliIVLIMvIIYLILRYRRKK 285 (299)
T PF02009_consen 261 SIIAILIIVLIMVIIYLILRYRRKK 285 (299)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHh
Confidence 3334444444444455555544433
No 432
>KOG4242 consensus Predicted myosin-I-binding protein [Cell motility]
Probab=64.53 E-value=12 Score=36.88 Aligned_cols=59 Identities=25% Similarity=0.298 Sum_probs=34.9
Q ss_pred CcEEEeeCCcccccCCccCcCC---ccCCeeecccCccc---ccCCcccccCcccceeecccccc
Q 041558 1 MALLIIHNNSLSGFIPLNIGNS---QFLWGLDLSNNQFS---SSIPLSFGNLSNLIFLYLYENSY 59 (495)
Q Consensus 1 L~~L~l~~n~l~~~~~~~~~~l---~~L~~L~l~~n~l~---~~~~~~~~~l~~L~~L~L~~n~~ 59 (495)
+.+++++.|.....+|..+..+ ..++.+|.+.-.+. +..+..++.-++|...+++.|..
T Consensus 216 lteldls~n~~Kddip~~~n~~a~~~vl~~ld~s~tgirlD~l~~~l~~g~~tkl~~~kls~ng~ 280 (553)
T KOG4242|consen 216 LTELDLSTNGGKDDIPRTLNKKAGTLVLFKLDRSTTGIRLDLLTSPLAAGRTTKLTFGKLSRNGT 280 (553)
T ss_pred ccccccccCCCCccchhHHHHhhhhhhhhcccccccccchhhcccccccccccccchhhhccCCC
Confidence 3567778787777777554322 24666777665553 12233345556777777777754
No 433
>PF12191 stn_TNFRSF12A: Tumour necrosis factor receptor stn_TNFRSF12A_TNFR domain; InterPro: IPR022316 The tumour necrosis factor (TNF) receptor (TNFR) superfamily comprises more than 20 type-I transmembrane proteins. Family members are defined based on similarity in their extracellular domain - a region that contains many cysteine residues arranged in a specific repetitive pattern []. The cysteines allow formation of an extended rod-like structure, responsible for ligand binding []. Upon receptor activation, different intracellular signalling complexes are assembled for different members of the TNFR superfamily, depending on their intracellular domains and sequences []. Activation of TNFRs can therefore induce a range of disparate effects, including cell proliferation, differentiation, survival, or apoptotic cell death, depending upon the receptor involved []. TNFRs are widely distributed and play important roles in many crucial biological processes, such as lymphoid and neuronal development, innate and adaptive immunity, and maintenance of cellular homeostasis []. Drugs that manipulate their signalling have potential roles in the prevention and treatment of many diseases, such as viral infections, coronary heart disease, transplant rejection, and immune disease []. TNF receptor 12 (also known as TWEAK receptor, and fibroblast growth factor-inducible-14 (Fn14)) has been implicated in endothelial cell growth and migration []. The receptor may also play a role in cell-matrix interactions [].; PDB: 2KN0_A 2RPJ_A 2KMZ_A 2EQP_A.
Probab=64.30 E-value=4 Score=31.87 Aligned_cols=9 Identities=11% Similarity=0.792 Sum_probs=0.0
Q ss_pred HHHHHhhhc
Q 041558 430 FFIFQKWKS 438 (495)
Q Consensus 430 ~~~~~~~~~ 438 (495)
+++|+|.|+
T Consensus 98 ~lv~rrcrr 106 (129)
T PF12191_consen 98 FLVWRRCRR 106 (129)
T ss_dssp ---------
T ss_pred HHHHhhhhc
Confidence 333444333
No 434
>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6. Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi
Probab=62.74 E-value=3.2 Score=39.86 Aligned_cols=32 Identities=28% Similarity=0.413 Sum_probs=25.7
Q ss_pred ecccccCCceeeeEEEEEeC--------------CeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHA--------------RHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~--------------~~~~LVyeym~n 495 (495)
++.+++|+|+|++++++... +..++|+||+++
T Consensus 55 ~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~ 100 (342)
T cd07854 55 IIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET 100 (342)
T ss_pred HHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeecccc
Confidence 78899999999999776543 356899999863
No 435
>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]
Probab=62.73 E-value=3.5 Score=37.33 Aligned_cols=28 Identities=18% Similarity=0.409 Sum_probs=25.8
Q ss_pred ccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 468 TGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 468 ~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
..||+|++|.-+..+....+||+|.||.
T Consensus 80 ~GHP~II~l~D~yes~sF~FlVFdl~pr 107 (411)
T KOG0599|consen 80 MGHPYIIDLQDVYESDAFVFLVFDLMPR 107 (411)
T ss_pred cCCCcEEEeeeeccCcchhhhhhhhccc
Confidence 4699999999999999999999999984
No 436
>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]
Probab=62.59 E-value=3.6 Score=39.37 Aligned_cols=31 Identities=16% Similarity=0.289 Sum_probs=28.8
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~ 494 (495)
+++.+.||||+.++....+.+...+|+||-.
T Consensus 106 IMSsLNHPhII~IyEVFENkdKIvivMEYaS 136 (668)
T KOG0611|consen 106 IMSSLNHPHIIQIYEVFENKDKIVIVMEYAS 136 (668)
T ss_pred HHhhcCCCceeehhhhhcCCceEEEEEEecC
Confidence 8999999999999999988999999999964
No 437
>PRK09188 serine/threonine protein kinase; Provisional
Probab=61.55 E-value=5.1 Score=38.80 Aligned_cols=29 Identities=17% Similarity=-0.104 Sum_probs=22.4
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.+++|+|+|+-+.. .+..++|||||++
T Consensus 74 iL~~L~h~~iv~~l~~---~~~~~LVmE~~~G 102 (365)
T PRK09188 74 ALKTVRGIGVVPQLLA---TGKDGLVRGWTEG 102 (365)
T ss_pred HHHhccCCCCCcEEEE---cCCcEEEEEccCC
Confidence 8899999999964432 2457999999974
No 438
>KOG4242 consensus Predicted myosin-I-binding protein [Cell motility]
Probab=60.25 E-value=30 Score=34.23 Aligned_cols=218 Identities=18% Similarity=0.061 Sum_probs=106.1
Q ss_pred ccceeecccccccccCCccccC---CCCCCeeeccCCcccc---cCChhhhcCCCCCEEecCCCcccc----cCCccc--
Q 041558 48 NLIFLYLYENSYFASIPSNVGK---LKSLGDLQLNGNQFIS---YIPSSFGNLTNLSTSRLSKNKLFV----SIPNEI-- 115 (495)
Q Consensus 48 ~L~~L~L~~n~~~~~~~~~~~~---l~~L~~L~l~~n~l~~---~~~~~~~~l~~L~~L~l~~n~~~~----~~~~~~-- 115 (495)
.+.+++|+.|.....+|..... -.-++.++.+...+.- ..+-.++.-++|++.+++.|..+. +++...
T Consensus 215 ~lteldls~n~~Kddip~~~n~~a~~~vl~~ld~s~tgirlD~l~~~l~~g~~tkl~~~kls~ng~s~skg~Egg~~~k~ 294 (553)
T KOG4242|consen 215 WLTELDLSTNGGKDDIPRTLNKKAGTLVLFKLDRSTTGIRLDLLTSPLAAGRTTKLTFGKLSRNGTSPSKGEEGGGAEKD 294 (553)
T ss_pred cccccccccCCCCccchhHHHHhhhhhhhhcccccccccchhhcccccccccccccchhhhccCCCCccccccccccccc
Confidence 4677777777766666654432 2335666665544321 122233445677777777776532 222222
Q ss_pred --cCCCCCCEEeeecccccCCCCC---------------CEEEccccccccC--CCccCcccccccccccccccccccCc
Q 041558 116 --GKMRSLNILEVLPLSVSNLTNP---------------KELALLYNCLSGS--IPPSLENPMLARLGLDFNHFKRTIPK 176 (495)
Q Consensus 116 --~~l~~L~~L~l~~~~l~~~~~L---------------~~L~l~~n~l~~~--~~~~~~~~~L~~L~l~~n~~~~~~~~ 176 (495)
..-.++ +|++.+... ....+ -.+++..|...+. ....+....++++....|...+....
T Consensus 295 ~fS~~~sg-hln~~~~~~-psE~lks~LLgla~ne~t~g~rldl~~cp~~~a~vleaci~g~R~q~l~~rdnnldgeg~~ 372 (553)
T KOG4242|consen 295 TFSPDPSG-HLNSRPRYT-PSEKLKSMLLGLAENEATLGARLDLRRCPLERAEVLEACIFGQRVQVLLQRDNNLDGEGGA 372 (553)
T ss_pred ccCcCccc-ccccccccC-chhhhhhhhcccccccccccccCChhhccccccchhhccccceeeeEeecccccccccccc
Confidence 222333 444311000 00001 1222222222111 11122224578888888877665443
Q ss_pred cC--CCCCCCCEEEccCceee-eccCcccc--------CCCCccEEEccCCcCcccCCC---CCCCCCCCCEEecccccc
Q 041558 177 SL--RSCTSLIRLCRNRNNLT-RDISEALG--------IYPYLTFIDLSRNNFHGEIPS---NREKCPKLGTLGVLMNTI 242 (495)
Q Consensus 177 ~~--~~l~~L~~L~l~~n~~~-~~~~~~~~--------~~~~L~~L~l~~n~l~~~~~~---~~~~~~~L~~L~l~~n~l 242 (495)
.. ...+..+.+++..-.-. ...+.... ...-++.+.++.+.+...... ....-+.++.|++++|..
T Consensus 373 vgk~~~s~s~r~l~agrs~~kqvm~s~~~a~~v~k~~~~~g~l~el~ls~~~lka~l~s~in~l~stqtl~kldisgn~m 452 (553)
T KOG4242|consen 373 VGKRKQSKSGRILKAGRSGDKQVMDSSTEAPPVSKKSRTHGVLAELSLSPGPLKAGLESAINKLLSTQTLAKLDISGNGM 452 (553)
T ss_pred ccceeeccccccccccccCCceeccccccchhhhhhhcccccccCcccCCCcccccHHHHHHhhccCcccccccccCCCc
Confidence 32 23445566655432110 01111111 122366777888877643222 234567889999999987
Q ss_pred ccc----CCccccCCCCCceeccCCCeee
Q 041558 243 TKG----IPREIRNSSQRQALDLSLNHII 267 (495)
Q Consensus 243 ~~~----~~~~~~~l~~L~~L~ls~n~l~ 267 (495)
... +|.....-.+++.+..+.|...
T Consensus 453 gd~gap~lpkalq~n~rlr~ipds~n~p~ 481 (553)
T KOG4242|consen 453 GDGGAPPLPKALQSNCRLRPIPDSLNLPE 481 (553)
T ss_pred ccCCCCcCccccCCCCccCCCCCCCCCcc
Confidence 643 4455555566777766666543
No 439
>KOG3763 consensus mRNA export factor TAP/MEX67 [RNA processing and modification]
Probab=60.05 E-value=3.7 Score=41.03 Aligned_cols=15 Identities=33% Similarity=0.346 Sum_probs=7.1
Q ss_pred CccCCeeecccCccc
Q 041558 22 SQFLWGLDLSNNQFS 36 (495)
Q Consensus 22 l~~L~~L~l~~n~l~ 36 (495)
.+.+..+.|++|++.
T Consensus 217 ~p~i~sl~lsnNrL~ 231 (585)
T KOG3763|consen 217 FPEILSLSLSNNRLY 231 (585)
T ss_pred Ccceeeeecccchhh
Confidence 344444555555543
No 440
>PF08114 PMP1_2: ATPase proteolipid family; InterPro: IPR012589 This family consists of small proteolipids associated with the plasma membrane H+ ATPase. Two proteolipids (PMP1 and PMP2) are associated with the ATPase and both genes are similarly expressed in the wild-type strain of yeast. No modification of the level of transcription of one PMP gene is detected in a strain deleted of the other. Though both proteolipids show similarity with other small proteolipids associated with other cation -transporting ATPases, their functions remain unclear [].
Probab=59.72 E-value=12 Score=22.61 Aligned_cols=8 Identities=50% Similarity=1.601 Sum_probs=3.3
Q ss_pred HHHHHhhh
Q 041558 430 FFIFQKWK 437 (495)
Q Consensus 430 ~~~~~~~~ 437 (495)
.+.+|+|.
T Consensus 27 ~~iYRKw~ 34 (43)
T PF08114_consen 27 LFIYRKWQ 34 (43)
T ss_pred HHHHHHHH
Confidence 33444443
No 441
>PF12273 RCR: Chitin synthesis regulation, resistance to Congo red; InterPro: IPR020999 RCR proteins are ER membrane proteins that regulate chitin deposition in fungal cell walls. Although chitin, a linear polymer of beta-1,4-linked N-acetylglucosamine, constitutes only 2% of the cell wall it plays a vital role in the overall protection of the cell wall against stress, noxious chemicals and osmotic pressure changes. Congo red is a cell wall-disrupting benzidine-type dye extensively used in many cell wall mutant studies that specifically targets chitin in yeast cells and inhibits growth. RCR proteins render the yeasts resistant to Congo red by diminishing the content of chitin in the cell wall []. RCR proteins are probably regulating chitin synthase III interact directly with ubiquitin ligase Rsp5, and the VPEY motif is necessary for this, via interaction with the WW domains of Rsp5 [].
Probab=58.70 E-value=8.4 Score=31.01 Aligned_cols=6 Identities=0% Similarity=-0.014 Sum_probs=2.8
Q ss_pred HHHhhh
Q 041558 432 IFQKWK 437 (495)
Q Consensus 432 ~~~~~~ 437 (495)
.+|+++
T Consensus 24 rRR~r~ 29 (130)
T PF12273_consen 24 RRRRRR 29 (130)
T ss_pred HHHhhc
Confidence 344554
No 442
>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated
Probab=58.50 E-value=6.7 Score=40.41 Aligned_cols=32 Identities=13% Similarity=0.046 Sum_probs=29.0
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+.+++|++++....|+...+..++||||+++
T Consensus 389 ~l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g 420 (535)
T PRK09605 389 LLSEARRAGVPTPVIYDVDPEEKTIVMEYIGG 420 (535)
T ss_pred HHHhhcccCCCeeEEEEEeCCCCEEEEEecCC
Confidence 78899999999999999988888999999974
No 443
>PF15102 TMEM154: TMEM154 protein family
Probab=57.93 E-value=13 Score=30.22 Aligned_cols=21 Identities=10% Similarity=0.254 Sum_probs=11.8
Q ss_pred HHHHHHHHHHHhhhcccCCCC
Q 041558 424 IALILIFFIFQKWKSNLGDRQ 444 (495)
Q Consensus 424 ~~~~~~~~~~~~~~~~~~~~~ 444 (495)
++++.+++...+.||++.++.
T Consensus 70 lLLl~vV~lv~~~kRkr~K~~ 90 (146)
T PF15102_consen 70 LLLLSVVCLVIYYKRKRTKQE 90 (146)
T ss_pred HHHHHHHHheeEEeecccCCC
Confidence 333344555677777666544
No 444
>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]
Probab=57.72 E-value=10 Score=37.78 Aligned_cols=32 Identities=22% Similarity=0.220 Sum_probs=28.7
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
+|+...++.+|||+---.+.+..+||+||+|+
T Consensus 194 iL~~~ds~~vVKLyYsFQD~~~LYLiMEylPG 225 (550)
T KOG0605|consen 194 ILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPG 225 (550)
T ss_pred HhhhcCCCcEEEEEEEecCCCeeEEEEEecCC
Confidence 78889999999998777778899999999985
No 445
>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]
Probab=57.22 E-value=2.7 Score=43.22 Aligned_cols=31 Identities=29% Similarity=0.363 Sum_probs=25.0
Q ss_pred ecccccCCceeeeEEEEEe------CCeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSH------ARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~------~~~~~LVyeym~ 494 (495)
++.|+.|+|||+++|.=.+ .+...+|+||.+
T Consensus 64 ilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~ 100 (732)
T KOG4250|consen 64 ILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCS 100 (732)
T ss_pred HHHHcCchhhhhhcccCCccccCcccccceEEEeecC
Confidence 8999999999998876433 346789999975
No 446
>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]
Probab=56.64 E-value=8.9 Score=36.98 Aligned_cols=32 Identities=19% Similarity=0.124 Sum_probs=30.3
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
+|+.+.||=|++|++.-..++..+||+||.|+
T Consensus 130 IL~~lDHPFlPTLYa~fet~~~~cl~meyCpG 161 (459)
T KOG0610|consen 130 ILSLLDHPFLPTLYASFETDKYSCLVMEYCPG 161 (459)
T ss_pred HHHhcCCCccchhhheeeccceeEEEEecCCC
Confidence 89999999999999999999999999999875
No 447
>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK
Probab=56.43 E-value=2.8 Score=40.29 Aligned_cols=31 Identities=16% Similarity=0.278 Sum_probs=26.2
Q ss_pred ecccccCCceeeeEEEEEeCCe------eEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHARH------SFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~------~~LVyeym~ 494 (495)
++.+++|+|+|+++++...++. .++|+||+.
T Consensus 67 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~ 103 (343)
T cd07851 67 LLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMG 103 (343)
T ss_pred HHHhccCCCHHHHHHHhhccccccccccEEEEEecCC
Confidence 7888999999999998766554 799999985
No 448
>PF15050 SCIMP: SCIMP protein
Probab=55.65 E-value=8.3 Score=29.72 Aligned_cols=18 Identities=6% Similarity=0.213 Sum_probs=15.3
Q ss_pred ecccccCCceeeeEEEEE
Q 041558 464 ALTETGHRNIVKFYGFCS 481 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~ 481 (495)
...++||+..|..-+|-.
T Consensus 98 ~vnk~r~kk~vsipsyie 115 (133)
T PF15050_consen 98 LVNKVRNKKTVSIPSYIE 115 (133)
T ss_pred hhHhhccceeeccccccC
Confidence 678899999999888864
No 449
>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]
Probab=55.59 E-value=3.9 Score=42.23 Aligned_cols=30 Identities=17% Similarity=0.438 Sum_probs=25.7
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~ 494 (495)
.+-+++|||+|+|+|.... .-.++|+|.-+
T Consensus 164 ~M~~L~H~hliRLyGvVl~-qp~mMV~ELap 193 (1039)
T KOG0199|consen 164 HMLKLQHPHLIRLYGVVLD-QPAMMVFELAP 193 (1039)
T ss_pred HHHhccCcceeEEeeeecc-chhhHHhhhcc
Confidence 7889999999999999876 66788888654
No 450
>PRK14879 serine/threonine protein kinase; Provisional
Probab=54.73 E-value=6.3 Score=34.63 Aligned_cols=32 Identities=9% Similarity=0.065 Sum_probs=27.8
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+.+++|++++....++...+...+|+||+++
T Consensus 52 ~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G 83 (211)
T PRK14879 52 IMSRARKAGVNVPAVYFVDPENFIIVMEYIEG 83 (211)
T ss_pred HHHHHHHCCCCCCeEEEEeCCCCEEEEEEeCC
Confidence 67788999999888888888888999999974
No 451
>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=52.70 E-value=2.4 Score=42.70 Aligned_cols=30 Identities=20% Similarity=0.297 Sum_probs=28.2
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEeccc
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESL 493 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym 493 (495)
.|.+++|||.|...||...+...-||+||.
T Consensus 79 FL~~l~HPntieYkgCyLre~TaWLVMEYC 108 (948)
T KOG0577|consen 79 FLRQLRHPNTIEYKGCYLREHTAWLVMEYC 108 (948)
T ss_pred HHHhccCCCcccccceeeccchHHHHHHHH
Confidence 799999999999999999998899999995
No 452
>PF08374 Protocadherin: Protocadherin; InterPro: IPR013585 The structure of protocadherins is similar to that of classic cadherins (IPR002126 from INTERPRO), but they also have some unique features associated with the cytoplasmic domains. They are expressed in a variety of organisms and are found in high concentrations in the brain where they seem to be localised mainly at cell-cell contact sites. Their expression seems to be developmentally regulated [].
Probab=52.55 E-value=16 Score=31.75 Aligned_cols=10 Identities=10% Similarity=0.152 Sum_probs=5.5
Q ss_pred CCeeEEEecc
Q 041558 483 ARHSFSVYES 492 (495)
Q Consensus 483 ~~~~~LVyey 492 (495)
+.+.+=+|||
T Consensus 206 ~SD~yS~~~c 215 (221)
T PF08374_consen 206 SSDPYSDSSC 215 (221)
T ss_pred CCCccccccc
Confidence 4455556655
No 453
>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=52.27 E-value=9.6 Score=37.93 Aligned_cols=29 Identities=21% Similarity=0.375 Sum_probs=24.8
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecc
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYES 492 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyey 492 (495)
.+.-++|||||+|+..--.....+||.|.
T Consensus 70 CMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 70 CMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred HHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 67778999999999988777788898874
No 454
>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]
Probab=51.92 E-value=7.2 Score=36.77 Aligned_cols=31 Identities=23% Similarity=0.374 Sum_probs=25.6
Q ss_pred ecccccCCceeeeEEEEEe-----CCeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSH-----ARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~-----~~~~~LVyeym~ 494 (495)
.|..++|+|+|.+.-.-.. -++..+|+|+|+
T Consensus 74 lLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elMe 109 (359)
T KOG0660|consen 74 LLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELME 109 (359)
T ss_pred HHHHhcCCCcceEEeecccccccccceeEEehhHHh
Confidence 7889999999998876544 356799999996
No 455
>KOG3763 consensus mRNA export factor TAP/MEX67 [RNA processing and modification]
Probab=49.94 E-value=12 Score=37.50 Aligned_cols=63 Identities=27% Similarity=0.287 Sum_probs=37.8
Q ss_pred cccccceeeccccccccc--CCcccCCCCCCCEEeCCCC--cCCCCchhhhhc--CCCCCEEeCcCCcCCc
Q 041558 276 KLNSLIKLILRRNQLVGC--LPTEIGSPIELEYLDFSVN--RFNNLIPESLEN--LLKLHYLGLCKNKLVQ 340 (495)
Q Consensus 276 ~~~~L~~L~L~~n~l~~~--~~~~~~~l~~L~~L~Ls~n--~l~~~~~~~~~~--l~~L~~L~l~~n~l~~ 340 (495)
+.+.+..++|++|++... +.+.-...++|+.|+|++| .+... ..+.. ...|++|-+.+|++..
T Consensus 216 n~p~i~sl~lsnNrL~~Ld~~sslsq~apklk~L~LS~N~~~~~~~--~el~K~k~l~Leel~l~GNPlc~ 284 (585)
T KOG3763|consen 216 NFPEILSLSLSNNRLYHLDALSSLSQIAPKLKTLDLSHNHSKISSE--SELDKLKGLPLEELVLEGNPLCT 284 (585)
T ss_pred CCcceeeeecccchhhchhhhhHHHHhcchhheeecccchhhhcch--hhhhhhcCCCHHHeeecCCcccc
Confidence 345677788888877532 1122234578888888888 44332 12222 2357788888888744
No 456
>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1. Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co
Probab=49.43 E-value=11 Score=35.85 Aligned_cols=31 Identities=26% Similarity=0.313 Sum_probs=23.2
Q ss_pred ecccc-cCCceeeeEEEEEeC----CeeEEEecccC
Q 041558 464 ALTET-GHRNIVKFYGFCSHA----RHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~-~H~NlV~l~G~c~~~----~~~~LVyeym~ 494 (495)
++.++ .|+|+|++++++... ...+++.|||+
T Consensus 54 ~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~ 89 (332)
T cd07857 54 LLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELME 89 (332)
T ss_pred HHHHhcCCCChheeeeeeeeccccCCcEEEEEeccc
Confidence 56677 499999999987643 34677888875
No 457
>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14
Probab=49.25 E-value=11 Score=36.18 Aligned_cols=30 Identities=17% Similarity=0.295 Sum_probs=23.8
Q ss_pred ecccccCCceeeeEEEEEeC------CeeEEEeccc
Q 041558 464 ALTETGHRNIVKFYGFCSHA------RHSFSVYESL 493 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~------~~~~LVyeym 493 (495)
.+.+++|+|+|++.+++... ...++|.||+
T Consensus 69 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~ 104 (345)
T cd07877 69 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM 104 (345)
T ss_pred HHHHcCCCcccceeeeeeecccccccccEEEEehhc
Confidence 78889999999999988643 2357788776
No 458
>PTZ00046 rifin; Provisional
Probab=47.31 E-value=14 Score=35.14 Aligned_cols=25 Identities=12% Similarity=0.494 Sum_probs=10.8
Q ss_pred hhHHHHHHHHHHHHHHHHHHhhhcc
Q 041558 415 LLVGALFVSIALILIFFIFQKWKSN 439 (495)
Q Consensus 415 ~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (495)
.++++++++++++.+|...|.||++
T Consensus 320 SiiAIvVIVLIMvIIYLILRYRRKK 344 (358)
T PTZ00046 320 SIVAIVVIVLIMVIIYLILRYRRKK 344 (358)
T ss_pred HHHHHHHHHHHHHHHHHHHHhhhcc
Confidence 3344444444444444444444443
No 459
>TIGR01477 RIFIN variant surface antigen, rifin family. This model represents the rifin branch of the rifin/stevor family (pfam02009) of predicted variant surface antigens as found in Plasmodium falciparum. This model is based on a set of rifin sequences kindly provided by Matt Berriman from the Sanger Center. This is a global model and assesses a penalty for incomplete sequence. Additional fragmentary sequences may be found with the fragment model and a cutoff of 20 bits.
Probab=46.76 E-value=14 Score=34.92 Aligned_cols=26 Identities=12% Similarity=0.482 Sum_probs=11.0
Q ss_pred ehhHHHHHHHHHHHHHHHHHHhhhcc
Q 041558 414 FLLVGALFVSIALILIFFIFQKWKSN 439 (495)
Q Consensus 414 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (495)
+.++++++++++++.+|...|.||++
T Consensus 314 aSiIAIvvIVLIMvIIYLILRYRRKK 339 (353)
T TIGR01477 314 ASIIAILIIVLIMVIIYLILRYRRKK 339 (353)
T ss_pred HHHHHHHHHHHHHHHHHHHHHhhhcc
Confidence 33344444444444444444444443
No 460
>TIGR03724 arch_bud32 Kae1-associated kinase Bud32. Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.
Probab=46.18 E-value=10 Score=32.86 Aligned_cols=32 Identities=13% Similarity=0.068 Sum_probs=26.1
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+.+++|+++.....++...+...+|+||+++
T Consensus 50 ~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g 81 (199)
T TIGR03724 50 LLSRARKAGVNTPVVYDVDPDNKTIVMEYIEG 81 (199)
T ss_pred HHHHHHHCCCCCCEEEEEECCCCEEEEEEECC
Confidence 67788888877777777777788999999974
No 461
>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is
Probab=45.71 E-value=6.8 Score=37.54 Aligned_cols=31 Identities=16% Similarity=0.282 Sum_probs=24.9
Q ss_pred ecccccCCceeeeEEEEEeC------CeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHA------RHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~------~~~~LVyeym~ 494 (495)
++.+++|+|+|++++++... .+.++|+||+.
T Consensus 67 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~ 103 (343)
T cd07878 67 LLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMG 103 (343)
T ss_pred HHHhcCCCchhhhhhhhcccccccccCcEEEEeecCC
Confidence 78899999999999987543 34688888874
No 462
>PTZ00283 serine/threonine protein kinase; Provisional
Probab=45.70 E-value=16 Score=37.35 Aligned_cols=32 Identities=16% Similarity=0.000 Sum_probs=25.1
Q ss_pred ecccccCCceeeeEEEEEeCC--------eeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSHAR--------HSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~--------~~~LVyeym~n 495 (495)
.+.+++|+|+|+........+ ...+|+||+++
T Consensus 84 ~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~ 123 (496)
T PTZ00283 84 CLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANA 123 (496)
T ss_pred HHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCC
Confidence 678899999999888765432 35799999974
No 463
>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=45.67 E-value=5.4 Score=37.06 Aligned_cols=26 Identities=27% Similarity=0.634 Sum_probs=23.6
Q ss_pred cCCceeeeEEEEEeCCeeEEEecccC
Q 041558 469 GHRNIVKFYGFCSHARHSFSVYESLE 494 (495)
Q Consensus 469 ~H~NlV~l~G~c~~~~~~~LVyeym~ 494 (495)
.|+||+.|+-|-.+++..+||+|-|.
T Consensus 134 gh~nilqLiefFEdd~~FYLVfEKm~ 159 (463)
T KOG0607|consen 134 GHKNILQLIEFFEDDTRFYLVFEKMR 159 (463)
T ss_pred CCccHHHHHHHhcccceEEEEEeccc
Confidence 59999999999988888899999885
No 464
>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]
Probab=45.25 E-value=4.2 Score=35.89 Aligned_cols=32 Identities=16% Similarity=0.278 Sum_probs=26.3
Q ss_pred eccccc-CCceeeeEEEEEeCC--eeEEEecccCC
Q 041558 464 ALTETG-HRNIVKFYGFCSHAR--HSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~-H~NlV~l~G~c~~~~--~~~LVyeym~n 495 (495)
+|..++ |+|||+|+-...+.. ...||+||+.|
T Consensus 85 IL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n 119 (338)
T KOG0668|consen 85 ILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNN 119 (338)
T ss_pred HHHhccCCCCeeehhhhhcCccccCchhHhhhhcc
Confidence 677777 999999999887754 45799999876
No 465
>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]
Probab=42.10 E-value=12 Score=37.50 Aligned_cols=32 Identities=22% Similarity=0.212 Sum_probs=25.4
Q ss_pred ecccccCCceeeeEEEEE----eCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCS----HARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~----~~~~~~LVyeym~n 495 (495)
...++.|.|+|++...-. .+...+|||+|.|+
T Consensus 326 ~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~ 361 (655)
T KOG3741|consen 326 AWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPS 361 (655)
T ss_pred HHHHhccCceeehhhhhhhhccCcceEEEEEecCCC
Confidence 678899999999876543 35577899999885
No 466
>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]
Probab=39.88 E-value=37 Score=33.33 Aligned_cols=29 Identities=21% Similarity=0.216 Sum_probs=21.4
Q ss_pred cccCCceeeeEEEEEeCC----eeEEEecccCC
Q 041558 467 ETGHRNIVKFYGFCSHAR----HSFSVYESLEK 495 (495)
Q Consensus 467 ~~~H~NlV~l~G~c~~~~----~~~LVyeym~n 495 (495)
.+||.||..++|.=..+. +..||.||=|+
T Consensus 261 mLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~ 293 (513)
T KOG2052|consen 261 MLRHENILGFIAADNKDNGSWTQLWLVTDYHEH 293 (513)
T ss_pred HhccchhhhhhhccccCCCceEEEEEeeecccC
Confidence 479999998888754332 45799999764
No 467
>smart00367 LRR_CC Leucine-rich repeat - CC (cysteine-containing) subfamily.
Probab=38.64 E-value=21 Score=19.17 Aligned_cols=12 Identities=33% Similarity=0.573 Sum_probs=6.8
Q ss_pred CCCCeeeccCCc
Q 041558 71 KSLGDLQLNGNQ 82 (495)
Q Consensus 71 ~~L~~L~l~~n~ 82 (495)
++|++|++++|.
T Consensus 2 ~~L~~L~l~~C~ 13 (26)
T smart00367 2 PNLRELDLSGCT 13 (26)
T ss_pred CCCCEeCCCCCC
Confidence 455666666553
No 468
>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]
Probab=37.58 E-value=18 Score=33.54 Aligned_cols=27 Identities=26% Similarity=0.407 Sum_probs=20.7
Q ss_pred cCCceeeeEEEEEe----CCeeEEEecccCC
Q 041558 469 GHRNIVKFYGFCSH----ARHSFSVYESLEK 495 (495)
Q Consensus 469 ~H~NlV~l~G~c~~----~~~~~LVyeym~n 495 (495)
.|+|||+++-...+ ....++|+|+|++
T Consensus 113 ~h~~iV~IidVyeNs~~~rkcLLiVmE~meG 143 (400)
T KOG0604|consen 113 GHPHIVSIIDVYENSYQGRKCLLIVMECMEG 143 (400)
T ss_pred CCCceEEeehhhhhhccCceeeEeeeecccc
Confidence 59999999987654 2345789999974
No 469
>PF05454 DAG1: Dystroglycan (Dystrophin-associated glycoprotein 1); InterPro: IPR008465 Dystroglycan is one of the dystrophin-associated glycoproteins, which is encoded by a 5.5 kb transcript in Homo sapiens. The protein product is cleaved into two non-covalently associated subunits, [alpha] (N-terminal) and [beta] (C-terminal). In skeletal muscle the dystroglycan complex works as a transmembrane linkage between the extracellular matrix and the cytoskeleton [alpha]-dystroglycan is extracellular and binds to merosin ([alpha]-2 laminin) in the basement membrane, while [beta]-dystroglycan is a transmembrane protein and binds to dystrophin, which is a large rod-like cytoskeletal protein, absent in Duchenne muscular dystrophy patients. Dystrophin binds to intracellular actin cables. In this way, the dystroglycan complex, which links the extracellular matrix to the intracellular actin cables, is thought to provide structural integrity in muscle tissues. The dystroglycan complex is also known to serve as an agrin receptor in muscle, where it may regulate agrin-induced acetylcholine receptor clustering at the neuromuscular junction. There is also evidence which suggests the function of dystroglycan as a part of the signal transduction pathway because it is shown that Grb2, a mediator of the Ras-related signal pathway, can interact with the cytoplasmic domain of dystroglycan. In general, aberrant expression of dystrophin-associated protein complex underlies the pathogenesis of Duchenne muscular dystrophy, Becker muscular dystrophy and severe childhood autosomal recessive muscular dystrophy. Interestingly, no genetic disease has been described for either [alpha]- or [beta]-dystroglycan. Dystroglycan is widely distributed in non-muscle tissues as well as in muscle tissues. During epithelial morphogenesis of kidney, the dystroglycan complex is shown to act as a receptor for the basement membrane. Dystroglycan expression in Mus musculus brain and neural retina has also been reported. However, the physiological role of dystroglycan in non-muscle tissues has remained unclear [].; PDB: 1EG4_P.
Probab=37.20 E-value=11 Score=34.81 Aligned_cols=10 Identities=0% Similarity=0.232 Sum_probs=0.0
Q ss_pred HHHHHHhhhc
Q 041558 429 IFFIFQKWKS 438 (495)
Q Consensus 429 ~~~~~~~~~~ 438 (495)
+++++||+|+
T Consensus 166 a~icyrrkR~ 175 (290)
T PF05454_consen 166 ACICYRRKRK 175 (290)
T ss_dssp ----------
T ss_pred HHHhhhhhhc
Confidence 3344444333
No 470
>PF01102 Glycophorin_A: Glycophorin A; InterPro: IPR001195 Proteins in this group are responsible for the molecular basis of the blood group antigens, surface markers on the outside of the red blood cell membrane. Most of these markers are proteins, but some are carbohydrates attached to lipids or proteins [Reid M.E., Lomas-Francis C. The Blood Group Antigen FactsBook Academic Press, London / San Diego, (1997)]. Glycophorin A (PAS-2) and glycophorin B (PAS-3) belong to the MNS blood group system and are associated with antigens that include M/N, S/s, U, He, Mi(a), M(c), Vw, Mur, M(g), Vr, M(e), Mt(a), St(a), Ri(a), Cl(a), Ny(a), Hut, Hil, M(v), Far, Mit, Dantu, Hop, Nob, En(a), ENKT, amongst others. Glycophorin A is the major sialoglycoprotein of the erythrocyte membrane []. Structurally, glycophorin A consists of an N-terminal extracellular domain, heavily glycosylated on serine and threonine residues, followed by a transmembrane region and a C-terminal cytoplasmic domain. Other glycophorins in this entry such as Glycophorin B and Glycophorin E represent minor sialoglycoproteins in the erythrocyte membrane.; GO: 0016021 integral to membrane; PDB: 2KPF_B 1AFO_B 2KPE_A.
Probab=35.90 E-value=29 Score=27.44 Aligned_cols=13 Identities=15% Similarity=0.347 Sum_probs=5.7
Q ss_pred eeeeehhHHHHHH
Q 041558 410 FTIVFLLVGALFV 422 (495)
Q Consensus 410 ~~i~~~~~~~~~~ 422 (495)
..+++++++.+++
T Consensus 67 ~~Ii~gv~aGvIg 79 (122)
T PF01102_consen 67 IGIIFGVMAGVIG 79 (122)
T ss_dssp HHHHHHHHHHHHH
T ss_pred eehhHHHHHHHHH
Confidence 3444444444443
No 471
>TIGR00864 PCC polycystin cation channel protein. Note: this model has been restricted to the amino half because for technical reasons.
Probab=34.78 E-value=27 Score=42.51 Aligned_cols=32 Identities=19% Similarity=0.162 Sum_probs=22.9
Q ss_pred ecccccccccCCcccCCCCCCCEEeCCCCcCC
Q 041558 284 ILRRNQLVGCLPTEIGSPIELEYLDFSVNRFN 315 (495)
Q Consensus 284 ~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~ 315 (495)
||++|+|+...+..|..+++|+.|+|++|.+.
T Consensus 1 DLSnN~LstLp~g~F~~L~sL~~LdLsgNPw~ 32 (2740)
T TIGR00864 1 DISNNKISTIEEGICANLCNLSEIDLSGNPFE 32 (2740)
T ss_pred CCCCCcCCccChHHhccCCCceEEEeeCCccc
Confidence 46777777555666777777888888777664
No 472
>PF06697 DUF1191: Protein of unknown function (DUF1191); InterPro: IPR010605 This family contains hypothetical plant proteins of unknown function.
Probab=33.75 E-value=33 Score=31.41 Aligned_cols=17 Identities=18% Similarity=0.514 Sum_probs=7.3
Q ss_pred eeeeeehhHHHHHHHHH
Q 041558 409 WFTIVFLLVGALFVSIA 425 (495)
Q Consensus 409 ~~~i~~~~~~~~~~~~~ 425 (495)
|.+++..+.+++++.++
T Consensus 213 W~iv~g~~~G~~~L~ll 229 (278)
T PF06697_consen 213 WKIVVGVVGGVVLLGLL 229 (278)
T ss_pred EEEEEEehHHHHHHHHH
Confidence 44344434444443333
No 473
>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]
Probab=31.89 E-value=13 Score=38.18 Aligned_cols=31 Identities=23% Similarity=0.199 Sum_probs=25.6
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~ 494 (495)
+|+...||++|+|++.+..++..-+..||.+
T Consensus 82 ILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 82 ILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred hhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 8999999999999997777666666667765
No 474
>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]
Probab=31.73 E-value=33 Score=35.03 Aligned_cols=28 Identities=29% Similarity=0.432 Sum_probs=24.2
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecc
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYES 492 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyey 492 (495)
++.+.||-|||=++|||.+... ++|.-+
T Consensus 441 ~lkkTRH~NIlLFMG~~~~p~~-AIiTqw 468 (678)
T KOG0193|consen 441 VLKKTRHENILLFMGACMNPPL-AIITQW 468 (678)
T ss_pred HHhhcchhhheeeehhhcCCce-eeeehh
Confidence 8999999999999999998776 766544
No 475
>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional
Probab=31.39 E-value=26 Score=31.40 Aligned_cols=32 Identities=13% Similarity=0.140 Sum_probs=24.6
Q ss_pred ecccccCCceeeeEEEEEe--------CCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCSH--------ARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~--------~~~~~LVyeym~n 495 (495)
.+++++|+++.....+-.. .....||+||+++
T Consensus 88 ~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G 127 (232)
T PRK10359 88 QTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEG 127 (232)
T ss_pred HHHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECC
Confidence 5888999999988877432 2357899999974
No 476
>PF06365 CD34_antigen: CD34/Podocalyxin family; InterPro: IPR013836 This family consists of several mammalian CD34 antigen proteins. The CD34 antigen is a human leukocyte membrane protein expressed specifically by lymphohematopoietic progenitor cells. CD34 is a phosphoprotein. Activation of protein kinase C (PKC) has been found to enhance CD34 phosphorylation [, ]. This family contains several eukaryotic podocalyxin proteins. Podocalyxin is a major membrane protein of the glomerular epithelium and is thought to be involved in maintenance of the architecture of the foot processes and filtration slits characteristic of this unique epithelium by virtue of its high negative charge. Podocalyxin functions as an anti-adhesin that maintains an open filtration pathway between neighbouring foot processes in the glomerular epithelium by charge repulsion [].
Probab=31.23 E-value=73 Score=27.75 Aligned_cols=17 Identities=24% Similarity=0.245 Sum_probs=7.9
Q ss_pred HHHHHHHHHHHHHHHhh
Q 041558 420 LFVSIALILIFFIFQKW 436 (495)
Q Consensus 420 ~~~~~~~~~~~~~~~~~ 436 (495)
.+++++.+++|+++.||
T Consensus 112 lLla~~~~~~Y~~~~Rr 128 (202)
T PF06365_consen 112 LLLAILLGAGYCCHQRR 128 (202)
T ss_pred HHHHHHHHHHHHhhhhc
Confidence 34444444445555443
No 477
>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=30.01 E-value=3.4 Score=37.66 Aligned_cols=30 Identities=27% Similarity=0.299 Sum_probs=22.3
Q ss_pred ecccccCCceeeeEEEEEeC-Ce-eEEEeccc
Q 041558 464 ALTETGHRNIVKFYGFCSHA-RH-SFSVYESL 493 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~-~~-~~LVyeym 493 (495)
+|..++|||||+..++-... .+ .-+|+||.
T Consensus 71 lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c 102 (375)
T KOG0591|consen 71 LLKQLNHPNIVQYYAHSFIEDNEVLNIVMELC 102 (375)
T ss_pred HHHhcCCchHHHHHHHhhhccchhhHHHHHhh
Confidence 89999999999988865433 33 45777764
No 478
>PHA03265 envelope glycoprotein D; Provisional
Probab=29.89 E-value=48 Score=31.21 Aligned_cols=15 Identities=7% Similarity=0.361 Sum_probs=6.5
Q ss_pred HHHHHHHHHHHHhhh
Q 041558 423 SIALILIFFIFQKWK 437 (495)
Q Consensus 423 ~~~~~~~~~~~~~~~ 437 (495)
+++.++.+++|||++
T Consensus 362 v~vg~il~~~~rr~k 376 (402)
T PHA03265 362 VLVGVILYVCLRRKK 376 (402)
T ss_pred hhhhHHHHHHhhhhh
Confidence 333334445555443
No 479
>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]
Probab=29.46 E-value=37 Score=34.77 Aligned_cols=31 Identities=29% Similarity=0.354 Sum_probs=27.6
Q ss_pred ecccccCCceeeeEEEEEeCCeeEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHARHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~ 494 (495)
.+---.|+|+|++.+.|.++.+..+|+|+|.
T Consensus 369 ~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~ 399 (612)
T KOG0603|consen 369 SLLVRDHPNIVKSHDVYEDGKEIYLVMELLD 399 (612)
T ss_pred hhhhcCCCcceeecceecCCceeeeeehhcc
Confidence 4555689999999999999999999999985
No 480
>PF15330 SIT: SHP2-interacting transmembrane adaptor protein, SIT
Probab=27.87 E-value=81 Score=24.35 Aligned_cols=6 Identities=0% Similarity=0.080 Sum_probs=2.3
Q ss_pred HHHHhh
Q 041558 431 FIFQKW 436 (495)
Q Consensus 431 ~~~~~~ 436 (495)
..|+.+
T Consensus 20 ~~wr~~ 25 (107)
T PF15330_consen 20 LAWRMK 25 (107)
T ss_pred HHHHHH
Confidence 334333
No 481
>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]
Probab=27.70 E-value=32 Score=36.39 Aligned_cols=31 Identities=16% Similarity=0.221 Sum_probs=23.5
Q ss_pred eccccc-CCceeeeEEE-EEe----C--CeeEEEecccC
Q 041558 464 ALTETG-HRNIVKFYGF-CSH----A--RHSFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~-H~NlV~l~G~-c~~----~--~~~~LVyeym~ 494 (495)
++.+++ |||||.+++- ... + -|.+|.+||.+
T Consensus 87 ~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~ 125 (738)
T KOG1989|consen 87 IMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCK 125 (738)
T ss_pred HHHHhcCCCceeeEeccccccccCCCceeEEEeehhhcc
Confidence 788888 9999999882 221 2 37789999976
No 482
>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]
Probab=27.66 E-value=44 Score=34.26 Aligned_cols=31 Identities=23% Similarity=0.306 Sum_probs=24.7
Q ss_pred ecccccCCceeeeEEEEEeCCe--eEEEecccC
Q 041558 464 ALTETGHRNIVKFYGFCSHARH--SFSVYESLE 494 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~~~~~--~~LVyeym~ 494 (495)
+|..++|+||||++-+-.+.+. .-+|.|.|.
T Consensus 94 lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~T 126 (632)
T KOG0584|consen 94 LLKSLKHPNIIRFYDSWVDTDNKTINFITELFT 126 (632)
T ss_pred HHccCCCCceeeeeeheecCCCceeeeeeeccc
Confidence 8999999999999987666443 567888774
No 483
>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family. The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves
Probab=26.78 E-value=30 Score=27.73 Aligned_cols=32 Identities=16% Similarity=0.082 Sum_probs=25.2
Q ss_pred ecccccC--CceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTETGH--RNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H--~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
.+.+++| ..+.+++++...++..++|+||+++
T Consensus 44 ~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 44 ILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred HHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 5666666 4888888888777889999999863
No 484
>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]
Probab=24.55 E-value=63 Score=31.78 Aligned_cols=32 Identities=31% Similarity=0.383 Sum_probs=27.0
Q ss_pred ecccccCCceeeeEEEEE-eCCeeEEEecccCC
Q 041558 464 ALTETGHRNIVKFYGFCS-HARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~~H~NlV~l~G~c~-~~~~~~LVyeym~n 495 (495)
+-..+.|+.||+++-|-. +.+..+-|.||.|.
T Consensus 520 IHKeLDHpRIVKlYDyfslDtdsFCTVLEYceG 552 (775)
T KOG1151|consen 520 IHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEG 552 (775)
T ss_pred hhhccCcceeeeeeeeeeeccccceeeeeecCC
Confidence 677899999999999875 56677899999874
No 485
>PF02009 Rifin_STEVOR: Rifin/stevor family; InterPro: IPR002858 Malaria is still a major cause of mortality in many areas of the world. Plasmodium falciparum causes the most severe human form of the disease and is responsible for most fatalities. Severe cases of malaria can occur when the parasite invades and then proliferates within red blood cell erythrocytes. The parasite produces many variant antigenic proteins, encoded by multigene families, which are present on the surface of the infected erythrocyte and play important roles in virulence. A crucial survival mechanism for the malaria parasite is its ability to evade the immune response by switching these variant surface antigens. The high virulence of P. falciparum relative to other malarial parasites is in large part due to the fact that in this organism many of these surface antigens mediate the binding of infected erythrocytes to the vascular endothelium (cytoadherence) and non-infected erythrocytes (rosetting). This can lead to the accumulation of infected cells in the vasculature of a variety of organs, blocking the blood flow and reducing the oxygen supply. Clinical symptoms of severe infection can include fever, progressive anaemia, multi-organ dysfunction and coma. For more information see []. Several multicopy gene families have been described in Plasmodium falciparum, including the stevor family of subtelomeric open reading frames and the rif interspersed repetitive elements. Both families contain three predicted transmembrane segments. It has been proposed that stevor and rif are members of a larger superfamily that code for variant surface antigens [].
Probab=23.97 E-value=56 Score=30.57 Aligned_cols=28 Identities=14% Similarity=0.204 Sum_probs=15.2
Q ss_pred eeehhHHHHHHHHHHHHHHHHHHhhhcc
Q 041558 412 IVFLLVGALFVSIALILIFFIFQKWKSN 439 (495)
Q Consensus 412 i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (495)
.++++++++++.+++..++.++|+++.+
T Consensus 261 SiiaIliIVLIMvIIYLILRYRRKKKmk 288 (299)
T PF02009_consen 261 SIIAILIIVLIMVIIYLILRYRRKKKMK 288 (299)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHhhhh
Confidence 3445555555555555566666655443
No 486
>PF12669 P12: Virus attachment protein p12 family
Probab=23.53 E-value=1.3e+02 Score=20.24 Aligned_cols=25 Identities=12% Similarity=0.171 Sum_probs=0.0
Q ss_pred ehhHHHHHHHHHHHHHHHHHHhhhc
Q 041558 414 FLLVGALFVSIALILIFFIFQKWKS 438 (495)
Q Consensus 414 ~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (495)
++++++++++++.+++...++++++
T Consensus 2 iII~~Ii~~~~~~v~~r~~~k~~K~ 26 (58)
T PF12669_consen 2 IIIGIIILAAVAYVAIRKFIKDKKK 26 (58)
T ss_pred eeHHHHHHHHHHHHHHHHHHHHhhc
No 487
>PF07213 DAP10: DAP10 membrane protein; InterPro: IPR009861 This family consists of several mammalian DAP10 membrane proteins. In activated mouse natural killer (NK) cells, the NKG2D receptor associates with two intracellular adaptors, DAP10 and DAP12, which trigger phosphatidyl inositol 3 kinase (PI3K) and Syk family protein tyrosine kinases, respectively. It has been suggested that the DAP10-PI3K pathway is sufficient to initiate NKG2D-mediated killing of target cells [].
Probab=23.52 E-value=87 Score=22.47 Aligned_cols=32 Identities=3% Similarity=0.244 Sum_probs=0.0
Q ss_pred ehhHHHHHHHHHHHHHHHHHHhhhcccCCCCC
Q 041558 414 FLLVGALFVSIALILIFFIFQKWKSNLGDRQC 445 (495)
Q Consensus 414 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (495)
++..-+++-++++.++|++.+.+++++.+..+
T Consensus 39 iV~~D~vlTLLIv~~vy~car~r~r~~~~~~k 70 (79)
T PF07213_consen 39 IVAADAVLTLLIVLVVYYCARPRRRPTQEDDK 70 (79)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccCCcccCCE
No 488
>PF05568 ASFV_J13L: African swine fever virus J13L protein; InterPro: IPR008385 This family consists of several African swine fever virus (ASFV) j13L proteins [, , ].
Probab=23.41 E-value=80 Score=25.39 Aligned_cols=27 Identities=15% Similarity=0.416 Sum_probs=0.0
Q ss_pred ehhHHHHHHHHHHHHHHHHHHhhhccc
Q 041558 414 FLLVGALFVSIALILIFFIFQKWKSNL 440 (495)
Q Consensus 414 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (495)
.+.+++++.++++++..+++.+|+|++
T Consensus 33 tILiaIvVliiiiivli~lcssRKkKa 59 (189)
T PF05568_consen 33 TILIAIVVLIIIIIVLIYLCSSRKKKA 59 (189)
T ss_pred HHHHHHHHHHHHHHHHHHHHhhhhHHH
No 489
>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]
Probab=23.12 E-value=32 Score=35.66 Aligned_cols=60 Identities=15% Similarity=0.183 Sum_probs=0.0
Q ss_pred HHHhhhcccCCCCCCCCCC---CCceEEEeeccceecccccCCceeeeEEEEEeCCeeEEEecc
Q 041558 432 IFQKWKSNLGDRQCNNQNP---QGLLSILNFKGKLALTETGHRNIVKFYGFCSHARHSFSVYES 492 (495)
Q Consensus 432 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~~~H~NlV~l~G~c~~~~~~~LVyey 492 (495)
+++-|.++..+........ ++.|+..+-..- ++...+|+|||.++|-....+.--+++||
T Consensus 31 vyKaRd~~s~elaavkvVkLep~dd~~~iqqei~-~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 31 VYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIG-MLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred hhhhcccccCchhhheeeeccCCcccccccccee-eeecCCCcChHHHHhhhhhhcCcEEEEEe
No 490
>PRK12274 serine/threonine protein kinase; Provisional
Probab=22.68 E-value=61 Score=28.70 Aligned_cols=28 Identities=14% Similarity=0.093 Sum_probs=0.0
Q ss_pred ecccc-cCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 464 ALTET-GHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 464 ~l~~~-~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
++.++ +|++++++++| +..++|+||++.
T Consensus 54 iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G 82 (218)
T PRK12274 54 ALRQLDGLPRTPRLLHW----DGRHLDRSYLAG 82 (218)
T ss_pred HHHhcCCCCCCCEEEEE----cCEEEEEeeecC
No 491
>PF00558 Vpu: Vpu protein; InterPro: IPR008187 The Human immunodeficiency virus 1 (HIV-1) Vpu protein acts in the degradation of CD4 in the endoplasmic reticulum and in the enhancement of virion release from the plasma membrane of infected cells [].; GO: 0019076 release of virus from host; PDB: 2JPX_A 1PI8_A 2GOH_A 2GOF_A 1PI7_A 1PJE_A 1VPU_A 2K7Y_A.
Probab=22.45 E-value=1.2e+02 Score=22.05 Aligned_cols=33 Identities=9% Similarity=0.188 Sum_probs=0.0
Q ss_pred eehhHHHHHHHHHHHHHHHHHHhhhcccCCCCC
Q 041558 413 VFLLVGALFVSIALILIFFIFQKWKSNLGDRQC 445 (495)
Q Consensus 413 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (495)
++++++.++++++++++|.+..+..++..++..
T Consensus 6 i~~iialiv~~iiaIvvW~iv~ieYrk~~rqrk 38 (81)
T PF00558_consen 6 ILAIIALIVALIIAIVVWTIVYIEYRKIKRQRK 38 (81)
T ss_dssp --HHHHHHHHHHHHHHHHHHH------------
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
No 492
>PRK10345 hypothetical protein; Provisional
Probab=22.35 E-value=76 Score=28.01 Aligned_cols=26 Identities=19% Similarity=0.350 Sum_probs=0.0
Q ss_pred ccCCceeeeEEEEEeCCeeEEEeccc
Q 041558 468 TGHRNIVKFYGFCSHARHSFSVYESL 493 (495)
Q Consensus 468 ~~H~NlV~l~G~c~~~~~~~LVyeym 493 (495)
..|||||+++|+-.++...-.|||.+
T Consensus 58 ~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 58 IDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred CCCcccceeeEEEEeCCCCeEEEEEE
No 493
>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]
Probab=22.30 E-value=1.1e+02 Score=31.01 Aligned_cols=45 Identities=18% Similarity=0.161 Sum_probs=0.0
Q ss_pred CCceEEEeeccce--------------ecccccCCceeeeEEEEEeCCeeEEEecccCC
Q 041558 451 QGLLSILNFKGKL--------------ALTETGHRNIVKFYGFCSHARHSFSVYESLEK 495 (495)
Q Consensus 451 ~~~~~~~~~~~~~--------------~l~~~~H~NlV~l~G~c~~~~~~~LVyeym~n 495 (495)
+..++++-.+..- +|.+++||-+|-|-.-|...+..+.|+|-|..
T Consensus 589 GrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 589 GRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred CceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
No 494
>PF05545 FixQ: Cbb3-type cytochrome oxidase component FixQ; InterPro: IPR008621 This family consists of several Cbb3-type cytochrome oxidase components (FixQ/CcoQ). FixQ is found in nitrogen fixing bacteria. Since nitrogen fixation is an energy-consuming process, effective symbioses depend on operation of a respiratory chain with a high affinity for O2, closely coupled to ATP production. This requirement is fulfilled by a special three-subunit terminal oxidase (cytochrome terminal oxidase cbb3), which was first identified in Bradyrhizobium japonicum as the product of the fixNOQP operon [].
Probab=22.03 E-value=1.1e+02 Score=19.53 Aligned_cols=26 Identities=8% Similarity=0.221 Sum_probs=0.0
Q ss_pred hhHHHHHHHHHHHHHHHHHHhhhccc
Q 041558 415 LLVGALFVSIALILIFFIFQKWKSNL 440 (495)
Q Consensus 415 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (495)
.+..+++.++.+.++++.++++++++
T Consensus 12 ~~~~v~~~~~F~gi~~w~~~~~~k~~ 37 (49)
T PF05545_consen 12 SIGTVLFFVFFIGIVIWAYRPRNKKR 37 (49)
T ss_pred HHHHHHHHHHHHHHHHHHHcccchhh
No 495
>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]
Probab=20.95 E-value=96 Score=33.44 Aligned_cols=24 Identities=29% Similarity=0.455 Sum_probs=0.0
Q ss_pred cCCceeeeEEEEEe-----CCeeEEEecc
Q 041558 469 GHRNIVKFYGFCSH-----ARHSFSVYES 492 (495)
Q Consensus 469 ~H~NlV~l~G~c~~-----~~~~~LVyey 492 (495)
.|||+|++.|+..- +|+.-||+||
T Consensus 74 ~hpnv~~fyg~~~k~~~~~~DqLWLVMEf 102 (953)
T KOG0587|consen 74 HHPNVATFYGAFIKKDPGNGDQLWLVMEF 102 (953)
T ss_pred CCCCcceEEEEEEEecCCCCCeEEEEeec
No 496
>PF01299 Lamp: Lysosome-associated membrane glycoprotein (Lamp); InterPro: IPR002000 Lysosome-associated membrane glycoproteins (lamp) [] are integral membrane proteins, specific to lysosomes, and whose exact biological function is not yet clear. Structurally, the lamp proteins consist of two internally homologous lysosome-luminal domains separated by a proline-rich hinge region; at the C-terminal extremity there is a transmembrane region (TM) followed by a very short cytoplasmic tail (C). In each of the duplicated domains, there are two conserved disulphide bonds. This structure is schematically represented in the figure below. +-----+ +-----+ +-----+ +-----+ | | | | | | | | xCxxxxxCxxxxxxxxxxxxCxxxxxCxxxxxxxxxCxxxxxCxxxxxxxxxxxxCxxxxxCxxxxxxxx +--------------------------++Hinge++--------------------------++TM++C+ In mammals, there are two closely related types of lamp: lamp-1 and lamp-2, which form major components of the lysosome membrane. In chicken lamp-1 is known as LEP100. Also included in this entry is the macrophage protein CD68 (or macrosialin) [] is a heavily glycosylated integral membrane protein whose structure consists of a mucin-like domain followed by a proline-rich hinge; a single lamp-like domain; a transmembrane region and a short cytoplasmic tail. Similar to CD68, mammalian lamp-3, which is expressed in lymphoid organs, dendritic cells and in lung, contains all the C-terminal regions but lacks the N-terminal lamp-like region []. In a lamp-family protein from nematodes [] only the part C-terminal to the hinge is conserved. ; GO: 0016020 membrane
Probab=20.38 E-value=60 Score=30.66 Aligned_cols=31 Identities=19% Similarity=0.327 Sum_probs=0.0
Q ss_pred eeeehhHHHHHHHHHHHHHHHHHHhhhcccC
Q 041558 411 TIVFLLVGALFVSIALILIFFIFQKWKSNLG 441 (495)
Q Consensus 411 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (495)
.++-+++|++++++++++++.+...|||.+.
T Consensus 271 ~~vPIaVG~~La~lvlivLiaYli~Rrr~~~ 301 (306)
T PF01299_consen 271 DLVPIAVGAALAGLVLIVLIAYLIGRRRSRA 301 (306)
T ss_pred chHHHHHHHHHHHHHHHHHHhheeEeccccc
No 497
>PF15656 Tox-HDC: Toxin with a H, D/N and C signature
Probab=20.09 E-value=66 Score=25.26 Aligned_cols=23 Identities=17% Similarity=0.239 Sum_probs=0.0
Q ss_pred ccCCceeeeEEEEEeCCeeEEEe
Q 041558 468 TGHRNIVKFYGFCSHARHSFSVY 490 (495)
Q Consensus 468 ~~H~NlV~l~G~c~~~~~~~LVy 490 (495)
++|.|=+-++|||.+..+..+-|
T Consensus 97 l~~~~~hvIlgyC~S~~De~~r~ 119 (119)
T PF15656_consen 97 LNNINGHVILGYCFSRNDEALRY 119 (119)
T ss_pred hcCCCCeEEEEEEecCCCchhcC
Done!